Disease,NCT Number,Study Title,Study URL,Study Results,Sex,Age,Phases,Conditions 1,Conditions 2,Conditions 3,Conditions 4,Conditions 5,Interventions 1,Interventions 2,Interventions 3,Interventions 4,Interventions 5,Locations_1,Locations_2,Locations_3,Principal Investigators 1,Principal Investigators 2,Principal Investigators 3,,
Epilepsy,NCT02269137,Assessment of Severity and Prognosis for Patients With Status Epileptics(SE),https://clinicaltrials.gov/study/NCT02269137,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Status Epileptics,,,,,,,,,,"The Department of Neurology, Xijing Hospital, Xi'an, Shaanxi, 710032, China",,,Wen Jiang,,,,
Epilepsy,NCT02560597,Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy,https://clinicaltrials.gov/study/NCT02560597,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsia Partialis Continua,Status Epilepticus,,,,PROCEDURE: repetitive transcranial magnetic stimulation,,,,,"University Hospital, Ghent, Ghent, 9000, Belgium",,,Alfred Meurs,,,,
Epilepsy,NCT03154307,Repeated TMS at Low Frequencies to Reduce Seizure Occurrence,https://clinicaltrials.gov/study/NCT03154307,YES,ALL,"ADULT, OLDER_ADULT",,Epilepsy,Status Epilepticus,Epilepsia Partialis Continua,"Epilepsia Partialis Continua, Refractory (Medically)",,DEVICE: Low frequency repeated TMS (LF-rTMS),,,,,"Baptist Hospital of Miami, Miami, Florida, 33176, United States",,,Alberto Pinzon,,,,
Epilepsy,NCT02968966,Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies,https://clinicaltrials.gov/study/NCT02968966,NO,ALL,CHILD,PHASE2,"Seizure, Epileptic",,,,,OTHER: Therapy regime,,,,,"Universtiy Hospital, TÃ¼bingen, 72076, Germany",,,Markus Wolff,,,,
Epilepsy,NCT05459597,Antiepileptic Drugs in Elderly Patients,https://clinicaltrials.gov/study/NCT05459597,NO,ALL,OLDER_ADULT,,"Seizure, Epileptic",,,,,DRUG: antiepileptic drugs,,,,,"Wei Zhao, Jinan, Shandong, China",,,Wei Zhao,,,,
Epilepsy,NCT01116700,Dexmedetomidine in Seizure Patients,https://clinicaltrials.gov/study/NCT01116700,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Seizure Disorders,,,,,DRUG: Dexmedetomidine,,,,,"University of California San Francisco, San Francisco, California, 94122, United States",,,Alana M Flexman,Pekka Talke,Paul Garcia,,
Epilepsy,NCT05431595,Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy,https://clinicaltrials.gov/study/NCT05431595,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Delirium,Epileptics,Neuroleptics,,,DRUG: Haloperidol,DRUG: Chlorpromazine,DRUG: Valproate,DRUG: Placebo,,"MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,David Hui,,,,
Epilepsy,NCT03860467,Epileptic Seizures in Intensive Care Units,https://clinicaltrials.gov/study/NCT03860467,NO,ALL,"ADULT, OLDER_ADULT",,Epileptic Seizure,,,,,OTHER: collection of patient data,,,,,"Clinic for Intensive Care Medicine, University Hospital Basel, Basel, 4031, Switzerland",,,Raoul Sutter,,,,
Epilepsy,NCT02229318,A Taste and Acceptance Study of FruitiVits in Children Aged 4-8 Years Following a Ketogenic Diet.,https://clinicaltrials.gov/study/NCT02229318,YES,ALL,CHILD,,Seizure Disorders,,,,,DIETARY_SUPPLEMENT: FruitiVits,,,,,"The Children's Hospital of Philadelphia, Division of Neurology, Philadelphia, Pennsylvania, 19104, United States",,,Christina Bergqvist,,,,
Epilepsy,NCT01159431,External Trigeminal Nerve Stimulation for Epilepsy,https://clinicaltrials.gov/study/NCT01159431,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Epilepsy,Seizure Disorders,,,,DEVICE: Trigeminal Nerve Stimulation,,,,,"USC Department of Neurology, Los Angeles, California, 90033, United States","Olive View/UCLA Medical Center, Sylmar, California, 91342, United States",,Christopher M DeGiorgio,Christi Heck,,,
Epilepsy,NCT02304029,Usefulness of Sodium MRI in the Presurgical Assessment of Drug-resistant Partial Epilepsy,https://clinicaltrials.gov/study/NCT02304029,NO,ALL,"ADULT, OLDER_ADULT",,Epileptic Seizures,,,,,DEVICE: MRI,,,,,"Assistance Publique - Hopitaux de Marseille, Marseille, 13005, France","CHU Montpellier, Montpellier, France","CHU NICE, Nice, France",,,,,
Epilepsy,NCT05567042,A Clinical Study of Epilepsy Localization and Prognosis Based on PET and Resting-state fMRI,https://clinicaltrials.gov/study/NCT05567042,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epileptic Seizure,,,,,OTHER: No intervention,,,,,,,,,,,,
Epilepsy,NCT01351727,Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors,https://clinicaltrials.gov/study/NCT01351727,NO,ALL,OLDER_ADULT,,Epileptic Seizures,,,,,,,,,,"Pima, Cochise, Santa Cruz Counties, Tucson, Arizona, 85724, United States",,,,,,,
Epilepsy,NCT02134366,Clobazam Use in Epilepsia Partialis Continua - Pilot Study,https://clinicaltrials.gov/study/NCT02134366,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Epilepsia Partialis Continua,Kojewnikov's Epilepsy,Epilepsy,,,DRUG: Clobazam,DRUG: Clonazepam,DRUG: Lorazepam,,,"Cooper Universtiy Hospital, Camden, New Jersey, 08103, United States",,,Melissa Carran,,,,
Epilepsy,NCT04204863,Status Epilepticus Population Study (STEPS),https://clinicaltrials.gov/study/NCT04204863,NO,ALL,"ADULT, OLDER_ADULT",,Epileptic Seizures,,,,,OTHER: collection of patient data,,,,,"Cantonal Hospital Aarau (KSA), Aarau, 5001, Switzerland","Clinic for Intensive Care Medicine, University Hospital Basel, Basel, 4031, Switzerland",,Raoul Sutter,,,,
Epilepsy,NCT05725174,Volatile Non-Invasive Biomarkers of Epileptic Seizures,https://clinicaltrials.gov/study/NCT05725174,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,Non-Epileptic Seizure,,,,OTHER: Sample Collection,,,,,"Chalfont Centre for Epilepsy, London, Buckinghamshire, SL9 0RJ, United Kingdom","National Hospital for Neurology and Neurosurgery, London, WC1N 3BG, United Kingdom",,Matthew Walker,,,,
Epilepsy,NCT05241366,TMS vs Conventional Therapy for the Treatment of Functional Neurological Non Epileptic Seizure Disorder,https://clinicaltrials.gov/study/NCT05241366,NO,ALL,"ADULT, OLDER_ADULT",,Psychogenic Non-Epileptic Seizure,,,,,DEVICE: Transcranial Magnetic Stimulation,DEVICE: Sham Transcranial Magnetic Stimulation coil,,,,"Instituto Nacional de Neurologia Y Neurocirugia Mvs, Mexico, Ciudad De Mexico, 14269, Mexico",,,Ã‰dgar Daniel Crail MelÃ©ndez,,,,
Epilepsy,NCT01313260,Structural and Functional Connectivity in Partial Epilepsies Studied With MRI and MEG,https://clinicaltrials.gov/study/NCT01313260,NO,ALL,ADULT,,Epilepsies,,,,,,,,,,"ICM (Brain and Spine Institute), Paris, 75013, France",,,,,,,
Epilepsy,NCT04572243,A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome,https://clinicaltrials.gov/study/NCT04572243,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Epilepsies, Myoclonic",,,,,DRUG: Placebo,DRUG: Lorcaserin,,,,"Children's of Alabama / University of Alabama at Birmingham, Birmingham, Alabama, 35226, United States","University of California Los Angeles (UCLA), Los Angeles, California, 90095, United States","UCSD Rady's Children's Hosptial, San Diego, California, 92123, United States",,,,,
Epilepsy,NCT06143241,Cognitive Function and Glymphatic System in Children With Epilepsy,https://clinicaltrials.gov/study/NCT06143241,NO,ALL,CHILD,,Epilepsy,Cognitive Dysfunction,"Seizure, Epileptic",,,DEVICE: Threshold IMT,DRUG: Antiepileptic medication,,,,"Ege University, Izmir, Bornova, 35080, Turkey",,,,,,,
Epilepsy,NCT01450423,Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy,https://clinicaltrials.gov/study/NCT01450423,NO,ALL,"CHILD, ADULT",PHASE2,Epilepsy,Epilepsia,Epileptic Seizures,Seizure Disorder,,BEHAVIORAL: Physical activity,,,,,"Center of Research in Childhood Health, University of Southern Denmark, Odense, Region of Southern Denmark, 5000, Denmark","Epilepsy clinic, Odense University Hospital, Odense, Region of Southern Denmark, 5000, Denmark",,Lars Bo Andersen,,,,
Epilepsy,NCT03329703,Project UPLIFT for Psychogenic Non-Epileptic Seizures,https://clinicaltrials.gov/study/NCT03329703,NO,ALL,"ADULT, OLDER_ADULT",,Psychogenic Non-Epileptic Seizure,Depression,Non-Epileptic Seizure,Psychogenic Seizure,,BEHAVIORAL: Project UPLIFT,,,,,"Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States",,,Lindsay Schommer,,,,
Epilepsy,NCT04061707,Subcutaneous EEG: Forecasting of Epileptic Seizures,https://clinicaltrials.gov/study/NCT04061707,NO,ALL,"ADULT, OLDER_ADULT",,"Epilepsies, Focal",,,,,,,,,,"King's College Hospital NHS Foundation Trust, London, SE5 9RS, United Kingdom",,,Mark P Richardson,,,,
Epilepsy,NCT01978470,External Trigeminal Nerve Stimulation for Drug Resistent Epilepsy,https://clinicaltrials.gov/study/NCT01978470,NO,ALL,"ADULT, OLDER_ADULT",,Seizure Disorder,,,,,DEVICE: External Trigeminal Nerve Stimulation (eTNS),,,,,"Olive View/UCLA Medical Center, Sylmar, California, United States",,,,,,,
Epilepsy,NCT00542802,Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis,https://clinicaltrials.gov/study/NCT00542802,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Epileptic Seizures,Stroke,,,,DRUG: Levetiracetam,DRUG: Carbamazepine,,,,"Ospedale S. Giacomo, Novi Ligure, AL, 15057, Italy","Ospedale S. Croce E Carle, Cuneo, CN, 12100, Italy","Ospedale S. Martino, Genova, GE, 16132, Italy",domenico consoli,,,,
Epilepsy,NCT02976545,Emotional Lived in Patients Suffering From Psychogenic Nonepileptic Seizures : Study by Functional Magnetic Resonance Imaging,https://clinicaltrials.gov/study/NCT02976545,NO,FEMALE,"ADULT, OLDER_ADULT",,Psychogenic Non-epileptic Seizures,,,,,DEVICE: fMRI (functional Magnetic Resonance Imaging),BEHAVIORAL: psychiatric evaluation,,,,"CHRU de Nancy, Nancy, 54000, France",,,,,,,
Epilepsy,NCT06374966,Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal Epilepsy,https://clinicaltrials.gov/study/NCT06374966,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,"Epilepsies, Partial",,,,,DRUG: Zonisamide,,,,,"Hangzhou Children's Hospital, Hangzhou, Zhejiang, 310005, China","The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China","Huzhou Third People's Hospital, Huzhou, Zhejiang, 313002, China",Shuang Wang,,,,
Epilepsy,NCT05958069,The Efficacy and Safety of Minocycline in the Treatment of Drug-resistant Epilepsy in NORSE Patients,https://clinicaltrials.gov/study/NCT05958069,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epileptic Seizures Related to Drugs,,,,,DRUG: minocycline,,,,,"XijingHospital, Xi'an, Shaanxi, 710032, China",,,Wen jiang,Lei Ma,yuanyuan Wang,,
Epilepsy,NCT05419180,Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies,https://clinicaltrials.gov/study/NCT05419180,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Pharmacoresistant Focal Epilepsies,,,,,DRUG: Stiripentol,,,,,"Centre de RÃ©fÃ©rence Epilepsies Rares / Centre Investigation Clinique (CIC) - HÃ´pital Necker-Enfants Malades, Paris, 75015, France",,,,,,,
Epilepsy,NCT03533374,Validation of Criteria for Identification of Epileptiform Discharges in EEG Recordings of Patients With Epilepsy,https://clinicaltrials.gov/study/NCT03533374,YES,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,Non-Epileptic Seizure,,,,DIAGNOSTIC_TEST: Electroencephalogram (EEG) and visual evaluation,,,,,,,,,,,,
Epilepsy,NCT04309812,Transcranial Direct Current to Treat Epilepsy at Home,https://clinicaltrials.gov/study/NCT04309812,NO,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,"Epilepsies, Partial",,,,,DEVICE: transcranial direct current stimulation (tDCS),,,,,"Stanford Hospital, Stanford, California, 94305-5235, United States","Stanford University School of Medicine, Stanford, California, 94305-5235, United States",,,,,,
Epilepsy,NCT06222840,Electro-clinical Features and Functional Connectivity Analysis in SYN1 Gene Mutation-related Epilepsy,https://clinicaltrials.gov/study/NCT06222840,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epileptic Syndromes,,,,,OTHER: Electro-clinical analysis of epileptic seizures,OTHER: Electro-encephalographic cases,OTHER: Clinical datas analysis,OTHER: Electro-encephalographic control,,"CHU Saint Etienne, Saint-Ã‰tienne, 42000, France",,,Laure,,,,
Epilepsy,NCT01663545,Brain P-gp and Inflammation in People With Epilepsy,https://clinicaltrials.gov/study/NCT01663545,NO,ALL,ADULT,,"Epilepsies, Partial",,,,,,,,,,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,William H Theodore,,,,
Epilepsy,NCT03054961,Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study,https://clinicaltrials.gov/study/NCT03054961,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,"Epilepsies, Partial",,,,,DEVICE: Near-infrared spectroscopy,,,,,"The Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States",,,Rene Andrade-Machado,,,,
Epilepsy,NCT06223334,Epileptic Syndromes in Infants and Early Childhood,https://clinicaltrials.gov/study/NCT06223334,NO,ALL,CHILD,,Epileptic Syndromes,,,,,OTHER: No intervention,,,,,"Assiut child university hospital, Assiut, 71515, Egypt","AlAzhar university hospital Assiut branch, Assiut, 71524, Egypt",,,,,,
Epilepsy,NCT03882151,Added Value of Automated Electrical Source Localization (EPILOG PreOpÂ®) to Presurgical Evaluation of Refractory Epilepsy,https://clinicaltrials.gov/study/NCT03882151,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,"Epilepsies, Partial",,,,,DIAGNOSTIC_TEST: electrical source imaging,,,,,"Saint-Luc University Hospital, Brussels, 1200, Belgium","Centre Hospitalier William Lennox, Ottignies, 1340, Belgium",,,,,,
Epilepsy,NCT03689114,"Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)",https://clinicaltrials.gov/study/NCT03689114,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,"Epilepsies, Partial",,,,,DRUG: Low dose carbamazepine,DRUG: Standard dose carbamazepine,DRUG: Low dose levetiracetam,DRUG: Standard dose levetiracetam,DRUG: Low dose valproate,"ASST Monza Ospedale San Gerardo, Monza, 20900, Italy",,,Ettore Beghi,,,,
Epilepsy,NCT03484039,Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy,https://clinicaltrials.gov/study/NCT03484039,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,Seizure Disorder,,,,BEHAVIORAL: Medication Adherence,BEHAVIORAL: Seizure Documentation,BEHAVIORAL: Memory Improvement,BEHAVIORAL: Stress Management,,"UF Health Jacksonville, Jacksonville, Florida, 32209, United States",,,Ramon Edmundo D Bautista,,,,
Epilepsy,NCT01919307,Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures,https://clinicaltrials.gov/study/NCT01919307,YES,ALL,"ADULT, OLDER_ADULT",,"Convulsion, Non-Epileptic",,,,,OTHER: Auricular acupuncture,,,,,"Denver Health Medical Center, Denver, Colorado, 80204, United States",,,Edward Maa,,,,
Epilepsy,NCT05273398,Effects of Diazepam on RNS Detections,https://clinicaltrials.gov/study/NCT05273398,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,"Epilepsies, Partial",,,,,DRUG: nasal diazepam,,,,,"University of Cincinnati, Cincinnati, Ohio, 45267, United States",,,Michael D Privitera,,,,
Epilepsy,NCT01762215,Policy on Optimal Epilepsy Management,https://clinicaltrials.gov/study/NCT01762215,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,Seizure Disorder,,,,BEHAVIORAL: PatientsLikeMe.com,,,,,"San Francisco VA Medical Center, San Francisco, California, 94121, United States",,,,,,,
Epilepsy,NCT01745952,Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS),https://clinicaltrials.gov/study/NCT01745952,YES,ALL,"CHILD, ADULT, OLDER_ADULT",,"Epilepsies, Partial",,,,,DEVICE: figure-of-eight active rTMS coil,DEVICE: round active rTMS coil,DEVICE: sham rTMS coil (figure-of-eight),,,"University Hospitals Leuven, department of Neurology, Leuven, 3000, Belgium",,,Van Paesschen Wim,,,,
Epilepsy,NCT02311829,Evaluation of a Telephone Follow-up Procedure on the Quality of Life in Psychogenic Non-epileptic Seizures,https://clinicaltrials.gov/study/NCT02311829,NO,ALL,"ADULT, OLDER_ADULT",,Psychogenic Non Epileptic Seizure,,,,,OTHER: Telephone follow-up device,,,,,"Chu Strasbourg, Strasbourg, Alsace, 67 098, France","Chu Dijon, Dijon, Bourgogne, 21 079, France","Chu Reims, Reims, Champagne Ardennes, 51 092, France",Louis,,,,
Epilepsy,NCT02635633,"Continuous Thetaburst Stimulation for the Treatment of Refractory Epilepsy - Safety, Feasibility and Proof-of-concept",https://clinicaltrials.gov/study/NCT02635633,NO,ALL,"ADULT, OLDER_ADULT",,"Epilepsies, Partial",,,,,DEVICE: continuous thetaburst stimulation,,,,,"University Hospital Ghent, Ghent, 9000, Belgium",,,Kristl Vonck,,,,
Epilepsy,NCT00179426,Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy,https://clinicaltrials.gov/study/NCT00179426,NO,MALE,ADULT,,Seizure Disorder,Epilepsy,,,,,,,,,"Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States",,,Andrew G. Herzog,,,,
Epilepsy,NCT00955357,Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures,https://clinicaltrials.gov/study/NCT00955357,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Partial Epilepsies,,,,,DRUG: Lacosamide,,,,,"103, Irvine, California, United States","123, Rancho Mirage, California, United States","156, Clearwater, Florida, United States",Clinical Trial Call Center,,,,
Epilepsy,NCT00280696,A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures,https://clinicaltrials.gov/study/NCT00280696,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Epilepsies, Partial",,,,,DRUG: Levetiracetam 250 mg,DRUG: Levetiracetam 500 mg,OTHER: Placebo,,,"Aichi-gun, Aichi, Japan","Nagoya, Aichi, Japan","Nayoga, Aichi, Japan",Clinical Trial Call Center,,,,
Epilepsy,NCT03807141,Evaluation of the Modified Atkins Diet in Children With Epileptic Spasms,https://clinicaltrials.gov/study/NCT03807141,NO,ALL,CHILD,PHASE2|PHASE3,Epileptic Spasms,,,,,OTHER: Modified Atkins diet,,,,,"Lady Hardinge Medical College, New Delhi, Delhi, 110018, India",,,,,,,
Epilepsy,NCT04802135,Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy,https://clinicaltrials.gov/study/NCT04802135,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epileptic Encephalopathy,,,,,OTHER: Survey,,,,,"CHU Angers, Angers, France","CHU Bordeaux, Bordeaux, France","CHU Brest, Brest, France",Jean Olivier Arnaud,,,,
Epilepsy,NCT00255411,Psychiatric Correlates of Psychogenic Movement Disorder and Non-Epileptic Seizure,https://clinicaltrials.gov/study/NCT00255411,NO,ALL,"ADULT, OLDER_ADULT",,Psychogenic Movement Disorders,Non-epileptic Seizures,,,,,,,,,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,
Epilepsy,NCT04147663,Epidemiology of Suspected Epileptic Seizures,https://clinicaltrials.gov/study/NCT04147663,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,OTHER: describe the management of the adult population suffering from suspected seizure by the emergency structures,,,,,"Centre Hospitalier St Joseph St Luc, Lyon, 69007, France",,,Sylvie,,,,
Epilepsy,NCT00212745,Pilot Trial of a Behavioral Treatment for Epilepsy,https://clinicaltrials.gov/study/NCT00212745,NO,ALL,"CHILD, ADULT",PHASE1|PHASE2,"Epilepsies, Partial",,,,,BEHAVIORAL: Andrews/Reiter behavioral treatment for epilepsy,,,,,"Oregon Health and Science University, Portland, Oregon, 97239, United States",,,Siegward M Elsas,,,,
Epilepsy,NCT01235403,Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure,https://clinicaltrials.gov/study/NCT01235403,YES,ALL,"ADULT, OLDER_ADULT",PHASE4,Partial Epilepsies,,,,,DRUG: Lacosamide,,,,,"Amiens, France","Aubenas, France","Auxerre, France",Clinical Trial Call Center,,,,
Epilepsy,NCT00072813,MRI in Autosomal Dominant Partial Epilepsy With Auditory Features,https://clinicaltrials.gov/study/NCT00072813,NO,ALL,"ADULT, OLDER_ADULT",,"Epilepsies, Partial",,,,,,,,,,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States","Columbia University, New York, New York, 10032-3784, United States",,,,,,
Epilepsy,NCT00771927,Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures,https://clinicaltrials.gov/study/NCT00771927,YES,ALL,"CHILD, ADULT, OLDER_ADULT",,"Epilepsies, Partial",,,,,DRUG: Lacosamide,,,,,"Bron, France","Dijon, France","La Tronche, France",Clinical Trial Call Center,,,,
Epilepsy,NCT00918047,Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients,https://clinicaltrials.gov/study/NCT00918047,NO,ALL,CHILD,PHASE1,"Epilepsies, Partial",,,,,DRUG: SPN-804O,,,,,"Little Rock, Arkansas, United States","Loxahatchee Groves, Florida, United States","Tampa, Florida, United States",,,,,
Epilepsy,NCT03169751,An Exploratory Trial Using sEMG to Differentiate PNES From Epileptic Seizures,https://clinicaltrials.gov/study/NCT03169751,NO,ALL,"ADULT, OLDER_ADULT",,Non-Epileptic Seizure,Motor Seizure,Epilepsy,,,DEVICE: Brain Sentinel Monitoring and Alerting System,,,,,"Krankenhaus Hietzing mit Neurologischem Zentrum Rosenhugel, Wien, 1130, Austria",,,Christoph Baumgartner,,,,
Epilepsy,NCT00512317,Open-label Extension to Protocol 1042-0600,https://clinicaltrials.gov/study/NCT00512317,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,"Epilepsies, Partial",,,,,DRUG: ganaxolone,,,,,"University of Alabama, Birmingham, Alabama, 35294-0021, United States","Barrow Neurological Institute, Phoenix, Arizona, 85013, United States","Arkansas Epilepsy Program, Little Rock, Arkansas, 72205, United States",,,,,
Epilepsy,NCT02598076,Motivational Interviewing to Enhance Adherence of Patients With Psychogenic Non-epileptic Seizures,https://clinicaltrials.gov/study/NCT02598076,YES,ALL,"ADULT, OLDER_ADULT",,"Psychogenic Non-epileptic Seizures, Motivational Interviewing",,,,,BEHAVIORAL: motivational interviewing,BEHAVIORAL: standard psychotherapy,,,,"Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States",,,,,,,
Epilepsy,NCT01098162,VimpatÂ® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug,https://clinicaltrials.gov/study/NCT01098162,YES,ALL,"CHILD, ADULT, OLDER_ADULT",,"Epilepsies, Partial",,,,,,,,,,"55, Aachen, Germany","119, Aalen, Germany","194, Aichach, Germany",Clinical Trial Call Center,,,,
Epilepsy,NCT00367432,A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures,https://clinicaltrials.gov/study/NCT00367432,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Epilepsies,Partial,,,,DRUG: Levetiracetam,,,,,"Aichi-gun, Aichi, Japan","Nagoya, Aichi, Japan","Hirosaki, Aomori, Japan",Clinical Trial Call Center,,,,
Epilepsy,NCT03559673,Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic Seizures,https://clinicaltrials.gov/study/NCT03559673,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,"Epilepsies, Partial",,,,,DRUG: Lacosamide,,,,,,,,,,,,
Epilepsy,NCT01441401,Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan),https://clinicaltrials.gov/study/NCT01441401,YES,ALL,CHILD,,"Epilepsies, Partial",,,,,DRUG: gabapentin,,,,,,,,Pfizer .gov Call Center,,,,
Epilepsy,NCT06007053,Retraining and Control Therapy (ReACT) R33 Phase,https://clinicaltrials.gov/study/NCT06007053,NO,ALL,"CHILD, ADULT",,"Convulsion, Non-Epileptic",,,,,BEHAVIORAL: ReACT,BEHAVIORAL: Supportive Therapy,,,,"University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States",,,Aaron Fobian,,,,
Epilepsy,NCT00422110,A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures,https://clinicaltrials.gov/study/NCT00422110,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,"Epilepsies, Partial",,,,,DRUG: Seletracetam,,,,,,,,,,,,
Epilepsy,NCT03024827,Cannabidiol in Children With Refractory Epileptic Encephalopathy,https://clinicaltrials.gov/study/NCT03024827,NO,ALL,CHILD,PHASE1,Epileptic Encephalopathy,,,,,DRUG: CanniMedÂ® 1:20,,,,,"University of British Columbia, Vancouver, British Columbia, V6T1Z4, Canada","University of Manitoba, Winnipeg, Manitoba, R3T 2N2, Canada","Universite de Montreal, Montreal, Quebec, H3T1J4, Canada",Richard Huntsman,Richard Tang-Wai,Jane Alcorn,,
Epilepsy,NCT05096273,Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES,https://clinicaltrials.gov/study/NCT05096273,NO,ALL,"CHILD, ADULT",,"Convulsion, Non-Epileptic",,,,,BEHAVIORAL: ReACT,,,,,"Sparks Center Office of Psychiatric Research, Birmingham, Alabama, 35294, United States",,,,,,,
Epilepsy,NCT03857074,Effects of Green Light Exposure on Epileptic Spikes in Patients With Refractory Epilepsy,https://clinicaltrials.gov/study/NCT03857074,NO,ALL,"CHILD, ADULT",,Epilepsy,Epilepsy Intractable,,,,DEVICE: Green Light Exposure,,,,,"Boston Children's Hospital, Boston, Massachusetts, 02130, United States",,,Alexander Rotenberg,Phillip Pearl,,,
Epilepsy,NCT00772603,Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures,https://clinicaltrials.gov/study/NCT00772603,YES,ALL,"ADULT, OLDER_ADULT",PHASE3,"Epilepsies, Partial",,,,,DRUG: Placebo,DRUG: 2400mg SPN-804,DRUG: 1200mg SPN-804,,,"Huntsville, Alabama, United States","Northport, Alabama, United States","Phoenix, Arizona, United States",,,,,
Epilepsy,NCT02603991,Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE),https://clinicaltrials.gov/study/NCT02603991,NO,ALL,"CHILD, ADULT",,Epileptic Encephalopathy,,,,,PROCEDURE: PINS Vagus Nerve Stimulator,DRUG: Levetiracetam,,,,"Beijing Tiantan Hospital, Beijing, Beijing, 100050, China",,,,,,,
Epilepsy,NCT00297323,An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy,https://clinicaltrials.gov/study/NCT00297323,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,"Seizures, Epileptic",,,,,DRUG: Topiramate,,,,,,,,,,,,
Epilepsy,NCT05865561,Identification of Volatile Organic Compounds (VOCs) as Biopredictors of Epileptic Seizures,https://clinicaltrials.gov/study/NCT05865561,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,OTHER: VOC sampling,,,,,,,,,,,,
Epilepsy,NCT02801136,Treatment Outcomes of ReACT for PNES,https://clinicaltrials.gov/study/NCT02801136,NO,ALL,"CHILD, ADULT",,"Convulsion, Non-Epileptic",,,,,BEHAVIORAL: ReACT,BEHAVIORAL: Supportive Therapy,,,,"Sparks Center Office of Psychiatric Research, Birmingham, Alabama, 35294, United States",,,,,,,
Epilepsy,NCT00522275,Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00522275,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Partial Epilepsies,,,,,DRUG: lacosamide,,,,,"Birmingham, Alabama, United States","Mobile, Alabama, United States","Phoenix, Arizona, United States",Clinical Trial Call Center,,,,
Epilepsy,NCT00524030,Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00524030,YES,ALL,"ADULT, OLDER_ADULT",PHASE3,"Epilepsies, Partial",,,,,DRUG: pregabalin 600 mg/day,DRUG: pregabalin 150 mg/day,,,,"Pfizer Investigational Site, Northport, Alabama, 35476, United States","Pfizer Investigational Site, Phoenix, Arizona, 85003, United States","Pfizer Investigational Site, Phoenix, Arizona, 85013, United States",Pfizer .gov Call Center,,,,
Epilepsy,NCT00215215,Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures,https://clinicaltrials.gov/study/NCT00215215,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Epilepsies, Partial",,,,,DEVICE: Vagus Nerve Stimulation Therapy,,,,,"Bronislav Shafran, M.D., P.C., Phoenix, Arizona, 85003, United States","Xenoscience, Phoenix, Arizona, 85013, United States","Dedicated Clinical Research, Inc., Sun City, Arizona, 85351, United States",Carol C Base,,,,
Epilepsy,NCT00437281,"Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures",https://clinicaltrials.gov/study/NCT00437281,YES,ALL,CHILD,PHASE1|PHASE2,"Epilepsies, Partial",,,,,DRUG: Placebo,DRUG: Pregabalin,,,,"Pfizer Investigational Site, Mobile, Alabama, 36604, United States","Pfizer Investigational Site, Mobile, Alabama, 36693, United States","Pfizer Investigational Site, Phoenix, Arizona, 85016, United States",Pfizer .gov Call Center,,,,
Epilepsy,NCT01764516,Study on Serum Zinc and Selenium Levels in Epileptic Patients,https://clinicaltrials.gov/study/NCT01764516,NO,ALL,ADULT,,Generalized Epileptic,,,,,,,,,,"Vali-Asr Hospital, Arak, Central province, Iran, Islamic Republic of",,,Heidar N Farahani,,,,
Epilepsy,NCT00620555,A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00620555,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Epilepsies, Partial",,,,,DRUG: gabapentin,,,,,"Pfizer Investigational Site, Obu-shi,Morioka-machi, Aichi, Japan","Pfizer Investigational Site, Jonan-ku, Fukuoka, Japan","Pfizer Investigational Site, Kobe, Hyogo, Japan",Pfizer .gov Call Center,,,,
Epilepsy,NCT00448916,Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures,https://clinicaltrials.gov/study/NCT00448916,YES,ALL,CHILD,PHASE3,"Epilepsies, Partial",,,,,DRUG: Pregabalin,,,,,"University of South Alabama, Mobile, Alabama, 36604, United States","University of South Alabama Department of Neurology, Mobile, Alabama, 36693, United States","Phoenix Children's Hospital, Phoenix, Arizona, 85016, United States",Pfizer .gov Call Center,,,,
Epilepsy,NCT00351611,Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo,https://clinicaltrials.gov/study/NCT00351611,YES,ALL,"ADULT, OLDER_ADULT",PHASE4,"Epilepsies, Partial",,,,,DRUG: Lyrica (pregabalin),DRUG: placebo,,,,"Neurology Center, P.C., Mobile, Alabama, 36607, United States","Premier Medical Group, Mobile, Alabama, 36608, United States","Neurology Clinic, PC, Northport, Alabama, 35476, United States",,,,,
Epilepsy,NCT00567268,Drug Use Investigation Of Gabapentin,https://clinicaltrials.gov/study/NCT00567268,YES,ALL,"CHILD, ADULT, OLDER_ADULT",,"Epilepsies, Partial",,,,,DRUG: Gabapentin,,,,,,,,Pfizer .gov Call Center,,,,
Epilepsy,NCT00603473,A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00603473,YES,ALL,CHILD,PHASE3,"Epilepsies, Partial",,,,,DRUG: gabapentin,,,,,"Pfizer Investigational Site, Obu-shi,Morioka-machi, Aichi, Japan","Pfizer Investigational Site, Jonan-ku, Fukuoka, Japan","Pfizer Investigational Site, Sapporo, Hokkaido, Japan",Pfizer .gov Call Center,,,,
Epilepsy,NCT00552305,To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00552305,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Partial Epilepsies,,,,,DRUG: lacosamide,,,,,"Birmingham, Alabama, United States","Huntsville, Alabama, United States","Phoenix, Arizona, United States",Clinical Trial Call Center,,,,
Epilepsy,NCT04515316,A Room Temperature Atomic Magnetrode System for Telemetry of Epileptic Seizures,https://clinicaltrials.gov/study/NCT04515316,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,DEVICE: OPM sensors,DEVICE: SQUID sensors,,,,"University of Colorado School of Medicine - Anschutz Medical Campus, Aurora, Colorado, 80045, United States",,,,,,,
Epilepsy,NCT05257915,A China RWS to Evaluate the Effectiveness and Safety of Perampanel as an add-on Treatment for Epileptic Seizure,https://clinicaltrials.gov/study/NCT05257915,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,DRUG: Perampanel,,,,,"Beijing Children's Hospital, Capital Medical University, Beijing, Beijing, 100045, China","Beijing TianTan Hospital, Capital Medical University, Beijing, Beijing, China","Beijing University First Hospital, Beijing, Beijing, China",,,,,
Epilepsy,NCT04102254,Thalamic Stimulation for Epilepsy Study,https://clinicaltrials.gov/study/NCT04102254,NO,ALL,"ADULT, OLDER_ADULT",,Seizures,Epilepsy,Seizure Disorder,,,PROCEDURE: ANT recording and stimulation,,,,,"Duke University Health System, Durham, North Carolina, 27710, United States",,,Derek Southwell,,,,
Epilepsy,NCT00151879,Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures,https://clinicaltrials.gov/study/NCT00151879,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,"Epilepsies, Partial",,,,,DRUG: SPM 927,,,,,"Schwarz, RTP, North Carolina, United States",,,Clinical Trial Call Center,,,,
Epilepsy,NCT05873062,"Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK",https://clinicaltrials.gov/study/NCT05873062,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,"Myoclonus Epilepsies, Progressive",,,,,DRUG: AUT00201,DRUG: Placebo,,,,"University of Pennsylvania, Penn Epilepsy Center, Philadelphia, Pennsylvania, 19104, United States",,,Michael Gelfand,,,,
Epilepsy,NCT05274035,A Multi-center RWS of Perampanel as an add-on Treatment for Epileptic Seizures in Chinese Children,https://clinicaltrials.gov/study/NCT05274035,NO,ALL,CHILD,,Epilepsy,,,,,DRUG: Perampanel,,,,,"Beijing Children's Hospital, Capital Medical University, Beijing, Beijing, 100045, China","Wuhan Children's Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, 430015, China","XuZhou Children's Hospital, XuZhou, Jiangsu, 221002, China",Fang Fang,,,,
Epilepsy,NCT06210022,Cognitive Impairment in Drug-resistant and Drug-responsive Focal Cryptogenic Epilepsy,https://clinicaltrials.gov/study/NCT06210022,NO,ALL,ADULT,,Epilepsy,Focal Epilepsy,,,,DIAGNOSTIC_TEST: Neuropsychological Assessment,,,,,"IRCCS San Raffaele, Milan, 20132, Italy",,,,,,,
Epilepsy,NCT02441478,Co-operative Behavior and Decision-making in Frontal Lobe Epilepsy,https://clinicaltrials.gov/study/NCT02441478,NO,ALL,ADULT,,Frontal Lobe Epilepsies,,,,,RADIATION: functional magnetic resonance imaging exam,,,,,"Hospices Civils de Lyon, Lyon, 69002, France",,,,,,,
Epilepsy,NCT00210652,An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT00210652,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Epilepsy,"Epilepsies, Partial",,,,DRUG: RWJ 333369:,,,,,,,,Johnson & Johnson Pharmaceutical Research & Development,,,,
Epilepsy,NCT04457687,Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies,https://clinicaltrials.gov/study/NCT04457687,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,"Epilepsies, Myoclonic",Drug Resistant Epilepsy,,,,DRUG: Lorcaserin,,,,,,,,,,,,
Epilepsy,NCT00210522,An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT00210522,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Epilepsy,"Epilepsies, Partial",,,,DRUG: RWJ 333369,,,,,,,,Johnson & Johnson Pharmaceutical Research & Development,,,,
Epilepsy,NCT05518578,Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy,https://clinicaltrials.gov/study/NCT05518578,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Epilepsy,"Seizures, Epileptic",,,,DRUG: SPN-817,,,,,"Alfred Hospital, Melbourne, Australia",,,,,,,
Epilepsy,NCT04284072,Clinical Scenarios for Long-term Monitoring of Epileptic Seizures With a Wearable Biopotential Technology,https://clinicaltrials.gov/study/NCT04284072,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,DEVICE: Sensor Dot,,,,,"University Hospitals Leuven, department of Neurology, Leuven, 3000, Belgium","Department of Epileptology and Neurology, Aachen, Germany","Epilepsy Center, University Medical Center, Freiburg University, Freiburg, Germany",Wim Van Paesschen,,,,
Epilepsy,NCT05066880,Yoga and Aerobic Exercise in Epilepsy,https://clinicaltrials.gov/study/NCT05066880,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,Epilepsy; Seizure,Epilepsy Idiopathic,,,OTHER: Exercise training,,,,,"Dokuz Eylul University, Izmir, Turkey",,,,,,,
Epilepsy,NCT00150293,Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.,https://clinicaltrials.gov/study/NCT00150293,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,"Seizure Disorder, Partial",,,,,DRUG: Pregabalin,,,,,"Pfizer Investigational Site, Deakin, Australian Capital Territory, 2600, Australia","Pfizer Investigational Site, Camperdown, New South Wales, 2050, Australia","Pfizer Investigational Site, Chastwood, New South Wales, 2067, Australia",Pfizer .gov Call Center,,,,
Epilepsy,NCT00141388,To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00141388,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,"Seizure Disorder, Partial",,,,,DRUG: Pregabalin,,,,,"Pfizer Investigational Site, Birmingham, Alabama, 35249, United States","Pfizer Investigational Site, Birmingham, Alabama, 35255, United States","Pfizer Investigational Site, Birmingham, Alabama, 35294-0021, United States",Pfizer .gov Call Center,,,,
Epilepsy,NCT00141336,To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.,https://clinicaltrials.gov/study/NCT00141336,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Seizure Disorder, Partial",,,,,DRUG: Pregabalin,,,,,"Pfizer Investigational Site, Phoenix, Arizona, 85013, United States","Pfizer Investigational Site, Tucson, Arizona, 85724, United States","Pfizer Investigational Site, Bakersfield, California, 93301, United States",Pfizer .gov Call Center,,,,
Epilepsy,NCT00141245,To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.,https://clinicaltrials.gov/study/NCT00141245,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,"Seizure Disorder, Partial",,,,,DRUG: Pregabalin,,,,,"Pfizer Investigational Site, Deakin, Australian Capital Territory, 2600, Australia","Pfizer Investigational Site, Chatswood, New South Wales, 2067, Australia","Pfizer Investigational Site, Westmead, New South Wales, 2145, Australia",Pfizer .gov Call Center,,,,
Epilepsy,NCT02286271,Preliminary Testing of a Novel Device to Detect Epileptic Seizures,https://clinicaltrials.gov/study/NCT02286271,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,,,,,,"Western General Hospital, Edinburgh, EH4 2XU, United Kingdom","Royal Hospital for Sick Children, Edinburgh, EH9 1LF, United Kingdom",,,,,,
Epilepsy,NCT00067431,A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children,https://clinicaltrials.gov/study/NCT00067431,NO,ALL,CHILD,PHASE3,Partial Seizure Disorder,,,,,DRUG: Divalproex Sodium (DepakoteÂ® Sprinkle Capsules),,,,,"Pediatric Epilepsy & Neurology Specialist, Tampa, Florida, 33607, United States","Rainbow Babies Children's Hospital, Cleveland, Ohio, 44106, United States","University Hospital of Cleveland, Cleveland, Ohio, United States",Laura Redden,,,,
Epilepsy,NCT03949478,Treating Postictal Symptoms Using Ibuprofen and Nifedipine,https://clinicaltrials.gov/study/NCT03949478,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Epilepsy,"Epilepsies, Partial",,,,DRUG: Ibuprofen,DRUG: Nifedipine,DRUG: Placebo,,,"Foothills Medical Centre, Calgary, Alberta, T2N T29, Canada","South Health Campus, Calgary, Alberta, T3M 1M4, Canada",,Paolo Federico,,,,
Epilepsy,NCT04291716,Study to Validate Novel Seizure-Detection Algorithm,https://clinicaltrials.gov/study/NCT04291716,NO,ALL,"ADULT, OLDER_ADULT",,"Seizures, Motor",Seizures,Seizure Disorder,Epilepsy,Epileptic Seizures,DEVICE: Motor Seizure Detection Algorithm (mSDA),,,,,"Covenant Hospital and Covenant Medical Group, Lubbock, Texas, 79410, United States",,,Haytham Elgammal,Subha Sarcar,,,
Epilepsy,NCT00050934,Pediatric Epilepsy Study,https://clinicaltrials.gov/study/NCT00050934,NO,ALL,CHILD,PHASE3,Epilepsy,"Epilepsies, Partial",,,,DRUG: oxcarbazepine,,,,,"Birmingham, Alabama, 35233, United States","Mobile, Alabama, 36693, United States","Los Angeles, California, 90027, United States",Novartis Pharmaceuticals,,,,
Epilepsy,NCT01657084,Stopping and Preventing Epileptic Seizures Using a Partial Rebreathing Mask,https://clinicaltrials.gov/study/NCT01657084,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,DEVICE: CDA Mask,DEVICE: Dummy mask,,,,"Aarhus University Hospital, Aarhus, 8000, Denmark","The Epilepsy Hospital Filadelfia, Dianalund, Denmark",,Jakob Christensen,,,,
Epilepsy,NCT06366009,Assessment of Patients With Drug-resistant Temporal Lobe Epilepsy With EEG Extended With Intra-auricular Electrodes,https://clinicaltrials.gov/study/NCT06366009,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,Focal Epilepsy,Drug Resistant Epilepsy,,,DEVICE: NaoX in-ear EEG system,,,,,"Kliniki Neurochirurgii CSK UCK WUM, Warsaw, Poland",,,,,,,
Epilepsy,NCT03643016,Improving EPilepsy Surgery Management and progNOsis Using Virtual Epileptic Patient Software (VEP),https://clinicaltrials.gov/study/NCT03643016,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,OTHER: Surgical strategy based on a software,,,,,"Assistance Publique Hopitaux de Marseille, Marseille, 13354, France",,,,,,,
Epilepsy,NCT04649008,Localizing Epileptic Networks Using MRI and iEEG,https://clinicaltrials.gov/study/NCT04649008,NO,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,Epilepsy,Epilepsy Intractable,"Epilepsy, Temporal Lobe",,,DIAGNOSTIC_TEST: 3T Magnetic Resonance Imaging,DIAGNOSTIC_TEST: Intracranial electroencephalography recordings,DIAGNOSTIC_TEST: 7T Magnetic Resonance Imaging,,,"University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States",,,Kathryn A Davis,,,,
Epilepsy,NCT03551431,Comparison of Efficacy Between Suggestion Method During Video EEG Recording by Verbal Suggestion in Isolation and Verbal Suggestion Along With Cotton Swab or Tuning Fork for Inducing the Paroxysmal Event in Children Aged 5 to 18 Years With Suspected Psychogenic Nonepileptic Events,https://clinicaltrials.gov/study/NCT03551431,NO,ALL,"CHILD, ADULT",,"EEG, Psychogenic Non Epileptic Events",,,,,DIAGNOSTIC_TEST: Video EEG with verbal suggestion,,,,,,,,,,,,
Epilepsy,NCT01311440,Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy,https://clinicaltrials.gov/study/NCT01311440,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,Focal Epilepsy,Generalized Epilepsy,,,OTHER: Modified Atkins diet treatment,,,,,"Oslo University Hospital, The national Centre for epilepsy, Sandvika, BÃ¦rum Postterminal, 1306, Norway",,,Karl Otto Nakken,,,,
Epilepsy,NCT05844696,Electrical Neuromodulation for Focal Epilepsy,https://clinicaltrials.gov/study/NCT05844696,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Epilepsy,,,,,DEVICE: Soterix MXN-5 HD-tES Model 5005A. Medtronic Percept DBS platform.,,,,,,,,,,,,
Epilepsy,NCT03403907,The Effect of Probiotic Supplementation in Drug-resistant Epilepsy Patients,https://clinicaltrials.gov/study/NCT03403907,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,Epilepsy Intractable,,,,OTHER: Probiotic,,,,,,,,MarÃ­a GÃ³mez EguÃ­laz,,,,
Epilepsy,NCT05285059,Implicit Learning in Epileptic Children,https://clinicaltrials.gov/study/NCT05285059,NO,ALL,CHILD,,Epilepsy,,,,,BEHAVIORAL: ASRT task,,,,,"Agathe Marcastel, PhD, Bron, 69675, France","Dezso Nemeth, Bron, 69675, France","Service d'Epileptologie Clinique, des Troubles du sommeil et de Neurologie fonctionnelle de l'enfant, Ã HÃ´pital Femme MÃ¨re et Enfant,, Bron, France",Marcastel Agathe,,,,
Epilepsy,NCT03013348,Automated Identification of Psychogenic Nonepileptic Seizures,https://clinicaltrials.gov/study/NCT03013348,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,"Convulsion, Non-Epileptic",,,,,DEVICE: Brain Sentinel's sEMG Post-processing algorithm,,,,,,,,Jonathan Halford,,,,
Epilepsy,NCT04158531,REC2Stim as a Treatment for Refractory Epilepsy in the Primary Sensorimotor Cortex.,https://clinicaltrials.gov/study/NCT04158531,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epileptic Seizure,Epilepsy Intractable,Motor Seizure,,,DEVICE: ECoG sensing and stimulation,,,,,"University Medical Center Utrecht, Utrecht, 3584 CX, Netherlands",,,Frans Leijten,,,,
Epilepsy,NCT04607317,Exercise as Adjunctive Treatment for Refractory Epilepsy,https://clinicaltrials.gov/study/NCT04607317,NO,ALL,"ADULT, OLDER_ADULT",,Refractory Epilepsy,Epilepsy,,,,BEHAVIORAL: Exercise program,BEHAVIORAL: Health Coach,BEHAVIORAL: Health Information,,,"Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States",,,Halley Alexander,,,,
Epilepsy,NCT00282854,Genetics of Rolandic Epilepsy,https://clinicaltrials.gov/study/NCT00282854,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,,,,,,"Mailman School of Public Health, Columbia University Medical Center, 722 West 168th St, 6th Floor, New York, New York, 10032, United States",,,Deb K. Pal,,,,
Epilepsy,NCT00236730,A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy,https://clinicaltrials.gov/study/NCT00236730,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Epilepsy,"Epilepsies, Partial",Seizures,,,DRUG: topiramate,,,,,,,,Johnson & Johnson Pharmaceutical Research & Development,,,,
Epilepsy,NCT05776745,Study of Speech Function in Epileptic Patients Based on Stereoelectroencephalography Signal,https://clinicaltrials.gov/study/NCT05776745,NO,ALL,"CHILD, ADULT",,Epilepsy,,,,,BEHAVIORAL: Speech,DEVICE: Stereoelectroencephalography,,,,"Zhejiang University School of Medicine Second Affiliated Hospital, Hangzhou, Zhejiang, 310009, China",,,,,,,
Epilepsy,NCT02682927,A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome,https://clinicaltrials.gov/study/NCT02682927,YES,ALL,"CHILD, ADULT",PHASE3,Dravet Syndrome,Seizure Disorder,,,,DRUG: ZX008 (Fenfluramine Hydrochloride),DRUG: Matching Placebo,,,,"Phoenix Children's, Phoenix, Arizona, 85016, United States","Center for Neurosciences - Tucson, Tucson, Arizona, 85718, United States","Rady Children's Hospital San Diego, San Diego, California, 92123, United States",Cares,,,,
Epilepsy,NCT05015868,"Contribution of Genetics, Non-invasive Methods and Neuropsychology in Focal Cryptogenic Epilepsies",https://clinicaltrials.gov/study/NCT05015868,NO,ALL,"CHILD, ADULT",,"Epilepsies, Partial",Epilepsy Intractable,,,,DIAGNOSTIC_TEST: Standard of care,DIAGNOSTIC_TEST: Functional magnetic resonance imaging-Electroencephalogram combined analysis,DIAGNOSTIC_TEST: High density- electroencephalogram or 7 Tesla magnetic resonance imaging,,,"Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Lecco, 23842, Italy",,,Stefania Zambrano,,,,
Epilepsy,NCT00236691,"A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.",https://clinicaltrials.gov/study/NCT00236691,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Epilepsy,"Epilepsies, Partial",Seizures,,,DRUG: topiramate,,,,,,,,,,,,
Epilepsy,NCT00236873,"A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.",https://clinicaltrials.gov/study/NCT00236873,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Epilepsy,"Epilepsies, Partial",Seizures,,,DRUG: topiramate,,,,,,,,Johnson & Johnson Pharmaceutical Research & Development,,,,
Epilepsy,NCT00236860,"A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures",https://clinicaltrials.gov/study/NCT00236860,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Epilepsy,"Epilepsies, Partial",Seizures,,,DRUG: topiramate,,,,,,,,Johnson & Johnson Pharmaceutical Research & Development,,,,
Epilepsy,NCT05561166,EPIDREAM 1 : Study of Dreaming in Epilepsy,https://clinicaltrials.gov/study/NCT05561166,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,OTHER: EPIDREAM Questionnaire,,,,,"Hospices Civils de Lyon, Bron, RhÃ´ne, 69500, France",,,,,,,
Epilepsy,NCT04716673,Stimulation of Sleep in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT04716673,NO,ALL,"CHILD, ADULT",,Epilepsy,,,,,OTHER: Down-phase targeted auditory stimulation,,,,,"University Children's Hospital Zurich, Zurich, 8032, Switzerland",,,Reto Huber,,,,
Epilepsy,NCT05269901,Association Between Ferroptosis and Epilepsy,https://clinicaltrials.gov/study/NCT05269901,NO,ALL,CHILD,,Epilepsy,,,,,"GENETIC: SLC7A11, GPX4, P53",,,,,"Affiliated Hospital of JiangNan University, Department of Pediatrics, Wuxi, Jiangsu, 226600, China",,,YueYing Liu,,,,
Epilepsy,NCT05671575,Study The Knowledge and Attitude Towards Epilepsy Among Relatives of People With Epilepsy and Their Impact on The Patient's Quality of Life,https://clinicaltrials.gov/study/NCT05671575,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,OTHER: Questionnaire about Epilepsy,,,,,"Sohag university hospital, Sohag, 82611, Egypt",,,,,,,
Epilepsy,NCT05450822,Precision Medicine in the Treatment of Epilepsy,https://clinicaltrials.gov/study/NCT05450822,NO,ALL,"CHILD, ADULT",,Epilepsy,,,,,DRUG: Levetiracetam,DRUG: Levetiracetam Tablets,DRUG: Lamotrigine tablet,,,"Neurobiology Research Unit, Rigshospitalet, Copenhagen, 2100, Denmark",,,Lars Hageman Pinborg,,,,
Epilepsy,NCT05698537,Risk Factors and Etiologies of Epilepsy in Urban and Rural Rwanda,https://clinicaltrials.gov/study/NCT05698537,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,DIAGNOSTIC_TEST: EEG,DIAGNOSTIC_TEST: Neuroimaging,DIAGNOSTIC_TEST: Blood sample,OTHER: Risk factor questionnaire,,"King Faisal Hospital, Kigali, Rwanda",,,Paul Boon,Dirk Teuwen,Ieme Garrez,,
Epilepsy,NCT04266990,Olfactive Discriminative Ability of Dogs When Confronted With Seizure and Non-seizure Samples // Identification of Potential Biomarkers for Epilepsy in Human Sweat.,https://clinicaltrials.gov/study/NCT04266990,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,OTHER: Planned Sweat collection,OTHER: Spontaneous Sweat collection,OTHER: Healthy volunteers sweat collection,,,"UZ Gent, Gent, Belgie, 9000, Belgium",,,,,,,
Epilepsy,NCT04526418,Evaluation of the 24/7 EEG SubQ System for Ultra Long-Term Recording of Patients With Temporal Lobe Epilepsy,https://clinicaltrials.gov/study/NCT04526418,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,DEVICE: 24/7 EEGâ„¢ SubQ system,,,,,"Mayo Clinic, Phoenix, Arizona, 85054, United States","University of California, Los Angeles, California, 90095, United States","Massachusetts General Hospital, Boston, Massachusetts, 02114, United States",Michael Gelfand,,,,
Epilepsy,NCT04705441,Self-management for People With Epilepsy,https://clinicaltrials.gov/study/NCT04705441,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,BEHAVIORAL: SMART 2,,,,,"University of Iowa, Iowa City, Iowa, 52242, United States","Case Western Reserve University, Cleveland, Ohio, 44106, United States",,Martha Sajatovic,Gena Ghearing,,,
Epilepsy,NCT03582345,Investigation of Human Epileptic Networks by fMRI,https://clinicaltrials.gov/study/NCT03582345,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,PROCEDURE: EEG/fMRI,,,,,,,,Anna Elisabetta Vaudano,,,,
Epilepsy,NCT05934786,Rehabilitation of Cognition and Psychosocial Well-being in Epilepsy,https://clinicaltrials.gov/study/NCT05934786,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,BEHAVIORAL: Cognitive rehabilitation,,,,,,,,,,,,
Epilepsy,NCT05082181,Telephone-Based Support Programs for People With Epilepsy,https://clinicaltrials.gov/study/NCT05082181,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,BEHAVIORAL: UPLIFT (Using Practice and Learning to Increase Favorable Thoughts),BEHAVIORAL: BOOST (Bringing Out Our Strength Together),,,,"NYU Langone Health, New York, New York, 10016, United States",,,Tanya Spruill,Daniel Friedman,,,
Epilepsy,NCT05683847,User Controlled Follow-up of Epilepsy,https://clinicaltrials.gov/study/NCT05683847,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,OTHER: User controlled epilepsy follow-up by means of patient reported outcome measures (PROM),,,,,"Drammen Hospital, Drammen, 3004, Norway",,,Marte Syvertsen,,,,
Epilepsy,NCT05384782,Computational Decision Support in Epilepsy Using Retrospective EEG,https://clinicaltrials.gov/study/NCT05384782,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,,,,,,"Cornwall Partnership NHS Foundation Trust, Bodmin, Cornwall, PL31 2QN, United Kingdom",,,,,,,
Epilepsy,NCT00236847,A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.,https://clinicaltrials.gov/study/NCT00236847,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Epilepsy,"Epilepsies, Partial",Seizures,,,DRUG: topiramate,,,,,,,,Johnson & Johnson Pharmaceutical Research & Development,,,,
Epilepsy,NCT05898438,The Role of Gut Microbiota in Children With Epilepsy Following Ketogenic Diet,https://clinicaltrials.gov/study/NCT05898438,NO,ALL,"CHILD, ADULT",,Epilepsy,,,,,,,,,,"Attikon Athens University Hospital, Athens, Haidari, 12462, Greece",,,Argirios Dinopoulos,,,,
Epilepsy,NCT06139198,Self-management Intervention for Reducing Epilepsy Burden Among Ugandans With Epilepsy.,https://clinicaltrials.gov/study/NCT06139198,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,BEHAVIORAL: Self-MAnagement intervention for Reducing The epilepsy burden among Ugandans,,,,,,,,Mark Kaddumukasa,Martha Sajatovic,,,
Epilepsy,NCT06052605,Healthy Aging in People With Epilepsy Program,https://clinicaltrials.gov/study/NCT06052605,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,BEHAVIORAL: Healthy Aging in People with Epilepsy Program,,,,,"University of Califonia, San Diego, San Diego, California, 92093, United States",,,,,,,
Epilepsy,NCT05200455,Microelectrodes in Epilepsy,https://clinicaltrials.gov/study/NCT05200455,YES,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,DEVICE: Microelectrodes,,,,,"Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States",,,Barbara C Jobst,,,,
Epilepsy,NCT04944641,"Epilepsy Prevalence and Intervention Study in Zhejiang Province, China",https://clinicaltrials.gov/study/NCT04944641,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,BEHAVIORAL: education on epilepsy,DRUG: routine and proper antiepileptic drugs,,,,"2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou, Zhejiang, China","Shengzhou People's Hospital, Shengzhou, China",,,,,,
Epilepsy,NCT01281956,PRX-00023 Therapy in Localization-Related Epilepsy,https://clinicaltrials.gov/study/NCT01281956,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Epilepsy,"Epilepsy, Temporal Lobe",Partial Epilepsy,,,DRUG: PRX-00023,DRUG: Placebo,,,,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,William H Theodore,,,,
Epilepsy,NCT06346262,Seizure Rescue Medication (RM) as Part of a Comprehensive Epilepsy Self-management Package of Care,https://clinicaltrials.gov/study/NCT06346262,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Epilepsy,,,,,BEHAVIORAL: SMART RM,DRUG: Valtoco Nasal Product,,,,"University Hospitals Medical Center, Cleveland, Ohio, 44106, United States",,,,,,,
Epilepsy,NCT04692701,Pulvinar Stimulation in Epilepsy: a Pilot Study,https://clinicaltrials.gov/study/NCT04692701,NO,ALL,ADULT,,Epilepsy,,,,,DEVICE: Pulvinar deep brain stimulation,,,,,"Service de Neurologie, Nice, 13385, France",,,Jean-Olivier Arnaud,,,,
Epilepsy,NCT05335187,Hybrid Micro-macro Electrodes in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT05335187,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,DEVICE: micro-macro electrode implantation,,,,,"HÃ´pitaux Universitaires de GenÃ¨ve, GenÃ¨ve, CH, 1205, Switzerland",,,Pierre MÃ©gevand,,,,
Epilepsy,NCT01273129,Surgery as a Treatment for Medically Intractable Epilepsy,https://clinicaltrials.gov/study/NCT01273129,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,"Epilepsy, Temporal Lobe",Partial Epilepsy,,,,,,,,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,Kareem A Zaghloul,,,,
Epilepsy,NCT02952456,Phenomenological Approach of Epilepsy in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT02952456,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,OTHER: interview with a psychologist,,,,,"Uhmontpellier, Montpellier, 34295, France",,,,,,,
Epilepsy,NCT04559919,Prospective Regional Epilepsy Database,https://clinicaltrials.gov/study/NCT04559919,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,OTHER: Seizure status,DIAGNOSTIC_TEST: Tests,OTHER: Epilepsy,OTHER: Demographics and psychosocial,OTHER: Health care,"SÃ¶dra Ã„lvsborgs Sjukhus, BorÃ¥s, Sweden","Sahlgrenska University Hospital, Gothenburg, 41345, Sweden","Sjukhusen i VÃ¤ster, Gothenburg, Sweden",Johan Zelano,,,,
Epilepsy,NCT06082999,Gene-STEPS: Shortening Time of Evaluation in Paediatric Epilepsy Services,https://clinicaltrials.gov/study/NCT06082999,NO,ALL,CHILD,,Epilepsy,,,,,,,,,,"Boston Children's Hospital, Boston, Massachusetts, 02115, United States","Murdoch Childrens Research Institute, Parkville, Victoria, 3052, Australia","The Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada",Amy McTague,,,,
Epilepsy,NCT00594945,Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures,https://clinicaltrials.gov/study/NCT00594945,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Epilepsy,,,,,DRUG: Clonazepam,,,,,"Clinical Trials. inc., Little Rock, Arkansas, 72205, United States","Mid-Atlantic Epilepsy & Sleep Center, Bethesda, Maryland, 20817, United States","Columbia Comprehensive Epilepsy Center, Neurological Institute, New York, New York, 10032, United States",Beverly Benson,,,,
Epilepsy,NCT05637086,Clinical Study Evaluating Safety of Pentoxifylline in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy,https://clinicaltrials.gov/study/NCT05637086,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Epilepsy,,,,,DRUG: Phenytoin,DRUG: Pentoxifylline 400 MG,,,,"Mansoura University, Mansoura, 35516, Egypt",,,,,,,
Epilepsy,NCT06202196,Risk Prevention Program and Therapeutic Patient Education Program of Patients With Uncontrolled Epilepsy,https://clinicaltrials.gov/study/NCT06202196,NO,ALL,ADULT,,Epilepsy,,,,,PROCEDURE: Risk prevention session,PROCEDURE: Usual Therapeutic Patient Education (TPE) management,,,,"CHU Gui de Chauliac, Montpellier, France",,,,,,,
Epilepsy,NCT05096871,Association of Brain Derived Neurotrophic Factor (BDNF) rs6265 Gene Polymorphism With Susceptibility to Epilepsy,https://clinicaltrials.gov/study/NCT05096871,NO,ALL,CHILD,,Epilepsy,,,,,GENETIC: Genotyping by Real Time PCR,,,,,,,,,,,,
Epilepsy,NCT05325047,Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy: A Case Study,https://clinicaltrials.gov/study/NCT05325047,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,PROCEDURE: Intensive speech rehabilitation,,,,,"CHU Bordeaux, Bordeaux, 33000, France",,,FranÃ§ois,,,,
Epilepsy,NCT00537940,Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures,https://clinicaltrials.gov/study/NCT00537940,YES,ALL,"ADULT, OLDER_ADULT",PHASE4,Epilepsy,Partial Seizure Disorder,"Epilepsies, Partial",Complex Partial Seizure Disorder,,DRUG: Pregabalin,DRUG: Gabapentin,,,,"Hospital Clinica Biblica, San Jose, Costa Rica","Instituto de Neurociencias, San Salvador, 01503, El Salvador","Clinica de Especialidades Neurologicas, San Salvador, El Salvador",Pfizer .gov Call Center,,,,
Epilepsy,NCT00706160,Language Mapping in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT00706160,NO,ALL,"CHILD, ADULT",,Epilepsy,"Epilepsy, Temporal Lobe",Partial Epilepsy,,,,,,,,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,William H Theodore,,,,
Epilepsy,NCT04876820,Impact of Pharmaceutical Interviews on the Medication Adherence of Epileptic Patients,https://clinicaltrials.gov/study/NCT04876820,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,OTHER: Pharmacist intervention,OTHER: Standard of care,,,,"Hopital Roger Salengro, CHU Lille, Lille, 59037, France",,,Philippe,,,,
Epilepsy,NCT00522418,Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients,https://clinicaltrials.gov/study/NCT00522418,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Epilepsy,Partial Epilepsy,,,,DEVICE: Vagal Nerve Simulation (VNS) Therapy,DRUG: Best Medical Practive,,,,"ULB-HÃ´pital Erasme, Centre de rÃ©fÃ©rence pour le traitement de l'Ã©pilepsie rÃ©fractaire - Neurologie, Brussels, 1070, Belgium","UZ Gent, Department of Neurology, 1K12/A, Gent, 9000, Belgium","Foothills Hospital, Neurology Department, Calgary, Alberta, T1Y6J4, Canada",Phillippe Ryvlin,Sophie Leyman,,,
Epilepsy,NCT00851331,Genetic Basis of Idiopathic Focal Epilepsies With Cognitif Deficits,https://clinicaltrials.gov/study/NCT00851331,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,GENETIC: genome analyzes (genetic defects and pathophysiological mechanisms ),,,,,"HÃ´pital Femme MÃ¨re Enfant - Hospices Civils de Lyon, Service Epilepsie, Sommeil et Exploration fonctionnelle neurologique pÃ©diatrique, Bron, 69500, France","American Memorial Hospital, CHU de Reims, UnitÃ© de Neurologie PÃ©diatrique - Service PÃ©diatrie A, Reims, 51092, France","Clinique neurologique, HÃ´pitaux Universitaires de Strasbourg, Strasbourg, 67091, France",Edouard,,,,
Epilepsy,NCT06427967,A Novel Social Emotional Learning Curriculum for Youth With Epilepsy,https://clinicaltrials.gov/study/NCT06427967,NO,ALL,"CHILD, ADULT",,Epilepsy,,,,,BEHAVIORAL: Project Dream Team,,,,,"Boston Medical Center, Neurology and remote, Boston, Massachusetts, 02118, United States",,,Laurie Douglass,,,,
Epilepsy,NCT05722951,Metformin Efficacy and Safety in Epileptic Patients,https://clinicaltrials.gov/study/NCT05722951,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Epilepsy,,,,,DRUG: Levetiracetam,DRUG: Metformin,,,,"Omnia Ashraf Abd El Aziz Ahmed Kotb, Alexandria, Egypt",,,,,,,
Epilepsy,NCT02358538,Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies,https://clinicaltrials.gov/study/NCT02358538,YES,ALL,"CHILD, ADULT",PHASE2,Epilepsy,,,,,DRUG: Ganaxolone,,,,,"Phoenix Children's Hospital, Phoenix, Arizona, 85016, United States","Sutter Institute for Medical Research, Sacramento, California, 95816, United States","University of California San Francisco, San Francisco, California, 94143, United States",,,,,
Epilepsy,NCT05491369,Effectiveness of an Epilepsy Application for Self-management in Viet Nam,https://clinicaltrials.gov/study/NCT05491369,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,OTHER: Epilepsy application,,,,,"Nguyen Tri Phuong Hospital, Ho Chi Minh City, 700000, Vietnam","University Medical Center at Ho Chi Minh City, Ho Chi Minh City, 70000, Vietnam",,Minh-An T Le,,,,
Epilepsy,NCT05552924,Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients,https://clinicaltrials.gov/study/NCT05552924,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,OTHER: Self-Acupressure,,,,,"Firat University, ElazÄ±g, Turkey",,,GÃ¼lcan BahÃ§ecioÄŸlu Turan,,,,
Epilepsy,NCT06175247,Low-Glycemic (LGI) Diet in Pregnant People With Epilepsy,https://clinicaltrials.gov/study/NCT06175247,NO,FEMALE,ADULT,,Epilepsy,,,,,OTHER: Low Glycemic Index Diet,,,,,"Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States",,,,,,,
Epilepsy,NCT06352476,The Effect of Sleep Hygiene Given to Epilepsy Patients on Seizure Frequency and Sleep Quality,https://clinicaltrials.gov/study/NCT06352476,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,BEHAVIORAL: Sleep Hygiene Training,,,,,"Marmara University, Istanbul, Turkey",,,,,,,
Epilepsy,NCT06105645,Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy,https://clinicaltrials.gov/study/NCT06105645,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,DEVICE: DIXI Medical MicrodeepÂ® Micro- Macro Depth electrodes,DEVICE: Standard electrodes,,,,"CHU Amiens Picardie, Amiens, France","CHU de Lille, Lille, France","Hospices Civils de Lyon, Lyon, France",Luc,,,,
Epilepsy,NCT05307146,Brain Activity in Epilepsy,https://clinicaltrials.gov/study/NCT05307146,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,DEVICE: macro/micro electrode recording,,,,,"UZ Leuven, Leuven, 3000, Belgium",,,,,,,
Epilepsy,NCT05559060,Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction),https://clinicaltrials.gov/study/NCT05559060,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,,,,,,,,,,,,,
Epilepsy,NCT05992402,Readiness Brain Operation Optimization Training (ReBOOT) for Epilepsy Surgery,https://clinicaltrials.gov/study/NCT05992402,NO,ALL,ADULT,,Epilepsy,,,,,BEHAVIORAL: ReBOOT program,,,,,"Cleveland Clinic, Cleveland, Ohio, 44195, United States",,,Kayela Arrotta,,,,
Epilepsy,NCT05290610,Intracranial Stimulation Mapping In Epilepsy,https://clinicaltrials.gov/study/NCT05290610,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,OTHER: Functional mapping,,,,,"University of Minnesota, Minneapolis, Minnesota, 55455, United States",,,Alexander Herman,,,,
Epilepsy,NCT06334029,Observational Study of the Structural-functional Connectome in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT06334029,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,DIAGNOSTIC_TEST: Functional and structural Connectome,,,,,"IRCCS E.Medea, Conegliano, Treviso, 31015, Italy",,,Gian Marco Duma,,,,
Epilepsy,NCT05182437,Precision Radiation Treatment for Epilepsy (PRECISION),https://clinicaltrials.gov/study/NCT05182437,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,RADIATION: LINAC-based Stereotactic Radiotherapy,,,,,"Maastricht Radiation Oncology, Maastricht, Limburg, 6202 AZ, Netherlands",,,,,,,
Epilepsy,NCT02318446,Efficacy Study of Folic Acid Supplementation in Adolescent Epileptics,https://clinicaltrials.gov/study/NCT02318446,NO,ALL,"CHILD, ADULT",PHASE3,Epilepsy,,,,,DRUG: Folic Acid,DRUG: Saccharine,,,,"Smt. Kashibai Navale Medical College and General Hospital, Pune, Maharashtra, 411041, India",,,A.,,,,
Epilepsy,NCT04290975,Bridging the Childhood Epilepsy Treatment Gap in Africa,https://clinicaltrials.gov/study/NCT04290975,NO,ALL,CHILD,,Epilepsy,,,,,OTHER: Task-shifting of follow-up care for pediatric epilepsy,OTHER: Enhanced usual care for pediatric epilepsy,,,,"Federal Neuro-Psychiatric Hospital, Kaduna, Nigeria","Aminu Kano Teaching Hospital, Kano, Nigeria","Ahmadu Bello University Teaching Hospital, Zaria, Nigeria",Edwin Trevathan,Aminu Taura,,,
Epilepsy,NCT04967326,Role of Clinical Pharmacists in Epilepsy Management,https://clinicaltrials.gov/study/NCT04967326,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Epilepsy,,,,,"DRUG: Optimizing therapy with antiepileptic drugs (carbamazepine, phenytoin, valproic acid)",,,,,,,,,,,,
Epilepsy,NCT05359003,Steps for Epilepsy,https://clinicaltrials.gov/study/NCT05359003,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,BEHAVIORAL: 12-week physical activity program,,,,,"Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, 27046, United States",,,Halley Alexander,,,,
Epilepsy,NCT02726919,Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy,https://clinicaltrials.gov/study/NCT02726919,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Epilepsy,,,,,DRUG: Clobazam,,,,,"MidAtlantic Epilepsy and Sleep Center, Bethesda, Maryland, 20817, United States",,,,,,,
Epilepsy,NCT05944692,Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG),https://clinicaltrials.gov/study/NCT05944692,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,DEVICE: Tripolar electroencephalography,,,,,"Barrow Neurological Institute Dignity Health dba St. Joseph's Hospital and Medical Center, Phoenix, Arizona, 85013, United States","Boston Children's Hospital, Boston, Massachusetts, 02115, United States",,,,,,
Epilepsy,NCT03926273,Serum and Urine Ghrelin in Adult Epileptic Patients,https://clinicaltrials.gov/study/NCT03926273,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,,,,,,"Nageeb, Zagazig, El Sharkia, 002, Egypt",,,nageeb rania,,,,
Epilepsy,NCT04749901,Symptoms of Post-traumatic Stress in Adult Drug-resistant Epilepsies,https://clinicaltrials.gov/study/NCT04749901,NO,ALL,ADULT,,Epilepsy,,,,,OTHER: Psycho-emotional and semiological measures,,,,,"Assistance Publique Hopitaux de Marseille, Marseille, 13354, France",,,,,,,
Epilepsy,NCT05741541,How Would the Creation of a Follow-up Methodology in Consultation Improve the Care of the Epileptic Patient?,https://clinicaltrials.gov/study/NCT05741541,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,,,,,,"HÃ´pital Nord Franche-ComtÃ©, TrÃ©venans, 90400, France",,,,,,,
Epilepsy,NCT06388174,Idiopathic Generalized Epilepsy Syndromes,https://clinicaltrials.gov/study/NCT06388174,NO,ALL,"CHILD, ADULT",,Epilepsy,"Epilepsy, Idiopathic Generalized",,,,,,,,,"2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou, Zhejiang, 310000, China",,,Chunhong Shen,,,,
Epilepsy,NCT04924933,Evaluation of Memory and Forgetting in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT04924933,NO,ALL,ADULT,,Epilepsy,,,,,DIAGNOSTIC_TEST: Computerised associative memory task using abstract words and landscape photographs,,,,,"Hospices Civils de Lyon Service de Neurologie Fonctionnelle et d'Epileptologie, Bron, 69500, France",,,Victoria Guinet,,,,
Epilepsy,NCT04687904,Mindfulness Meditation for Epilepsy,https://clinicaltrials.gov/study/NCT04687904,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,BEHAVIORAL: Mindfulness meditation training,BEHAVIORAL: Therapeutic education,,,,"Centre Hospitalier Universitaire, Rennes, 35033, France",,,Isabelle,,,,
Epilepsy,NCT04106284,Comorbidities of Epilepsy,https://clinicaltrials.gov/study/NCT04106284,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,,,,,,,,,,,,,
Epilepsy,NCT03738072,Intracerebral Electrical Stimulation and the Optimisation of Presurgical Planning in Drug-refractory Partial Epilepsy,https://clinicaltrials.gov/study/NCT03738072,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,DIAGNOSTIC_TEST: StiMiC stimulation condition,,,,,"CHU de Toulouse, Toulouse, 3100, France",,,,,,,
Epilepsy,NCT00165828,Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization,https://clinicaltrials.gov/study/NCT00165828,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Epilepsy,,,,,DRUG: Zonegran,,,,,"Epilepsieklinik Tabor, Bernau, Brandenburg, 16321, Germany","Universtitatsklinikum Bonn, Bonn, Nordrhein-Westphalen, 53105, Germany","Universtitatsklinikum Munster, Klinik und Poliklinik fur Neurologie, Munster, Nordrhein-Westphalen, 48129, Germany",Christian Elger,,,,
Epilepsy,NCT05127499,The Effect of Progressive Relaxation Exercises Applied to Patients With Epilepsy,https://clinicaltrials.gov/study/NCT05127499,NO,ALL,ADULT,,Epilepsy,,,,,OTHER: progressive relaxation exercises,,,,,"FÄ±rat Ãœniversitesi, ElazÄ±ÄŸ, Turkey",,,GÃ¼lcan Bahcecioglu Turan,,,,
Epilepsy,NCT05864612,Tools for Anxiety and Depression Screening in Epilepsy,https://clinicaltrials.gov/study/NCT05864612,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,BEHAVIORAL: Screening Questionnaires,,,,,"Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, 27157, United States",,,Heidi M. Munger Clary,,,,
Epilepsy,NCT06180538,Exploring Patient Impact & Value in Epilepsy Wearables for Seizure Monitoring,https://clinicaltrials.gov/study/NCT06180538,NO,ALL,"ADULT, OLDER_ADULT",,Epilepsy,,,,,,,,,,,,,,,,,
Epilepsy,NCT06321822,Genetic Diagnosis and Personalized Medicine for Patients With Epilepsy,https://clinicaltrials.gov/study/NCT06321822,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,DIAGNOSTIC_TEST: Whole exome sequencing (WES),,,,,"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, 20122, Italy",,,Robertino Dilena,,,,
Epilepsy,NCT04725162,Epileptogenic Focus Localization for Children With Epilepsy Using 18F-FDG PET Molecular Imaging,https://clinicaltrials.gov/study/NCT04725162,NO,ALL,"CHILD, ADULT",,Epilepsy,,,,,RADIATION: 18F-FDG,,,,,"Department of Nuclear Medicine and PET/CT Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China",,,,,,,
Epilepsy,NCT04569071,Clinical Trial of MgLiTT for Medical Refractory Epilepsy,https://clinicaltrials.gov/study/NCT04569071,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Epilepsy,,,,,DEVICE: Sinovation Laser Ablation System,,,,,"Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, 100070, China",,,Kai Zhang,,,,
Vitiligo,NCT01206374,Questionnaire and Laboratory Data on Vitiligo Vulgaris,https://clinicaltrials.gov/study/NCT01206374,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Vitiligo Vulgaris,,,,,,,,,,"Department of Dermatology, Beth Israel Medical Center, New York, New York, 10003, United States","Department of Dermatology, St. Luke's-Roosevelt Hospital Center, New York, New York, 10025, United States",,,,,,
Vitiligo,NCT01401374,Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo,https://clinicaltrials.gov/study/NCT01401374,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Vitiligo Vulgaris,,,,,,,,,,"St. Luke's-Roosevelt Hospital Center, New york, New York, 10025, United States",,,,,,,
Vitiligo,NCT00907062,Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents,https://clinicaltrials.gov/study/NCT00907062,NO,ALL,"CHILD, ADULT",PHASE1,Vitiligo Vulgaris,,,,,DIETARY_SUPPLEMENT: Ginkgo biloba,,,,,"Noumena Naturopathic Health Clinic, Mississauga, Ontario, L5H 1H2, Canada",,,Orest Szczurko,Heather Boon,,,
Vitiligo,NCT00372307,Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris,https://clinicaltrials.gov/study/NCT00372307,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Vitiligo Vulgaris,,,,,DRUG: Application of pimecrolimus,,,,,"University Hospital Ghent, Ghent, 9000, Belgium",,,Jean-Marie Naeyaert,,,,
Vitiligo,NCT03234673,"The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo",https://clinicaltrials.gov/study/NCT03234673,NO,ALL,"CHILD, ADULT",PHASE1,Vitiligo Vulgaris,,,,,DRUG: Tacrolimus ointment,DRUG: calcipotriol ointment,DRUG: NB-UVB,,,,,,,,,,
Vitiligo,NCT05607316,Evaluating the Efficacy and Safety of Metformin in Vitiligo,https://clinicaltrials.gov/study/NCT05607316,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Metformin Hydrochloride,,,,,"UMass Chan Medical School, Worcester, Massachusetts, 01605, United States",,,John E Harris,,,,
Vitiligo,NCT05869942,Histochemical Study of Vitiligo in Sohag University Hospital Patients,https://clinicaltrials.gov/study/NCT05869942,NO,ALL,ADULT,,Vitiligo,,,,,DIAGNOSTIC_TEST: Light microscopic studies,DIAGNOSTIC_TEST: Immunohistochemical studies,,,,"Sohag University Hospital, Sohag, Egypt",,,Doha S Mohamed,Zeinab A Goda,,,
Vitiligo,NCT05971381,Repigmentation of Stable Vitiligo Lesions Using Spray-On Skinâ„¢ Cells,https://clinicaltrials.gov/study/NCT05971381,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DEVICE: RECELLÂ® Autologous Cell Harvesting Device,,,,,"Affiliated Dermatology, Scottsdale, Arizona, 85225, United States","University of California, Irvine, Irvine, California, 92697, United States","West Dermatology Research Center, San Diego, California, 92121, United States",,,,,
Vitiligo,NCT05706636,T Central Memory Cells in Early Localized Non-Segmental Vitiligo,https://clinicaltrials.gov/study/NCT05706636,NO,ALL,"CHILD, ADULT",,Vitiligo,,,,,DRUG: oral mini pulse,DRUG: Topical cream,DEVICE: targeted phototherapy,,,"Cairo university hospitals, dermatology outpatient clinic, Cairo, Egypt",,,Samia Esmat,,,,
Vitiligo,NCT06209138,5-fluorouracil for Treatment of Stable Vitiligo,https://clinicaltrials.gov/study/NCT06209138,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Vitiligo,,,,,DRUG: 5 fluorouracil,OTHER: Saline,,,,"Al-Azhar University, Assiut, No State, Egypt",,,,,,,
Vitiligo,NCT06446063,Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients.,https://clinicaltrials.gov/study/NCT06446063,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,OTHER: Test product,OTHER: Control Product,,,,"COSDERMA, Bordeaux, Gironde, 33000, France",,,Julien,,,,
Vitiligo,NCT05233735,Enhanced Transcutaneous Delivery of Betamethasone for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT05233735,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,OTHER: Enhanced Transcutaneous Delivery of Topical Betamethasone after the treatment with Tixel,OTHER: Topical treatment,,,,"Department of Dermatology, Tel Aviv Sourasky medical center, Tel Aviv, 64239, Israel",,,Mor Pavlovski,,,,
Vitiligo,NCT06163326,A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo,https://clinicaltrials.gov/study/NCT06163326,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Vitiligo,,,,,DRUG: Ritlecitinib,DRUG: Ritlecitinib 100 mg,DRUG: Placebo,,,"California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States","Marvel Clinical Research, Huntington Beach, California, 92647, United States","Wallace Medical Group, Inc, Los Angeles, California, 90056, United States",Pfizer .gov Call Center,,,,
Vitiligo,NCT06097494,Investigating Healthcare Disparities in Vitiligo,https://clinicaltrials.gov/study/NCT06097494,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Vitiligo,,,,,OTHER: No intervention,,,,,"Momentum Data Limited, London, United Kingdom",,,Andrew McGovern,,,,
Vitiligo,NCT05577637,Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT05577637,NO,ALL,ADULT,PHASE1,Vitiligo,,,,,DRUG: 0.03% tacrolimus twice daily was applied on group A patients with uvb phototherapy thrice daily,,,,,"cmh Abbottabad, Abbottabad, Khyber Pakhtunkhwa, 22020, Pakistan",,,,,,,
Vitiligo,NCT05991596,Vitiligo and Psychodrama Therapy,https://clinicaltrials.gov/study/NCT05991596,NO,ALL,ADULT,,Vitiligo,,,,,BEHAVIORAL: Psychodramatic psychotherapy,BEHAVIORAL: Self-help activities,,,,"APSS Trento, Trento, Italy",,,Gabriella PravatÃ,,,,
Vitiligo,NCT06394349,Platelet-rich Plasma Intradermal Injection Combined With 308 nm Excimer Light for Treating Stable Acral Vitiligo,https://clinicaltrials.gov/study/NCT06394349,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,COMBINATION_PRODUCT: PRP+308nm,COMBINATION_PRODUCT: NS+308nm,,,,"Huashan Hospital, Shanghai, Shanghai, 200040, China",,,,,,,
Vitiligo,NCT06118411,A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo,https://clinicaltrials.gov/study/NCT06118411,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Vitiligo,,,,,DRUG: Upadacitinib,DRUG: Placebo,,,,"Advanced Research Associates - Glendale /ID# 259915, Glendale, Arizona, 85308, United States","Alliance Dermatology and MOHs Center, PC /ID# 259926, Phoenix, Arizona, 85032, United States","Private Practice - Dr. Joseph Raoof /ID# 260055, Encino, California, 91436, United States",,,,,
Vitiligo,NCT06068218,Translational Assessment of Vitiligo According to Body Locations,https://clinicaltrials.gov/study/NCT06068218,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,OTHER: Biopsy for the patient group,OTHER: biopsy for the volunteer group,,,,"CHU de Nice - HÃ´pital de l'Archet, Nice, Alpes-maritimes, 06200, France",,,Passeron Thierry,,,,
Vitiligo,NCT05549869,Assessment of Serum Leptin in Vitiligo Patients,https://clinicaltrials.gov/study/NCT05549869,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DIAGNOSTIC_TEST: serum leptin,,,,,"Sohag University Hospital, Sohag, Egypt",,,,,,,
Vitiligo,NCT06454461,Efficacy of Upadacitinib After NECS in Vitiligo,https://clinicaltrials.gov/study/NCT06454461,NO,ALL,ADULT,,Vitiligo,,,,,DRUG: Upadacitinib 15 MG,,,,,,,,,,,,
Vitiligo,NCT05342519,Daily Topical Rapamycin for Vitiligo,https://clinicaltrials.gov/study/NCT05342519,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Rapamycin,DRUG: Rapamycin,DRUG: Placebo,,,"Medical University of South Carolina, Charleston, South Carolina, 29425, United States",,,Ahmad Aleisa,,,,
Vitiligo,NCT06261073,Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients,https://clinicaltrials.gov/study/NCT06261073,NO,ALL,ADULT,,Vitiligo,,,,,DIAGNOSTIC_TEST: blood sample and tissue biopsy,,,,,,,,,,,,
Vitiligo,NCT03611348,Microneedling and Latanoprost in Acrofacial Vitiligo,https://clinicaltrials.gov/study/NCT03611348,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Vitiligo,,,,,DRUG: Latanoprost,DEVICE: Microneedling,,,,,,,Ramadan Saleh,,,,
Vitiligo,NCT05290077,Role of NGAL in Vitiligo,https://clinicaltrials.gov/study/NCT05290077,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DIAGNOSTIC_TEST: NGAL,,,,,"Sohag fuculty, Sohag, Egypt",,,,,,,
Vitiligo,NCT05927272,Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions,https://clinicaltrials.gov/study/NCT05927272,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,PROCEDURE: SKIN SAMPLES,PROCEDURE: BLOOD SAMPLES,DEVICE: narrowband UVB,DRUG: Systemic Steroids,,"University Hospital of Bordeaux - St AndrÃ© Hospital, Bordeaux, 33000, France",,,,,,,
Vitiligo,NCT05836441,Improved Phototherapy in Patients With Vitiligo,https://clinicaltrials.gov/study/NCT05836441,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Vitiligo,,,,,RADIATION: Exposure to white patches,RADIATION: Exposure to edge of white patches and normal skin around white patches,,,,"The first Affiliated hospital with Nanjing medical university, Nanjing, Jiangsu, 210009, China",,,Lu Yan,,,,
Vitiligo,NCT05917561,Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo,https://clinicaltrials.gov/study/NCT05917561,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Anifrolumab Infusion Product,DRUG: Placebo,,,,"CHU de Bordeaux, Bordeaux, 33075, France","Centre Hospitalier RÃ©gional Le Mans, Le Mans, 72037, France","Centre Hospitalier Universitaire de Nice, Nice, 06000, France",,,,,
Vitiligo,NCT05506995,Tissue-resident Memory T Cells Expression Among the Repigmentation Patterns Induced by NB-UVB Phototherapy in Vitiligo,https://clinicaltrials.gov/study/NCT05506995,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,,,,,,"Dermatology Department. Hospital Central ""Dr. Ignacio Morones Prieto"", San Luis PotosÃ­, 78290, Mexico",,,Juan P Castanedo-Cazares,,,,
Vitiligo,NCT05298033,"Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo",https://clinicaltrials.gov/study/NCT05298033,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Crisaborole 2 % Topical Ointment,DRUG: PF-07038124 0.01% topical ointment,DEVICE: NBUVB phototherapy,DEVICE: Sham phototherapy,DRUG: Vehicle,"University of Colorado Anschutz - Clinical and Translational Research Centers, Aurora, Colorado, 80045, United States",,,Stanca Birlea,,,,
Vitiligo,NCT04843059,ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation,https://clinicaltrials.gov/study/NCT04843059,NO,ALL,ADULT,,Vitiligo,,,,,OTHER: The resident memory T-cell infiltrate in perilesional vitiligo skin,,,,,"CHU de Nice, Nice, Alpes Maritimes, 06001, France","CHU Bordeaux, Bordeaux, 33440, France",,Passeron Thierry,,,,
Vitiligo,NCT05812079,Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo,https://clinicaltrials.gov/study/NCT05812079,NO,ALL,ADULT,,Vitiligo,,,,,DIAGNOSTIC_TEST: skin biopsy examined by ELISA technique,,,,,,,,,,,,
Vitiligo,NCT05247489,A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo,https://clinicaltrials.gov/study/NCT05247489,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Ruxolitinib 1.5% cream,DEVICE: NB-UVB phototherapy,,,,"First Oc Dermatology, Fountain Valley, California, 92708, United States","UC Davis Health, Sacramento, California, 95816, United States","Palo Alto Medical Foundation, Sunnyvale, California, 94086, United States",Haq Nawaz,,,,
Vitiligo,NCT05223738,Resident Memory T Cells in Vitiligo,https://clinicaltrials.gov/study/NCT05223738,NO,ALL,ADULT,,Vitiligo,,,,,,,,,,"Kasr El Ainy University hospital, Cairo, Egypt",,,Hilal,,,,
Vitiligo,NCT04374435,Evaluating the Efficacy of the Melanocyte Keratinocyte Transplantation Procedure in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT04374435,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,PROCEDURE: MKTP with Surgical blade,DEVICE: MKTP with Negative Pressure Instrument,DEVICE: Suction blister grafting without cell dissociation,,,"University of California, Irvine, Irvine, California, 92697, United States",,,Anand K Ganesan,,,,
Vitiligo,NCT04896385,A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA),https://clinicaltrials.gov/study/NCT04896385,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Ruxolitinib cream,DRUG: Vehicle Cream,,,,"First Oc Dermatology, Fountain Valley, California, 92708, United States","UC Irvine, Irvine, California, 92697, United States","George Washington Medical Faculty Associates, Washington, District of Columbia, 20037, United States",,,,,
Vitiligo,NCT06410898,Assessment of Hypoxia Inducible Factor and Autophagy Related Genes in Patients With Non-Segmental Vitiligo,https://clinicaltrials.gov/study/NCT06410898,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DEVICE: Punch Biopsy 5mm,,,,,"Sohag University hospitals, Sohag, Egypt",,,,,,,
Vitiligo,NCT04858152,Hair Transplantation for Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT04858152,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,PROCEDURE: Follicular Unit Extraction via punch biopsy,,,,,"University of Massachusetts Medical School, Worcester, Massachusetts, 01605, United States",,,Mehdi Rashighi,,,,
Vitiligo,NCT04271501,Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions,https://clinicaltrials.gov/study/NCT04271501,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,PROCEDURE: Melanocyte-Keratinocyte Transplantation and Ultraviolet Lamp (UVB),DEVICE: RECELL 1:5 and Ultraviolet Lamp (UVB),DEVICE: RECELL 1:10 and Ultraviolet Lamp (UVB),DEVICE: RECELL 1:20 and Ultraviolet Lamp (UVB),,"University of Massachusetts, Worcester, Massachusetts, 01655, United States",,,,,,,
Vitiligo,NCT04237103,Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo,https://clinicaltrials.gov/study/NCT04237103,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Methotrexate,DRUG: Placebos,,,,"Service de Dermatologie - HÃ´pital Saint-AndrÃ©, Bordeaux, 33075, France","Centre Hospitalier de Pau, Pau, 64000, France","Centre Hospitalier de PÃ©rigueux, PÃ©rigueux, 24000, France",Julien,,,,
Vitiligo,NCT05513924,Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo.,https://clinicaltrials.gov/study/NCT05513924,NO,ALL,"CHILD, ADULT",PHASE2|PHASE3,Vitiligo,,,,,DRUG: Latanoprost 0.005% Ophthalmic Solution,DRUG: 5Fluorouracil,,,,"South Valley University, QinÄ, Qena Governorate, 83523, Egypt",,,,,,,
Vitiligo,NCT04822584,Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo,https://clinicaltrials.gov/study/NCT04822584,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Baricitinib Oral Product,DRUG: Placebo,,,,"Service de Dermatologie - HÃ´pital Saint-AndrÃ©, Bordeaux, 33075, France","Service de dermatologie - HÃ´pital Henri Mondor - EA EpiDermE (EpidÃ©miologie en Dermatologie et Evaluation des ThÃ©rapeutiques), CrÃ©teil, 94010, France","Centre Hospitalier Universitaire de Nice - Service de Dermatologie, Nice, 06000, France",,,,,
Vitiligo,NCT05037981,Effect of Early Systemic Stabilization Therapy on Recent Onset Vitiligo,https://clinicaltrials.gov/study/NCT05037981,NO,ALL,"CHILD, ADULT",,Vitiligo,,,,,,,,,,,,,Samia Esmat,Rania Mogawer,Dalia Bassiony,Nanis Ragab,Sarah Ibrahim
Vitiligo,NCT04765826,"Comparison Between Systemic Steroids, Topical Steroids, or Calcineurin Inhibitors With Mini Punch Grafting in Treatment of Stable Non-segmental Vitiligo",https://clinicaltrials.gov/study/NCT04765826,NO,ALL,ADULT,,Vitiligo,,,,,PROCEDURE: Autologous mini punch grafting,,,,,"Alexandria faculty of medicine, Alexandria, Egypt",,,Carmen brahiem farid amin,Ai Ahmed fouad El Eriny,Eman Hamed El Morsy,,
Vitiligo,NCT04775979,Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo,https://clinicaltrials.gov/study/NCT04775979,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Vitiligo,,,,,DRUG: diphenylcyclopropenone (DPCP),,,,,"University hospitals faculty of medicine ain shams university, Cairo, Egypt",,,Marwa  Abdallah,Rania M Elhusseiny,,,
Vitiligo,NCT05121532,Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo,https://clinicaltrials.gov/study/NCT05121532,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Vitiligo,,,,,DIAGNOSTIC_TEST: Interleukin-15 and Interleukin-22,,,,,,,,,,,,
Vitiligo,NCT04030988,Contribution of Skin Color in Stabilization of Active Cases of Vitiligo by Narrow Band UVB,https://clinicaltrials.gov/study/NCT04030988,NO,ALL,"CHILD, ADULT",PHASE1,Vitiligo,,,,,DRUG: Oral dexamethasone minipulse,DRUG: Placebo oral tablet,,,,"Ain Shams University, Cairo, Abbaseya, 00202, Egypt",,,,,,,
Vitiligo,NCT03872804,Punch Minigraft Versus Transverse Needling or Combination of Both in Treatment of Non-Segmental Vitiligo,https://clinicaltrials.gov/study/NCT03872804,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Vitiligo,,,,,PROCEDURE: Autologous punch mini grafts:,PROCEDURE: Transverse needling,PROCEDURE: Punch minigrafts followed by transverse needling,OTHER: Oral pulse steroid with narrow band,,"Omneya abd el aziz el zagh, Alexandria, 21500, Egypt",,,Carmen Ibrahiem farid amin,Magdy Abd el aziz ragab,,,
Vitiligo,NCT05287776,E-cadherin and Integrin Alpha v Beta 1 in Vitiligo,https://clinicaltrials.gov/study/NCT05287776,NO,ALL,ADULT,,Vitiligo,,,,,DEVICE: Narrow band UVB,,,,,"Kasr El Ainy university hospital, Faulty of medicine,Cairo university, Cairo, El Manial, 11956, Egypt",,,,,,,
Vitiligo,NCT04338581,Evaluation of AMG 714 for Vitiligo,https://clinicaltrials.gov/study/NCT04338581,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,BIOLOGICAL: AMG 714,BIOLOGICAL: Placebo,PROCEDURE: nbUVB phototherapy,,,"University of California, Irvine: Department of Dermatology, Irvine, California, 92697, United States","University of California Davis Health System: Department of Dermatology, Sacramento, California, 95816, United States","Yale University School of Medicine: Department of Dermatology, New Haven, Connecticut, 06824, United States",,,,,
Vitiligo,NCT03099304,A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo,https://clinicaltrials.gov/study/NCT03099304,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Ruxolitinib cream,DRUG: Vehicle cream,,,,"UNIVERSITY OF ALABAMA AT BIRMINGHAM (UAB), 1802 6th Ave S, Birmingham, Alabama, 35233, United States","BURKE PHARMACEUTICAL RESEARCH LLC, 3633 Central Ave, Hot Springs, Arkansas, 71913, United States","NORTHWEST AR CLINICAL TRIALS CENTER, PLLC/HULL DERMATOLOGY, PA, 500 S 52nd Street, Rogers, Arkansas, 72758, United States",Kathleen Butler,,,,
Vitiligo,NCT05053022,A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo,https://clinicaltrials.gov/study/NCT05053022,NO,ALL,ADULT,,Vitiligo,,,,,DEVICE: Skinpen Precision System,,,,,"Crown Laboratories, Dallas, Texas, 75234, United States",,,,,,,
Vitiligo,NCT04738149,"Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment",https://clinicaltrials.gov/study/NCT04738149,NO,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,Vitiligo,,,,,DRUG: Bimatoprost,DEVICE: Excimer laser,DEVICE: Microneedling with a dermaroller,,,"Medical University of South Carolina, Charleston, South Carolina, 29407, United States",,,,,,,
Vitiligo,NCT03411135,Vitiligo Extent Score (VES) Score in Comparison to Vitiligo Area and Severity Index (VASI) Score,https://clinicaltrials.gov/study/NCT03411135,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,OTHER: VES and VASI scores as assessment methods for vitiligo,,,,,,,,,,,,
Vitiligo,NCT02962180,Transplantation of Basal Cell Layer Suspension Using Derma-rolling System in Vitiligo,https://clinicaltrials.gov/study/NCT02962180,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DEVICE: Dermabrasion with dermaroller,,,,,"Department of Dermatology, Ibn Sina University Hospital, Rabat, 10000, Morocco",,,laila benzekri,,,,
Vitiligo,NCT01082393,Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis),https://clinicaltrials.gov/study/NCT01082393,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Vitiligo,,,,,DRUG: topical tacrolimus treatment,DRUG: topical pimecrolimus treatment,DRUG: local mometasone furoate treatment,DRUG: cold cream,,"University Hospital Ghent, Ghent, Belgium",,,Nanny Van Geel,,,,
Vitiligo,NCT05872477,Promoting Repigmentation After Epidermal Cell Suspension Grafting and preVENTing the Loss of Melanocytes Using Topical Ruxolitinib for Vitiligo in Resistant Areas,https://clinicaltrials.gov/study/NCT05872477,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Ruxolitinib Topical,DRUG: Placebo,,,,"CHU de Nice - HÃ´pital de l'Archet, Nice, Alpes-maritimes, 06200, France",,,Passeron Thierry,,,,
Vitiligo,NCT03123016,Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT03123016,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Apremilast,PROCEDURE: NB-UVB phototherapy,,,,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States",,,Mark Lebwohl,,,,
Vitiligo,NCT03036995,Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO,https://clinicaltrials.gov/study/NCT03036995,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Apremilast,OTHER: Placebo,,,,"CHU de Nice - Dermatologie - HÃ´pital Archet, Nice, Alpes-Maritimes, 06, France",,,,,,,
Vitiligo,NCT03864315,"To Study the Efficacy of Therapeutic Pulsed Ultrasound in the Treatment of Vitiligo: a Randomized, Intra-individual, Left-right Comparison Study",https://clinicaltrials.gov/study/NCT03864315,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DEVICE: HGM,,,,,"National Taiwan University Hospital, Taipei, 10002, Taiwan",,,,,,,
Vitiligo,NCT05008887,Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental Vitiligo,https://clinicaltrials.gov/study/NCT05008887,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Vitiligo,,,,,DRUG: Methotrexate,DRUG: 5-fluorouracil,DEVICE: Fractional CO2 laser,,,,,,,,,,
Vitiligo,NCT01051687,Botulinum Toxin Treatment for Localized Vitiligo,https://clinicaltrials.gov/study/NCT01051687,NO,ALL,ADULT,PHASE4,Vitiligo,,,,,DRUG: Botulinum toxin A,,,,,"King Khalid University Hospital, Riyadh, 11524, Saudi Arabia",,,Ghada Binsaif,,,,
Vitiligo,NCT06109649,A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo,https://clinicaltrials.gov/study/NCT06109649,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Vitiligo,,,,,DRUG: Afamelanotide and NB-UVB Light,PROCEDURE: NB-UVB Light,,,,"CLINUVEL site, Los Angeles, California, 00000, United States","CLINUVEL site, Miami, Florida, 00000, United States","CLINUVEL site, Miramar, Florida, 00000, United States",,,,,
Vitiligo,NCT01787708,Efficacy of Red Light in Vitiligo,https://clinicaltrials.gov/study/NCT01787708,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,PROCEDURE: Red light,,,,,"The Skin Care Center, Vancouver General Hospital, Vancouver, British Columbia, V5Z 4E8, Canada",,,Harvey Lui,,,,
Vitiligo,NCT03755830,Prostaglandin F2-alpha (PGF2Î±) in Vitiligo,https://clinicaltrials.gov/study/NCT03755830,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,OTHER: Skin biopsy,,,,,,,,,,,,
Vitiligo,NCT03859518,Study of the Role of Innate Lymphoid Cells and Natural Killer Cells in Immune Activation of Vitiligo - INNATE Vitiligo,https://clinicaltrials.gov/study/NCT03859518,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,OTHER: blood and skin samples,,,,,"CH de Frejus, FrÃ©jus, France",,,Thierry,,,,
Vitiligo,NCT01478945,HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home,https://clinicaltrials.gov/study/NCT01478945,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Vitiligo,,,,,DEVICE: 311 nm NB-UVB light,,,,,"Queens Medical Centre,Nottingham University Hospitals NHS Trust, Nottingham, East Midlands, NG7 2UH, United Kingdom","Leicester Royal Infirmary, Leicester, Leicestershire, LE1 5WW, United Kingdom",,Hywel C. Williams,Viktoria Eleftheriadou,Jane C Ravenscroft,,
Vitiligo,NCT02625012,Repigmentation Patterns Induced by NB-UVB and Their Relationship With Melanocytic Migration in Vitiligo,https://clinicaltrials.gov/study/NCT02625012,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,,,,,,,,,Diego Cortes-Garcia,,,,
Vitiligo,NCT02466997,Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC,https://clinicaltrials.gov/study/NCT02466997,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Vitiligo,,,,,DRUG: tacrolimus,DRUG: Placebo,,,,"University Hospital of Bordeaux - St AndrÃ© Hospital, Bordeaux, 33000, France","Regional Hospital Center of Le Mans -, Le Mans, 72000, France","University Hospital Center of Nice - HÃ´pital de l'Archet, Nice, 06000, France",,,,,
Vitiligo,NCT03832751,Human Beta-defensin 1 in Vitiligo,https://clinicaltrials.gov/study/NCT03832751,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,OTHER: skin biopsy before and after NB-UVB phototherapy,,,,,,,,,,,,
Vitiligo,NCT05210582,A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the Face,https://clinicaltrials.gov/study/NCT05210582,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Afamelanotide,,,,,"CLINUVEL Investigational site, Detroit, Michigan, 48202, United States",,,,,,,
Vitiligo,NCT04774809,Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo,https://clinicaltrials.gov/study/NCT04774809,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Vitiligo,,,,,DRUG: Low Dose SHR0302 Ointment BID,DRUG: High Dose SHR0302 Ointment BID,OTHER: Placebo Comparator: Vehicle,,,"The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China","Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong, China","Wuhan No.1 Hospital, Wuhan, Hubei, China",,,,,
Vitiligo,NCT01517893,Clinical Trial of Simvastatin to Treat Generalized Vitiligo,https://clinicaltrials.gov/study/NCT01517893,YES,MALE,ADULT,PHASE2,Vitiligo,,,,,DRUG: Simvastatin,DRUG: Placebo,,,,"University of Massachusetts Medical School Clinical Research Center, Worcester, Massachusetts, 01655, United States",,,John E. Harris,,,,
Vitiligo,NCT03608917,Efficacy and Safety of Total Glucosides of Paeony Combined With NB-UVB on Treating Vitiligo,https://clinicaltrials.gov/study/NCT03608917,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DRUG: Total Glucosides of Paeony(TGP),DEVICE: Narrow band-ultraviolet bï¼ˆNB-UVBï¼‰,DRUG: Total Glucosides of Paeony(TGP) analogue,,,"Xijing Hospital, Xi'an, Shaanxi, 710032, China",,,Tianwen Gao,,,,
Vitiligo,NCT03367273,Thymic Stromal Lymphopoietin (TSLP) in Vitiligo,https://clinicaltrials.gov/study/NCT03367273,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,OTHER: skin biopsy,,,,,,,,,,,,
Vitiligo,NCT03497208,Comparative Study of Surgical Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT03497208,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Vitiligo,,,,,PROCEDURE: Microneedling,PROCEDURE: Cell suspension,RADIATION: Phototherapy,,,"HCPA, Porto Alegre, RS, 90035903, Brazil",,,Tania Cestari,,,,
Vitiligo,NCT04811131,Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo,https://clinicaltrials.gov/study/NCT04811131,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: ARQ-252 cream 0.3%,DRUG: ARQ-252 Vehicle cream,DEVICE: NB-UVB phototherapy active treatment,DEVICE: NB-UVB phototherapy sham treatment,,"Arcutis Site 123, San Diego, California, 92123, United States","Arcutis Site 167, Coral Gables, Florida, 33134, United States","Arcutis Clinical Site 102, Rolling Meadows, Illinois, 60008, United States",David Berk,,,,
Vitiligo,NCT03973073,Effects of Combination Therapy With Camouflage in the Repigmentation of Vitiligo,https://clinicaltrials.gov/study/NCT03973073,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,Vitiligo,,,,,COMBINATION_PRODUCT: CapulinTM,OTHER: topical applications and NB-UVB,,,,"Peking university people's hospital, Beijing, Beijing, 100044, China",,,Juan Du,,,,
Vitiligo,NCT01259986,Treatment of Vitiligo With Low-energy Visible Light Laser,https://clinicaltrials.gov/study/NCT01259986,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,PROCEDURE: Laser treatment,,,,,,,,,,,,
Vitiligo,NCT04530344,Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo,https://clinicaltrials.gov/study/NCT04530344,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Vitiligo,,,,,DRUG: ruxolitinib,DRUG: Vehicle,,,,"Cahaba Dermatology, Hoover, Alabama, 35244, United States","Desert Sky Dermatology, Gilbert, Arizona, 85295, United States","First Oc Dermatology, Fountain Valley, California, 92708, United States",Kathleen Butler,,,,
Vitiligo,NCT03762551,Janus Kinase 1 in Vitiligo & Psoriasis,https://clinicaltrials.gov/study/NCT03762551,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Vitiligo,,,,,OTHER: skin biopsy,,,,,,,,,,,,
Vitiligo,NCT02432534,Atorvastatin in Active Vitiligo,https://clinicaltrials.gov/study/NCT02432534,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Atorvastatin,OTHER: UVB,,,,"CHU de Nice, Nice, Alpes-Maritimes, 06001, France","National Skin center - 1 Mandalay Rd, Bedok, Singapore, 308205, Indonesia",,,,,,
Vitiligo,NCT04547998,Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions,https://clinicaltrials.gov/study/NCT04547998,YES,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DEVICE: Control Intervention (UVB),DEVICE: Investigational Interventions (Ablative Laser Resurfacing + RECELL + UVB),,,,"University of California, Irvine, Irvine, California, 92697, United States","University of California, Davis, Sacramento, California, 95817, United States","West Dermatology, San Diego, California, 92121, United States",,,,,
Vitiligo,NCT03133871,Evaluation of Scanoskin for the Assessment of Vitiligo,https://clinicaltrials.gov/study/NCT03133871,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,,,,,,"Chelsea and Westminster Hospital, London, SW10 9NH, United Kingdom",,,Lucy J Thomas,Declan Colllins,,,
Vitiligo,NCT02510651,Effect of Procedural Variables on Outcome of Surgical Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT02510651,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Vitiligo,,,,,PROCEDURE: Melanocyte-keratinocyte suspension,,,,,,,,,,,,
Vitiligo,NCT01732965,NB-UVB and PUVA Vitiligo Study,https://clinicaltrials.gov/study/NCT01732965,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Vitiligo,,,,,OTHER: Phototherapy,OTHER: Phototherapy and Photochemotherapy,,,,"Henry Ford Dermatology, Detroit, Michigan, 48202, United States",,,Iltefat Hamzavi,,,,
Vitiligo,NCT02797574,Stress Response Pathways in Vitiligo,https://clinicaltrials.gov/study/NCT02797574,NO,ALL,ADULT,,Vitiligo,,,,,PROCEDURE: Punch Biopsy at a Lesional Site,PROCEDURE: Punch Biopsy at a Non- Lesional site,,,,"New York University School of Medicine, New York, New York, 10016, United States",,,Prashiela Manga,,,,
Vitiligo,NCT00830713,Vitiligo Skin Transplantation,https://clinicaltrials.gov/study/NCT00830713,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Vitiligo,,,,,PROCEDURE: Melanocyte-keratinocyte transplantation procedure (MKTP),,,,,"Henry Ford Medical Center, New Center One, Detroit, Michigan, 48202, United States",,,Iltefat H Hamzavi,,,,
Vitiligo,NCT02290717,Fractional Laser in Combination With UVB Therapy in Vitiligo Patients,https://clinicaltrials.gov/study/NCT02290717,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DEVICE: Fractional CO2 laser,OTHER: NB-UVB therapy,DRUG: Fluticasone Propionate Cream 0.05%,,,"Academic Medical Centre, Amsterdam, Netherlands",,,,,,,
Vitiligo,NCT04103060,"Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo",https://clinicaltrials.gov/study/NCT04103060,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Cerdulatinib 0.37% gel,DRUG: Vehicle gel,,,,"Dermavant Investigational Site, Irvine, California, 92617, United States","Dermavant Investigational Site, Worcester, Massachusetts, 01605, United States",,Michael McLaughlin,,,,
Vitiligo,NCT01766609,Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01766609,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Triamcinolone Acetonide,,,,,"The Skin Care Center, Vancouver General Hospital, Vancouver, British Columbia, V5Z 4E8, Canada",,,,,,,
Vitiligo,NCT04171427,Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo,https://clinicaltrials.gov/study/NCT04171427,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,OTHER: Lithium liposome,OTHER: Placebo,,,,"Hbib thamer Hospital, Tunis, Tunisia",,,,,,,
Vitiligo,NCT03941808,Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo.,https://clinicaltrials.gov/study/NCT03941808,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DRUG: Glisodin tablet,DRUG: Placebo tablet,,,,"Passeron, Nice, Alpes-Maritime, 06001, France",,,Passeron Thierry,,,,
Vitiligo,NCT03717025,Comparison of Surgical Methods on Resistant Sites in Stable Vitiligo Patients,https://clinicaltrials.gov/study/NCT03717025,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,PROCEDURE: SUCTION BLISTER EPIDERMAL GRAFTING,PROCEDURE: MINI PUNCH GRAFTING,PROCEDURE: NON CULTURED EPIDERMAL CELL SUSPENSION,,,"Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India",,,,,,,
Vitiligo,NCT04525157,Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV),https://clinicaltrials.gov/study/NCT04525157,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Afamelanotide,DRUG: Placebo,,,,,,,,,,,
Vitiligo,NCT04320160,Evaluation of Human Melanocytes After the Use of PRP Versus Fractional CO2 Laser in Vitiligo,https://clinicaltrials.gov/study/NCT04320160,NO,ALL,ADULT,,Vitiligo,,,,,PROCEDURE: Platelet rich plasma,PROCEDURE: Fractional CO2 laser,,,,,,,Amal T. ELghait,,,,
Vitiligo,NCT00696358,Excimer Lamp Versus Excimer Laser in Vitiligo Treatment,https://clinicaltrials.gov/study/NCT00696358,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Vitiligo,,,,,RADIATION: 308nm excimer lamp,RADIATION: 308nm excimer laser,,,,"Department of Dermatology, University Hospital of Nice, Nice, 06200, France",,,,,,,
Vitiligo,NCT02809976,Topical Ruxolitinib for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT02809976,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Ruxolitinib 1.5% Phosphate Cream,,,,,"Tufts Medical Center, Boston, Massachusetts, 02111, United States",,,,,,,
Vitiligo,NCT01923142,Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01923142,NO,ALL,ADULT,PHASE2,Vitiligo,,,,,BIOLOGICAL: Outer-Root-Sheath Melanocytes Suspension,BIOLOGICAL: Placebo,,,,"Papa Giovanni XXIII Hospital, Bergamo, 24127, Italy","Spedali Civili, Brescia, 25123, Italy",,Luigi Naldi,,,,
Vitiligo,NCT03468855,A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT03468855,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: ATI-50002 topical solution,,,,,"Aclaris Investigator Site, Encinitas, California, 92024, United States","Aclaris Investigator Site, Los Angeles, California, 90036, United States","Aclaris Investigator Site, Worcester, Massachusetts, 01655, United States",,,,,
Vitiligo,NCT03155698,Treatment of Acral Vitiligo : Narrowband Ultraviolet-B and Microneedling With and Without Platelet Rich Plasma,https://clinicaltrials.gov/study/NCT03155698,NO,ALL,ADULT,,Vitiligo,,,,,COMBINATION_PRODUCT: microneedling and Platelet rich plasma,RADIATION: NB-UVB phototherapy,,,,"Assiut university, Assiut, Egypt",,,Lamiaa Ahmad Abd El-khalek,,,,
Vitiligo,NCT01419964,Efficacy and Safety of ACH24 in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01419964,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Vitiligo,,,,,DRUG: Group 01,DRUG: Group 02,,,,"Irmandade da Santa Casa de MisericÃ³rdia de Curitiba, Curitiba, ParanÃ¡, 80010-030, Brazil",,,,,,,
Vitiligo,NCT02925767,Efficacy of 311-nm Ti:Sapphire Laser Versus 308-nm Excimer Laser Treatment in Vitiligo,https://clinicaltrials.gov/study/NCT02925767,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DEVICE: 311-nm Ti:Sapphire laser,DEVICE: 308-nm excimer laser,,,,"St. Vincent's Hospital, Suwon, Gyeonggi-do, 16247, Korea, Republic of",,,,,,,
Vitiligo,NCT01992185,Photocil (Topical) for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01992185,YES,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DRUG: Photocil for Vitiligo,OTHER: Placebo - Sunscreen (SPF 2),,,,"Physicians Institute, Tucson, Arizona, 85719, United States",,,John McCoy,,,,
Vitiligo,NCT03199664,Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo,https://clinicaltrials.gov/study/NCT03199664,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Vitiligo,,,,,RADIATION: NB-UVB,COMBINATION_PRODUCT: NB-UVB & Tacrolimus 0.03%,,,,"South valley university, QinÄ, Egypt",,,Ramdan Saleh,,,,
Vitiligo,NCT03158675,"Fractional Carbon Dioxide Laser,Topical Corticosteroid and Narrow Band Ultraviolet B in Treatment of Stable Vitiligo",https://clinicaltrials.gov/study/NCT03158675,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Vitiligo,,,,,PROCEDURE: fractional carbon dioxide(CO2) laser,DRUG: Topical corticosteroid,RADIATION: Ultraviolet B narrow band,,,,,,Muna Abdullah,,,,
Vitiligo,NCT02281058,Open-label Pilot Study of Abatacept for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT02281058,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Vitiligo,,,,,DRUG: Abatacept,,,,,"Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States",,,,,,,
Vitiligo,NCT03013049,A Novel Surgical Method in the Treatment of Unstable Vitiligo,https://clinicaltrials.gov/study/NCT03013049,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,PROCEDURE: Non cultured epidermal cell suspension,PROCEDURE: Non cultured dermal cell suspension,,,,"PGIMER, Chandigarh, 160012, India",,,,,,,
Vitiligo,NCT01382589,Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo,https://clinicaltrials.gov/study/NCT01382589,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Afamelanotide,DEVICE: NB-UVB,,,,,,,Giovanni Leone,,,,
Vitiligo,NCT01430195,Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV),https://clinicaltrials.gov/study/NCT01430195,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Vitiligo,,,,,DRUG: Afamelanotide,PROCEDURE: Narrow-Band UVB Light Treatment,,,,"Henry Ford Medical Center, Detroit, Michigan, 48202, United States","The Mount Sinai School of Medicine, New York, New York, 10029, United States",,,,,,
Vitiligo,NCT01333410,Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo,https://clinicaltrials.gov/study/NCT01333410,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Vitiligo,,,,,DRUG: tacrolimus ointment,DRUG: Mometasone furoate,,,,"Department of Dermatology, Faculty of Medicine Siriraj Hospital, Bangkok, Thailand",,,Chanisada Wongpraparut,,,,
Vitiligo,NCT01629979,Epidermal Cell Transplantation in Vitiligo Skin,https://clinicaltrials.gov/study/NCT01629979,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,VITILIGO,,,,,PROCEDURE: Grafting with epidermal cells,RADIATION: UVB treatment,,,,"Centre hospitalier Universitaire de Nice, Nice, 06000, France",,,philippe bahadoran,,,,
Vitiligo,NCT03249064,Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo,https://clinicaltrials.gov/study/NCT03249064,NO,ALL,"ADULT, OLDER_ADULT",,VITILIGO,,,,,DIAGNOSTIC_TEST: CD 91 levels,DIAGNOSTIC_TEST: Tregs,,,,"Hospital de la Santa Creu i Sant Pau, Barcelona, 08025, Spain",,,,,,,
Vitiligo,NCT03741738,"The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity",https://clinicaltrials.gov/study/NCT03741738,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,,,,,,"Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, 03722, Korea, Republic of",,,,,,,
Vitiligo,NCT00807690,Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo,https://clinicaltrials.gov/study/NCT00807690,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Vitiligo,,,,,DRUG: Tacrolimus ointment,,,,,,,,Eli Johanne Nordal,,,,
Vitiligo,NCT02191748,Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo,https://clinicaltrials.gov/study/NCT02191748,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Vitiligo,,,,,PROCEDURE: Needling,DRUG: Triamcinolone,,,,"RWJUH Dermatology office, Somerset, New Jersey, 08873, United States",,,,,,,
Vitiligo,NCT03668834,"Comparing Recipient Site Preparation Using Dermabrasion, Dermaroller and Liquid Nitrogen Induced Blister in Non Cultured Epidermal Cell Suspension in Stable Vitiligo",https://clinicaltrials.gov/study/NCT03668834,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,PROCEDURE: Dermabrasion with NCES,PROCEDURE: Dermaroller with NCES,PROCEDURE: Liquid nitrogen induced blister with NCES,,,"PGIMER, Chandigarh, 160012, India",,,,,,,
Vitiligo,NCT00615355,Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment,https://clinicaltrials.gov/study/NCT00615355,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,RADIATION: UVB 311 nm radiation,DEVICE: UVB 311nm,,,,"Medical University, Department of Dermatology, Graz, 8036, Austria",,,Angelika Hofer,,,,
Vitiligo,NCT00134368,Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo,https://clinicaltrials.gov/study/NCT00134368,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DRUG: Etanercept,,,,,"UMDNJ Psoriasis Center of Excellence, New Brunswick, New Jersey, 08903, United States",,,Alice Gottlieb,,,,
Vitiligo,NCT00367224,Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo,https://clinicaltrials.gov/study/NCT00367224,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,PROCEDURE: 6 to 9 ultraviolet B treatments,PROCEDURE: Skin biopsies,,,,"Department of Dermatology/Henry Ford Hospital, Detroit, Michigan, 48202, United States",,,,,,,
Vitiligo,NCT01787695,UVA 1 Phototherapy for Vitiligo,https://clinicaltrials.gov/study/NCT01787695,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,PROCEDURE: UVA1,,,,,"The Skin Care Center, Vancouver General Hospital, Vancouver, British Columbia, V5Z 4E8, Canada",,,Harvey Lui,,,,
Vitiligo,NCT01459055,Long-term Follow-up in Patients Affected With Acrofacial Vitiligo,https://clinicaltrials.gov/study/NCT01459055,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,,,,,,"Irmandade da Santa Casa de MisericÃ³rdia de Curitiba, Curitiba, Parana, 80730000, Brazil",,,Caio C Silva de Castro,,,,
Vitiligo,NCT00368407,Optimal Treatment Frequency of 308-Nm Excimer Laser for Vitiligo on the Face and Neck,https://clinicaltrials.gov/study/NCT00368407,NO,ALL,"CHILD, ADULT",,Vitiligo,,,,,DEVICE: 308-nm excimer laser,,,,,"Department of dermatology, Xijing Hospital, Xi'an, SHANNXI, 710032, China",,,gao tianwen,,,,
Vitiligo,NCT01262547,A New Micrografting Technique for Vitiligo,https://clinicaltrials.gov/study/NCT01262547,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DEVICE: Dermabrasion-Micrografting,PROCEDURE: Dermabrasion,,,,"Mgh Curtis, Boston, Massachusetts, 02114, United States",,,,,,,
Vitiligo,NCT00622180,The Efficacy of Hand Narrow-Band Ultraviolet B (NBUVB) Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands,https://clinicaltrials.gov/study/NCT00622180,YES,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DEVICE: NBUVB,DEVICE: Monochromacitc Excimer light,,,,"UT Southwestern Medical Center at Dallas - Dermatology Clinical Trials, Dallas, Texas, 75390-8802, United States",,,Amit Pandya,,,,
Vitiligo,NCT01822379,Comparative Study of Techniques in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01822379,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Vitiligo,,,,,PROCEDURE: Melanocyte Keratinocyte transplantation,,,,,"Henry Ford Hospital Department of Dermatology, Detroit, Michigan, 48202, United States",,,Iltefat H Hamzavi,,,,
Vitiligo,NCT00631865,Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin,https://clinicaltrials.gov/study/NCT00631865,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Vitiligo,,,,,BIOLOGICAL: Melanocyte transplantation,,,,,"Royan Institute, Tehran, 1665659911, Iran, Islamic Republic of",,,Hossein Baharvand,Saeeid Shafieian,Nasser Aghdami,,
Vitiligo,NCT00380471,Treatment and Complication of Bath PUVA in Vitiligo,https://clinicaltrials.gov/study/NCT00380471,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DEVICE: Bath PUVA,,,,,"Skin Research Center, Shaheed Beheshti Medical University, Tehran, 19899, Iran, Islamic Republic of",,,Parviz Toossi,,,,
Vitiligo,NCT03022019,ReNovaCell in Non-segmental Vitiligo,https://clinicaltrials.gov/study/NCT03022019,NO,ALL,"ADULT, OLDER_ADULT",,Non-segmental Vitiligo,Vitiligo,,,,DEVICE: ReNovaCell,,,,,"Nipd / Amc, Amsterdam, 1105AZ, Netherlands",,,,,,,
Vitiligo,NCT00398723,Narrowband UVB Treatment in Patients With Vitiligo,https://clinicaltrials.gov/study/NCT00398723,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DEVICE: Narrowband UVB,,,,,"Rockefeller University Hospital, New York, New York, 10021, United States",,,,,,,
Vitiligo,NCT06261086,Evaluation of Pyroptosis-related Indicators in the Pathogenesis of Vitiligo:Across-sectional Comparative Study,https://clinicaltrials.gov/study/NCT06261086,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,"DIAGNOSTIC_TEST: evaluate serum levels pyroptosis-related indicators (GASDM-D, IL 1Î² & IL-18)",,,,,,,,,,,,
Vitiligo,NCT01006421,Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01006421,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Vitiligo,,,,,DIETARY_SUPPLEMENT: GINGKO BILOBA,,,,,"King Khalid University Hospital, Riyadh, Central, Saudi Arabia",,,M,,,,
Vitiligo,NCT05467839,Evaluation of Efficacy of Microneedling and Topical Methotrexate Versus Microneedling and Topical 5-flourouracil in Treatment of Vitillgo Patients,https://clinicaltrials.gov/study/NCT05467839,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Vitiligo,,,,,DEVICE: derma pen,,,,,"Sohag University Hospital, Sohag, Egypt",,,,,,,
Vitiligo,NCT00525395,Virus Early Transcription Factor (VETF) Multicenter Phototherapy Protocol,https://clinicaltrials.gov/study/NCT00525395,NO,ALL,ADULT,PHASE3,Vitiligo,,,,,GENETIC: Sequential phototherapy,PROCEDURE: Continuous phototherapy,,,,"Istituto San Gallicano -, Rome, 00100, Italy",,,Mauro Picardo,,,,
Vitiligo,NCT00172939,Molecular Mechanisms of Helium-Neon Laser on Melanocyte Regeneration in Skin Equivalent Vitiligo Model,https://clinicaltrials.gov/study/NCT00172939,NO,MALE,ADULT,PHASE1,Vitiligo,,,,,PROCEDURE: foreskin from healthy adults,,,,,"National Taiwan University Hospital, Taipei, Taiwan",,,Hsin-Su Yu,,,,
Vitiligo,NCT05256147,Effect of Combination Non Steroidal Antiinflammatory Drugs and Narrowband UVB Treatment in Non-Photoadapters,https://clinicaltrials.gov/study/NCT05256147,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DRUG: Ibuprofen,,,,,"Henry Ford Dermatology, Detroit, Michigan, 48202, United States",,,,,,,
Vitiligo,NCT00177034,Examination Of Vitiligo Skin Samples Before and After UVB Treatment,https://clinicaltrials.gov/study/NCT00177034,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DRUG: Narrow Band UVB Treatment,,,,,"University of Minnesota, Minneapolis, Minnesota, 55455, United States",,,Mimi Cho,,,,
Vitiligo,NCT01511965,Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01511965,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Vitiligo,,,,,OTHER: autologous (cellular therapy),,,,,"service de Dermatologie - HÃ´pital l'Archet, Nice, 06200, France",,,Philippe Bahadoran,,,,
Vitiligo,NCT01087216,Interest of the Dermabrasion by Laser Erbium in the Treatment of the Vitiligo,https://clinicaltrials.gov/study/NCT01087216,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Vitiligo,,,,,DEVICE: Group Laser = Arm A,DRUG: Bras B : The group control,,,,"CHU de Nice - 4 avenue Reine Victoria - HÃ´pital de Cimiez, Nice, Alpes-Maritimes, 06001, France",,,Ph Thierry,,,,
Vitiligo,NCT03933774,"PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation",https://clinicaltrials.gov/study/NCT03933774,YES,ALL,"ADULT, OLDER_ADULT",,Vitiligo,,,,,DRUG: Tretinoin 0.05% cream,DRUG: Placebo cream,,,,"St. Vincent's Hospital, Suwon, Gyeonggi-do, 16247, Korea, Republic of",,,Jung Min Bae,,,,
Vitiligo,NCT01792245,Topical Psoralen Ultraviolet Light A Versus Narrow Band Ultraviolet Light B Treatment for Recalcitrant Dermatoses of the Hand,https://clinicaltrials.gov/study/NCT01792245,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Vitiligo,,,,,DEVICE: Phototherapy,,,,,"The Skin Care Center, Vancouver General Hospital, Vancouver, British Columbia, V5Z 4E8, Canada",,,Harvey Lui,,,,
Vitiligo,NCT05676333,Secukinumab in Active Non-segmental Vitiligo,https://clinicaltrials.gov/study/NCT05676333,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Vitiligo,Secukinumab,,,,DRUG: Secukinumab,,,,,"Department of Dermatology, Ghent University Hospital, Gent, Oost-Vlaanderen, 9000, Belgium",,,van Geel Nanja,,,,
Vitiligo,NCT05980390,IL35 Level in Vitiligo,https://clinicaltrials.gov/study/NCT05980390,NO,ALL,ADULT,,"IL35, Vitiligo",,,,,DIAGNOSTIC_TEST: IL 35 in tissue biopsy,,,,,,,,,,,,
Vitiligo,NCT05503368,Autologous Cellular Graft in Surgical Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT05503368,NO,ALL,"ADULT, OLDER_ADULT",,"Vitiligo, Generalized",,,,,PROCEDURE: surgical treatment of vitiligo using NCES,,,,,"Cairo university hospitals, dermatology outpatient clinic, Cairo, Egypt",,,Rania M Mogawer,Samia M Esmat,,,
Vitiligo,NCT06327321,Vitiligo Treatment by Targeting TYK2 Mediated Responses,https://clinicaltrials.gov/study/NCT06327321,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,"Vitiligo, Generalized",,,,,DRUG: Deucravacitinib,OTHER: Volunteer without treatment,,,,"CHU de Nice - HÃ´pital de l'Archet, Nice, Alpes-Maritimes, 06200, France","APHP, Henri Mondor, Paris, Creteil, France","CHU de Bordeaux, Bordeaux, Talence, 33000, France",Thierry,,,,
Vitiligo,NCT06113471,A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2),https://clinicaltrials.gov/study/NCT06113471,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,NonSegmental Vitiligo,,,,,DRUG: Povorcitinib,DRUG: Placebo,,,,"University of Alabama At Birmingham Hospital-Whitaker Clinic, Birmingham, Alabama, 35294-0007, United States","C2 Research Center, Llc, Montgomery, Alabama, 36117, United States","Tien Q Nguyen Md Inc, Fountain Valley, California, 92708-3701, United States",Incyte Medical Monitor,,,,
Vitiligo,NCT06113445,A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1),https://clinicaltrials.gov/study/NCT06113445,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,NonSegmental Vitiligo,,,,,DRUG: Povorcitinib,DRUG: Placebo,,,,"Cahaba Dermatology, Hoover, Alabama, 35244, United States","University of California Irvine, Irvine, California, 92697, United States","Clinical Science Institute Clinical Research Specialists Inc, Santa Monica, California, 90404, United States",Incyte Medical Monitor,,,,
Vitiligo,NCT05950542,"Evaluation Safety ,Efficacy Baricitinib Plus Excimer Light Versus Excimer Light Alone in Non Segmental Vitiligo",https://clinicaltrials.gov/study/NCT05950542,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,"Vitiligo, Generalized",,,,,DRUG: Baricitinib,,,,,,,,Yasmin mostafa Tawfik,,,,
Vitiligo,NCT05511493,Efficacy of PRP With Er-YAG Laser Versus With Microneedling in Localized Stable Vitiligo,https://clinicaltrials.gov/study/NCT05511493,NO,ALL,"CHILD, ADULT",,Localized Vitiligo,,,,,DEVICE: fractional Erbium-YAG laser,DEVICE: microneedling,,,,,,,,,,,
Vitiligo,NCT04440371,Phototherapy Combination With Topicals in Vitiligo,https://clinicaltrials.gov/study/NCT04440371,NO,ALL,"ADULT, OLDER_ADULT",,"Vitiligo, Generalized",,,,,COMBINATION_PRODUCT: Tacrolimus 0.1% ointment twice daily plus NBUVB 3 times weekly,COMBINATION_PRODUCT: Calcipotriol/Betamethasone ointment plus NBUVB,,,,"Diala Alshiyab, Irbid, Jordan",,,Diala Alshiyab,,,,
Vitiligo,NCT04803461,Catecholamines Level in Vitiligo Patients Before and After Excimer Light,https://clinicaltrials.gov/study/NCT04803461,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,"Vitiligo, Generalized",,,,,DIAGNOSTIC_TEST: serum and urinary catecholamines,,,,,,,,,,,,
Vitiligo,NCT05238077,Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized Vitiligo,https://clinicaltrials.gov/study/NCT05238077,NO,ALL,"ADULT, OLDER_ADULT",,Generalized Vitiligo,,,,,PROCEDURE: Visible Light-Ultraviolet A Light or Narrowband-Ultraviolet B phototherapy,,,,,"Department of Dermatology, Henry Ford Medical Center, 3031 West Grand Boulevard,, Detroit, Michigan, 48202, United States",,,Iltefat Hamzavi,,,,
Vitiligo,NCT03378011,UVA1 Phototherapy in Acral Vitiligo,https://clinicaltrials.gov/study/NCT03378011,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Acral Vitiligo,,,,,OTHER: phototherapy,,,,,"Maha Fathy Elmasry, Cairo, Egypt",,,Maha Elmasry,,,,
Vitiligo,NCT04039451,"Prevalence of Psoriasis and Vitiligo in Assiut Governorate, Egypt",https://clinicaltrials.gov/study/NCT04039451,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Psoriasis,Vitiligo,,,,,,,,,"Assiut University, Assiut, Egypt",,,,,,,
Vitiligo,NCT03535051,Efficiency of Fractional-Laser Resurfacing Followed by Topical Tacrolimus 0.03% Cream vs Tacrolimus Alone in Vitiligo,https://clinicaltrials.gov/study/NCT03535051,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Stable Vitiligo,,,,,DEVICE: fractional carbon dioxide laser,DRUG: Tacrolimus Oint 0.03%,,,,,,,Ola M AbuZeid,Dina ElSharkawy,,,
Vitiligo,NCT04818346,A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo,https://clinicaltrials.gov/study/NCT04818346,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,NonSegmental Vitiligo,,,,,DRUG: INCB054707,DRUG: Placebo,,,,"Investigative Site 010, Hoover, Alabama, 35244, United States","Investigative Site 015, Gilbert, Arizona, 85295, United States","Investigative Site 028, Scottsdale, Arizona, 85260, United States",,,,,
Vitiligo,NCT03358082,Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo,https://clinicaltrials.gov/study/NCT03358082,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,Vitiligo,Tacrolimus,,,,DRUG: Tacrolimus 0.03% Ointment,DRUG: Hydrocortisone Acetate 1% Ointment,,,,"Sohag University, Sohag, Egypt",,,Ramadan Saleh,,,,
Vitiligo,NCT03577327,The Gut and Skin Microbiome in Vitiligo Disease Progression,https://clinicaltrials.gov/study/NCT03577327,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,Healthy,,,,,,,,,"Northwestern University, Chicago, Illinois, 60611, United States",,,I. Caroline Le Poole,,,,
Vitiligo,NCT01701648,Melanocyte Transplantation for Patients With Stable Vitiligo.,https://clinicaltrials.gov/study/NCT01701648,NO,ALL,ADULT,PHASE1|PHASE2,Stable Vitiligo,,,,,OTHER: Laser CO2,,,,,"University Clinic of Navarre, Pamplona, Navarre, 31008, Spain",,,,,,,
Vitiligo,NCT03487042,Bimatoprost 0.03% Solution With NB-UVB Versus Their Use With Fractional Carbon Dioxide Laser in Treatment of Generalized Vitiligo,https://clinicaltrials.gov/study/NCT03487042,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Generalized Vitiligo,,,,,DRUG: Bimatoprost 0.03% ophthalmic solution,,,,,,,,,,,,
Vitiligo,NCT01202513,Topical Bimatoprost Solution 0.03%in Stable Vitiligo,https://clinicaltrials.gov/study/NCT01202513,NO,ALL,"CHILD, ADULT",PHASE4,Vitiligo,Repigmentation,,,,DRUG: Bimatoprost 0.03% topical ophthalmic solution,,,,,,,,Rajeev Jain,Tarun Narang,,,
Vitiligo,NCT02156427,Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism,https://clinicaltrials.gov/study/NCT02156427,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Vitiligo,Piebaldism,,,,DEVICE: VITICELL,DEVICE: PLACEBO,,,,"Department of Dermatology - Ghent University Hospital, Ghent, Belgium","University Hospital Center of Bordeaux, Bordeaux, France","CHU Le Mans, Le Mans, France",Nanja Van Geel,,,,
Vitiligo,NCT06072183,A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2,https://clinicaltrials.gov/study/NCT06072183,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Stable Nonsegmental Vitiligo,Active Nonsegmental Vitiligo,,,,DRUG: Ritlecitinib,DRUG: Ritlecitinib,DRUG: Placebo,,,"Total Dermatology, Birmingham, Alabama, 35203, United States","Total Skin & Beauty Dermatology Center, PC, Birmingham, Alabama, 35205, United States","Center for Dermatology and Plastic Surgery/CCT Research, Scottsdale, Arizona, 85260, United States",Pfizer .gov Call Center,,,,
Vitiligo,NCT05583526,A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo,https://clinicaltrials.gov/study/NCT05583526,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Stable Nonsegmental Vitiligo,Active Nonsegmental Vitiligo,,,,DRUG: Ritlecitinib,DRUG: Placebo,,,,"University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States","University of Alabama at Birmingham Faculty Office Towers (Regulatory, Birmingham, Alabama, 35294, United States","California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States",Pfizer .gov Call Center,,,,
Vitiligo,NCT01377077,Punchgrafting Techniques for Vitiligo,https://clinicaltrials.gov/study/NCT01377077,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Non-segmental Vitiligo,Segmental Vitiligo,Piebaldism,,,PROCEDURE: punchgrafting,PROCEDURE: punchgrafting,,,,"Netherlands Institute for Pigmentdisorders, Amsterdam, Noord-Holland, 1105 AZ, Netherlands",,,,,,,
Vitiligo,NCT05335746,Ocular Changes in Vitiligo Patients on Therapy,https://clinicaltrials.gov/study/NCT05335746,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,Chorioretinopathy,Chorioretinitis,,,DIAGNOSTIC_TEST: Optical coherence tomography angiography (OCT-A),,,,,"Benha University, BanhÄ, QA, 13511, Egypt",,,Amal A Yousif,,,,
Vitiligo,NCT00509314,The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis,https://clinicaltrials.gov/study/NCT00509314,NO,ALL,ADULT,,Melanocyte,Vitiligo,,,,BEHAVIORAL: melanocyte self-assembly and functional analysis,,,,,"National Taiwan University Hospital, Taipei, 100, Taiwan",,,Sung-Jan Lin,,,,
Vitiligo,NCT04057573,Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2),https://clinicaltrials.gov/study/NCT04057573,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Non-segmental Vitiligo,,,,,DRUG: Ruxolitinib cream,DRUG: Vehicle,,,,"Desert Sky Dermatology, Gilbert, Arizona, 85295, United States","Center For Dermatology Cosmetic and Laser Surgery, Fremont, California, 94538, United States","Uci Beckman Laser Institute and Medical Clinic, Irvine, California, 92617, United States",Kathleen Butler,,,,
Vitiligo,NCT04052425,Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1),https://clinicaltrials.gov/study/NCT04052425,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Non-segmental Vitiligo,,,,,DRUG: Ruxolitinib cream,DRUG: Vehicle,,,,"Cahaba Dermatology, Hoover, Alabama, 35244, United States","Cognitive Clinical Trials Scottsdale Btc Ppds, Scottsdale, Arizona, 85260, United States","Burke Pharmaceutical Research, Hot Springs National Park, Arkansas, 71913, United States",Kathleen Butler,,,,
Vitiligo,NCT06218082,Vitiligo Registry for Adults and Children in the UK,https://clinicaltrials.gov/study/NCT06218082,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Dermatologic Disease,Vitiligo,,,,,,,,,"The Royal Wolverhampton NHS Trust, Wolverhampton, WV10 0QP, United Kingdom",,,Viktoria Eleftheriadou,,,,
Vitiligo,NCT05990309,ASSESSMENT OF TRISTETRAPROLIN EXPRESSION IN LESIONAL SKIN OF PATIENTS WITH NON SEGMENTAL VITILIGO,https://clinicaltrials.gov/study/NCT05990309,NO,ALL,"ADULT, OLDER_ADULT",,Non-segmental Vitiligo,,,,,DIAGNOSTIC_TEST: skin biopsy,,,,,,,,,,,,
Vitiligo,NCT04927975,Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo,https://clinicaltrials.gov/study/NCT04927975,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Non-Segmental Vitiligo,,,,,DRUG: Upadacitinib,DRUG: Placebo,,,,"University of California Irvine /ID# 229390, Irvine, California, 92697-1385, United States","Stanford University /ID# 228000, Redwood City, California, 94063, United States","Clearlyderm Dermatology /ID# 227993, Boca Raton, Florida, 33428, United States",.,,,,
Vitiligo,NCT06113328,A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007),https://clinicaltrials.gov/study/NCT06113328,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Non-segmental Vitiligo,,,,,BIOLOGICAL: MK-6194,DRUG: Placebo,,,,"Cahaba Dermatology & Skin Health Center ( Site 0127), Birmingham, Alabama, 35244, United States","Burke Pharmaceutical Research ( Site 0124), Hot Springs, Arkansas, 71913, United States","The Vitiligo & Pigmentation Institute of Southern California ( Site 0115), Los Angeles, California, 90036, United States",Medical Director,,,,
Vitiligo,NCT04811326,Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation,https://clinicaltrials.gov/study/NCT04811326,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Non-segmental Vitiligo,,,,,RADIATION: NB-UVB,DRUG: Latanoprost,,,,"faculty of medicine, Aswan University, Aswan, Aswan Governorate, 81528, Egypt",,,Moustafa A El Taieb,,,,
Vitiligo,NCT04942860,The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo,https://clinicaltrials.gov/study/NCT04942860,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Non-segmental Vitiligo,,,,,DRUG: 1% Methotrexate gel,DRUG: 0.5% Methotrexate gel,,,,"Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University, Faculty of Medicine in Bydgoszcz, Bydgoszcz, Cuiavian-Pomeranian, 85094, Poland",,,RafaÅ‚ Czajkowski,,,,
Vitiligo,NCT04920162,Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma,https://clinicaltrials.gov/study/NCT04920162,NO,ALL,"ADULT, OLDER_ADULT",,Melanoma and Vitiligo,,,,,OTHER: Biospecimen into patients who had skin diseases,,,,,"CHU de Nice, Nice, Provence Alpes Cote d'Azur, 06000, France",,,,,,,
Vitiligo,NCT03047733,Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for Vitiligo,https://clinicaltrials.gov/study/NCT03047733,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Dermatologic Disease,Vitiligo,,,,DEVICE: The XTRAC Excimer Laser System,DRUG: Topical tacrolimus 0.1% ointment,,,,"Ajou university hospital, Suwon-si, Gyeonggi-do, 16499, Korea, Republic of",,,,,,,
Vitiligo,NCT04487860,Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo,https://clinicaltrials.gov/study/NCT04487860,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Non-segmental Vitiligo,,,,,DRUG: AS012,DRUG: Placebo,,,,"Sun Pharma Site 15, Phoenix, Arizona, 85018, United States","Sun Pharma Site 02, Bryant, Arkansas, 72022, United States","Sun Pharma Site 09, Fremont, California, 94538, United States",,,,,
Vitiligo,NCT02458417,Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients,https://clinicaltrials.gov/study/NCT02458417,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Segmental Vitiligo,Piebaldism,,,,DEVICE: ReCell,DEVICE: Full surface CO2 laser 200 mJ,DEVICE: Full surface CO2 laser 150 mJ,"DEVICE: Fractional CO2 laser 7.5 mJ, 20%",,"Netherlands Institute for Pigment disorders, Amsterdam, 1105 AZ, Netherlands",,,Albert Wolkerstorfer,Menno A. De Rie,,,
Vitiligo,NCT03622320,Metabolic Syndrome in Early Onset Versus Late Onset Vitiligo,https://clinicaltrials.gov/study/NCT03622320,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Metabolic Syndrome,Vitiligo,,,,OTHER: Blood sample,,,,,"Cairo university hospitals, dermatology outpatient clinic, Cairo, Egypt",,,Samar El-Tahlawi,,,,
Vitiligo,NCT04734704,Defining the Role of the Skin Microbiome in Immune-related Adverse Events,https://clinicaltrials.gov/study/NCT04734704,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,Skin Melanoma,,,,PROCEDURE: skin swabs at lesional and non-lesional sites,PROCEDURE: skin swabs on skin,,,,"Service de Dermatologie - HÃ´pital Saint-AndrÃ©, Bordeaux, 33075, France",,,Julien,,,,
Vitiligo,NCT02506101,"Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo",https://clinicaltrials.gov/study/NCT02506101,YES,ALL,"ADULT, OLDER_ADULT",,Vitiligo,Pigmentation,Dyschromia,,,DEVICE: narrow-band ultraviolet B phototherapy,,,,,"Johns Hopkins Dept. of Dermatology, Baltimore, Maryland, 21287, United States",,,Ginette Okoye,,,,
Vitiligo,NCT02660320,"Comparison of the Efficacy of Micro-holes vs. Laser-assisted Dermabrasion, for Repigmenting in Vitiligo Skin",https://clinicaltrials.gov/study/NCT02660320,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo - Macular Depigmentation,,,,,DEVICE: Dermabrasion,DEVICE: Laser placebo,,,,"CHU de Nice, Nice, Alpes-Maritimes, 06200, France","CH Creteil, Paris, Ile De France, France","CHU de Bordeaux, Bordeaux, 33 000, France",Passeron Thierry,,,,
Vitiligo,NCT03247400,The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo,https://clinicaltrials.gov/study/NCT03247400,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Non-segmental Vitiligo,,,,,DRUG: 1% simvastatin-acid sodium salt ointment,DRUG: 1% atorvastatin calcium salt ointment,,,,"Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University, Faculty of Medicine in Bydgoszcz, Bydgoszcz, Cuiavian-Pomeranian, 85094, Poland",,,Rafal Czajkowski,,,,
Vitiligo,NCT01640678,Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients,https://clinicaltrials.gov/study/NCT01640678,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Piebaldism,Segmental Vitiligo,,,,PROCEDURE: ReCell epidermal cell suspension grafting,PROCEDURE: CO2 laser abrasion + UV-therapy,,,,"The Netherlands Institute for pigment disorders, AMC, Amsterdam, 1105 AZ, Netherlands",,,,,,,
Vitiligo,NCT01841008,Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control,https://clinicaltrials.gov/study/NCT01841008,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Pigmentation Disorders,Vitiligo,,,,DRUG: Protopic,DRUG: Placebo : Diprobase,,,,"CHU de Nice - HÃ´pital de l'Archet, Nice, Alpes-Maritimes, 06200, France","CHU de Bordeaux, Bordeaux, Gironde, 33 404, France",,Thierry,,,,
Vitiligo,NCT05554523,How Does Skin Tone Affect Quantitative Photoacoustic Imaging,https://clinicaltrials.gov/study/NCT05554523,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,Skin Abnormalities,,,,DEVICE: Photoacoustic imaging,,,,,,,,,,,,
Vitiligo,NCT00484224,Audiological Disturbances in Vitiligo,https://clinicaltrials.gov/study/NCT00484224,NO,ALL,"CHILD, ADULT",,Vitiligo,Hearing Loss,,,,,,,,,"Hadassah Medical Organization, Jerusalem, Israel",,,Arieh Ingber,,,,
Vitiligo,NCT05293119,Role of Tofacitinib in Vitiligo Patients,https://clinicaltrials.gov/study/NCT05293119,NO,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,Vitiligo,Effect of Drug,,,,DRUG: JAK-2 inhibitor,DRUG: Topical corticosteroid,,,,,,,Mohammad Jahid Hasan,,,,
Vitiligo,NCT04872257,Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo,https://clinicaltrials.gov/study/NCT04872257,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,"Vitiligo, Generalized",Autoimmune,Autoimmune Diseases,Autoimmune Disease Skin,DRUG: Oral Vitamin D,PROCEDURE: NB-UVB Phototherapy,DRUG: Placebo,,,"Hospital Universitario ""Dr. Jose Eleuterio Gonzalez"", Monterrey, Nuevo Leon, 64460, Mexico",,,Adrian B Cuellar-Barboza,,,,
Vitiligo,NCT03270241,Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy,https://clinicaltrials.gov/study/NCT03270241,YES,ALL,"ADULT, OLDER_ADULT",,Vitiligo,Dermatology/Skin - Other,,,,DEVICE: Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet,,,,,"Johns Hopkins Outpatient Center, Baltimore, Maryland, 21287, United States",,,Noori Kim,,,,
Vitiligo,NCT06370650,Effect of Platelet Rich Plasma on Outcome of Narrow Band UVB in Treatment of Vitiligo; Clinical and Histopathological Study,https://clinicaltrials.gov/study/NCT06370650,NO,ALL,"CHILD, ADULT",,Management of Stable Vitiligo,,,,,"PROCEDURE: platelet rich plasma, narrow band UVB",,,,,"Faculty of Medicine, Sohag University, Sohag, 82515, Egypt",,,,,,,
Vitiligo,NCT05364567,Synergistic Effect of Vitamin D Supplementation in Patients With Vitiligo and Vitamin D Deficiency,https://clinicaltrials.gov/study/NCT05364567,NO,ALL,"ADULT, OLDER_ADULT",,Vitamin D Deficiency,Vitiligo,,,,DRUG: cholecalciferol (vitamin D3),PROCEDURE: Phototherapy,,,,"Kangnam Sacred Heart Hospital, Seoul, Korea, Republic of",,,Bo Young Chung,,,,
Vitiligo,NCT05316987,Effect of NB-UVB on the Tissue Level of IL 15 and IL-15RÎ± in Active Non Segmental Vitiligo Cases.,https://clinicaltrials.gov/study/NCT05316987,NO,ALL,"ADULT, OLDER_ADULT",,Active Non Segmental Vitiligo,,,,,RADIATION: Narrow band ultraviolet B,,,,,"Nourhan Emad, Cairo, Helwan, Egypt",,,Nourhan Emad,,,,
Vitiligo,NCT03185312,Cutaneous JAK in Vitiligo and Acne Vulgaris.,https://clinicaltrials.gov/study/NCT03185312,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Vitiligo and Acne Vulgaris,,,,,DIAGNOSTIC_TEST: skin biopsy,,,,,,,,Amira Abdel Motaleb,,,,
Vitiligo,NCT03715829,A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects,https://clinicaltrials.gov/study/NCT03715829,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Active Non-segmental Vitiligo,,,,,DRUG: PF-06651600,DRUG: PF-06651600,DRUG: PF-06651600,DRUG: PF-06651600,DRUG: PF-06651600,"Marvel Research, LLC, Huntington Beach, California, 92647, United States","University of California, Irvine, Dermatology Clinical Research Center, Irvine, California, 92697, United States","Vitiligo and Pigmentation Institute Of Southern California, Los Angeles, California, 90036, United States",Pfizer .gov Call Center,,,,
Vitiligo,NCT05536856,Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT05536856,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Vitiligo,Topical Fluorouracil,Effervescent Mixture,,,DRUG: a new effervescent mixture 5-florouracil formula,DRUG: 5-Fluorouracil plain powder,,,,"Facualty of Pharmacy, Al Azhar University, Cairo, 11765, Egypt",,,,,,,
Vitiligo,NCT05750823,A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo,https://clinicaltrials.gov/study/NCT05750823,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Nonsegmental Vitiligo With Genital Involvement,,,,,DRUG: Ruxolitinib Cream,,,,,"Center For Dermatology Clinical Research, Inc, Fremont, California, 94538, United States","Vitiligo & Pigmentation Institute of Southern California, Los Angeles, California, 90036, United States","Hamzavi Dermatology, Fort Gratiot, Michigan, 48059-3526, United States",,,,,
Vitiligo,NCT03365141,Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT03365141,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,Treatment,Intralesional Injection,Corticosteroid,,DRUG: Triamcinolone acetonide 0.4mg/cc,DEVICE: Phototherapy (NBUVB or excimer laser),DRUG: Topical tacrolimus,,,"St. Vincent's Hospital, Suwon, Gyonggi-do, 16247, Korea, Republic of",,,,,,,
Vitiligo,NCT02038257,Comparative Study Using Dermabrasion vs CO2 Laser & Collagen Dressing vs Vaseline Gauze in MKTP,https://clinicaltrials.gov/study/NCT02038257,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,Depigmented Scars,Depigmentation,,,PROCEDURE: MKTP (melanocyte keratinocyte transplant procedure),DEVICE: Collagen Dressing,DEVICE: Vaseline Impregnated Gauze,DEVICE: Carbon Dioxide Laser,DEVICE: Dermabrasion,"Henry Ford Dermatology, Detroit, Michigan, 48202, United States",,,Iltefat H Hamzavi,,,,
Hypothyroidism,NCT04953195,Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT04953195,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Subclinical Hypothyroidisms,,,,,DRUG: Levothyroxine Sodium Tablets,,,,,"Beijing Chao-Yang Hospital, Capital Medical University, Beijing, Beijing, China",,,,,,,
Hypothyroidism,NCT06083636,Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine,https://clinicaltrials.gov/study/NCT06083636,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,OTHER: Single extra blood draw and completion of single questionnaire,OTHER: Single blood draw and completion of single questionnaire,,,,"Amsterdam UMC, Amsterdam, Noord-Holland, 1105 AZ, Netherlands",,,Annemieke C Heijboer,,,,
Hypothyroidism,NCT05143918,Quality of Life Among Egyptian Hypothyroid Patients,https://clinicaltrials.gov/study/NCT05143918,NO,ALL,ADULT,,Hypothyroidism,,,,,OTHER: assessment of quality of life using questionnaire,,,,,,,,Nabawia M Tawfik,Ghada Abd El Rahman,Doaa M Osman,,
Hypothyroidism,NCT04795947,Correlation Between Thyroid Function and Quality of Life in Hypothyroidism,https://clinicaltrials.gov/study/NCT04795947,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,BEHAVIORAL: Behavioral,,,,,"BeijingCYH, Beijing, Beijing, 100020, China",,,Guang Wang,,,,
Hypothyroidism,NCT06345339,A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants,https://clinicaltrials.gov/study/NCT06345339,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Hypothyroidism,,,,,DRUG: Armour Thyroid,DRUG: Levothyroxine,,,,"Central Research Associates /ID# 255719, Birmingham, Alabama, 35205, United States","John Muir Medical Center /ID# 257103, Concord, California, 94520, United States","Diagnamics Inc. /ID# 262680, Encinitas, California, 92024, United States",,,,,
Hypothyroidism,NCT05334771,Early Detection of Endolymphatic Hydrops in Hypothyroid Patients,https://clinicaltrials.gov/study/NCT05334771,NO,ALL,ADULT,,Hypothyroidism,,,,,DEVICE: Dual band pure tune audiometer,,,,,,,,Enas Mostafa Osman,mohamed salama bakr,,,
Hypothyroidism,NCT05015725,"The Relationship Between Serum rT3 Concentrations, T3/T4 Ratio, and Symptoms/Quality of Life in Treated Hypothyroid Patients",https://clinicaltrials.gov/study/NCT05015725,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,"DIAGNOSTIC_TEST: Quality of life assessment, biochemical measures",,,,,"Semmelweis University - Departement Medicine and Oncology, Budapest, 1083, Hungary",,,,,,,
Hypothyroidism,NCT05823012,Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism,https://clinicaltrials.gov/study/NCT05823012,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Hypothyroidism,,,,,DRUG: levothyroxine sodium,,,,,"ProSciento, Inc., Chula Vista, California, 91911, United States","Catalina Research Institute, L.L.C., Montclair, California, 91763, United States","Panax Clinical Research, LLC, Miami Lakes, Florida, 33014, United States",Valentina Conoscenti,,,,
Hypothyroidism,NCT04878614,Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding,https://clinicaltrials.gov/study/NCT04878614,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Hypothyroidism,,,,,DRUG: Levothyroxine Tablet,DRUG: Levothyroxine Sodium,,,,"UCLA Center for Human Nutrition, Los Angeles, California, 90024, United States",,,Vijiya Surampudi,,,,
Hypothyroidism,NCT04236232,The Impact of Subclinical Hypothyroidism on Cardiovascular System,https://clinicaltrials.gov/study/NCT04236232,NO,ALL,ADULT,,Hypothyroidism,,,,,DIAGNOSTIC_TEST: Thyroid function,,,,,,,,,,,,
Hypothyroidism,NCT04332770,Biosignals by Wearable Devices in Hypothyroidism,https://clinicaltrials.gov/study/NCT04332770,NO,ALL,ADULT,,Hypothyroidism,,,,,OTHER: levothyroxine withdrawal,,,,,"Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, Korea, Republic of",,,,,,,
Hypothyroidism,NCT03631771,Pediatric Risk of Hypothyroidism With Iodinated Contrast Media,https://clinicaltrials.gov/study/NCT03631771,NO,ALL,CHILD,PHASE4,Hypothyroidism,,,,,DRUG: Iohexol,DRUG: Iodixanol,DRUG: Iopromide,DRUG: Ioversol,,,,,Paul F. Sherwin,Zuzana Jirakova Trnkova,Philippe Bourrinet,,
Hypothyroidism,NCT02024906,Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants,https://clinicaltrials.gov/study/NCT02024906,NO,ALL,"ADULT, OLDER_ADULT",,Cardiovascular Disease,Subclinical Hypothyroid,,,,DIETARY_SUPPLEMENT: soy protein isolate (SPI),DIETARY_SUPPLEMENT: milk protein isolate (MPI),,,,"University of Kansas Medical Center, Kansas City, Kansas, 66160, United States",,,Jill Hamilton-Reeves,,,,
Hypothyroidism,NCT03342001,Hypothyroidism Treated With Calcitonin,https://clinicaltrials.gov/study/NCT03342001,YES,ALL,"ADULT, OLDER_ADULT",PHASE4,Hypothyroidism,,,,,DRUG: Calcitonin,,,,,"University of Maryland Center for Diabetes and Endocrinology, Baltimore, Maryland, 21201, United States",,,Kashif Munir,,,,
Hypothyroidism,NCT02959827,Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States,https://clinicaltrials.gov/study/NCT02959827,YES,ALL,CHILD,,Hypothyroidism,,,,,DRUG: Iodinated contrast agents,,,,,"Oakland, Oakland, California, 94612, United States",,,,,,,
Hypothyroidism,NCT05314790,"Management of Patients With Diagnosis of Hypothyroidism, as Hospitalized and as Outpatients, in Internal Medicine Units: Observational Study Before & After Educational Programme",https://clinicaltrials.gov/study/NCT05314790,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,OTHER: intervening Educational Program,,,,,"ULSS1 Belluno San Martino, Belluno, Italy","Ospedale Versilia, Camaiore, Italy","Ospedale di CanicattÃ¬, CanicattÃ¬, Italy",,,,,
Hypothyroidism,NCT03180892,Non-immune Related Hypothyroidism in Iodine Sufficient Area,https://clinicaltrials.gov/study/NCT03180892,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,OTHER: The investigators did not apply any intervention for the participants.,,,,,,,,,,,,
Hypothyroidism,NCT05712421,A Study Evaluation the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Patients With Primary Hypothyroidism,https://clinicaltrials.gov/study/NCT05712421,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Hypothyroidism,,,,,DRUG: North Star,DRUG: Levothyroxine,,,,"Neuvosyn Investigational Site, Birmingham, Alabama, 35209, United States","Neuvosyn Investigational Site, Canoga Park, California, 91304, United States","Neuvosyn Investigational Site, Greenbrae, California, 94904, United States",,,,,
Hypothyroidism,NCT05412979,A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism,https://clinicaltrials.gov/study/NCT05412979,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Hypothyroidism,,,,,DRUG: ST-1891,DRUG: Levothyroxine,,,,"Sention Investigational Site, Greenbrae, California, 94904, United States","Sention Investigational Site, Newhall, California, 91321, United States","Sention Investigational Site, Denver, Colorado, 80246, United States",,,,,
Hypothyroidism,NCT03257566,Hypothyroidism in Patients With Type 1 Diabetes,https://clinicaltrials.gov/study/NCT03257566,NO,ALL,CHILD,,Hypothyroidism,,,,,,,,,,,,,,,,,
Hypothyroidism,NCT02993562,"Hypothyroidism, Metabolism and Food Intake",https://clinicaltrials.gov/study/NCT02993562,NO,FEMALE,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,DRUG: Levothyroxine,,,,,"Center for Diabetes Research, Herlev and Gentofte Hospitals, Copenhagen, Region Hovedstaden, 2900, Denmark",,,Bjarke B Medici,,,,
Hypothyroidism,NCT02577367,Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding,https://clinicaltrials.gov/study/NCT02577367,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Hypothyroidism,,,,,DRUG: Levothyroxine,,,,,"Maimonides Medical Center, Brooklyn, New York, 11219, United States",,,,,,,
Hypothyroidism,NCT00565864,Neurocognitive and Metabolic Effects of Mild Hypothyroidism,https://clinicaltrials.gov/study/NCT00565864,YES,ALL,"ADULT, OLDER_ADULT",PHASE4,Hypothyroidism,,,,,DRUG: L-thyroxine (L-T4),,,,,"Oregon Health and Science University, Portland, Oregon, 97201, United States",,,Mary Samuels,,,,
Hypothyroidism,NCT03095963,Interaction Between Levothyroxine and Probiotics in Hypothyroid Patients,https://clinicaltrials.gov/study/NCT03095963,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,OTHER: a mixture of highly charged Lactobacilli and Bifidobacteria (VSL#3Â®),DRUG: levothyroxin,,,,,,,,,,,
Hypothyroidism,NCT00818896,Maternal Hypothyroidism in Pregnancy,https://clinicaltrials.gov/study/NCT00818896,NO,FEMALE,"CHILD, ADULT",,Hypothyroidism,,,,,,,,,,"Women & Infants Hospital, Providence, Rhode Island, 02905, United States",,,James E. Haddow,,,,
Hypothyroidism,NCT02766283,Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure,https://clinicaltrials.gov/study/NCT02766283,YES,ALL,CHILD,,Hypothyroidism,,,,,DRUG: iodinated contrast agents,,,,,"Multiple Locations, Israel",,,Bayer Study Director,,,,
Hypothyroidism,NCT06205303,Interventional Study to Improve Medication Adherence Using Patient Decision Aid,https://clinicaltrials.gov/study/NCT06205303,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,OTHER: Patient Decision Aid (Video),,,,,"SingHealth Polyclinics, Singapore, Singapore",,,Kalaipriya Gunasekaran,,,,
Hypothyroidism,NCT00524238,Metabolic Changes in Hypothyroid Patients,https://clinicaltrials.gov/study/NCT00524238,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,DRUG: L-thyroxine,,,,,"Aarhus University Hospital, Aarhus, 8000, Denmark",,,,,,,
Hypothyroidism,NCT02917863,Randomized Crossover Trial for the Evaluation of the Possible Effects in the Intestine of Two Different Pharmaceutical Forms of L - Thyroxine in Patients With Primary Acquired Hypothyroidism,https://clinicaltrials.gov/study/NCT02917863,NO,ALL,"CHILD, ADULT",PHASE4,Hypothyroidism,,,,,"DRUG: L-Thyroxine (tablet, per os)","DRUG: L-Thyroxine (oral drops, solution)",,,,"Meyer Children's Hospital, Florence, Italy",,,,,,,
Hypothyroidism,NCT02364102,Effect of Hypothyroidism on Brown Adipose Tissue,https://clinicaltrials.gov/study/NCT02364102,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,,,,,,"University Hospital Basel, Department of Endocrinology, Basel, BS, 4031, Switzerland",,,Mirjam Christ-Crain,,,,
Hypothyroidism,NCT02891668,"Hypothyroidism, Metabolism and Quality of Life - Focus on QOL, REE, Cognitive Function and Body Composition",https://clinicaltrials.gov/study/NCT02891668,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,DRUG: Levothyroxine treatment,,,,,"Department of internal Medicine, Herlev Hospital, Herlev, Region Hovedstaden, DK-2730, Denmark",,,Bjarke Medici,,,,
Hypothyroidism,NCT01197183,"Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France",https://clinicaltrials.gov/study/NCT01197183,NO,ALL,ADULT,,Hypothyroidism,,,,,,,,,,"Merck Lipha SantÃ© Laboratories, Saint Romain, Lyon, 69008, France",,,Dr. Frederic Landron,,,,
Hypothyroidism,NCT02567877,Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?,https://clinicaltrials.gov/study/NCT02567877,NO,ALL,"ADULT, OLDER_ADULT",,Postsurgical Hypothyroidism,Hypothyroidism,,,,PROCEDURE: thyroidectomy,DRUG: levothyroxine in thyroidectomy patients,,,,"University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, United States",,,Bryan R Haugen,,,,
Hypothyroidism,NCT02467244,"Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism",https://clinicaltrials.gov/study/NCT02467244,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,DRUG: Levothyroxine,,,,,"AIIMS, Bhubaneswar, Bhubaneshwar, Odisha, 751019, India",,,,,,,
Hypothyroidism,NCT00206375,Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism,https://clinicaltrials.gov/study/NCT00206375,YES,ALL,CHILD,PHASE4,Hypothyroidism,,,,,DRUG: Growth hormone,DRUG: Growth hormone treatment and puberty,,,,"Baylor college of Medicine, Houston, Texas, 77030, United States",,,Parvin Yazdani,,,,
Hypothyroidism,NCT01769157,Effects of L-carnitine on Hypothyroidism,https://clinicaltrials.gov/study/NCT01769157,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Hypothyroidism,,,,,DRUG: L-carnitine,DRUG: Placebo,,,,"Korea University Anam Hospital, Seoul, Korea, Republic of",,,,,,,
Hypothyroidism,NCT01800617,A Study of T3 Therapy in Patients With Hypothyroidism,https://clinicaltrials.gov/study/NCT01800617,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Hypothyroidism,,,,,"DRUG: Liothyronine, Sodium",,,,,"Georgetown University Hospital, Washington, District of Columbia, 20007, United States",,,,,,,
Hypothyroidism,NCT00403390,Generic vs. Name-Brand Levothyroxine,https://clinicaltrials.gov/study/NCT00403390,YES,ALL,"CHILD, ADULT",,Congenital Hypothyroidism,Hypothyroidism,,,,DRUG: Brand Name Levothyroxine (Synthroid),DRUG: Generic formulation of Levothyroxine,,,,"Children's Hospital Boston, Boston, Massachusetts, 02115, United States",,,Rosalind S Brown,,,,
Hypothyroidism,NCT02094079,Monitoring and Evaluation of the Levothyroxin Replacement Therapy in Pregnant Women With Hypothyroidism,https://clinicaltrials.gov/study/NCT02094079,NO,FEMALE,ADULT,,Hypothyroidism,,,,,OTHER: biomedical outcomes,,,,,"Endocrine Unit O, Herlev Hospital, University of Copenhagen, Herlev, dk 2730, Denmark",,,Birte Nygaard,,,,
Hypothyroidism,NCT05821881,REduction of LEvothyroxine in Adults; a SElf Controlled Study,https://clinicaltrials.gov/study/NCT05821881,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,OTHER: Discontinuation of levothyroxine treatment,,,,,"Leiden University Medical Center, Leiden, 2300 RC, Netherlands",,,Jacobijn Gussekloo,,,,
Hypothyroidism,NCT03926585,Variations in the DIO2 and MCT10 Genes and Effect of Triiodothyronine Treatment,https://clinicaltrials.gov/study/NCT03926585,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,,,,,,"Herlev Hospital, Herlev, 2730, Denmark",,,,,,,
Hypothyroidism,NCT06073665,Dosing of LT4 in Older Individuals,https://clinicaltrials.gov/study/NCT06073665,NO,ALL,OLDER_ADULT,PHASE4,Hypothyroidism,,,,,DRUG: Levothyroxine Sodium,,,,,"Penn Medicine, Smilow Translational Research Center, Philadelphia, Pennsylvania, 19104, United States",,,Anne R. Cappola,,,,
Hypothyroidism,NCT00770016,Insulin Sensitivity and Metabolism Before and After Treatment in Patients With Hypothyroidism,https://clinicaltrials.gov/study/NCT00770016,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,DRUG: Levothyroxin,,,,,"Medical department M (Endocrinology and Diabetes), Aarhus University Hospital, Aarhus Sygehus,, Aarhus, 8000, Denmark",,,,,,,
Hypothyroidism,NCT03779906,Thyroid Function of Pediatric Subjects Following IsovueÂ® Administration,https://clinicaltrials.gov/study/NCT03779906,NO,ALL,CHILD,PHASE4,Hypothyroidism,,,,,DRUG: Isovue,,,,,"Children's Hospital and Medical Center, Omaha, Nebraska, 68114, United States",,,,,,,
Hypothyroidism,NCT05421468,Timing of Thyroxine Dose In Ramadan,https://clinicaltrials.gov/study/NCT05421468,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,OTHER: L-Thyroxine time B (5-15 minutes Before dawn),,,,,"Reem Alamoudi, Jeddah, 21423, Saudi Arabia","KingAbullahIMRC, Jeddah, Saudi Arabia",,,,,,
Hypothyroidism,NCT00715572,Combined Therapy With L-Thyroxine and L-Triiodothyronine Compared to L-Thyroxine Alone,https://clinicaltrials.gov/study/NCT00715572,NO,FEMALE,ADULT,,Hypothyroidism,,,,,DRUG: thyroxine,DRUG: thyroxine and triiodothyronine,,,,,,,Valentin V Fadeyev,,,,
Hypothyroidism,NCT05033496,The Yield of Postnatal Thyroid Function Test in the Well Baby Nursery,https://clinicaltrials.gov/study/NCT05033496,NO,ALL,CHILD,,Hypothyroidism,,,,,DIAGNOSTIC_TEST: Thyroid function test,,,,,"Hillel Yaffe medical center, HÌ±adera, Hadera, 38100, Israel",,,Erez Nadir,,,,
Hypothyroidism,NCT04877665,Establishing RIs for TSH in Children Under the Age of Two Years,https://clinicaltrials.gov/study/NCT04877665,NO,ALL,CHILD,,Hypothyroidism,,,,,,,,,,"The Aga Khan University, Karachi, Sindh, 3500, Pakistan",,,Siraj Muneer,,,,
Hypothyroidism,NCT02317926,Desiccated Thyroid Extract Versus Synthetic T3/T4 Combination (ThyrolarTM) Versus L-T4 Alone in the Therapy of Primary Hypothyroidism With Special Attention to the Gene Polymorphism,https://clinicaltrials.gov/study/NCT02317926,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,DRUG: Levothyroxine,DRUG: Levothyroxine Plus Liothyronine,DRUG: Desiccated Thyroid Extract,,,"Walter Reed National Military Medical Center, Besthesda, Maryland, 20889, United States",,,,,,,
Hypothyroidism,NCT04098991,Improving White Matter Integrity With Thyroid Hormone,https://clinicaltrials.gov/study/NCT04098991,NO,ALL,ADULT,,Hypothyroidism,,,,,DRUG: Levothyroxine,,,,,"University of Illinois at Chicago, Chicago, Illinois, 60612, United States",,,Olusola A Ajilore,,,,
Hypothyroidism,NCT03988517,Comparing Two-time Points of Thyroid Hormone Replacement During the Holy Month of Ramadan,https://clinicaltrials.gov/study/NCT03988517,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,OTHER: timing of receiving the drug,,,,,"Hamad General Hospital, Doha, 3050, Qatar",,,,,,,
Hypothyroidism,NCT01744743,Preconceptional Thyroid Screening and Childhood Nerocognitive Function,https://clinicaltrials.gov/study/NCT01744743,NO,FEMALE,ADULT,,Hypothyroidism,,,,,PROCEDURE: levothyroxine,,,,,"Obstetrics and Gynecology Hospital, Fudan University, Shanghai, Shanghai, 200011, China",,,Xiaotian Li,,,,
Hypothyroidism,NCT01921452,Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit,https://clinicaltrials.gov/study/NCT01921452,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Hypothyroidism,,,,,DEVICE: Quantitative POC TSH Kit,DEVICE: Qualitative POC TSH Kit,DEVICE: Third generation TSH Kit,,,"Research site, Shanghai, China",,,Medical Responsible,,,,
Hypothyroidism,NCT03053115,Combined Replacement Therapy With Levothyroxine and Liothyronine in Thyroidectomized Patients,https://clinicaltrials.gov/study/NCT03053115,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Hypothyroidism,,,,,DRUG: Liothyronine,DRUG: Levothyroxin,DRUG: Placebos,,,"AziendaUSLModena, Modena, 41126, Italy",,,,,,,
Hypothyroidism,NCT01744769,Effects of Thyroid Hormone Withdrawal on Metabolic Parameters During Radioactive Iodine Therapy in Thyroid Cancer,https://clinicaltrials.gov/study/NCT01744769,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,,,,,,"Konkuk University Medical Center, Seoul, 143-729, Korea, Republic of",,,Suk Kyeong Kim,,,,
Hypothyroidism,NCT00111735,Thyroxine Titration Study,https://clinicaltrials.gov/study/NCT00111735,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Hypothyroidism,,,,,DRUG: Thyroxine,,,,,"Sir Charles Gairdner Hospital, Nedlands, Western Australia, 6009, Australia",,,,,,,
Hypothyroidism,NCT01916304,Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation,https://clinicaltrials.gov/study/NCT01916304,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Hypothyroidism,,,,,DRUG: Levothyroxine sodium new formulation,,,,,"Leuven, Belgium",,,Medical Responsible,,,,
Hypothyroidism,NCT01647750,Study of Optimal Replacement of Thyroxine in the Elderly,https://clinicaltrials.gov/study/NCT01647750,NO,ALL,OLDER_ADULT,PHASE4,Hypothyroidism,,,,,DRUG: Levothyroxine,DRUG: Levothyroxine,,,,"Bensham Hospital, Gateshead, Tyne and Wear, NE8 4YL, United Kingdom","Clinical Research Facility, Newcastle upon Tyne, Tyne and Wear, NE1 4LP, United Kingdom",,Salman Razvi,,,,
Hypothyroidism,NCT01536678,Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian Volunteers,https://clinicaltrials.gov/study/NCT01536678,NO,MALE,ADULT,PHASE4,Hypothyroidism,,,,,DRUG: Levothyroxine,DRUG: Levothyroxine,,,,"GSK Investigational Site, Hyderabad, 500051, India",,,Clinical Trials,,,,
Hypothyroidism,NCT00287144,Post Partum Thyroiditis 2: Long Term Observations,https://clinicaltrials.gov/study/NCT00287144,NO,FEMALE,"CHILD, ADULT, OLDER_ADULT",,Hypothyroidism,,,,,,,,,,"Sykehuset Telemark HF, Skien, 3710, Norway",,,Janna Berg,,,,
Hypothyroidism,NCT03823859,Metabolomics of Thyroid Hormones,https://clinicaltrials.gov/study/NCT03823859,NO,ALL,"ADULT, OLDER_ADULT",,Central Hypothyroidism,Hypothyroidism,Hyperthyroidism,,,DIAGNOSTIC_TEST: Indirect calorimetry,DIAGNOSTIC_TEST: Dual energy X-ray Absorptiometry (DXA),DIAGNOSTIC_TEST: Blood sampling,,,"University Hospital Basel, Department of Endocrinology, Basel, BS, 4031, Switzerland",,,,,,,
Hypothyroidism,NCT00747760,TSH Receptor Mutations Among a Consanguineous Community,https://clinicaltrials.gov/study/NCT00747760,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Hypothyroidism,,,,,,,,,,"Samuell Refetoff, Chicago, Illinois, 60637-1470, United States","Ha'Emek Medical Center, Afula, 18101, Israel",,Yardena Tenenbaum-Rakover,Samuel Refetoff,,,
Hypothyroidism,NCT00205348,Swallowing Function Before and After Surgery for Thyroid Goiter,https://clinicaltrials.gov/study/NCT00205348,YES,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,,,,,,,,,,,,,,,,,
Hypothyroidism,NCT04712760,Congenital Hypothyroidism in Children With Eutopic Gland or Thyroid Hemiagenesis: Predictive Factors for Transient vs Permanent Hypothyroidism.,https://clinicaltrials.gov/study/NCT04712760,NO,ALL,CHILD,,Congenital Hypothyroidism,,,,,,,,,,"CHRU Nancy, Nancy, 54000, France",,,Emeline Renard,,,,
Hypothyroidism,NCT04831957,Hypothyroidism After the TAVI Procedure in Elderly Patients,https://clinicaltrials.gov/study/NCT04831957,NO,ALL,OLDER_ADULT,,Hypothyroidism,TAVI,,,,DIAGNOSTIC_TEST: Assesment of thyroÃ¯d function,,,,,"UZ brussel, Brussel, 1090, Belgium",,,,,,,
Hypothyroidism,NCT05801822,Screening of Subclinical Hypothyroidism in Pregnant Women,https://clinicaltrials.gov/study/NCT05801822,NO,FEMALE,ADULT,,Subclinical Hypothyroidism,,,,,DIAGNOSTIC_TEST: serum T.S.H level test,,,,,,,,Amira M Mahmoud,,,,
Hypothyroidism,NCT05276856,Recovery Rate in Secondary Hypothyroidism,https://clinicaltrials.gov/study/NCT05276856,NO,ALL,"ADULT, OLDER_ADULT",,Secondary Hypothyroidism,,,,,DRUG: Levothyroxine,,,,,,,,,,,,
Hypothyroidism,NCT03036956,The Prevalence of Sub Clinical Hypothyroidism During Early Pregnancy in Pakistan,https://clinicaltrials.gov/study/NCT03036956,NO,FEMALE,ADULT,,Subclinical Hypothyroidism,,,,,,,,,,"Isra University hospital, Hyderabad, 71800, Pakistan","Pakistam Insititute of Medical science, Islamabad, 144001, Pakistan","Atia Hospital Hospital, Karachi, 75100, Pakistan",,,,,
Hypothyroidism,NCT03465176,The Effect of Aroma on Fatigue Scores Among Women With Hypothyroidism,https://clinicaltrials.gov/study/NCT03465176,NO,FEMALE,ADULT,,Fatigue,Hypothyroidism,,,,OTHER: Aromatherapy Blend,OTHER: Placebo,,,,"Franklin Institute of Wellness, Franklin, Tennessee, 37067, United States",,,,,,,
Hypothyroidism,NCT05316922,TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients,https://clinicaltrials.gov/study/NCT05316922,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Hypothyroidism; Irradiation,,,,,DRUG: Levothyroxine,,,,,"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy",,,,,,,
Hypothyroidism,NCT05371262,Influence of Initial Levothyroxine Dose on Neurodevelopmental and Growth Outcomes in Congenital Hypothyroidism,https://clinicaltrials.gov/study/NCT05371262,NO,ALL,CHILD,PHASE4,Congenital Hypothyroidism,,,,,DRUG: Levothyroxin,,,,,,,,Mariacarolina Salerno,,,,
Hypothyroidism,NCT02430857,Osteopathy and Latent Hypothyroidism,https://clinicaltrials.gov/study/NCT02430857,NO,FEMALE,"ADULT, OLDER_ADULT",,Latent Hypothyroidism,,,,,OTHER: OMT,,,,,,,,Emanuel Diekmann,,,,
Hypothyroidism,NCT04288115,Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT04288115,YES,ALL,"ADULT, OLDER_ADULT",PHASE4,Subclinical Hypothyroidism,,,,,DRUG: Levothyroxine,OTHER: Placebo,,,,"Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR, North Little Rock, Arkansas, 72114-1706, United States",,,Spyridoula Maraka,,,,
Hypothyroidism,NCT04784208,A Study to Determine the Validity and Sensitivity of 'Questionnaire to Screen for HYpothyroidism' (Q'SHY),https://clinicaltrials.gov/study/NCT04784208,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,Healthy,,,,DIAGNOSTIC_TEST: Blood test for Thyroid stimulating hormone (TSH),,,,,"Diabecare, Mumbai, Maharashtra, 400706, India","Center for Diabetes and Endocrine care, Bangalore, 560043, India","Apollo Excelcare Hospital, Guwahati, 781033, India",Shivani Acharya,,,,
Hypothyroidism,NCT05228184,Use of TirosintÂ®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH),https://clinicaltrials.gov/study/NCT05228184,NO,ALL,CHILD,PHASE4,Congenital Hypothyroidism,,,,,DRUG: TirosintÂ®-SOL,DRUG: Levothyroxine Sodium,,,,"Children's Hospital of Los Angeles, Los Angeles, California, 90027, United States","CHOC Children's Hospital, Orange, California, 92868, United States","University of California San Francisco, San Francisco, California, 94143, United States",Giuseppe Mautone,,,,
Hypothyroidism,NCT01997554,Validation of a New TSH Test,https://clinicaltrials.gov/study/NCT01997554,NO,ALL,"ADULT, OLDER_ADULT",,Sub-clinical Hypothyroidism,Hypothyroidism,Euthyroidism,,,OTHER: Blood sample,,,,,"Centre Hospitalier de ChambÃ©ry, ChambÃ©ry, 73000, France","Centre Hospitalier Lyon Sud, Pierre-BÃ©nite, 69495, France",,,,,,
Hypothyroidism,NCT01280292,"Central Hypothyroidism, a Novel Laboratory Measurement",https://clinicaltrials.gov/study/NCT01280292,NO,ALL,"ADULT, OLDER_ADULT",,Central Hypothyroidism,,,,,DRUG: Eltroxin,,,,,,,,Ruth Percik,,,,
Hypothyroidism,NCT05682482,LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients With Autoimmune Hypothyroidism.,https://clinicaltrials.gov/study/NCT05682482,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Autoimmune Hypothyroidism,,,,,DRUG: LT3 (liothyronine),DRUG: Placebo,,,,"Amsterdam UMC - Location AMC, Amsterdam, Netherlands","Rijnstate, Arnhem, Netherlands","Van Weel-Bethesda Hospital, Dirksland, Netherlands",,,,,
Hypothyroidism,NCT02090907,Effects of Levothyroxine on Endothelial Function of Patients With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT02090907,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Subclinical Hypothyroidism,,,,,DRUG: Levothyroxine,DRUG: Placebo,,,,"Khorshid endocrinology clinic, Isfahan, Iran, Islamic Republic of",,,Nasmi Niknam,,,,
Hypothyroidism,NCT01801033,Effects of Thyroid Hormone Enzyme Blocking on Hypothyroidism,https://clinicaltrials.gov/study/NCT01801033,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,Thyroidectomy,,,,,,,,,,,,Francesco S Celi,,,,
Hypothyroidism,NCT02399475,Mechanistic Study of Subclinical Hypothyroidism In the Elderly,https://clinicaltrials.gov/study/NCT02399475,YES,ALL,OLDER_ADULT,,Subclinical Hypothyroidism,,,,,DRUG: Levothyroxine,DRUG: Liothyronine,DRUG: Thyrotropin-Releasing Hormone,,,"University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States",,,Anne R Cappola,,,,
Hypothyroidism,NCT00962221,Lipids Profile in Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT00962221,NO,ALL,"ADULT, OLDER_ADULT",,Subclinical Hypothyroidism,,,,,PROCEDURE: laboratory analysis,,,,,"Endocrine Institute, Haemek Medical Center, Afula, 18101, Israel",,,Rafael Luboshitzky,Manfredi Rizzo,Giatgen Spinas,,
Hypothyroidism,NCT02689609,Post-radiation Hypothyroidism After IMRT for Nasopharyngeal Carcinoma,https://clinicaltrials.gov/study/NCT02689609,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,Complications,,,,RADIATION: Intensity-modulated radiation therapy,,,,,,,,Victor  Lee,,,,
Hypothyroidism,NCT02374593,Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism,https://clinicaltrials.gov/study/NCT02374593,YES,ALL,CHILD,,Congenital Hypothyroidism,,,,,DRUG: Levothyroxine,DEVICE: Ultrasound,,,,"Riley Hospital for Children, Indianapolis, Indiana, 46202, United States",,,Erica Eugster,,,,
Hypothyroidism,NCT01660126,Thyroid Hormone Replacement for Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT01660126,NO,ALL,OLDER_ADULT,PHASE4,Subclinical Hypothyroidism,,,,,DRUG: Levothyroxine,DRUG: Placebo,,,,"Glasgow Royal Infirmary, NHS Greater Glasgow and Clyde, Glasgow, G31 2ER, United Kingdom",,,,,,,
Hypothyroidism,NCT05019118,Dietary Intervention With Ãšnicla Dairy Products (DANTIAN),https://clinicaltrials.gov/study/NCT05019118,NO,FEMALE,"ADULT, OLDER_ADULT",,Subclinical Hypothyroidism,,,,,OTHER: Experimental milk,OTHER: Experimental yogur,OTHER: Experimental fresh cheese,OTHER: Placebo milk,OTHER: Placebo yogur,"Nursing University School of Ourense, Ourense, 32005, Spain",,,Maria Reyes PÃ©rez- FernÃ¡ndez,,,,
Hypothyroidism,NCT02005250,Bone Structure and Strength Evaluated by Extreme-CT Scan Before and After Treatment of Hyper- and Hypothyroidism,https://clinicaltrials.gov/study/NCT02005250,YES,FEMALE,"ADULT, OLDER_ADULT",,Hyperthyroidism,Hypothyroidism,,,,,,,,,"Odense University Hospital, Odense, 5000, Denmark",,,Steen Bonnema,,,,
Hypothyroidism,NCT00493103,TG Gene Mutations and Congenital Hypothyroidism,https://clinicaltrials.gov/study/NCT00493103,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Congenital Hypothyroidism,,,,,,,,,,,,,Viviane Pardo,Geraldo Medeiros-Neto,,,
Hypothyroidism,NCT04734457,Final Height in Patients With CH Diagnosed by the Screening,https://clinicaltrials.gov/study/NCT04734457,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Congenital Hypothyroidism,,,,,DRUG: Levothyroxin,,,,,"Ain Shams University, Cairo, Abbasiya, 1181, Egypt",,,Wessam Mouharram,Rana Mahmoud,,,
Hypothyroidism,NCT01916018,Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis.,https://clinicaltrials.gov/study/NCT01916018,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Congenital Hypothyroidism,,,,,OTHER: Clinical and radiologic exams and blood samples,,,,,"Pediatric endocrinology gynecology and diabetology, HÃ´pital Necker Enfants Malades, Assistance Publique - HÃ´pitaux de Paris , UniversitÃ© Paris Descartes, INSERM unit U 845, Paris, 75015, France",,,,,,,
Hypothyroidism,NCT01739972,Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment,https://clinicaltrials.gov/study/NCT01739972,NO,ALL,"ADULT, OLDER_ADULT",,Primary Hypothyroidism.,,,,,DRUG: Levothyroxine,DRUG: Desiccated thyroid extract,,,,"Walter Reed National Military Medical Center, Endocrinology, Bethesda, Maryland, 20889-5600, United States","Walter Reed National Military Medical Center, Bethesda, Maryland, 20889-5600, United States",,,,,,
Hypothyroidism,NCT05733078,Effect of Vitamin C Supplementation in Patients With Primary Hypothyroidism,https://clinicaltrials.gov/study/NCT05733078,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Hypothyroidism,Primary Hypothyroidism,Vitamin C Deficiency,,,DRUG: Vitamin C,DRUG: Oral Rehydration Salt Formulations,,,,"Internal Medicine, College of Medicine and Health Sciences, Al Ain, Abu Dhabi, 15551, United Arab Emirates",,,Adnan Agha,,,,
Hypothyroidism,NCT03102177,"Effect of Age, Weight and Sex on Levothyroxine Pharmacokinetics",https://clinicaltrials.gov/study/NCT03102177,NO,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,Hypothyroidism Primary,,,,,DRUG: Administration of stable Isotope labeled levothyroxine,,,,,,,,,,,,
Hypothyroidism,NCT00921050,Subclinical Hypothyroidism and Mind in the Elderly,https://clinicaltrials.gov/study/NCT00921050,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Subclinical Hypothyroidism,,,,,DRUG: levothyroxine sodium,DRUG: excipient without levothyroxine (placebo),,,,"Endocrinology, Outpatient Hospital Clinic, Monterrey, Nuevo Leon, 64460, Mexico","Community Health Center (Fomerrey 19), Monterrey, Nuevo Leon, Mexico",,Lilia Cardenas-Ibarra,Jesus Z Villarreal-Perez,,,
Hypothyroidism,NCT03496363,Hypothyroidism With Congenital Heart Disease (CHD),https://clinicaltrials.gov/study/NCT03496363,NO,ALL,CHILD,,Hypothyroidism,CHD,,,,"DIAGNOSTIC_TEST: TSH , T4",,,,,,,,,,,,
Hypothyroidism,NCT04806269,Biosignals by Wearables in Thyroid Dysfunction,https://clinicaltrials.gov/study/NCT04806269,NO,ALL,ADULT,,Thyrotoxicosis,Hypothyroidism,,,,DEVICE: Fitbit and Glandy,,,,,"Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, Korea, Republic of",,,,,,,
Hypothyroidism,NCT00230802,Thyroid Hormone Dose Adjustment in Pregnancy,https://clinicaltrials.gov/study/NCT00230802,YES,FEMALE,"CHILD, ADULT, OLDER_ADULT",,Pregnancy,Hypothyroidism,,,,DRUG: Anticipatory dose increase of levothyroxine,DRUG: levothyroxine,DRUG: levothyroxine,,,"Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States",,,Erik Alexander,,,,
Hypothyroidism,NCT00498238,The Effect of Levothyroxine on Arterial Stiffness and Lipid Profile in Patients With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT00498238,NO,ALL,"ADULT, OLDER_ADULT",,Subclinical Hypothyroidism,,,,,DRUG: Levothyroxine,,,,,,,,Ronit Koren,,,,
Hypothyroidism,NCT04988802,The Effect of Dietary Supplements for Pregnant Women on Levothyroxine Absorption,https://clinicaltrials.gov/study/NCT04988802,NO,FEMALE,"ADULT, OLDER_ADULT",,Hypothyroidism Primary,,,,,DIETARY_SUPPLEMENT: Prenatal Nutrients Solgar,OTHER: Placebo,,,,"Dubrava University Hospital, Zagreb, Grad Zagreb, 10000, Croatia",,,,,,,
Hypothyroidism,NCT04648722,Higher Levothyroxine Requirements After Right-side Hemithyroidectomy,https://clinicaltrials.gov/study/NCT04648722,NO,ALL,"ADULT, OLDER_ADULT",,Hemithyroidectomy,Hypothyroidism,,,,PROCEDURE: Hemithyroidectomy,,,,,"Medical University of Vienna, Vienna, 1090, Austria",,,Lana Kosi-Trebotic,,,,
Hypothyroidism,NCT04767763,Thyroid Function in Critically Ill Patients With Acute Kidney Injury,https://clinicaltrials.gov/study/NCT04767763,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Secondary Hypothyroidism,,,,,"DIAGNOSTIC_TEST: Assessment of TSH, fT3, fT4,TRH, TT3, TT4, rT3 in patients with CVVHDF",,,,,"Medical University of Gdansk - Departament of Anesthesiology and Intensive Care, GdaÅ„sk, Pomorskie, 80-214, Poland",,,,,,,
Hypothyroidism,NCT01838031,Thyroid Screening Protocol During Pregnancy: a Multi-center Prospective Controlled Study,https://clinicaltrials.gov/study/NCT01838031,NO,FEMALE,ADULT,,Subclinical Hypothyroidism,,,,,OTHER: thyroid screening,,,,,"Peking Union Medical College Hospital, Beijing, Beijing, 100730, China",,,Liangkun Ma,,,,
Hypothyroidism,NCT03094416,Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors,https://clinicaltrials.gov/study/NCT03094416,YES,ALL,"ADULT, OLDER_ADULT",PHASE4,Hypothyroidism;Postablative,,,,,DRUG: levothyroxine sodium capsule,DRUG: Proton pump inhibitor (PPI),DRUG: Levothyroxine Sodium (LT4) Tablets,,,"California Head and Neck Specialists, La Jolla, California, 92037, United States","Coastal Metabolic Research Centre, Ventura, California, 93003, United States","Washington Hospital Center, Washington, District of Columbia, 20010-2975, United States",Kenneth D Burman,,,,
Hypothyroidism,NCT01145040,NOMOTHETICOS: Nonlinear Modelling of Thyroid Hormones' Effect on Thyrotropin Incretion in Confirmed Open-loop Situation,https://clinicaltrials.gov/study/NCT01145040,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Hypothyroidism,Hyperthyroidism,,,,,,,,,"Klinikum Ludwigsburg-Bietigheim, Bietigheim, BW, D-74321, Germany","Institute for diagnostical radiology, interventional radiology and nuclear medicine, Bergmannsheil University Hospitals, Ruhr University of Bochum, Bochum, NRW, D-44789, Germany","Medical Hospital I, Bergmannsheil University Hospitals, Ruhr University of Bochum, Bochum, NRW, D-44789, Germany",Johannes W Dietrich,Harald H Klein,Johannes W Dietrich,,
Hypothyroidism,NCT01204359,The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions,https://clinicaltrials.gov/study/NCT01204359,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Hypothyroidism,Exophthalmos,,,,RADIATION: Iodine 131,,,,,"Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, 510120, China","Ningyi Jiang, Guangzhou, China",,#NAME?,,,,
Hypothyroidism,NCT01379170,Thyroid Study Type 2 Diabetes Mellitus (T2DM),https://clinicaltrials.gov/study/NCT01379170,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Diabetes,Hypothyroidism,,,,DRUG: Euthyrox (levothyroxine),,,,,"Maastricht University Medical Centre, Maastricht, Limburg, 6200MD, Netherlands",,,,,,,
Hypothyroidism,NCT06096454,Effect of Life Style Modification and Metformin on Hypothyroidism With Insulin Resistance,https://clinicaltrials.gov/study/NCT06096454,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Hypothyroidism,Insulin Resistance,,,,DRUG: Metformin,,,,,,,,Mohammad  AbdEllah-Alawi,,,,
Hypothyroidism,NCT02512978,Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction(ThyroHeart-AMI),https://clinicaltrials.gov/study/NCT02512978,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Myocardial Infarction,Hypothyroidism,,,,DRUG: Levothyroxine,,,,,"Fuwai Cardiovascular Hospital, Beijing, 100037, China",,,,,,,
Hypothyroidism,NCT04354896,The Effect of Thyroid Hormone Therapy on Muscle Mass and Function in Older Adults With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT04354896,NO,ALL,OLDER_ADULT,PHASE4,Subclinical Hypothyroidism,Sarcopenia,,,,DRUG: Levothyroxin,DRUG: Placebo,,,,"Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, Netherlands","Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands","Institute for Evidence-Based Medicine in Old Age, Leiden, Netherlands",Nicolas Rodondi,,,,
Hypothyroidism,NCT03178253,Hypothyroidism in Patients With Type 2 Diabetes With Early Diabetic Nephropathy,https://clinicaltrials.gov/study/NCT03178253,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism in Diabetes,,,,,,,,,,"Maria Hamdy, Assuit, Egypt",,,,,,,
Hypothyroidism,NCT00488644,Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors,https://clinicaltrials.gov/study/NCT00488644,YES,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,Brain Tumor,,,,DRUG: Levothyroxine,DRUG: Liothyronine,,,,"UT MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,Victor Levin,,,,
Hypothyroidism,NCT01853579,The TRUST Study - Depression Substudy,https://clinicaltrials.gov/study/NCT01853579,NO,ALL,OLDER_ADULT,PHASE4,Subclinical Hypothyroidism,Depression,,,,DRUG: Levothyroxine,DRUG: Placebo,,,,"Leiden University Medical Center, Leiden, 2300, Netherlands","Department of General Internal Medicine, Lausanne, Vaud, 1011, Switzerland","University Clinic for General Internal Medicine, Bern University Hospital, Bern, 3010, Switzerland",,,,,
Hypothyroidism,NCT00001730,Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.,https://clinicaltrials.gov/study/NCT00001730,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Hypothyroidism,Thyroid Neoplasms,,,,DRUG: Thyrogen,,,,,"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, 20892, United States",,,,,,,
Hypothyroidism,NCT04747275,Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients,https://clinicaltrials.gov/study/NCT04747275,YES,ALL,CHILD,PHASE4,Hypothyroidism,Trisomy 21,,,,DRUG: Liquid stable levothyroxine (L-T4) Tirosint-SOL,DRUG: Oral tablet levothyroxine (L-T4),,,,"Children's Mercy Hospital, Kansas City, Missouri, 64108, United States",,,,,,,
Hypothyroidism,NCT03120221,Iodine Status in Pregnant Women in Israel,https://clinicaltrials.gov/study/NCT03120221,NO,FEMALE,ADULT,,Iodine-Deficiency; Hypothyroidism,,,,,DIAGNOSTIC_TEST: Urine sample for iodine measurement,,,,,"Women Health Service, Ashdod, Israel","Women Health Center, Tel Aviv, Israel",,,,,,
Hypothyroidism,NCT05760131,Awareness of Osteoporosis in Patients With Hypothyroidism,https://clinicaltrials.gov/study/NCT05760131,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,Osteoporosis,Osteoporosis Risk,,,OTHER: Patient Participation Form,,,,,,,,Mustafa H Temel,,,,
Hypothyroidism,NCT02499471,Brown Adipose Tissue Activity and Thyroid Hormone,https://clinicaltrials.gov/study/NCT02499471,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,Hyperthyroidism,Obesity,,,OTHER: Levothyroxine therapy (137.75 Â± 23.75 Î¼g/day),,,,,"Maastricht UMC, Maastricht, Limburg, 6229HX, Netherlands",,,Wouter van Marken Lichtenbelt,,,,
Hypothyroidism,NCT01707056,The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma,https://clinicaltrials.gov/study/NCT01707056,NO,ALL,ADULT,,Thyroid Carcinoma,Hypothyroidism,,,,OTHER: Black Coffee,OTHER: Coffee with Milk,OTHER: Black Tea,OTHER: Water,,"Georgetown University Hospital, Washington, District of Columbia, 20007, United States","Washington Hospital Center, Washington, District of Columbia, 20010, United States","MedStar St. Mary's Hospital, Leonardtown, Maryland, 20650, United States",Dorota Krajewski,,,,
Hypothyroidism,NCT06408909,Pharmacist Role in Thyroid Disorders,https://clinicaltrials.gov/study/NCT06408909,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,Hyperthyroidism,Thyroid Diseases,,,BEHAVIORAL: Clinical Pharmacist Intervention Group,,,,,"Marmara University, Istanbul, 34854, Turkey",,,,,,,
Hypothyroidism,NCT05247476,Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.,https://clinicaltrials.gov/study/NCT05247476,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,"Thyroid Cancer, Papillary",Hypothyroidism,,,,DRUG: L-T4,DRUG: L-T4+T3 (thyroid tablet),,,,"Yan Ling, Xiamen, Fujian, 361004, China",,,Yilin Zhao,,,,
Hypothyroidism,NCT03096613,Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF),https://clinicaltrials.gov/study/NCT03096613,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Heart Failure,Subclinical Hypothyroidism,,,,DRUG: Levothyroxine,,,,,"Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing, Beijing, 100037, China",,,Yi-Da Tang,,,,
Hypothyroidism,NCT02548715,Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery,https://clinicaltrials.gov/study/NCT02548715,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Hypothyroidism,Neoplasms,Postoperative Complications,,,DRUG: Levothyroxine,DRUG: Placebo,,,,,,,,,,,
Hypothyroidism,NCT00360074,Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation,https://clinicaltrials.gov/study/NCT00360074,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Secondary Hypothyroidism,Hypopituitarism,Hyperlipidemias,,,"DRUG: Thyroxin, Triiodothyronine",,,,,"University Hospital Freiburg, Department of Medicine, Freiburg, Baden-WÃ¼rttemberg, 79104, Germany",,,,,,,
Hypothyroidism,NCT01358136,ThyrOp: A Study of Individual Subclinical Hypothyroidism After Hemithyroidectomy for Benign Nontoxic Goiter,https://clinicaltrials.gov/study/NCT01358136,NO,ALL,"ADULT, OLDER_ADULT",,Goiter,Hypothyroidism,Weight Gain,,,,,,,,"Slagelse Hospital, Hospital South, Slagelse, Region Zealand, 4200, Denmark",,,,,,,
Hypothyroidism,NCT01832753,Treatment Trial of Subclinical Hypothyroidism in Down Syndrome,https://clinicaltrials.gov/study/NCT01832753,YES,ALL,"CHILD, ADULT",,Down Syndrome,Subclinical Hypothyroidism,,,,DRUG: Levothyroxine,,,,,"Children's National Medical Center, Washington, District of Columbia, 20010, United States","The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States",,Andrea Kelly,,,,
Hypothyroidism,NCT01223638,The Prevalence of Hearing Loss Among Children With Congenital Hypothyroidism,https://clinicaltrials.gov/study/NCT01223638,NO,ALL,"CHILD, ADULT",,Congenital Hypothyroidism,Hearing Loss,,,,OTHER: Audiometry,,,,,"Ha'Emek Medical Center, Afula, 18101, Israel",,,,,,,
Hypothyroidism,NCT00388297,Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy,https://clinicaltrials.gov/study/NCT00388297,YES,FEMALE,"CHILD, ADULT, OLDER_ADULT",PHASE3,Subclinical Hypothyroidism,Hypothyroxinemia,Pregnancy,,,DRUG: Levothyroxine,DRUG: Placebo for Levothyroxine,,,,"University of Alabama - Birmingham, Birmingham, Alabama, 35249, United States","Northwestern University, Chicago, Illinois, 60611, United States","Wayne State University, Detroit, Michigan, 48201, United States",Brian Casey,Menachem Miodovnik,,,
Hypothyroidism,NCT06455371,Patient-centered Dosage of Levothyroxine,https://clinicaltrials.gov/study/NCT06455371,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,Thyroid Cancer,Thyroid,,,OTHER: Decision support tool,,,,,,,,,,,,
Hypothyroidism,NCT03612908,TSHÎ²X1 and D2 THR92ALA in Pregnancy,https://clinicaltrials.gov/study/NCT03612908,NO,FEMALE,ADULT,,Pregnancy Related,Hypothyroidism,Hyperthyroidism,,,,,,,,"Materno-Perinatal Hospital ""MÃ³nica Pretelini"", Toluca, 50130, Mexico",,,Mendieta ZerÃ³n,,,,
Hypothyroidism,NCT03712683,Thyroxin in Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT03712683,NO,FEMALE,ADULT,,Sub Clinical Hypothyroidism,Pregnancy Loss,,,,DRUG: Thyroxine,,,,,,,,Ariana Kh. Jawad,,,,
Hypothyroidism,NCT05240911,Individual Dosing of Levothyroxine After Thyroidectomy,https://clinicaltrials.gov/study/NCT05240911,NO,ALL,"ADULT, OLDER_ADULT",,Thyroid Neoplasms,Hypothyroidism,Surgery,,,DRUG: Levothyroxine Sodium Tablets,,,,,"Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China",,,,,,,
Hypothyroidism,NCT06276205,Vitamin D & Levothyroxine Combination Versus Levothyroxine on Lipid Profile in Hypothyroidism,https://clinicaltrials.gov/study/NCT06276205,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Hypothyroidism Primary,Lipid Disorder,Dyslipidemias,,,DRUG: Vitamin D,DRUG: Levothyroxin,,,,"King Edward Medical University, Lahore, Punjab, 54000, Pakistan",,,,,,,
Hypothyroidism,NCT05385029,Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19,https://clinicaltrials.gov/study/NCT05385029,NO,,"CHILD, ADULT, OLDER_ADULT",,Thyroid Dysfunction,Hypothyroidism,Hyperthyroidism,,,DRUG: Thyroxine,,,,,"Security Forces Hospital, Riyadh, Central, 11481, Saudi Arabia",,,,,,,
Hypothyroidism,NCT01985204,Iodine Supplementation in Obesity,https://clinicaltrials.gov/study/NCT01985204,NO,FEMALE,ADULT,,Iodine Deficiency,Subclinical Hypothyroidism,,,,DIETARY_SUPPLEMENT: Iodine tablet,DIETARY_SUPPLEMENT: Placebo tablet,,,,"Universite Caddi Ayad, Faculte de Medecine et de Pharmacie, Marrakech, Morocco","University Cadi Ayyad, Faculte des Sciences, Marrakech, Morocco",,,,,,
Hypothyroidism,NCT02946918,Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy,https://clinicaltrials.gov/study/NCT02946918,YES,ALL,"ADULT, OLDER_ADULT",PHASE4,Thyroid Cancer,Postsurgical Hypothyroidism,,,,DRUG: Levothyroxine,,,,,"University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States",,,Alex Tessnow,,,,
Hypothyroidism,NCT04528225,A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer,https://clinicaltrials.gov/study/NCT04528225,NO,FEMALE,"ADULT, OLDER_ADULT",,Breast Neoplasms,Hypothyroidism,Radiation Toxicity,,,,,,,,"Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, 100021, China",,,Shu-lian Wang,,,,
Hypothyroidism,NCT00336102,Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers,https://clinicaltrials.gov/study/NCT00336102,NO,FEMALE,"ADULT, OLDER_ADULT",,Breast Cancer,Fatigue,Hypothyroidism,,,OTHER: physiologic testing,PROCEDURE: fatigue assessment and management,PROCEDURE: management of therapy complications,,,"CCOP - Western Regional, Arizona, Phoenix, Arizona, 85006-2726, United States","North Colorado Medical Center, Greeley, Colorado, 80631-5199, United States","McKee Medical Center, Loveland, Colorado, 80538, United States",,,,,
Hypothyroidism,NCT00001159,Natural History of Thyroid Function Disorders,https://clinicaltrials.gov/study/NCT00001159,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Hyperthyroidism,Hypothyroidism,Grave's Disease,,,,,,,,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,Sriram M Gubbi,,,,
Hypothyroidism,NCT02824016,Evaluation of Hypothyroidism Incidence After Breast Cancer Supraclavicular Irradiation,https://clinicaltrials.gov/study/NCT02824016,NO,FEMALE,"ADULT, OLDER_ADULT",,Irradiation; Adverse Effect,Irradiation Hypothyroidism,,,,BIOLOGICAL: biological sample,RADIATION: supraclavicular irradiation,,,,"Institut Jean Godinot, Reims, 51100, France","Centre Paul Strauss, Strasbourg, 67000, France","Institut de Cancerologie de Lorraine, Vandoeuvre-les-nancy, 54519, France",Yacine,,,,
Hypothyroidism,NCT06112886,Identification of Important Symptoms and Diagnostic Hypothyroidism Patients Using Machine Learning Algorithms,https://clinicaltrials.gov/study/NCT06112886,NO,ALL,"ADULT, OLDER_ADULT",,Prediction Hypothyroidism Patients Using Machine Learning Algorithms,Identification of Important Symptoms of Hypothyroidism,,,,OTHER: There was no intervention in this study,,,,,"Faculty of Health, Kerman University of Medical Sciences, Kerman, 7616913555, Iran, Islamic Republic of",,,,,,,
Hypothyroidism,NCT00535561,Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT00535561,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Iron Deficiency Anemia,Subclinical Hypothyroidism,,,,"DRUG: Ferrous sulfate tablets 325 mg, po, TID",DRUG: Ferrous sulfate plus levothyroxine,,,,"Duzce University School of Medicine, Duzce, 81620, Turkey",,,Hakan Cinemre,,,,
Hypothyroidism,NCT00505479,Iodine Status in Pregnant Women and Their Newborns: is Congenital Hypothyroidism Related to Iodine Deficiency in Pregnancy?,https://clinicaltrials.gov/study/NCT00505479,NO,FEMALE,ADULT,,Congenital Hypothyroidism,Pregnancy,Iodine Deficiency,,,,,,,,"Children's Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China",,,zhengyan Zhao,,,,
Hypothyroidism,NCT05975866,"The Effects of an Anti-inflammatory Diet With or Without Curcumin Supplementation on Anthropometric Measurements, Concentrations of Thyroid Hormones, Anti-TPO, and Systemic Inflammation in Plasma and NFK-B in Peripheral Blood Mononuclear Cells in Patients With Hashimato",https://clinicaltrials.gov/study/NCT05975866,NO,ALL,"ADULT, OLDER_ADULT",,Thyroid Diseases,Hypothyroidism,Hashimoto Disease,,,DIETARY_SUPPLEMENT: curcumin,BEHAVIORAL: Anti-inflammatory diet,,,,"Golbon Sohrab, Tehran, National Nutrition And Food Technology Research Institute, Iran, Islamic Republic of",,,,,,,
Hypothyroidism,NCT05581147,Thyroid Function and Structure IN Klinefelter Syndrome,https://clinicaltrials.gov/study/NCT05581147,NO,MALE,"CHILD, ADULT, OLDER_ADULT",,Klinefelter Syndrome,"Thyroiditis, Autoimmune",Hypothyroidism,,,,,,,,"Sapienza' University of Rome, Roma, 00161, Italy",,,Andrea M Isidori,,,,
Hypothyroidism,NCT05804149,Effect of Acupuncture and Low Caloric Diet on Primary Hypothyroidism and Irregular Menstruation in Infertile Women,https://clinicaltrials.gov/study/NCT05804149,NO,FEMALE,ADULT,PHASE2,Primary Hypothyroidism,Acupuncture,Irregular Menstruation,PCO,,DEVICE: acupuncture,DRUG: Thyroxine,DIETARY_SUPPLEMENT: low caloric diet,,,"Eman Sedky, Cairo, Maadi, 002, Egypt",,,,,,,
Hypothyroidism,NCT06268600,The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma,https://clinicaltrials.gov/study/NCT06268600,NO,ALL,"ADULT, OLDER_ADULT",,Nasopharyngeal Carcinoma,Nasopharyngeal Cancer,Hypothyroidism,,,RADIATION: Modified neck target volume delineation,,,,,"Department of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital, Nanchang, None Selected, 330029, China",,,,,,,
Hypothyroidism,NCT04782856,Energy Metabolism in Thyroidectomized Patients,https://clinicaltrials.gov/study/NCT04782856,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Thyroid Goiter,Hypothyroidism,Thyroid Cancer,,,DRUG: Levothyroxine,DRUG: Liothyronine,DRUG: Placebo,,,"Virginia Commonwealth University, Richmond, Virginia, 23298, United States",,,,,,,
Hypothyroidism,NCT01862510,Detection of Celiac Disease in Patients With Hypothyroidism,https://clinicaltrials.gov/study/NCT01862510,NO,ALL,"ADULT, OLDER_ADULT",,Celiac Disease,Hypothyroidism,Celiac Sprue,Malabsorption,,,,,,,"Fletcher Allen Health Care, Burlington, Vermont, 05405, United States",,,Richard Zubarik,,,,
Hypothyroidism,NCT03977207,A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients,https://clinicaltrials.gov/study/NCT03977207,NO,ALL,"ADULT, OLDER_ADULT",,Thyroid; Functional Disturbance,Hypothyroidism,Hemodialysis,,,DRUG: Levothyroxine Sodium,DRUG: Placebos,,,,"University of California Irvine, Orange, California, 92868, United States",,,,,,,
Hypothyroidism,NCT03627611,Identification of Non-responders to Levothyroxine Therapy,https://clinicaltrials.gov/study/NCT03627611,NO,FEMALE,"ADULT, OLDER_ADULT",PHASE2,Hypothyroidism,Biomarkers,Endocrine System Diseases,,,DRUG: Levothyroxin,DRUG: Liothyronine,,,,"Oslo University Hospital, Oslo, Norway",,,Erik Fink Eriksen,,,,
Hypothyroidism,NCT03898622,Supplementation of Thyroid Hormone for TSH Control in Patients With Chronic Kidney Disease Without TRR.,https://clinicaltrials.gov/study/NCT03898622,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Chronic Kidney Diseases,Subclinical Hypothyroidism,,,,DRUG: Levothyroxine,,,,,"Kidney health clinic, Civil Hospital of Guadalajara, Guadalajara, Jalisco, 44280, Mexico",,,Jonathan Chavez,,,,
Hypothyroidism,NCT02307175,A Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan Indication,https://clinicaltrials.gov/study/NCT02307175,NO,ALL,"ADULT, OLDER_ADULT",,Autoimmune Thyroid Disease,Congenital Hypothyroidism,,,,,,,,,"Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, J1H 5N4, Canada",,,Eric Turcotte,,,,
Hypothyroidism,NCT00147433,The Effect of Thyroid Hormone Levels in Pregnant Women on the Intelligence Quotient (IQ) of Their Children,https://clinicaltrials.gov/study/NCT00147433,NO,FEMALE,"CHILD, ADULT, OLDER_ADULT",,Child Development Disorders,Pregnancy,Subclinical Hypothyroidism,,,,,,,,"Foundation for Blood Research, Scarborough, Maine, 04021, United States",,,Wendy Y. Craig,,,,
Hypothyroidism,NCT00437931,Color Flow Doppler Ultrasound in Subclinical Thyroid Dysfunction,https://clinicaltrials.gov/study/NCT00437931,NO,ALL,"ADULT, OLDER_ADULT",,Subclinical Hypothyroidism,Hyperthyroidism,Thyroid Dysfunction,,,,,,,,"Haemek Medical Center, Department of Radiology, Afula, 18101, Israel",,,Avraham Ishay,Leonid Chervinsky,Rafael Luboshitzky,,
Hypothyroidism,NCT05813301,NAFLD in Patient of Hypothyroidism,https://clinicaltrials.gov/study/NCT05813301,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,NAFLD,,,,,,,,,,,,,wael ahmed abbas,walaa anwer shehata,mena sawerss fathy,,
Hypothyroidism,NCT01574859,Central Hypothyroidism and Cardiovascular Risk,https://clinicaltrials.gov/study/NCT01574859,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Hypopituitarism,,,,,OTHER: levothyroxine,,,,,"Rigshospitalet, Copenhagen, 2100, Denmark",,,Ulla Feldt-Rasmussen,,,,
Hypothyroidism,NCT01335802,Relation Between Subclinical Hypothyroidism and Outcome of Pregnancy,https://clinicaltrials.gov/study/NCT01335802,NO,FEMALE,ADULT,,"Abortion, Spontaneous",Pregnancy Complications,Subclinical Hypothyroidism,,,GENETIC,,,,,"Naestved Hospital, Naestved, 4700, Denmark",,,Jan Kvetny,,,,
Hypothyroidism,NCT05782725,Subclinical Hypothyroidism and Normogonadotropic Anovulation,https://clinicaltrials.gov/study/NCT05782725,NO,FEMALE,ADULT,,Polycystic Ovary Syndrome,Hypothalamic-Pituitary-Ovarian Axis Dysfunction (Disorder),,,,OTHER: Comparison of laboratory test results in women in the 4 study arms,,,,,"Jagiellonian University Medical College, Department of Gynecology and Obstetrics, Krakow, 31-501, Poland",,,Robert Jach,,,,
Hypothyroidism,NCT01831869,Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT01831869,NO,ALL,ADULT,PHASE4,Hypothyroidism,Thyroid Diseases,Endocrine System Diseases,,,DRUG: L-thyroxine,,,,,"Shandong Provincial Hospital, Jinan, Shandong, 250021, China",,,Jiajun Zhao,,,,
Hypothyroidism,NCT01848171,Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism,https://clinicaltrials.gov/study/NCT01848171,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Hypothyroidism,Thyroid Diseases,Endocrine System Diseases,,,DRUG: L-thyroxine,,,,,"Shandong Provincial Hospital, Jinan, Shandong, 250021, China",,,Zhao jiajun,,,,
Hypothyroidism,NCT02316743,Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT02316743,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Systolic Heart Failure,Sub-clinical Hypothyroidism,,,,DRUG: Levothyroxine supplementation,,,,,"Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, J1H 5N4, Canada",,,Michel Nguyen,,,,
Hypothyroidism,NCT05708456,The Effect of Mobile Application on Hypothyroid Patients,https://clinicaltrials.gov/study/NCT05708456,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,Symptom Management,Symptoms and Signs,Mobile Application,Digital Health,OTHER: Mobile application with symptom management,,,,,"Seyma Trabzon, Sakarya, 54100, Turkey",,,,,,,
Hypothyroidism,NCT03614988,Evaluation of Evening Versus Morning Levothyroxine Intake in Elderly,https://clinicaltrials.gov/study/NCT03614988,NO,ALL,"ADULT, OLDER_ADULT",,Aging,Primary Hypothyroidism,Interaction Drug Food,,,OTHER: Evening Levothyroxine Administration,OTHER: Morning Levothyroxine Administration,,,,"Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, 90035-903, Brazil",,,Renato Gorga Bandeira de Mello,,,,
Hypothyroidism,NCT00497575,Diagnosis and Follow-up of Patients With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT00497575,NO,ALL,CHILD,,Congenital Hypothyroidism,L-Thyroxine,Follow-Up,,,,,,,,,,,,,,,
Hypothyroidism,NCT06051279,Pattern of Congenital Hypothyroidism in Newborns.,https://clinicaltrials.gov/study/NCT06051279,NO,ALL,CHILD,,Pattern of CH,,,,,,,,,,,,,,,,,
Hypothyroidism,NCT06452823,Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone Stabilization,https://clinicaltrials.gov/study/NCT06452823,NO,ALL,"ADULT, OLDER_ADULT",,Atrial Fibrillation and Flutter,Hyperthyroidism,Hypothyroidism,,,PROCEDURE: Catheter Ablation,,,,,"Cardiovascular Medicine Department of Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, 314000, China",,,,,,,
Hypothyroidism,NCT02280330,Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months,https://clinicaltrials.gov/study/NCT02280330,NO,ALL,CHILD,PHASE4,Iodine Deficiency,Iodine Deficiency Disorder,Hypothyroidism,,,DIETARY_SUPPLEMENT: MNP group,OTHER: Placebo group,,,,"La Trinidad Benguet Day Care Centers, La Trinidad, Benguet, 2601, Philippines",,,Imelda O Degay,,,,
Hypothyroidism,NCT03754621,Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey,https://clinicaltrials.gov/study/NCT03754621,NO,FEMALE,"ADULT, OLDER_ADULT",,Thyroid,Thyroid Dysfunction,Hypothyroidism,Pregnancy Early,,DIAGNOSTIC_TEST: Serum thyroid functions tests,,,,,"Bartin State Hospital, Bartin, Turkey",,,,,,,
Hypothyroidism,NCT06373523,MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin,https://clinicaltrials.gov/study/NCT06373523,NO,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,Hepatic Steato-Fibrosis,Non-Alcoholic Fatty Liver Disease,,,,DRUG: Dapagliflozin 10mg Tab,DRUG: Placebo,DRUG: Levothyroxine Replacement daily,,,"PGIMER, Chandigarh, Punjab, 160012, India",,,Ashu Rastogi,,,,
Hypothyroidism,NCT04682340,Analysis of BPA Concentration in Serum in Women of Reproductive Age With Autoimmune Thyroid Disease,https://clinicaltrials.gov/study/NCT04682340,NO,FEMALE,ADULT,,Hypothyroidism,Hyperthyroidism,Hashimoto Disease,Graves Disease,,DIAGNOSTIC_TEST: Serum BPA,,,,,"Jagiellonian University Medical College, KrakÃ³w, Malopolska, 31-591, Poland",,,,,,,
Hypothyroidism,NCT06399796,Insulin Resistance in Relation to Hyperthyroidism and Hypothyroidism,https://clinicaltrials.gov/study/NCT06399796,NO,ALL,"ADULT, OLDER_ADULT",,Insulin Resistance,,,,,,,,,,,,,,,,,
Hypothyroidism,NCT05842096,Subclinical Hypothyroidism and Chronic Inflammation in PCOS,https://clinicaltrials.gov/study/NCT05842096,NO,FEMALE,ADULT,,PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries,Subclinical hypothyroÃ¯dism,Hypothalamic-Pituitary-Gonadal Axis Dysfunction,,,"DIAGNOSTIC_TEST: Measurement and comparison of leucocytosis and concentrations of CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha in both study arms","DIAGNOSTIC_TEST: Evaluation of the impact of subclinical hypothyroidism, with present/ absent antithyroid antibodies, on the balance between anti- and pro-inflammatory factors in women in both study arms",DIAGNOSTIC_TEST: Assessment of the impact of imbalance between anti- and pro-inflammatory factors in women with different PCOS and HPOD phenotypes on ovarian reserve indices,,,"Jagiellonian University Medical College, Department of Gynecology and Obstetrics, Krakow, 31-501, Poland","Jagiellonian University Medical College, Department of Gynecology and Obstetrics, KrakÃ³w, 31-501, Poland",,,,,,
Hypothyroidism,NCT02190214,Thyroid Disorders in Malaysia: A Nationwide Multicentre Study,https://clinicaltrials.gov/study/NCT02190214,NO,ALL,"ADULT, OLDER_ADULT",,Hypothyroidism,Subclinical Hypothyroidism,Hyperthyroidism,Subclinical Hyperthyroidism,Graves Disease,,,,,,,,,Nor Azmi Kamaruddin,Norlela Sukor,Norhanita Othman,Siew Kim Kwa,Kuck Meng Chong
Hypothyroidism,NCT06272721,Hypothyroidism in Pregnancy and Neuropsychological Development in Children,https://clinicaltrials.gov/study/NCT06272721,NO,ALL,"CHILD, ADULT",,Thyroid Dysfunction,Pregnancy Related,Language Development,,,DIAGNOSTIC_TEST: Griffiths Scale,,,,,"Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, 00168, Italy",,,,,,,
Hypothyroidism,NCT04860622,Normal Range of TSH and FT4 in Pregnancy,https://clinicaltrials.gov/study/NCT04860622,NO,FEMALE,ADULT,,Hypothyroidism,Pregnancy Related,Thyroid,Dysfunction,Iodine Deficiency,DIAGNOSTIC_TEST: Serum thyroid function tests,,,,,"Sehit Prof Dr Ilhan Varank Sancaktepe Training and Research Hospital, Istanbul, Turkey",,,,,,,
Hypothyroidism,NCT06154382,Eltroxin Administration to Patients With Extremely Low T4 Values in the Intensive Care Unit,https://clinicaltrials.gov/study/NCT06154382,NO,ALL,"ADULT, OLDER_ADULT",,Thyroid; Functional Disturbance,,,,,DRUG: Eltroxin administration,,,,,"Meir Medical Center, Kfar Saba, Israel",,,,,,,
Hypothyroidism,NCT06179368,Throid Dysfunction in Liver Failure and Its Eddects Upon Outcome,https://clinicaltrials.gov/study/NCT06179368,NO,ALL,ADULT,,Hepatic Encephalopathy,Hepatic Impairment,Hypothyroidism,Hepatic Failure,,DIAGNOSTIC_TEST: hypothroidism,DIAGNOSTIC_TEST: euothyroid,,,,"Emad Zarief Kamel Said, Assiut, 71111, Egypt",,,,,,,
Hypothyroidism,NCT05918497,Comparison Between Variable Time Regimen of Dosing L-Thyroxine for Treatment Hypothyroid Fasting Ramadan,https://clinicaltrials.gov/study/NCT05918497,NO,ALL,ADULT,,Different Regimens in Treatment of Hypothyroidism During Fasting in Ramadan,,,,,,,,,,"Sohag Faculty of Medicine, Sohag, Egypt",,,,,,,
Hypothyroidism,NCT05643365,Factors Affecting Timing of Hypothyroidism Following Radioactive Iodine Therapy Patients With Graves Disease,https://clinicaltrials.gov/study/NCT05643365,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Radioactive Iodine-Induced Hypothyroidism in Graves Disease Patients,,,,,RADIATION: Radioactive Iodine therapy,,,,,"Nuclear medicine unit, department of clinical oncology and nuclear medicine, Assiut university hospital, Assiut, Egypt",,,Hemat A Mahmoud,Hanan G Mostafa,,,
Hypothyroidism,NCT01528904,Maternal Autoimmune Thyroid Disease and Fetal Thyroxin,https://clinicaltrials.gov/study/NCT01528904,NO,FEMALE,ADULT,,Pregnancy Complicated by Hyperthyroidism,Hypothyroidism in Pregnancy,,,,,,,,,"Clinic for Gynecology and Obstetrics, Belgrade, 11000, Serbia",,,Svetlana Spremovic-Radjenovic,,,,
Hypothyroidism,NCT05803967,Baduanjin Exercising Effects on Sub-clinical Hypothyroidism and Cognitive Problems,https://clinicaltrials.gov/study/NCT05803967,NO,FEMALE,OLDER_ADULT,,Subclinical hypothyroÃ¯dism,Cognitive Impairment,,,,BEHAVIORAL: Baduanjin exercising,,,,,"Cairo Unoversity, Giza, Egypt",,,Ali  Ismail,,,,
Hypothyroidism,NCT04270110,Assessment of Bone Mineral Density in Patients With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT04270110,NO,ALL,"CHILD, ADULT",,Subclinical hypothyroÃ¯dism,,,,,,,,,,"Assiut university Hospital, Assuit, 71511Assuit, Egypt",,,,,,,
Hypothyroidism,NCT04124705,A Study of ArmourÂ® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants,https://clinicaltrials.gov/study/NCT04124705,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Hypothyroidism,Thyroid Disease,Euthyroid,Thyroid Gland,Thyroid Hormones,DRUG: ArmourÂ® Thyroid,DRUG: Levothyroxine,,,,"Sponsor Site /ID# 237950, Birmingham, Alabama, 35205, United States","Sponsor Site /ID# 237986, Little Rock, Arkansas, 72209-7040, United States","Sponsor Site /ID# 235210, Greenbrae, California, 94904, United States",,,,,
Hypothyroidism,NCT03574051,the Microbiota Are Associated With Iodine-131 Therapy and Hypothyroidism,https://clinicaltrials.gov/study/NCT03574051,NO,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,Microbiota,,,,,DRUG: Probiotic,,,,,"First affiliated hospital of Harbin medical university, Harbin, Heilongjiang, 150001, China",,,Yunwei Wei,,,,
Hypothyroidism,NCT02017080,Fetal Thyroid Ultrasound And Fetal Thyroid Hormones,https://clinicaltrials.gov/study/NCT02017080,NO,FEMALE,ADULT,,Pregnancy Complicated by Hyperthyroidism,Hypothyroidism in Pregnancy,,,,,,,,,"Clinic for Gynecology and Obstetrics , Clinical Center of Serbia, Belgrade, 11000, Serbia",,,,,,,
Hypothyroidism,NCT01488721,Clinical Evaluation of NeoPlex4 Assay and NeoPlex System,https://clinicaltrials.gov/study/NCT01488721,NO,ALL,CHILD,,"Adrenal Hyperplasia, Congenital",Congenital Hypothyroidism,Cystic Fibrosis,,,,,,,,"New York State Department of Health, Albany, New York, 12201, United States","Tennessee Department of Health, Nashville, Tennessee, 37243, United States","Unified State Laboratories: Public Health, Taylorsville, Utah, 84129, United States",Dennis Smith,,,,
Hypothyroidism,NCT06135948,Impact of Increasing Levothyroxine Dose in Ramadan for UAE Patients With Hypothyroidism,https://clinicaltrials.gov/study/NCT06135948,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,L-thyroxine,,,,,"DRUG: Extra dose of L-thyroxine, 25 mcg during Ramadan",,,,,"Family Promotion Centre, Endocrinology Clinic, Sharjah, United Arab Emirates",,,,,,,
Hypothyroidism,NCT06377826,"Comparison of Aerobic and Resistance Training on Exercise Capacity, Depression and Quality of Life in Hypothyroidism.",https://clinicaltrials.gov/study/NCT06377826,NO,ALL,ADULT,,Comparison of Aerobic Exercise and Resistance Training,,,,,OTHER: aerobic exercises,OTHER: resistance training,DRUG: medication,,,"Abbottabad medical complex, AbbottÄbÄd, Khyber Pakhtunkhwa, 21300, Pakistan",,,saira jahan,,,,
Hypothyroidism,NCT02186405,Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT02186405,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Subclinical hypothyroÃ¯dism,,,,,DRUG: LEVOTHYROXINE,,,,,"Nephrology Department, Nice, 06202, France",,,Guillaume,,,,
Hypothyroidism,NCT06036576,Thyroxine Therapy for Recurrent Pregnancy Loss in Hypothyroid Women,https://clinicaltrials.gov/study/NCT06036576,NO,FEMALE,ADULT,PHASE3,Recurrent Early Pregnancy Loss,Thyroid Diseases,,,,DRUG: Levothyroxine Pill,,,,,"AL-Elwiyah Maternity Teaching Hospital, Baghdad, 10011, Iraq",,,Sarah Al-Musawi,,,,
Hypothyroidism,NCT03115515,Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy,https://clinicaltrials.gov/study/NCT03115515,NO,FEMALE,ADULT,,Pregnancy Related,Thyroid,,,,DRUG: levothyroxine,,,,,"Medstar Washington Hospital Center, Washington, District of Columbia, 20010, United States",,,,,,,
Hypothyroidism,NCT04178928,Can Levothyroxine Treatment Reduce the Development of Cardio-metabolic Disorder in Subclinical Hypothyroidism?,https://clinicaltrials.gov/study/NCT04178928,NO,ALL,CHILD,PHASE1|PHASE2,Subclinical hypothyroÃ¯dism,,,,,DRUG: Levothyroxine,,,,,,,,,,,,
Hypothyroidism,NCT02710799,Evaluation of the Effects of Teleconsultations on a Endocrinology Referral List,https://clinicaltrials.gov/study/NCT02710799,NO,ALL,"ADULT, OLDER_ADULT",,Diabetes Mellitus,Hypothyroidism,Hyperthyroidism,Goiter,Thyroid Nodule,OTHER: Teleconsultation,OTHER: Protocol,,,,"Secretaria Estadual da SaÃºde, Porto Alegre, Rio Grande do Sul, 90110-150, Brazil",,,Erno Harzheim,,,,
Hypothyroidism,NCT06353555,Efficacy of Thyroid Hormone Replacement for Secondary Hypothyroidism Following Intracerebral Hemorrhage,https://clinicaltrials.gov/study/NCT06353555,NO,ALL,"ADULT, OLDER_ADULT",,Intracerebral Hemorrhage,Low T3 Syndrome,Neurocritical Care,Hormone Replacement Therapy,,DRUG: Euthyrox,DRUG: Euthyrox,,,,"Peking union medical college hospital, Beijing, Beijing, 100730, China",,,,,,,
Hypothyroidism,NCT06041204,Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT06041204,NO,FEMALE,ADULT,,PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries,Subclinical Hypothyroidism,Female Infertility,,,DRUG: Letrozole 2.5mg,DRUG: Levothyroxine 25 Mcg (0.025 Mg) Oral Tablet,,,,"Al-Hussein University Hospital, Cairo, 11633, Egypt",,,Muhamed Alhagrasy,,,,
Hypothyroidism,NCT04663451,An Assessment of the Occurrence of Hypothyroidism in Patients Treated With RAI for Hyperthyroidism.,https://clinicaltrials.gov/study/NCT04663451,NO,ALL,"ADULT, OLDER_ADULT",,Nodule Solitary Thyroid,Toxic Multinodular Goiter,Radioactive Iodine-Induced Hypothyroidism,,,RADIATION: radioacive iodine therapy,,,,,"Universitair Ziekenhuis Brussel, Brussels, 1090, Belgium",,,Corina Andreescu,,,,
Hypothyroidism,NCT03699098,The Incidence and Risk Factors of Radiotherapy Induced Hypothyroidism in Head and Neck Cancer With Long Term Follow up,https://clinicaltrials.gov/study/NCT03699098,NO,ALL,"ADULT, OLDER_ADULT",,Head and Neck Cancer,,,,,"DIAGNOSTIC_TEST: TSH, T3, T4 and thyroid gland DVH",,,,,"Department of clinical oncology and nuclear medicine, Cairo university, Cairo, 11311, Egypt",,,,,,,
Hypothyroidism,NCT01950260,Early Levothyroxine Post Radioactive Iodine,https://clinicaltrials.gov/study/NCT01950260,YES,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Graves' Disease,,,,,DRUG: Levothyroxine,OTHER: Placebo,,,,"Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States",,,Marius Stan,,,,
Hypothyroidism,NCT02500342,Effect of Thyroid Hormone Replacement on Fatigability in Untreated Older Adults With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT02500342,NO,ALL,OLDER_ADULT,PHASE4,Thyroid Dysfunction,Mental Fatigue,Fatigue,,,DRUG: Levothyroxine,DRUG: Placebo,,,,"University College Cork, National University of Ireland, Cork, Cork, Ireland","Department of General Internal Medicine, Lausanne, Vaud, 1011, Switzerland","Clinic for General Internal Medicine, Bern University Hospital Bern, Bern, 3010, Switzerland",Nicolas Rodondi,,,,
Hypothyroidism,NCT03372772,Effect of Levocarnitine Supplementation for the Management of Fatigue in Levothyroxine-Treated Hypothyroid Patients,https://clinicaltrials.gov/study/NCT03372772,NO,ALL,ADULT,,Patient Compliance,,,,,DRUG: Levocarnitine,,,,,"Phamacology Department, BSMMU, Dhaka, Shahbag, 1000, Bangladesh",,,Farjana Akhter,,,,
Atopic Dermatitis,NCT06230991,A Pilot Study of Efficacy and Safety of SIM05 in Adults With Atopic Eczema,https://clinicaltrials.gov/study/NCT06230991,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Eczema,,,,,DIETARY_SUPPLEMENT: SIM05,,,,,"Prince of Wales Hospital, Hong Kong, Hong Kong",,,,,,,
Atopic Dermatitis,NCT05454722,A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema.,https://clinicaltrials.gov/study/NCT05454722,NO,ALL,CHILD,,Atopic Eczema,,,,,DEVICE: ADEX Gel,,,,,"Cripps Health Centre, Nottingham, Nottinghamshire, United Kingdom","Atherstone Surgery, Atherstone, Warwickshire, CV9 1EU, United Kingdom",,,,,,
Atopic Dermatitis,NCT06453512,A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema,https://clinicaltrials.gov/study/NCT06453512,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Eczema,,,,,DEVICE: Doublebase Once,,,,,,,,Simon T Royal,,,,
Atopic Dermatitis,NCT03143504,A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) Study,https://clinicaltrials.gov/study/NCT03143504,NO,ALL,CHILD,,Atopic Eczema,,,,,DIAGNOSTIC_TEST: Skin Testing for Atopic eczema,,,,,"Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, South Yorkshire, S10 SJF, United Kingdom",,,Simon G Danby,,,,
Atopic Dermatitis,NCT02915146,Narrowband Ultraviolet B Versus Narrowband Ultraviolet B Plus Ultraviolet A1 for Atopic Eczema,https://clinicaltrials.gov/study/NCT02915146,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Eczema,,,,,RADIATION: combined ultraviolet phototherapy (NB-UVB + UVA1) vs. NB-UVB monotherapy,,,,,"Ninewells Hospital, Dundee, DD1 9SY, United Kingdom",,,Robert S Dawe,,,,
Atopic Dermatitis,NCT00576238,Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser,https://clinicaltrials.gov/study/NCT00576238,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Atopic Eczema,,,,,DRUG: betamethasone valerate,DRUG: betamethasone valerate,DRUG: urea,,,"Nacka hudmottagning, Nacka, 13183, Sweden","Nacka nÃ¤rsjukhus, Nacka, 13183, Sweden","Sophiahemmet, Stockholm, 11486, Sweden",Berit Berne,,,,
Atopic Dermatitis,NCT05624112,Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China,https://clinicaltrials.gov/study/NCT05624112,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Atopic Dermatitis,Dermatitis Atopic,,,,DRUG: Dupilumab,,,,,"Dermatology Hospital of Southern Medical University (Guangdong Provincial Dermatology Hospital), Guangzhou, Guangdong, 510091, China",,,Clinical Sciences & Operations,,,,
Atopic Dermatitis,NCT00676884,A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema,https://clinicaltrials.gov/study/NCT00676884,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Eczema,,,,,"DRUG: Aeroderm (also known as pitrakinra, AER 001, BAY 16-9996)",DRUG: placebo,,,,"Guy's Drug Research unit, Quintiles Limited, London, SE1 1YR, United Kingdom",,,Darren Wilbraham,Richard Groves,,,
Atopic Dermatitis,NCT02381028,Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young Children,https://clinicaltrials.gov/study/NCT02381028,NO,ALL,CHILD,,Atopic Eczema,,,,,OTHER: Human milk and emollient: Apobase cremeÂ® (Actavis Norway AS),OTHER: Emollient: Apobase cremeÂ® (Actavis Norway AS),,,,,,,Teresa L Berents,,,,
Atopic Dermatitis,NCT03270566,Softened Water for Eczema Prevention Pilot Trial,https://clinicaltrials.gov/study/NCT03270566,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Eczema,,,,,DEVICE: Domestic ion-exchange water softener,,,,,"St Thomas' Hospital, London, SE1 7EH, United Kingdom",,,Carsten Flohr,,,,
Atopic Dermatitis,NCT06469385,Topical ENS-002 for Atopic Dermatitis in Adults,https://clinicaltrials.gov/study/NCT06469385,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Atopic Dermatitis,Atopic Dermatitis Eczema,,,,BIOLOGICAL: ENS-002,,,,,"Derm Research, Austin, Texas, 78759, United States",,,Bernardo Cervantes,,,,
Atopic Dermatitis,NCT00354510,Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis,https://clinicaltrials.gov/study/NCT00354510,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,"Dermatitis, Atopic",,,,DRUG: GW842470X cream,,,,,"GSK Investigational Site, Augsburg, Bayern, 86179, Germany","GSK Investigational Site, Mahlow, Brandenburg, 15831, Germany","GSK Investigational Site, Duelmen, Niedersachsen, 48249, Germany",Clinical Trials,,,,
Atopic Dermatitis,NCT05578482,Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05578482,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Atopic Dermatitis,Atopic Dermatitis Eczema,Atopic Dermatitis Flare,,,DRUG: Dicloxacillin Oral Capsule,DRUG: Elocon 0.1 % Topical Cream,,,,"Department of Dermatology, Copenhagen NV, 2100, Denmark",,,Jacob Thyssen,,,,
Atopic Dermatitis,NCT01119313,Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema,https://clinicaltrials.gov/study/NCT01119313,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Eczema,,,,,DRUG: LAS 41002,DRUG: Active,,,,"Almirall Investigational Sites#1, Hamburg, Germany",,,Christoph Willers,,,,
Atopic Dermatitis,NCT05704205,The UPDATE Trial (Uvb Phototherapy in Dermatology for ATopic Eczema),https://clinicaltrials.gov/study/NCT05704205,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis Eczema,Atopic Dermatitis,,,,DEVICE: NB-UVB phototherapy,COMBINATION_PRODUCT: Optimal topical therapy,,,,"Flevoziekenhuis, Almere, Flevoland, 1315RA, Netherlands","Medisch Centrum Leeuwarden, Leeuwarden, Friesland, 8934 AD, Netherlands","Jeroen Bosch Ziekenhuis, Den Bosch, Noord-Brabant, 5223 GZ, Netherlands",Louise  Gerbens,,,,
Atopic Dermatitis,NCT04800185,Characterizing Skin Microbiome Change in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04800185,NO,ALL,"CHILD, ADULT, OLDER_ADULT",EARLY_PHASE1,Atopic Dermatitis,Atopic Dermatitis Eczema,,,,DRUG: Crisaborole 2% Top Oint,GENETIC: Skin Microbiome Swabs,,,,"University of California, Irvine - Dermatology Clinical Research, Irvine, California, 92697, United States",,,Natasha Atanaskova Mesinkovska,,,,
Atopic Dermatitis,NCT03667014,The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients,https://clinicaltrials.gov/study/NCT03667014,YES,ALL,"ADULT, OLDER_ADULT",PHASE4,Atopic Dermatitis,Atopic Dermatitis Eczema,,,,DRUG: Dupilumab,,,,,"UCSF Psoriasis and Skin Treatment Center, San Francisco, California, 94118, United States",,,Tina Bhutani,,,,
Atopic Dermatitis,NCT05719649,The Efficacy of NTU 101 Lactic Acid Bacteria Powder in the Adjuvant Improvement of Atopic Dermatitis Clinical Trial,https://clinicaltrials.gov/study/NCT05719649,NO,ALL,CHILD,,Atopic Dermatitis,Atopic Dermatitis Eczema,,,,DIETARY_SUPPLEMENT: Lactic acid bacteria NTU 101,DIETARY_SUPPLEMENT: Placebo,,,,,,,,,,,
Atopic Dermatitis,NCT06174493,Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials,https://clinicaltrials.gov/study/NCT06174493,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,,,,,,"Power Life Sciences, San Francisco, California, 94107, United States",,,Michael B Gill,,,,
Atopic Dermatitis,NCT06004986,DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema,https://clinicaltrials.gov/study/NCT06004986,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Atopic Dermatitis,Atopic Dermatitis Eczema,,,,DRUG: Dupilumab,,,,,"Amsterdam University Medical Centers, Amsterdam, Noord-Holland, 1105 AZ, Netherlands","Erasmus Medical Center, Rotterdam, Zuid-Holland, 3015 GD, Netherlands",,Louise  Gerbens,Phyllis I Spuls,DirkJan Hijnen,,
Atopic Dermatitis,NCT05502185,Targeting Staphylococci in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05502185,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,,,,,,,,,Alan,,,,
Atopic Dermatitis,NCT06455891,MYCobiome Analysis in Atopic Dermatitis With Head and Neck Involvement,https://clinicaltrials.gov/study/NCT06455891,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,,,,,,"Tenon Hospital APHP dermatology and allergology department, Paris, 75020, France",,,AngÃ¨le,,,,
Atopic Dermatitis,NCT06395948,A Study Evaluating APG777 in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06395948,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: APG777,DRUG: Placebo,,,,"Investigational Site #14, Fountain Valley, California, 92708, United States","Investigational Site # 8, San Diego, California, 92123, United States","Investigational Site # 1, Coral Gables, Florida, 33134, United States",,,,,
Atopic Dermatitis,NCT05467046,Clinical Relevance of Scratching and Sleep in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05467046,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,DEVICE: Smartwatch system,,,,,"University of Utrecht, Utrecht, Netherlands",,,Marjolein de Buin-Weller,,,,
Atopic Dermatitis,NCT04715087,Staphylococcus Aureus in Atopic Dermatitis Immunopathology,https://clinicaltrials.gov/study/NCT04715087,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,"OTHER: Blood sample (Day -42 to Day -28, Day 3),Skin swab sampling (Day -42 to Day -28, Day 0, Day 13) , patch test application (Day 0) , skin biopsies (Day 13)","OTHER: Blood sample (Day 0 ,Day 3),Skin swab sampling (Day 0,Day 13), patch test application (Day 1), skin biopsies (Day 13)",,,,"Centre Hospitalier Lyon Sud, Pierre-BÃ©nite, 69495, France",,,Audrey,,,,
Atopic Dermatitis,NCT05904509,Insulin Resistance in Atopic Dermatitis Patients,https://clinicaltrials.gov/study/NCT05904509,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,,,,,,"Bezmialem Vakif University Hospital, Istanbul, Turkey",,,,,,,
Atopic Dermatitis,NCT06244212,Topical Treatment for Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06244212,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,OTHER: Demonstration of applying triamcinolone cream,BEHAVIORAL: Mobile App Use,OTHER: Standard of Care,,,"Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States",,,,,,,
Atopic Dermatitis,NCT05286047,Probiotic on Atopic Dermatitis in Infant,https://clinicaltrials.gov/study/NCT05286047,NO,ALL,CHILD,,Atopic Dermatitis,,,,,DIETARY_SUPPLEMENT: Bifidobacterium longum CCFM1029,DIETARY_SUPPLEMENT: Placebo,,,,"Glac Biotech Co., Ltd., Tainan City, 74442, Taiwan",,,,,,,
Atopic Dermatitis,NCT06316609,Prenatal Exposure to Emerging Contaminants and Children's Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06316609,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,OTHER: Gestational Exposure to Emerging Contaminants (ECs),,,,,"Children Hospital of Fudan University, Shanghai, Shanghai, 201102, China",,,,,,,
Atopic Dermatitis,NCT05969730,Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05969730,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,DRUG: Baricitinib 4 MG,DRUG: Azathioprine 1.5-2.5 mg/kg,,,,"Iran, Sari, Mazandaran, Iran, Islamic Republic of",,,,,,,
Atopic Dermatitis,NCT05971355,Comparison of LimpiAD Cream 2.5% Plus Versus Vehicle and an Emollient in Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05971355,NO,ALL,CHILD,,Atopic Dermatitis,,,,,"DEVICE: LimpiAD cream 2,5% plus",OTHER: Vehicle,OTHER: Emollient,,,"University of Bari Hospital, Bari, Italy","University of Modena e Reggio Emilia, Modena, Italy","University of Naples Hospital, Naples, Italy",,,,,
Atopic Dermatitis,NCT05783453,CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTS,https://clinicaltrials.gov/study/NCT05783453,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,OTHER: Cosmetic study,,,,,"CIDP, Rio de Janeiro, 20231-048, Brazil",,,Daniele Miranda,,,,
Atopic Dermatitis,NCT05523986,Vitamin D Treatment Effect for Atopic Dermatitis in Children,https://clinicaltrials.gov/study/NCT05523986,NO,ALL,"CHILD, ADULT",,Atopic Dermatitis,,,,,OTHER: Vitamin D,OTHER: Placebo,,,,"China Medical University Hospital, Taichung, 404, Taiwan",,,,,,,
Atopic Dermatitis,NCT06447506,Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.,https://clinicaltrials.gov/study/NCT06447506,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,"Dermatitis, Atopic",,,,,DRUG: GSK1070806,,,,,"GSK Investigational Site, Phoenix, Arizona, 85006, United States","GSK Investigational Site, North Little Rock, Arkansas, 72117, United States","GSK Investigational Site, Canoga Park, California, 91303, United States",,,,,
Atopic Dermatitis,NCT05466877,A Study of MG-K10 in Subjects With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05466877,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: MG-K10,DRUG: Placebo,,,,"The First Affiliated Hospital of Bengbu Medical College, Bengbu, China","Huashan Hospital Affiliated to Fudan University, Shanghai, China",,Jinhua Xu,,,,
Atopic Dermatitis,NCT05833880,Use of Complementary and Alternative Medicine in Children and Adults With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05833880,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,BEHAVIORAL: Self-administered questionnaire,,,,,"University Hospital of Nancy, Nancy, France",,,Anne-Claire Bursztejn,,,,
Atopic Dermatitis,NCT06026891,Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06026891,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: MG-K10/Placebo,,,,,"Peking University People's Hospital, Beijing, China",,,Jianzhong Zhang,,,,
Atopic Dermatitis,NCT02087943,Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT02087943,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,"Dermatitis, Atopic Dermatitis",,,,,DRUG: Apremilast,DRUG: Apremilast,DRUG: Placebo,DRUG: Placebo,,"Arizona Research Center, Phoenix, Arizona, 85023, United States","Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield, California, 93309, United States","Dermatology Research Associates, Los Angeles, California, 90045, United States",,,,,
Atopic Dermatitis,NCT02906475,Atopic Dermatitis in Atopy Predisposed Infants,https://clinicaltrials.gov/study/NCT02906475,NO,ALL,CHILD,,"Dermatitis, Atopic",,,,,OTHER: standardized skin care regimen,,,,,"Charite UniversitÃ¤tsmedizin Berlin, Berlin, 10117, Germany",,,Ulrike Blume-Peytavi,,,,
Atopic Dermatitis,NCT05399368,An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05399368,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: RPT193,OTHER: Placebo,,,,"Cahaba Dermatology and Skin Health Center, Birmingham, Alabama, 35244, United States","Perseverance Research Center, Scottsdale, Arizona, 85254, United States","Arkansas Research Trials, LLC, North Little Rock, Arkansas, 72117, United States",,,,,
Atopic Dermatitis,NCT06116526,Dupilumab De-escalation in Pediatric Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06116526,NO,ALL,CHILD,PHASE4,Atopic Dermatitis,,,,,DRUG: Dupilumab - Discontinuation,DRUG: Dupilumab - Dose Reduction,DRUG: Dupilumab - Standard Dose,,,"Johns Hopkins Univerisity, Baltimore, Maryland, 21210, United States",,,Joy Wan,,,,
Atopic Dermatitis,NCT06492902,Adding Auricular Acupuncture to Xiao-Feng-San Decoction for Treating Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06492902,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,OTHER: Auricular acupuncture,OTHER: Sham auricular acupuncture,,,,"University of Medical Center HCMC - Branch no.3, Ho Chi Minh City, 700000, Vietnam","Traditional Medicine Hospital of Ho Chi Minh City, Ho Chi Minh City, 70000, Vietnam",,Nga Th Tran,,,,
Atopic Dermatitis,NCT05844618,Short-Term Efficacy of Triamcinolone Acetonide (AristocortÂ® C) in Subjects With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05844618,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Atopic Dermatitis,,,,,DRUG: Triamcinolone Acetonide (AristocortÂ® C),DRUG: Vehicle,,,,"Innovaderm Research Inc., MontrÃ©al, Quebec, H2X 2V1, Canada",,,Robert Bissonnette,,,,
Atopic Dermatitis,NCT05090982,Creation of a Shared Medical Decision-making Tool for Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05090982,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,OTHER: Audio recordings during the consultations,OTHER: Audio recordings during the consultations and test of the shared medical decision-making tool for modification,OTHER: Audio recordings during the consultations and test of the shared medical decision-making tool for validation,,,"Hospital Henri Mondor, CrÃ©teil, 64010, France",,,Pierre-AndrÃ© Natella,,,,
Atopic Dermatitis,NCT06238817,"A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis",https://clinicaltrials.gov/study/NCT06238817,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: Ruxolitinib Cream,DRUG: Vehicle Cream,,,,"Lynn Institute of the Ozarks, Little Rock, Arkansas, 72204, United States","First Oc Dermatology, Fountain Valley, California, 92708, United States","Center For Dermatology Cosmetic and Laser Surgery, Fremont, California, 94538, United States",Incyte Medical Monitor,,,,
Atopic Dermatitis,NCT05439941,A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials,https://clinicaltrials.gov/study/NCT05439941,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: EDP1815,,,,,"USA-131, Birmingham, Alabama, 35244, United States","USA 112, Fountain Valley, California, 92708, United States","USA 123, Fremont, California, 94538, United States",,,,,
Atopic Dermatitis,NCT04826744,Frequency of Palpebral Involvement in Adult With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04826744,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,OTHER: Standard dermatology consultation,,,,,"Hop Claude Huriez Chu Lille, Lille, 59037, France","Hopital Charles Nicolle Chu Rouen, Rouen, France",,Delphine Staumont-Salle,,,,
Atopic Dermatitis,NCT04218877,The Factors Affecting Atopic Dermatitis in Children Age 1-3,https://clinicaltrials.gov/study/NCT04218877,NO,ALL,CHILD,,Atopic Dermatitis,,,,,OTHER,,,,,"Amedclinic, Moscow, 129626, Russian Federation",,,,,,,
Atopic Dermatitis,NCT06444165,Lebrikizumab Pen Ease of Use in Participants With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06444165,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: Lebrikizumab Pen,,,,,"Concentrics Research, Indianapolis, Indiana, 46240, United States",,,Call 1-877- (1-877-285-4559) or 1-317-615-4559 : Mon - Fri 9  - 5  Eastern time (/ - 5 hours,,,,
Atopic Dermatitis,NCT04435392,Jaktinib Hydrochloride Cream For Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04435392,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Atopic Dermatitis,,,,,DRUG: Jaktinib Hydrochloride Cream,DRUG: Placebo,,,,"The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410008, China",,,Qianjin Lu,,,,
Atopic Dermatitis,NCT05437887,Effects of Fucoidan on the Gut Microbiota in the Patients of Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05437887,NO,ALL,"CHILD, ADULT",,Atopic Dermatitis,,,,,DIETARY_SUPPLEMENT: Fucoidan,,,,,"Chang Gung Memorial Hospital, Taoyuan, Taiwan",,,Sien-hung Yang,,,,
Atopic Dermatitis,NCT06024499,Phase 2 Trial of HY209gel in Atopic Dermatitis Patients,https://clinicaltrials.gov/study/NCT06024499,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,Atopic Dermatitis Eczema,Atopic Dermatitis of Scalp,,,DRUG: HY209GEL Active,OTHER: Placebo,,,,"Cahaba Dermatology Skin Health Center, Birmingham, Alabama, 35244, United States","RAOOF MD Dermatology, Encino, California, 16133, United States","Continental Clinical Solutions, LLC, Towson, Maryland, 21204, United States",,,,,
Atopic Dermatitis,NCT05509023,Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD),https://clinicaltrials.gov/study/NCT05509023,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: ADX-914,DRUG: Placebo,,,,"Cahaba Dermatology Skin Health Center, Birmingham, Alabama, 35244, United States","First OC Dermatology, Fountain Valley, California, 92708, United States","California Allergy and Asthma Medical Group- Los Angeles, Los Angeles, California, 90025, United States",,,,,
Atopic Dermatitis,NCT05868824,Dynamic Blood Inflammatory Profile in Atopic Dermatitis Patients (ADAMUNE),https://clinicaltrials.gov/study/NCT05868824,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,OTHER: Blood sample,,,,,"Nice University Hospital, Nice, 06200, France",,,,,,,
Atopic Dermatitis,NCT05391061,A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05391061,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,"Dermatitis, Atopic",,,,,DRUG: Abrocitinib,,,,,"Pfizer Tower, Seoul, 04631, Korea, Republic of",,,,,,,
Atopic Dermatitis,NCT06361992,Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children,https://clinicaltrials.gov/study/NCT06361992,NO,ALL,"CHILD, ADULT",PHASE3,Atopic Dermatitis,Atopic Dermatitis and Related Conditions,Atopic Dermatitis Eczema,Atopic Dermatitis \(AD\),,OTHER: Blue Cap Foam,,,,,"University of NiÅ¡ Faculty of Medicine, Department of Dermatology and Venereology, University Clinical Center of NiÅ¡, NiÅ¡, NiÅ¡ava, 18108, Serbia","City Institute for Skin and Venereal Diseases Belgrade, Belgrade, 11000, Serbia","University of Belgrade Faculty of Medicine, University Clinical Center of Serbia, Belgrade, 11000, Serbia",,,,,
Atopic Dermatitis,NCT05276323,MedihoneyÂ® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children Study,https://clinicaltrials.gov/study/NCT05276323,NO,ALL,"CHILD, ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: Medihoney Derma Cream,DRUG: Hydrocortisone 1% cream,,,,"Soroka University Medical Center, Beer Sheva, Israel",,,,,,,
Atopic Dermatitis,NCT06035835,Probiotics and Breastmilk Decrease Risk of Atopic Dermatitis in Premature Infants,https://clinicaltrials.gov/study/NCT06035835,NO,ALL,CHILD,,Atopic Dermatitis,,,,,COMBINATION_PRODUCT: Lacticaseibacillus rhamnosus,COMBINATION_PRODUCT: Lactobacillus acidophilus + Bifidobacterium bifidum,,,,,,,JosÃ© Uberos-FernÃ¡ndez,,,,
Atopic Dermatitis,NCT04556461,Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function,https://clinicaltrials.gov/study/NCT04556461,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: Tralokinumab,,,,,"UKSH, Campus Kiel, Kiel, Schleswig-Holstein, 24105, Germany",,,,,,,
Atopic Dermatitis,NCT06129136,The Effect of Nature-based Exposure on the Immune System and Skin Health of Atopic Dermatitis Patients.,https://clinicaltrials.gov/study/NCT06129136,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,OTHER: Nature-based exposure by biodiversity component in lotion.,OTHER: Placebo group using colored lotion.,,,,"Uute Scientific Oy, Helsinki, 00290, Finland",,,Olli Laitinen,,,,
Atopic Dermatitis,NCT05644691,Impact of the Daily Use of Emollient on Corticosteroids Consumption in Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05644691,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,OTHER: Lipikar Baume AP+M,OTHER: Usual emollient,,,,"DOST, SvidnÃ­k, 08901, Slovakia",,,,,,,
Atopic Dermatitis,NCT06238765,CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry,https://clinicaltrials.gov/study/NCT06238765,NO,ALL,CHILD,,Atopic Dermatitis,,,,,,,,,,"CorEvitas, LLC, Waltham, Massachusetts, 02451, United States",,,,,,,
Atopic Dermatitis,NCT05023668,China Atopic Dermatitis Registry Study,https://clinicaltrials.gov/study/NCT05023668,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,"Dermatitis, Atopic",,,,,OTHER: No intervention,,,,,"Peking University People's Hospital, Beijing, Beijing, 100044, China",,,Jianzhong Zhang,,,,
Atopic Dermatitis,NCT04310189,The Role of IL-22/IL-22BP Axis in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04310189,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,PROCEDURE: Biopsy,,,,,"Nantes University Hospital, Nantes, France",,,SÃ©bastien,,,,
Atopic Dermatitis,NCT05455060,Effects of a Mixed Chinese Herbal Formula on Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05455060,NO,ALL,"CHILD, ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: Chinese herbal formula (CHF),DRUG: Placebo,,,,,,,,,,,
Atopic Dermatitis,NCT05034822,Study of Ruxolitinib Cream in Children With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05034822,NO,ALL,CHILD,PHASE1,Atopic Dermatitis,,,,,DRUG: Ruxolitinib cream,,,,,"Desert Sky Dermatology, Gilbert, Arizona, 85295, United States","Burke Pharmaceutical Research, Hot Springs National Park, Arkansas, 71913, United States","Orange County Research Center, Anaheim, California, 92801, United States",Haq Nawaz,,,,
Atopic Dermatitis,NCT04444726,Phototherpy Versus Tapwater Iontophoresis for Management of Atopic Dermatitis in Children.,https://clinicaltrials.gov/study/NCT04444726,NO,ALL,CHILD,,Atopic Dermatitis,,,,,DEVICE: Ultra Violet A Device.+ Topical medical treatment,DEVICE: Iontophoresis device + Topical medical treatment,"DRUG: Topical medical treatment (Betamethasone dipropionate 0.05% "" diprolene "" )",,,"Banha University, BanhÄ, Egypt",,,,,,,
Atopic Dermatitis,NCT06363461,Study of TDM-180935 in Atopic Dermatitis Patients,https://clinicaltrials.gov/study/NCT06363461,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: TDM-180935 topical ointment 1.0%,DRUG: TDM-180935 topical ointment 2.0%,DRUG: TDM-180935 topical vehicle ointment 1,DRUG: TDM-180935 topical vehicle ointment 2,,"Site 5, Rolling Meadows, Illinois, 60008, United States","Site 8, Covington, Louisiana, 70433, United States","Site 4, New Brighton, Minnesota, 55112, United States",Daniel J. Piacquadio,,,,
Atopic Dermatitis,NCT05669794,An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World,https://clinicaltrials.gov/study/NCT05669794,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,,,,,,"Ch Saint Quentin /Id# 249270, St Quentin CEDEX, Aisne, 02321, France","CHU Clermont-Ferrand /ID# 248611, Clermont, Auvergne-Rhone-Alpes, 63100, France","Hopital Saint Joseph /ID# 255537, Marseille, Bouches-du-Rhone, 13008, France",.,,,,
Atopic Dermatitis,NCT06397781,Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients,https://clinicaltrials.gov/study/NCT06397781,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Atopic Dermatitis,,,,,DRUG: Skin Cleanser Combination No.1,,,,,,,,,,,,
Atopic Dermatitis,NCT06022874,The Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06022874,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,OTHER: Phoilex Releaf Gel,,,,,"Phoenix Medical Spa X Peak Human, Brampton, Ontario, L6W 3E1, Canada",,,Sanjeev Goel,,,,
Atopic Dermatitis,NCT05694884,Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab,https://clinicaltrials.gov/study/NCT05694884,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: Placebo,DRUG: ASLAN004,,,,"ASLAN Investigative Site, Birmingham, Alabama, 35244, United States","ASLAN Investigative Site, Encino, California, 91436, United States","ASLAN Investigative Site, Fountain Valley, California, 92708, United States",Chief Medical Officer,,,,
Atopic Dermatitis,NCT06412094,Use of a Mobile Health App in Managing Pediatric Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06412094,NO,ALL,CHILD,,Atopic Dermatitis,,,,,OTHER: Standard care,"BEHAVIORAL: Access to the ""AtopicApp"" mobile application",BEHAVIORAL: Virtual oversight through the AtopicApp,,,"Samara State Medical University, Samara, 443079, Russian Federation",,,Natalia Migacheva,,,,
Atopic Dermatitis,NCT05158023,Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05158023,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: Placebo Comparator,BIOLOGICAL: ASLAN004,BIOLOGICAL: ASLAN004,BIOLOGICAL: ASLAN004,BIOLOGICAL: ASLAN004,"ASLAN Investigative Site, Birmingham, Alabama, 35209, United States","ASLAN Investigative Site, Birmingham, Alabama, 35244, United States","ASLAN Investigative Site, Little Rock, Arkansas, 72205, United States",Chief Medical Officer,,,,
Atopic Dermatitis,NCT05717920,A Clinical Trial in Subjects With Atopic Dermatitis (Part 1),https://clinicaltrials.gov/study/NCT05717920,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: Part 1 ADX-629 (Open-label),,,,,"Bexley Dermatology Research, Bexley, Ohio, 43209, United States",,,,,,,
Atopic Dermatitis,NCT05398445,A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE),https://clinicaltrials.gov/study/NCT05398445,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: Rocatinlimab,DRUG: Placebo,,,,"Cahaba Dermatology and Skin Health Center, Birmingham, Alabama, 35244, United States","Alliance Dermatology and Mohs Center, Phoenix, Arizona, 85032, United States","Anaheim Clinical Trials, Anaheim, California, 92801, United States",,,,,
Atopic Dermatitis,NCT03559075,Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis,https://clinicaltrials.gov/study/NCT03559075,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,,,,,,"Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, 27157, United States",,,Stevan Feldman,,,,
Atopic Dermatitis,NCT06176040,A Study of TAVO101 in Atopic Dermatitis Patients,https://clinicaltrials.gov/study/NCT06176040,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: TAVO101,,,,,"Optimal Clinical Trials, Auckland, New Zealand",,,Penelope Montgomery,,,,
Atopic Dermatitis,NCT04564755,Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04564755,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,DRUG: abrocitinib,,,,,"Cahaba Dermatology and Skin Health Center, Birmingham, Alabama, 35244, United States","Antelope Valley Clinical Trials, Lancaster, California, 93534, United States","Allergy & Asthma Care Center, Long Beach, California, 90808, United States",Pfizer .gov Call Center,,,,
Atopic Dermatitis,NCT05121480,"A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis",https://clinicaltrials.gov/study/NCT05121480,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: EDP1815,DRUG: Placebo,,,,"USA-131, Birmingham, Alabama, 35244, United States","USA-112, Fountain Valley, California, 92708, United States","USA-123, Fremont, California, 94538, United States",Benjamin Ehst,Yanislav Mihaylov,,,
Atopic Dermatitis,NCT05436535,Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis,https://clinicaltrials.gov/study/NCT05436535,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Atopic Dermatitis,,,,,BIOLOGICAL: Dupilumab,DRUG: Vanicream- Dupilumab-naÃ¯ve,DRUG: Triamcinolone Acetonide,DRUG: Hydrocortisone,DRUG: Vanicream- Active,"University of California, San Diego: Dermatology Clinical Trials Unit, La Jolla, California, 92093, United States","Children's Hospital Los Angeles: Division of Clinical Immunology & Allergy, Los Angeles, California, 90027, United States","National Jewish Health: Division of Pediatric Allergy and Clinical Immunology, Denver, Colorado, 80206, United States",,,,,
Atopic Dermatitis,NCT05081557,"A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis",https://clinicaltrials.gov/study/NCT05081557,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,,,,,,"Hospital Universitario Austral /ID# 241607, Pilar, Buenos Aires, 1629, Argentina","Buenos Aires Skin /ID# 241606, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, 1055, Argentina","CEDIC Centro de Investigaciones Clinicas /ID# 241605, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, 1425, Argentina",.,,,,
Atopic Dermatitis,NCT04761978,Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04761978,NO,ALL,"ADULT, OLDER_ADULT",,"Dermatitis, Atopic",,,,,,,,,,"Hop Claude Huriez Chu Lille, Lisle-sur-Tarn, 59037, France",,,Delphine Staumont-Salle,,,,
Atopic Dermatitis,NCT06032403,Patient With Atopic Dermatitis' Needs for Self-management Support - Flexible Patient Centred Consultations,https://clinicaltrials.gov/study/NCT06032403,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,BEHAVIORAL: flexible patient centred consultations,,,,,"Gentofte University Hospital, Hellerup, Copenhagen, 2900, Denmark",,,,,,,
Atopic Dermatitis,NCT05704738,A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD),https://clinicaltrials.gov/study/NCT05704738,NO,ALL,CHILD,PHASE3,Atopic Dermatitis,,,,,DRUG: Rocatinlimab,DRUG: Placebo,,,,"Cahaba Dermatology and Skin Health Center, Birmingham, Alabama, 35244, United States","AllerVie Clinical Research- Cullman, Cullman, Alabama, 35058, United States","Eclipse Clinical Research, Tucson, Arizona, 85745, United States",,,,,
Atopic Dermatitis,NCT05014438,A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05014438,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,"Dermatitis, Atopic",,,,,DRUG: BMS-986166,DRUG: Branebrutinib,OTHER: Placebo,,,"Local Institution - 0091, Fremont, California, 94538, United States","Local Institution - 0112, Brandon, Florida, 33511, United States","Local Institution - 0061, Coral Gables, Florida, 33134, United States",Bristol-Myers Squibb,,,,
Atopic Dermatitis,NCT05507580,A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05507580,NO,ALL,ADULT,PHASE4,Atopic Dermatitis,,,,,DRUG: Upadacitinib,,,,,"Holdsworth House Medical Practice /ID# 254028, Darlinghurst, New South Wales, 2010, Australia","Premier Specialist /ID# 246150, Kogarah, New South Wales, 2217, Australia","Veracity Clinical Research /ID# 246154, Woolloongabba, Queensland, 4102, Australia",.,,,,
Atopic Dermatitis,NCT05250115,A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05250115,NO,ALL,"ADULT, OLDER_ADULT",,"Dermatitis, Atopic",,,,,,,,,,"Dermatologische Gemeinschaftspraxis Dres. Quist PartG, Mainz, Rheinland-pfalz, 55128, Germany","HautÃ¤rztliche Gemeinschaftspraxis, Ahaus, 48688, Germany","Praxis Dr. A. Magerl, Bensheim, 64625, Germany",Pfizer .gov Call Center,,,,
Atopic Dermatitis,NCT05502848,The Effect of Intervention and Mechanism of ICBT on Chronic Itching in Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05502848,NO,ALL,ADULT,,Atopic Dermatitis,,,,,BEHAVIORAL: Internet Cognitive Behavior Therapy,,,,,,,,,,,,
Atopic Dermatitis,NCT05651711,A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon),https://clinicaltrials.gov/study/NCT05651711,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: Rocatinlimab,OTHER: Placebo,,,,"Research Solutions of Arizona, PC, Litchfield Park, Arizona, 85340, United States","Center for Dermatology and Plastic Surgery, Scottsdale, Arizona, 85260, United States","Clinical Trials Institute of Northwest Arkansas, Fayetteville, Arkansas, 72703, United States",,,,,
Atopic Dermatitis,NCT05326672,Phase III Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05326672,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: Benvitimod Cream,DRUG: Placebo,,,,"Peking University People's Hospital, Beijing, China",,,,,,,
Atopic Dermatitis,NCT05882877,"A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)",https://clinicaltrials.gov/study/NCT05882877,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: Rocatinlimab,OTHER: Placebo,,,,"Cahaba Dermatology and Skin Health Center, Birmingham, Alabama, 35244, United States","Medical Dermatology Specialists, Phoenix, Arizona, 85006, United States","Alliance Dermatology and Mohs Center, Phoenix, Arizona, 85032, United States",,,,,
Atopic Dermatitis,NCT05614817,CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05614817,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: CBP-201,DRUG: Placebo,,,,,,,Suzhou Connect,,,,
Atopic Dermatitis,NCT05984420,Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05984420,NO,ALL,CHILD,,Atopic Dermatitis,,,,,"DEVICE: LimpiAD 2,5% plus cream",OTHER: Vehicle,OTHER: Emollient,,,"Dr. Chianese Pierluigi, Castellammare di Stabia, Napoli, 80053, Italy","Dr. Carlomagno Francesco, Nola, Napoli, 80035, Italy","Dr. D'Onofrio Antonietta, Pomigliano d'Arco, Napoli, 80038, Italy",Ruggiero Giuseppe,,,,
Atopic Dermatitis,NCT05099315,Microbiome in Atopic Dermatitis Under Systemic Therapy,https://clinicaltrials.gov/study/NCT05099315,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,"OTHER: not applicable, observational study",,,,,"Dpt of Dermatology and Allergology, CharitÃ© - UniversitÃ¤tsmedizin Berlin, Berlin, 10117, Germany",,,,,,,
Atopic Dermatitis,NCT05215808,SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis Subjects,https://clinicaltrials.gov/study/NCT05215808,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Atopic Dermatitis,,,,,DRUG: RBN-3143,,,,,"Veracity Clinical Research, Woolloongabba, Queensland, Australia","CMAX Clinical Research Pty Ltd, Adelaide, SA 5000, Australia","Optimal Clinical Trials, Auckland, New Zealand",,,,,
Atopic Dermatitis,NCT05916365,Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05916365,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,BIOLOGICAL: Lebrikizumab,,,,,"Investigator Site 7, Darmstadt, Hessen, 64283, Germany","Investigator Site 8, Frankfurt, Hessen, 60590, Germany","Investigator Site 9, OsnabrÃ¼ck, Lower Saxony, 49074, Germany",Aleksandra Stjepanovic,,,,
Atopic Dermatitis,NCT06194045,Nutritional Study to Determine the Effect of Fish Oil on Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06194045,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,DIETARY_SUPPLEMENT: LC-MUFA oil,DIETARY_SUPPLEMENT: Placebo,,,,"Helse MÃ¸re og Romsdal HF, Ã…lesund, MÃ¸re Og Romsdal, 6017, Norway",,,Dag Arne Lihaug Hoff,,,,
Atopic Dermatitis,NCT03710044,Investigation of Flare and Remission in Subjects With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT03710044,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Atopic Dermatitis,,,,,DRUG: Cyclosporine A,,,,,"Investigational site, Rotterdam, 3015 GD, Netherlands",,,Medical Expert,,,,
Atopic Dermatitis,NCT06366932,Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models,https://clinicaltrials.gov/study/NCT06366932,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Atopic Dermatitis,,,,,DRUG: Second-line systemic treatment,OTHER: Folllow-up of second-line systemic treatment already started,,,,"Hospital La Paz, Madrid, 28046, Spain",,,Irene GarcÃ­a,,,,
Atopic Dermatitis,NCT05598762,The Transcriptomic Study of Thai Patients With Atopic Dermatitis by Tape Strips,https://clinicaltrials.gov/study/NCT05598762,NO,ALL,"CHILD, ADULT",,Atopic Dermatitis,,,,,GENETIC: Tape strips,,,,,"Queen Sirikit National Institute of Child Health, Bangkok, 10400, Thailand",,,,,,,
Atopic Dermatitis,NCT06248814,"A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis",https://clinicaltrials.gov/study/NCT06248814,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,"Dermatitis, Atopic",,,,,DRUG: BMS-986326,OTHER: Placebo,,,,"Local Institution - 0009, Pardubice, 530 02, Czechia","CHU Estaing, Clermont-Ferrand, 63003, France","CHU de Nice - L'Archet, Nice, 06200, France",Bristol-Myers Squibb,,,,
Atopic Dermatitis,NCT05004324,Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD),https://clinicaltrials.gov/study/NCT05004324,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,"Dermatitis, Atopic",,,,,BIOLOGICAL: FURESTEM-ADÂ® inj. 5.0 X 10^7 cells/1.5 mL,BIOLOGICAL: Placebo,,,,"Chosun University Hospital, Gwangju, Jeollanam-do, 61453, Korea, Republic of",,,Yeonglib Park,Yangwon Lee,Sanguk Son,Donghoon Lee,Chanho Na
Atopic Dermatitis,NCT05969717,Induced Pluripotent Stem Cell Derived Exosomes for the Treatment of Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05969717,NO,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,Atopic Dermatitis,,,,,DRUG: GD-iExo-001,OTHER: normal saline,,,,"Chinese Academy of Medical Science & Peking Union Medical College Hospital, Beijing, Beijing, 100730, China",,,Hongzhong Jin,,,,
Atopic Dermatitis,NCT06169527,A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab,https://clinicaltrials.gov/study/NCT06169527,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,DRUG: Dupilumab,,,,,"Investigational Site Number: 2500021, Argenteuil, 95100, France","Investigational Site Number: 2500018, Arras, 62022, France","Investigational Site Number: 2500011, Ars Laquenexy, 57530, France",,,,,
Atopic Dermatitis,NCT04836858,A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.,https://clinicaltrials.gov/study/NCT04836858,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,BIOLOGICAL: CMK389,BIOLOGICAL: Placebo,,,,"Novartis Investigative Site, Pardubice, Czech Republic, 530 02, Czechia","Novartis Investigative Site, Praha 10, 100 34, Czechia","Novartis Investigative Site, Marseille, 13008, France",,,,,
Atopic Dermatitis,NCT05048056,"Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis",https://clinicaltrials.gov/study/NCT05048056,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: Placebo,DRUG: AK120,DRUG: AK120,,,"AkesoBio Investigative Site 2003, Little Rock, Arkansas, 72204, United States","AkesoBio Investigative Site 2010, Canoga Park, California, 91303, United States","AkesoBio Investigative Site 2021, San Diego, California, 92119, United States",,,,,
Atopic Dermatitis,NCT05633355,"A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)",https://clinicaltrials.gov/study/NCT05633355,NO,ALL,CHILD,PHASE3,Atopic Dermatitis,,,,,DRUG: Rocatinlimab,,,,,"Phoenix Childrens Hosptial, Phoenix, Arizona, 85016, United States","Medical Advancement Centers of Arizona, Tempe, Arizona, 85283, United States","Dermatology Trial Associates, Bryant, Arkansas, 72022, United States",,,,,
Atopic Dermatitis,NCT05375929,A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India,https://clinicaltrials.gov/study/NCT05375929,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: Abrocitinib 100 mg,DRUG: Abrocitinib 200 mg,,,,"All India Institute of Medical Sciences, New Delhi, Delhi, 110029, India","Sir Ganga Ram Hospital, New Delhi, Delhi, 110060, India","Nirmal Hospital Pvt Ltd., Surat, Gujarat, 395002, India",Pfizer .gov Call Center,,,,
Atopic Dermatitis,NCT05127421,Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis Involvement,https://clinicaltrials.gov/study/NCT05127421,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: Ruxolitinib cream,DRUG: Vehicle,,,,"Science37, Culver City, California, 90230, United States",,,Haq Nawaz,,,,
Atopic Dermatitis,NCT00484003,"A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis",https://clinicaltrials.gov/study/NCT00484003,NO,ALL,CHILD,PHASE4,Atopic Eczema,,,,,DRUG: Pimecrolimus cream 1%,,,,,"Investigative Sites, Various Cities, South Africa",,,Novartis Pharmaceuticals,,,,
Atopic Dermatitis,NCT05155085,A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05155085,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: AK002,OTHER: Placebo,,,,"Allakos Investigational Site 218-034, Birmingham, Alabama, 35209, United States","Allakos Investigational Site 218-074, Cullman, Alabama, 35058, United States","Allakos Investigational Site 218-025, Gilbert, Arizona, 85018, United States",Chin Lee,,,,
Atopic Dermatitis,NCT04392154,Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin),https://clinicaltrials.gov/study/NCT04392154,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,BIOLOGICAL: Lebrikizumab,,,,,"Pinnacle Research Group, LLC, Anniston, Alabama, 36207, United States","Clinical Research Center of Alabama- Birmingham, Birmingham, Alabama, 35244, United States","Investigate MD, Scottsdale, Arizona, 85255, United States",Call 1-877- (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9  - 5  Eastern time (/ - 5 hours,,,,
Atopic Dermatitis,NCT06277245,A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.,https://clinicaltrials.gov/study/NCT06277245,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: LNK01001,DRUG: Placebo,,,,"Dermatological Hospital of Southern Medical University, Guangzhou, China",,,Jianzhong Zhang,,,,
Atopic Dermatitis,NCT05566262,Bodewell Products for the Treatment of Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05566262,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Atopic Dermatitis,,,,,DRUG: Bodewell Calming Cream,,,,,"The University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States",,,Tiffany Mayo,,,,
Atopic Dermatitis,NCT06216392,Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06216392,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,BIOLOGICAL: GR1802 injection,BIOLOGICAL: placebo,,,,"Huashan Hospital, Shanghai, Shanghai, 200000, China",,,,,,,
Atopic Dermatitis,NCT05692843,Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response,https://clinicaltrials.gov/study/NCT05692843,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Atopic Dermatitis,,,,,DRUG: Cyclosporin A,OTHER: Follow-up of Cyclospoin treatment already started,,,,"Hospital La Paz, Madrid, 28046, Spain",,,Alberto M Borobia,,,,
Atopic Dermatitis,NCT06309355,Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06309355,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: YR001 ointment,OTHER: Placebo,,,,"DelRicht Research, Baton Rouge, Louisiana, 70809, United States",,,,,,,
Atopic Dermatitis,NCT02091037,S. Aureus Colonization in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT02091037,NO,ALL,"CHILD, ADULT",,Atopic Dermatitis,,,,,,,,,,"Columbia University Medical Center / Department of Dermatology, New York, New York, 10032, United States",,,Christine T Lauren,,,,
Atopic Dermatitis,NCT02001181,Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema),https://clinicaltrials.gov/study/NCT02001181,YES,ALL,ADULT,PHASE2,"Dermatitis, Atopic",,,,,DRUG: Tofacitinib ointment 20mg/g,DRUG: Placebo ointment (Vehicle),,,,"SKiN Centre for Dermatology, Peterborough, Ontario, K9J 1Z2, Canada","The Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada","K. Papp Clinical Research, Waterloo, Ontario, N2J 1C4, Canada",Pfizer .gov Call Center,,,,
Atopic Dermatitis,NCT05819463,Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland,https://clinicaltrials.gov/study/NCT05819463,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,,,,,,"UniversitÃ¤tsspital Basel, Allergologie, Basel, 4031, Switzerland","Inselspital, Department of Dermatology, Bern, 3010, Switzerland","Dermatology & Skin Care Clinic, Buochs, 6374, Switzerland",Dagmar Simon,,,,
Atopic Dermatitis,NCT05363904,Atopic Dermatitis: Sub-Saharan Africa vs. Central Europe,https://clinicaltrials.gov/study/NCT05363904,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,OTHER: Observation,,,,,"University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar","University Hospital Zurich, ZÃ¼rich, Switzerland","Regional Dermatology Training Centre (RDTC), Moshi, Tanzania",Marie-Charlotte BrÃ¼ggen,Daudi Mavura,John Masenga,,
Atopic Dermatitis,NCT05029895,A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD),https://clinicaltrials.gov/study/NCT05029895,NO,ALL,CHILD,,Atopic Dermatitis,,,,,,,,,,"Takeo Skin Clinic /ID# 248095, Asahi Owari, Aichi, 488-0032, Japan","Ichinomiya Municipal Hospital /ID# 245070, Ichinomiya-shi, Aichi, 491-8558, Japan","Nagoya City University Hospital /ID# 250809, Nagoya shi, Aichi, 467-8602, Japan",.,,,,
Atopic Dermatitis,NCT04212169,Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04212169,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: MEDI3506,DRUG: Placebo,,,,"Research Site, Birmingham, Alabama, 35209, United States","Research Site, Santa Monica, California, 90404, United States","Research Site, Jacksonville, Florida, 32256, United States",,,,,
Atopic Dermatitis,NCT04921969,A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3),https://clinicaltrials.gov/study/NCT04921969,YES,ALL,CHILD,PHASE3,Atopic Dermatitis,,,,,DRUG: Ruxolitinib,DRUG: Vehicle Cream,,,,"Clinical Research Center of Alabama, Birmingham, Alabama, 35209, United States","Cahaba Dermatology, Hoover, Alabama, 35244, United States","Physicians Research Group Ii, Gilbert, Arizona, 85295, United States",Brett Angel,,,,
Atopic Dermatitis,NCT05696392,The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.,https://clinicaltrials.gov/study/NCT05696392,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Atopic Dermatitis,,,,,DRUG: ruxolitinib cream,,,,,"First Oc Dermatology, Fountain Valley, California, 92708, United States","Ark Clinical Research, Long Beach, California, 90815, United States","The Gw Medical Faculty Associates, Washington, District of Columbia, 20037, United States",,,,,
Atopic Dermatitis,NCT04178967,Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04178967,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,BIOLOGICAL: Lebrikizumab,OTHER: Placebo,,,,"Investigate MD, Scottsdale, Arizona, 85255, United States","Northwest Arkansas Clinical Trials Center, Rogers, Arkansas, 72758, United States","Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield, California, 93309, United States",Call 1-877- (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9  - 5  Eastern time (/ - 5 hours,,,,
Atopic Dermatitis,NCT03569293,Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema),https://clinicaltrials.gov/study/NCT03569293,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: Placebo for Upadacitinib,DRUG: Upadacitinib,,,,"Alliance Dermatology and MOHs /ID# 200375, Phoenix, Arizona, 85032, United States","Clear Dermatology & Aesthetics Center /ID# 201256, Scottsdale, Arizona, 85255-4134, United States","Bakersfield Derma & Skin Cance /ID# 200433, Bakersfield, California, 93309, United States",.,,,,
Atopic Dermatitis,NCT05098821,Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation,https://clinicaltrials.gov/study/NCT05098821,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,"OTHER: not applicable, observational study",,,,,"Dpt of Dermatology and Allergology, CharitÃ© - UniversitÃ¤tsmedizin Berlin, Berlin, 10117, Germany",,,,,,,
Atopic Dermatitis,NCT02594098,Secukinumab for Treatment of Atopic Dermatitis,https://clinicaltrials.gov/study/NCT02594098,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: Secukinumab,DRUG: Placebo,,,,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States",,,Emma Guttman,,,,
Atopic Dermatitis,NCT05383378,"A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis",https://clinicaltrials.gov/study/NCT05383378,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Atopic Dermatitis,,,,,DRUG: si-544,DRUG: Placebo,,,,"selectION Clinical Trial Site, Berlin, Germany","selectION Clinical Trial Site, Hamburg, Germany","selectION Clinical Trial Site, Magdeburg, Germany",,,,,
Atopic Dermatitis,NCT05671445,The Study of CM326 in Adult Subjects With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05671445,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,BIOLOGICAL: CM326,,,,,"Peking University People's hospital, Beijing, China",,,,,,,
Atopic Dermatitis,NCT05139836,A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting,https://clinicaltrials.gov/study/NCT05139836,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,,,,,,"Universitaetsklinik Heidelberg /ID# 245834, Heidelberg, Baden-Wuerttemberg, 69120, Germany","Beldio Research GmbH /ID# 245830, Memmingen, Bayern, 87700, Germany","Dermazent /Id# 268146, Munich, Bayern, 80331, Germany",.,,,,
Atopic Dermatitis,NCT04725136,Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04725136,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Atopic Dermatitis,,,,,BIOLOGICAL: FURESTEM-AD inj,,,,,"Dongguk University Medical Center, Ilsan, Korea, Republic of","Seoul National Hospital, Seoul, Korea, Republic of",,,,,,
Atopic Dermatitis,NCT05372003,IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05372003,NO,ALL,ADULT,EARLY_PHASE1,Atopic Dermatitis,,,,,DRUG: Dupilumab,OTHER: Photo therapy,,,,"Mayo Clinic Arizona, Scottsdale, Arizona, 85259, United States",,,Elena Anna De Filippis,,,,
Atopic Dermatitis,NCT04110873,"A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis",https://clinicaltrials.gov/study/NCT04110873,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: Antroquinonol Capsule 50mg,DRUG: Antroquinonol Capsule 100mg,DRUG: Placebo oral capsule,,,"Chung Shan Medical University Hospital, Taichung, 402, Taiwan",,,Wei C- C,,,,
Atopic Dermatitis,NCT05999799,A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05999799,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,"Dermatitis, Atopic",,,,,DRUG: GSK1070806,DRUG: Placebo,,,,"GSK Investigational Site, Phoenix, Arizona, 85006, United States","GSK Investigational Site, North Little Rock, Arkansas, 72117, United States","GSK Investigational Site, Canoga Park, California, 91303, United States",Clinical Trials,,,,
Atopic Dermatitis,NCT04146363,Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1),https://clinicaltrials.gov/study/NCT04146363,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,BIOLOGICAL: Lebrikizumab,OTHER: Placebo,,,,"Johnson Dermatology, Fort Smith, Arkansas, 72916, United States","Wallace Medical Group, Inc., Beverly Hills, California, 90211, United States","California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States",Call 1-877- (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9  - 5  Eastern time (/ - 5 hours,,,,
Atopic Dermatitis,NCT05891119,Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05891119,NO,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,Atopic Dermatitis,,,,,DIETARY_SUPPLEMENT: Caffeine,DRUG: Metoprolol,DRUG: Midazolam,DRUG: Warfarin,DIETARY_SUPPLEMENT: Vitamin K,"Velocity Clinical Research, North Hollywood, North Hollywood, California, 91606-1570, United States","Accel Research Sites (ACR), DeLand, Florida, 32720-3134, United States","Direct Helpers Research Center (DHRC), Hialeah, Florida, 33012-3618, United States",,,,,
Atopic Dermatitis,NCT03920852,A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT03920852,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,Atopic Dermatitis,,,,,DRUG: Ruxolitinib cream,,,,,"Orange County Research Center, Anaheim, California, 92801, United States","Encino Research Center, Encino, California, 91436, United States","San Marcus Research Clinic, Inc., Miami Lakes, Florida, 33014, United States",,,,,
Atopic Dermatitis,NCT06116565,A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06116565,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,BIOLOGICAL: CM310,,,,,,,,,,,,
Atopic Dermatitis,NCT05324618,Tacrolimus Versus Hydrocortisone in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05324618,NO,ALL,CHILD,PHASE4,Atopic,Dermatitis,,,,DRUG: Tacrolimus,DRUG: Hydrocortisone,,,,"Dermatology Clinic of National Hepatology and Tropical Medicine Research Institute, Cairo, 123456, Egypt",,,Amal A. Mohamed,,,,
Atopic Dermatitis,NCT05059509,Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05059509,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,BIOLOGICAL: FB825,,,,,"National Taiwan University Hospital, Taipei, Taiwan",,,,,,,
Atopic Dermatitis,NCT05724199,A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD),https://clinicaltrials.gov/study/NCT05724199,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: Rocatinlimab,OTHER: Placebo,,,,"The University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States","Medical Dermatology Specialists, Phoenix, Arizona, 85006, United States","Southwest Skin Specialists, Phoenix, Arizona, 85018, United States",,,,,
Atopic Dermatitis,NCT05394792,An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab,https://clinicaltrials.gov/study/NCT05394792,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,,,,,,"Dermatology Research Institute Inc. /ID# 246344, Calgary, Alberta, T2J 7E1, Canada","Laser Rejuvenation Clinics Inc. /ID# 255303, Calgary, Alberta, T2W 4X9, Canada","Rejuvenation Dermatology Clinic Calgary North /ID# 255623, Calgary, Alberta, T3K 6B8, Canada",.,,,,
Atopic Dermatitis,NCT05442645,A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in Taiwan,https://clinicaltrials.gov/study/NCT05442645,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,,,,,,"Investigational site number TAIWAN, Taiwan, Taiwan",,,,,,,
Atopic Dermatitis,NCT06085521,A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06085521,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: LNK01001 Dose A,DRUG: LNK01001 Dose B,DRUG: placebo,,,"Jianzhong Zhang, Beijing, China",,,Jianzhong Zhang,,,,
Atopic Dermatitis,NCT03610386,Effects of an Anti-TRPM8 in the Atopic Dermatitis Pruritus,https://clinicaltrials.gov/study/NCT03610386,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,OTHER: Adding menthoxypropanediol to the biopsy,OTHER: No adding menthoxypropanediol to the biopsy,,,,"CHU Brest, Brest, France",,,,,,,
Atopic Dermatitis,NCT04250350,Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04250350,YES,ALL,CHILD,PHASE3,Atopic Dermatitis,,,,,BIOLOGICAL: Lebrikizumab,,,,,"Pinnacle Research Group, Anniston, Alabama, 36207, United States","Arkansas Research Trials, LLC, North Little Rock, Arkansas, 72117, United States","Hope Clinical Research, Canoga Park, California, 91303, United States",,,,,
Atopic Dermatitis,NCT06487000,To Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate or Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06487000,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: EC-18,DRUG: Placebo EC-18,,,,,,,,,,,
Atopic Dermatitis,NCT05601882,A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05601882,NO,ALL,"CHILD, ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: Upadacitinib,DRUG: Dupilumab,,,,"Medical Dermatology Specialists /ID# 250212, Phoenix, Arizona, 85006, United States","Alliance Dermatology and MOHs Center, PC /ID# 249671, Phoenix, Arizona, 85032, United States","Clinical Trials Institute - Northwest Arkansas /ID# 249838, Fayetteville, Arkansas, 72703, United States",.,,,,
Atopic Dermatitis,NCT06192563,A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab Treatment,https://clinicaltrials.gov/study/NCT06192563,NO,ALL,CHILD,,Dermatitis Atopic,,,,,DRUG: Dupilumab,,,,,"Investigational Site Number: 002, Bologna, 40138, Italy","Investigational Site Number: 006, Brescia, 25123, Italy","Investigational Site Number: 004, Firenze, 50139, Italy",Clinical Sciences & Operations,,,,
Atopic Dermatitis,NCT06463353,Clinical Study of Trilinolein Cream for Prevention of Relapse in Remission of Moderate-to-severe Atopic Dermatitis.,https://clinicaltrials.gov/study/NCT06463353,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,OTHER: trilinolein cream group,OTHER: cream base group,,,,,,,,,,,
Atopic Dermatitis,NCT04686955,The Efficacy of Patients With Moderate to Severe Atopic Dermatitis Treated With Chinese Herbal Medicine,https://clinicaltrials.gov/study/NCT04686955,NO,ALL,"CHILD, ADULT",,Atopic Dermatitis,,,,,DRUG: Xiao-Xian-Gui-Fu-Tang,,,,,"Center for Traditional Medicine, Taipei VGH, Taipei, 11217, Taiwan","Taipei Veterans General Hospital, Taipei, Taiwan",,Fang-Pey Chen,,,,
Atopic Dermatitis,NCT02889081,Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis (MKNFOAD),https://clinicaltrials.gov/study/NCT02889081,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,OTHER: maternal biological folate level,OTHER: maternal biological Vitamin D level,,,,"Children Hospital of Fudan University, Shanghai, 201102, China",,,Guoying Huang,,,,
Atopic Dermatitis,NCT03843437,Tencel vs. Standard Cotton Therapeutic Garments as an Adjunct Treatment for Moderate to Severe Atopic Dermatitis in Children,https://clinicaltrials.gov/study/NCT03843437,NO,ALL,CHILD,,Atopic Dermatitis,,,,,DEVICE: Tencel Therapeutic Garments,DEVICE: Cotton Therapeutic Garments,,,,"Johns Hopkins Pediatric Dermatology Clinic, Baltimore, Maryland, 21287, United States",,,Annie Grossberg,,,,
Atopic Dermatitis,NCT06058156,Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06058156,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: SAR444656 (KT-474),DRUG: Placebo,,,,"Clear Dermatology & Aesthetics Center Site Number: 8400003, Scottsdale, Arizona, 85255-4140, United States","Encore Medical Research Site Number: 8400002, Boynton Beach, Florida, 33436-7245, United States","Encore Medical Research Site Number: 8400004, Hollywood, Florida, 33021-6467, United States",,,,,
Atopic Dermatitis,NCT05285839,Dupixent and Narrowband UVB for Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05285839,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Atopic Dermatitis,,,,,DRUG: Dupixent,,,,,"Eczema Treatment Center of New Jersey, East Windsor, New Jersey, 08520, United States",,,,,,,
Atopic Dermatitis,NCT04352270,Clinic-Based Atopic Dermatitis Therapeutic Patient Education,https://clinicaltrials.gov/study/NCT04352270,NO,ALL,CHILD,,Atopic Dermatitis,,,,,OTHER: AD printed educational materials,OTHER: AD educational videos,,,,"BMC Pediatric Dermatology Clinics, Boston, Massachusetts, 02118, United States",,,Margaret Lee,,,,
Atopic Dermatitis,NCT05613062,Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children,https://clinicaltrials.gov/study/NCT05613062,NO,ALL,CHILD,PHASE1|PHASE2,Atopic Dermatitis,,,,,DRUG: Modified Huang-Lian-Jie-Du Decoction (MHLJDD),DRUG: Placebo,,,,"School of Chinese Medicine, Hong Kong, Hong Kong",,,Zhixiu Lin,,,,
Atopic Dermatitis,NCT05200403,Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05200403,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Atopic Dermatitis,,,,,DRUG: Crisaborole 2%,DRUG: Vehicle treatment,DEVICE: Accelerometry device for children,DEVICE: Accelerometry device for adult caregivers,,"BU CAMed Laboratory for Human Neurobiology, Boston, Massachusetts, 02118, United States",,,Kevin C Thomas,,,,
Atopic Dermatitis,NCT06009094,"Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis",https://clinicaltrials.gov/study/NCT06009094,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Atopic Dermatitis,,,,,DRUG: VC005,DRUG: VC005 Placebo,,,,"Chinese Academy of Medical Sciences Hospital of Skin Disease, Nanjing, Jiangsu, China",,,Qianjin Lu,,,,
Atopic Dermatitis,NCT06421740,An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China,https://clinicaltrials.gov/study/NCT06421740,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,,,,,,"Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 264193, Beijing, Beijing, 100730, China","The First Affiliated Hospital Of Fujian Medical University /ID# 268210, Fuzhou, Fujian, 350005, China","Changgeng Hospital /ID# 268209, Xiamen, Fujian, 361022, China",.,,,,
Atopic Dermatitis,NCT02779426,Texting Atopic Dermatitis Patients to Optimize Learning and EASI Scores,https://clinicaltrials.gov/study/NCT02779426,NO,ALL,CHILD,,Atopic Dermatitis,,,,,BEHAVIORAL: Text messages,,,,,"Columbia University Medical Center, Department of Dermatology, New York, New York, 10032, United States",,,Christine Lauren,,,,
Atopic Dermatitis,NCT06101823,Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06101823,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,BIOLOGICAL: OpSCF,BIOLOGICAL: Placebo,BIOLOGICAL: OpSCF (Open Label Extension),,,"Cahaba Dermatology & Skin Health Center, Birmingham, Alabama, 33607, United States","First OC Dermatology Research, Fountain Valley, California, 92708, United States","Axon Clinical Research, Inglewood, California, 90301, United States",Martin Phillips,,,,
Atopic Dermatitis,NCT04706559,Efficacy of Oral Supplementation of Probiotics in Children With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04706559,NO,ALL,CHILD,,Atopic Dermatitis,,,,,"DRUG: Probiotic sachet containing mixture of four strains i.e.Lactobacillus rhamnosus, Lactobacillus acidophilus, Bifidobacterium longum, and Saccharomyces boulardii",DRUG: Conventional treatment,,,,"B.P. Koirala Institute of Health Sciences, DharÄn BÄzÄr, 7053, Nepal",,,,,,,
Atopic Dermatitis,NCT04250337,Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.,https://clinicaltrials.gov/study/NCT04250337,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,BIOLOGICAL: Lebrikizumab,OTHER: Placebo,OTHER: Topical Corticosteroid,,,"Investigate MD, Scottsdale, Arizona, 85255, United States","Orange County Research Institute, Anaheim, California, 92801, United States","Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield, California, 93309, United States",Call 1-877- (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9  - 5  Eastern time (/ - 5 hours,,,,
Atopic Dermatitis,NCT06397911,"Evaluate Efficacy, Pharmacokinetics, and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis",https://clinicaltrials.gov/study/NCT06397911,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: FB825,DRUG: Placebo,,,,,,,Chia-Yu Chu,,,,
Atopic Dermatitis,NCT03921411,A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD),https://clinicaltrials.gov/study/NCT03921411,YES,ALL,CHILD,PHASE2,Atopic Dermatitis,,,,,BIOLOGICAL: Nemolizumab,,,,,"Galderma Investigational Site, Fountain Valley, California, 92708, United States","Galderma Investigational Site, Fremont, California, 94538, United States","Galderma Investigational Site, Jacksonville, Florida, 32256, United States",,,,,
Atopic Dermatitis,NCT04195698,Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04195698,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: Upadacitinib,,,,,"University of Arkansas for Medical Sciences /ID# 221021, Little Rock, Arkansas, 72205, United States","First OC Dermatology Research Inc /ID# 218619, Fountain Valley, California, 92708-3701, United States","UCSF Fresno /ID# 218453, Fresno, California, 93701-2302, United States",.,,,,
Atopic Dermatitis,NCT05318300,Evaluation of an Adapted Formula on Atopic Dermatitis.,https://clinicaltrials.gov/study/NCT05318300,NO,ALL,CHILD,,Atopic Dermatitis,,,,,DIETARY_SUPPLEMENT: tested formula with fiber,DIETARY_SUPPLEMENT: Control,,,,"Center_13, Namur, Belgium","Center_14, Thuin, Belgium","Center_05, Nice, France",Fabienne Cahn-Sellem,Sebastien Barbarot,Elena Bradatan,,
Atopic Dermatitis,NCT03901144,A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier,https://clinicaltrials.gov/study/NCT03901144,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,"Dermatitis, Atopic",,,,,DRUG: 2% urea/20% glycerol cream,DRUG: MinidermÂ® 20% cream,DRUG: DiprobaseÂ® cream,,,"The University of Sheffield Medical School, Sheffield, S10 2RX, United Kingdom",,,,,,,
Atopic Dermatitis,NCT04668066,Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04668066,YES,ALL,"ADULT, OLDER_ADULT",PHASE1,Atopic Dermatitis,,,,,DRUG: PF-07242813,DRUG: Placebo,,,,"Anaheim Clinical Trials, LLC, Anaheim, California, 92801, United States","First OC Dermatology, Fountain Valley, California, 92708, United States","Keck School of Medicine of USC, Los Angeles, California, 90033, United States",,,,,
Atopic Dermatitis,NCT06058000,A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06058000,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: 1.5% QLM3003,DRUG: 2% QLM3003,DRUG: Vehicle (Placebo),,,"The First Hospital of China Medical University, Shenyang, Liaoning, 110001, China","Dermatology Hospital of Shandong First Medical University, Jinan, Shandong, 276000, China",,Xinghua Gao,Furen zhang,,,
Atopic Dermatitis,NCT04613037,Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04613037,NO,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,Atopic Dermatitis,,,,,BIOLOGICAL: Fecal Microbial Transplantation,,,,,"Department of Dermatology, Tel Aviv Sourasky medical center, Tel Aviv, 64239, Israel",,,Jacob Mashiah,Nitsan Maharshak,,,
Atopic Dermatitis,NCT04193670,"Sensory Nociceptive Nerve Fibers, Key Regulator of Immune Response Type 2 in Atopic Dermatitis",https://clinicaltrials.gov/study/NCT04193670,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,OTHER: Clinical examination,PROCEDURE: Biopsies,OTHER: Blood test,,,"CHU de TOULOUSE, Toulouse, 31059, France",,,Marie,,,,
Atopic Dermatitis,NCT05970432,A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05970432,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: TQH2722 injection 300mg-150mg,DRUG: TQH2722 injection 600mg-300mg,DRUG: TQH2722 injection 900mg-450mg,DRUG: TQH2722 injection matching Placebo,,"The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, 241000, China","Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, 510030, China","The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510260, China",,,,,
Atopic Dermatitis,NCT06477835,A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06477835,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,BIOLOGICAL: SIM0718 Injection,,,,,,,,Jianzhong Zhang,Cheng Zhou,,,
Atopic Dermatitis,NCT02865356,Topical Solution for the Treatment of Atopic Dermatitis,https://clinicaltrials.gov/study/NCT02865356,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: Cyclosporine 5% solution,DRUG: Placebo,,,,"Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain","Hospital Sant Joan de DÃ©u, Esplugues de Llobregat, Barcelona, 08950, Spain","Hospital General Universitario de Alicante, Alicante, 03010, Spain",Carlos FerrÃ¡ndiz,,,,
Atopic Dermatitis,NCT02949960,DMT210 Topical Gel in the Treatment of Atopic Dermatitis,https://clinicaltrials.gov/study/NCT02949960,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: DMT210 Topical Gel,DRUG: Vehicle Control,,,,"Dermata Investigational Site, Houston, Texas, 77056, United States","Dermata Investigational Site, Norfolk, Virginia, 23502, United States",,Christopher Nardo,,,,
Atopic Dermatitis,NCT06175143,A Study to Evaluate the Safety and Efficacy of GR2002 Injection in Patients With Atopic Dermatitis.,https://clinicaltrials.gov/study/NCT06175143,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Atopic Dermatitis,,,,,BIOLOGICAL: GR2002 injection,,,,,"Peking University People's Hospital, Beijing, Beijing, 100044, China",,,Jianzhong Zhang,Cheng Zhou,,,
Atopic Dermatitis,NCT02763722,Evaluating Results of Regularly Applied Emollient - Spray in Atopic Dermatitis Therapy,https://clinicaltrials.gov/study/NCT02763722,NO,ALL,"CHILD, ADULT",,Atopic Dermatitis,,,,,OTHER: Emollient spray product,,,,,"Katarzyna Osinka, Warszawa, Å»wirki i Wigury 63A, 00-090, Poland",,,Wojciech Feleszko,,,,
Atopic Dermatitis,NCT02669888,Indigo Naturalis in Treating Atopic Dermatitis Topically,https://clinicaltrials.gov/study/NCT02669888,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: Indigo naturalis ointment,DRUG: Placebo,,,,"Chang Gung Memorial Hospital at Keelung, Kelung, 204, Taiwan","Chang Gung Memorial Hospital at Taipei, Taipei, 105, Taiwan","Chang Gung Memorial Hospital at Linkou, Taoyuan, 333, Taiwan",Yin-Ku Lin,,,,
Atopic Dermatitis,NCT06383468,A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06383468,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: AK120,,,,,"Beijing Friendship Hospital Capital Medical University, Beijing, Beijing, China","Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, Beijing, China","Beijing Tongren Hospital, Beijing, Beijing, China",,,,,
Atopic Dermatitis,NCT05491447,A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05491447,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: BMX-010,DRUG: Placebo,,,,"Cahaba Dermatology & Skin Health Center, Birmingham, Alabama, 35244, United States","Dermatology Trial Associates, Bryant, Arkansas, 72022, United States","Johnson Dermatology, Fort Smith, Arkansas, 72916, United States",,,,,
Atopic Dermatitis,NCT05531188,Efficacy Evaluation and Cutaneous Acceptability of the Lipikar Med Product on Subjects With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05531188,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,,,,,,"Insight Research, Quatre Bornes, Mauritius",,,Aslham Doarika,,,,
Atopic Dermatitis,NCT05715320,Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05715320,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,BIOLOGICAL: CM310,,,,,"Hangzhou First People's Hospital, Hangzhou, Zhejiang, China",,,,,,,
Atopic Dermatitis,NCT03397979,Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis,https://clinicaltrials.gov/study/NCT03397979,NO,ALL,CHILD,,Atopic Dermatitis,,,,,BEHAVIORAL: Infrequent versus Frequent Soaking Baths,,,,,"Allergy and Asthma Associates of Maine, Portland, Maine, 04102, United States",,,Ivan D Cardona,,,,
Atopic Dermatitis,NCT04345367,Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy,https://clinicaltrials.gov/study/NCT04345367,YES,ALL,"ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: Abrocitinib 200 mg,COMBINATION_PRODUCT: Dupilumab 300 mg,,,,"Total Skin & Beauty Dermatology Center, PC, Birmingham, Alabama, 35205, United States","Clinical Research Center Of Alabama, Birmingham, Alabama, 35209, United States","Alliance Dermatology & MOHS Center, PC, Phoenix, Arizona, 85032, United States",Pfizer .gov Call Center,,,,
Atopic Dermatitis,NCT06144424,"Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis",https://clinicaltrials.gov/study/NCT06144424,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: Oral EP262,DRUG: Placebo,,,,"Allervie Clinical Research, Birmingham, Alabama, 35209, United States","RM Medical Research, Inc., Miami Lakes, Florida, 33014, United States","Indiana Clinical Trials Center, Plainfield, Indiana, 46168, United States",,,,,
Atopic Dermatitis,NCT05602207,Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab,https://clinicaltrials.gov/study/NCT05602207,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Atopic Dermatitis,,,,,DRUG: Abrocitinib,,,,,"Inno-6050 Site 22, Birmingham, Alabama, 35244, United States","Inno-6050 Site 13, Fountain Valley, California, 92708, United States","Inno-6050 Site 21, Miami Lakes, Florida, 33014, United States",Robert Bissonnette,,,,
Atopic Dermatitis,NCT05680298,Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China,https://clinicaltrials.gov/study/NCT05680298,NO,ALL,CHILD,PHASE4,Atopic Dermatitis,,,,,DRUG: Dupilumab,,,,,"Beijing Children's hospital, Beijing, China",,,Clinical Sciences & Operations,,,,
Atopic Dermatitis,NCT03915496,Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT03915496,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Atopic Dermatitis,,,,,DRUG: PF-04965842 200 mg,DRUG: PF-04965842 100 mg,DRUG: Placebo,,,"California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States","Keck School of Medicine of USC - IDS Pharmacy, Los Angeles, California, 90033, United States","USC/Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States",Pfizer .gov Call Center,,,,
Atopic Dermatitis,NCT06280716,A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06280716,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: Placebo,DRUG: Lebrikizumab,DRUG: Topical Corticosteroid,,,"Wannan Medical College Yijishan Hospital, Wuhu, Anhui, 241001, China","China-Japan Friendship Hospital, Beijing, Beijing, 100029, China","Peking University People's Hospital, Beijing, Beijing, 100034, China",Call 1-877- (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9  - 5  Eastern time (/ - 5 hours,,,,
Atopic Dermatitis,NCT05525715,A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05525715,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Atopic Dermatitis,,,,,"DRUG: 2mg QY201 tablets or 2mg QY201 placebo,BID","DRUG: 5mg QY201 tablets or 5mg QY201 placebo,BID","DRUG: 10mg QY201 tablets or 10mg QY201 placebo,QD","DRUG: 10mg QY201 tablets or 10mg QY201 placebo,BID","DRUG: 15mg QY201 tablets or 15mg QY201 placebo,BID",,,,LiMing Wu,,,,
Atopic Dermatitis,NCT03327116,Effect of Methotrexate on Inflammatory Response in Adult Atopic Dermatitis Patients,https://clinicaltrials.gov/study/NCT03327116,NO,ALL,"ADULT, OLDER_ADULT",,Atopic Dermatitis,,,,,DRUG: Methotrexate,,,,,"Hospital das ClÃ­nicas of the University of SÃ£o Paulo Medical School, Department of Dermatology, SÃ£o Paulo, SP, 05403900, Brazil",,,,,,,
Atopic Dermatitis,NCT06389136,A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab,https://clinicaltrials.gov/study/NCT06389136,NO,ALL,ADULT,PHASE3,Atopic Dermatitis,,,,,DRUG: Upadacitinib Dose A,DRUG: Dupilumab Dose A,DRUG: Upadacitinib Dose B,,,"Joseph Raoof Md,Inc /Id# 263849, Encino, California, 91436, United States","Integrative Skin Science and Research /ID# 264537, Sacramento, California, 95815, United States","Skin Care Research Boca Raton /ID# 263733, Boca Raton, Florida, 33486-2269, United States",.,,,,
Atopic Dermatitis,NCT06035354,"A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic Dermatitis",https://clinicaltrials.gov/study/NCT06035354,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Atopic Dermatitis,,,,,DRUG: AK120,DRUG: AK120,DRUG: Placebo,DRUG: AK120,DRUG: AK120,"AkesoBio Investigative Site 2037, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China","AkesoBio Investigative Site 2036, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China","AkesoBio Investigative Site 1001, Peking University People's Hospital, Beijing, Beijing, China",,,,,
Atopic Dermatitis,NCT05674695,Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy,https://clinicaltrials.gov/study/NCT05674695,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,"Dermatitis, Atopic",,,,,DRUG: Ciclosporin,,,,,"Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain","Hospital General Universitario de Alicante, Alicante, Spain","Hospital del Mar IMIM, Barcelona, Spain",,,,,
Atopic Dermatitis,NCT03745651,TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT03745651,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Atopic Dermatitis,,,,,DRUG: Ruxolitinib cream,DRUG: Vehicle cream,,,,"University Of Alabama At Birmingham, Birmingham, Alabama, 35233, United States","Center For Dermatology Cosmetic And Laser Surgery, Fremont, California, 94538, United States","Marvel Clinical Research - Clinedge - PPDS, Huntington Beach, California, 92647, United States",Michael E. Kuligowski,,,,
Alopecia Areata,NCT05594316,New Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT05594316,NO,ALL,"CHILD, ADULT",,Alopecia Areata,,,,,DRUG: Trichloroacetic acid,,,,,"Al-Azhar university, faculty of medicine, Cairo, Egypt","Al-Azhar university, Cairo, Egypt",,,,,,
Alopecia Areata,NCT05744505,1565nm Non-ablative Fractional Laser Treat Alopecia Areata,https://clinicaltrials.gov/study/NCT05744505,NO,ALL,ADULT,,Alopecia Areata,,,,,PROCEDURE: 1565nm Non-ablative Fractional Laser,PROCEDURE: placebo,,,,"Xianjie Wu, Hangzhou, Zhejiang, 310009, China",,,,,,,
Alopecia Areata,NCT04833179,Fecal Transplant for Alopecia Areata,https://clinicaltrials.gov/study/NCT04833179,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,BIOLOGICAL: fecal transplant,OTHER: placebo,,,,,,,,,,,
Alopecia Areata,NCT06088147,Methotrexate Versus Triamcinilone Acetonide in Treatment of Recalcitrant Alopecia Areata,https://clinicaltrials.gov/study/NCT06088147,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Alopecia Areata,,,,,DRUG: Methotrexate,DRUG: Triamcinolone Acetonide,,,,"Al-Azhar University, Assiut, Egypt",,,,,,,
Alopecia Areata,NCT06087796,Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.,https://clinicaltrials.gov/study/NCT06087796,NO,ALL,"CHILD, ADULT",PHASE1,Alopecia Areata,,,,,DRUG: Betamethasone Valerate 0.1% Cream,DRUG: Pentoxifylline,DRUG: Metformin,,,"Assiut university, Assiut, 71515, Egypt",,,Nada K. Mostafa,,,,
Alopecia Areata,NCT05865041,Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants,https://clinicaltrials.gov/study/NCT05865041,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Farudodstat,DRUG: Placebo,,,,"1 Site, Birmingham, Alabama, 35205, United States","1 Site, Fountain Valley, California, 92708, United States","1 Site, Santa Ana, California, 92701, United States",Chief Medical Officer,,,,
Alopecia Areata,NCT05600673,Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT05600673,NO,ALL,"CHILD, ADULT",PHASE1|PHASE2,Alopecia Areata,,,,,DRUG: Bimatoprost 0.03% solution,DEVICE: CO2 fractional laser,,,,"AL-Azhar University Hospital, Cairo, 11865, Egypt",,,,,,,
Alopecia Areata,NCT04680234,Superficial Cryotherapy Versus Microneedling in Alopecia Areata,https://clinicaltrials.gov/study/NCT04680234,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Alopecia Areata,,,,,PROCEDURE: DMEP kit,DEVICE: Dermapen,,,,"Sohag Faculty of Medicine, Sohag, 52324, Egypt",,,,,,,
Alopecia Areata,NCT05496426,A Study of KL130008 in Adults With Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT05496426,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: KL130008/Placebo,,,,,"The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangzhou, 510080, China",,,Xingqi Zhang,,,,
Alopecia Areata,NCT05588310,Quantification of the Socio-economic Multifacet Burden of Alopecia Areata and Identification of the Associated Factors,https://clinicaltrials.gov/study/NCT05588310,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,,,,,,"Toulouse University hospital, Toulouse, 31300, France",,,Juliette Mazereeuw-Hautier,,,,
Alopecia Areata,NCT05727306,Healthcare Disparities in Alopecia Areata,https://clinicaltrials.gov/study/NCT05727306,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Alopecia Areata,,,,,OTHER: No intervention,,,,,"Momentum Data Limited, London, United Kingdom",,,,,,,
Alopecia Areata,NCT03732807,PF-06651600 for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT03732807,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,Alopecia Areata,,,,,DRUG: PF-06651600 Induction Dose,DRUG: PF-06651600 Maintenance Dose #1,DRUG: PF-06651600 Maintenance Dose #2,DRUG: PF-06651600 Maintenance Dose #3,DRUG: Placebo,"The University of Alabama at Birmingham Hospital Outreach Lab, Birmingham, Alabama, 35233, United States","The University of Alabama at Birmingham, Department of Dermatology, Birmingham, Alabama, 35233, United States","The University of Alabama at Birmingham, Department of Dermatology, Birmingham, Alabama, 35294, United States",,,,,
Alopecia Areata,NCT05866562,Dupilumab in the Treatment of Pediatric Alopecia Areata,https://clinicaltrials.gov/study/NCT05866562,NO,ALL,CHILD,PHASE2,Alopecia Areata,,,,,DRUG: Dupilumab,DRUG: Placebo,,,,"University of California, Irvine, Irvine, California, 92697, United States","Yale University, New Haven, Connecticut, 06511, United States","Northwestern University Feinberg School of Medicine, Chicago, Illinois, 60611, United States",Emma Guttman-Yassky,,,,
Alopecia Areata,NCT06149936,Excimer Light(308) Therapy for Resistant Alopecia Areata,https://clinicaltrials.gov/study/NCT06149936,NO,ALL,ADULT,,Alopecia Areata,,,,,DEVICE: excimer light,,,,,,,,,,,,
Alopecia Areata,NCT06402630,"A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA)",https://clinicaltrials.gov/study/NCT06402630,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: STS01,DRUG: Placebo,,,,"Queen Margaret Hospital, Glasgow, Dunfirmline, KY12 0SU, United Kingdom","St Lukes Hospital, Bradford, Little Horton Lane, BD5 0NA, United Kingdom","Royal Alexandra Children's Hospital, Brighton, BN2 5BE, United Kingdom",,,,,
Alopecia Areata,NCT05745389,CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry,https://clinicaltrials.gov/study/NCT05745389,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,,,,,,"CorEvitas, LLC, Waltham, Massachusetts, 02451, United States",,,,,,,
Alopecia Areata,NCT01385839,Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata,https://clinicaltrials.gov/study/NCT01385839,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,Alopecia,Balding,,,PROCEDURE: Hair transplantation,PROCEDURE: Hypodermic needle irritation,,,,"Icahn School of Medicine at Mount Sinai, Department of Dermatology Clinical Trials Center, New York, New York, 10029, United States",,,Robin Unger,,,,
Alopecia Areata,NCT06018428,"Randomized, Double-Blind, Placebo-Controlled Phase 2a, Proof-of-Concept Trial of ADX-914 Phase 2a Trial for the Treatment of Severe Alopecia Areata",https://clinicaltrials.gov/study/NCT06018428,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: ADX-914,DRUG: Placebo,,,,"Scottsdale, Arizona, Scottsdale, Arizona, 85255, United States","Fayetteville, Arkansas, Fayetteville, Arkansas, 72703, United States","Hot Springs, Arkansas, Hot Springs, Arkansas, 71913, United States",,,,,
Alopecia Areata,NCT06012240,A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT06012240,NO,ALL,"CHILD, ADULT",PHASE3,Alopecia Areata,,,,,DRUG: Upadacitinib,DRUG: Placebo,,,,"Total Skin and Beauty Dermatology Center /ID# 259539, Birmingham, Alabama, 35205, United States","Advanced Research Associates - Glendale /ID# 259108, Glendale, Arizona, 85308, United States","Southwest Skin Specialists /ID# 258234, Phoenix, Arizona, 85018-3953, United States",.,,,,
Alopecia Areata,NCT05803070,Topical Cetirizine in Treatment of Localized Alopecia Areata,https://clinicaltrials.gov/study/NCT05803070,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Alopecia Areata,,,,,DRUG: Topical Cetirizine 1 %,DRUG: Topical betamethasone valerate 0.1%,,,,,,,,,,,
Alopecia Areata,NCT06399783,Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT06399783,NO,ALL,"CHILD, ADULT",PHASE4,Alopecia Areata,,,,,DRUG: Simvastatin,DRUG: Mometasone Furoate,PROCEDURE: Fractional CO2 laser,,,"Assiut university, Assiut, 73333, Egypt",,,,,,,
Alopecia Areata,NCT04006457,Long-Term PF-06651600 for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT04006457,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Alopecia Areata,,,,,DRUG: PF-06651600,BIOLOGICAL: Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine,"BIOLOGICAL: Meningococcal (groups A, C, W-135 and Y [ACWY]) oligosaccharide diphtheria CRM197 conjugate vaccine",,,"The University of Alabama at Birmingham Hosptial Outreach Lab, Birmingham, Alabama, 35233, United States","The University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States","The University of Alabama at Birmingham, Department of Dermatology, Birmingham, Alabama, 35294, United States",,,,,
Alopecia Areata,NCT03800979,Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata,https://clinicaltrials.gov/study/NCT03800979,YES,ALL,ADULT,PHASE4,Alopecia Areata,,,,,DRUG: Tofacitinib,,,,,"Institute of Dermatology, Bangkok, Thailand",,,Chinmanat Lekhavat,,,,
Alopecia Areata,NCT03847441,Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT03847441,NO,ALL,"CHILD, ADULT",,Alopecia Areata,,,,,DRUG: Calcipotriol,DEVICE: Narrow Band UVB,DIAGNOSTIC_TEST: vitamin D3 level,,,"Aswan University Hospital, Aswan, 81528, Egypt",,,,,,,
Alopecia Areata,NCT05885269,Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata,https://clinicaltrials.gov/study/NCT05885269,NO,ALL,ADULT,PHASE1,Alopecia Areata,,,,,DRUG: Group A applied topical Clobetasol Propionate,DRUG: Group B applied topical Tacrolimus,,,,"Danyal Sajjad, Abbottabad, Khyber Pakhtunkhwa, Pakistan",,,,,,,
Alopecia Areata,NCT05485571,Efficacy of Combined Microneedling With Methotrexate in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT05485571,NO,ALL,ADULT,,Alopecia Areata,,,,,DEVICE: derma pen,,,,,"Sohag University Hospital, Sohag, Egypt",,,,,,,
Alopecia Areata,NCT05910138,Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT05910138,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Alopecia Areata,,,,,DIAGNOSTIC_TEST: Serum Interlukin-15,DIAGNOSTIC_TEST: Serum Interlukin-21,,,,"Sohag University hospitals, Sohag, Egypt",,,,,,,
Alopecia Areata,NCT04660786,Intralesional Vitamin D in Alopecia Areata,https://clinicaltrials.gov/study/NCT04660786,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,Alopecia Areata,,,,,DRUG: triamcinolone acetonide,DRUG: vitamin D,,,,"Faculty of Medicine, Alexandria, 21521, Egypt",,,,,,,
Alopecia Areata,NCT02691117,Topical Garlic Concentrate for Alopecia Areata in Children,https://clinicaltrials.gov/study/NCT02691117,NO,ALL,"CHILD, ADULT",PHASE3,Alopecia Areata,,,,,DRUG: garlic concentrate,,,,,"Th Hospital for Sick Children, Toronto, Ontario, M5G1X8, Canada",,,,,,,
Alopecia Areata,NCT04412148,Modified SALT Score for Alopecia Areata,https://clinicaltrials.gov/study/NCT04412148,NO,ALL,ADULT,PHASE4,Alopecia Areata,,,,,DRUG: Triamcinolone Acetonide,OTHER: saline,,,,"Kasr El Ainy university hospital, Faulty of medicine,Cairo university, Cairo, Egypt",,,,,,,
Alopecia Areata,NCT00167102,Alefacept in Patients With Severe Scalp Alopecia Areata,https://clinicaltrials.gov/study/NCT00167102,YES,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,DRUG: Alefacept,,,,,"University of Minnesota, Minneapolis, Minnesota, 55455, United States",,,,,,,
Alopecia Areata,NCT05017454,Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids,https://clinicaltrials.gov/study/NCT05017454,NO,ALL,"CHILD, ADULT, OLDER_ADULT",EARLY_PHASE1,Alopecia Areata,,,,,DRUG: the optimized sodium valproate-loaded nanospanlastic dispersion,DRUG: mometasone furoate lotion,,,,"Kasralainy Hospital, Dermatology Department, Cairo, Egypt",,,heba ahmed,,,,
Alopecia Areata,NCT02599129,A Study of Secukinumab for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT02599129,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Secukinumab,DRUG: Placebo,,,,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States",,,,,,,
Alopecia Areata,NCT04556734,Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT04556734,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Etrasimod,DRUG: Etrasimod,DRUG: Placebo,,,"Investigate MD, Scottsdale, Arizona, 85255, United States","Dermatology Trial Associates, Bryant, Arkansas, 72022, United States","California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States",Pfizer .gov Call Center,,,,
Alopecia Areata,NCT05926882,"Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.",https://clinicaltrials.gov/study/NCT05926882,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Alopecia Areata,,,,,DRUG: Apremilast 30mg,,,,,"JPMC, Karachi, Sindh, Pakistan",,,Nazia Jabeen,Khadija Asadullah,Faiza Inam,,
Alopecia Areata,NCT05861401,Polymorphism of Janus Kinase 1 and 2 (JAK 1&2) in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT05861401,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Alopecia Areata,,,,,GENETIC: Janus Kinase 1 and 2,,,,,"Sohag University hospitals, Sohag, Egypt",,,,,,,
Alopecia Areata,NCT01802177,Excimer Light for Alopecia Areata,https://clinicaltrials.gov/study/NCT01802177,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,PROCEDURE: UVB excimer light,,,,,"The Skin Care Center, Vancouver General Hospital, Vancouver, British Columbia, V5Z 4E8, Canada",,,Harvey Lui,,,,
Alopecia Areata,NCT01736007,Childhood Alopecia Areata Study Using the 308-nm Excimer Laser,https://clinicaltrials.gov/study/NCT01736007,NO,ALL,CHILD,,Alopecia Areata,,,,,DEVICE: 308-nm excimer laser to alopecia patch,DEVICE: Liquid light guide tip on laser,,,,"Phoenix Children's Hospital, Phoenix, Arizona, 85016, United States",,,Harper N Price,Judith  O'Haver,,,
Alopecia Areata,NCT04517864,PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA,https://clinicaltrials.gov/study/NCT04517864,YES,ALL,ADULT,PHASE2,Alopecia Areata,,,,,DRUG: PF-06651600,DRUG: Placebo,,,,"Marvel Clinical Research 002, LLC, Huntington Beach, California, 92647, United States","University of California, Irvine, Irvine, California, 92697, United States","Skin Care Research, LLC, Boca Raton, Florida, 33486, United States",Pfizer .gov Call Center,,,,
Alopecia Areata,NCT04964349,Efficacy of Jessener Solution Versus Intralesional Steroid in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT04964349,NO,ALL,"CHILD, ADULT",EARLY_PHASE1,Alopecia Areata,,,,,DRUG: Corticosteroids Acting Locally,,,,,"Alazhar faculty of meidicine, Cairo, Egypt",,,Ahmed Elshahid,,,,
Alopecia Areata,NCT05414266,Study Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents With Alopecia Areata,https://clinicaltrials.gov/study/NCT05414266,NO,ALL,"CHILD, ADULT",EARLY_PHASE1,Alopecia Areata,,,,,DRUG: Placebo,DRUG: SADBE 5%,,,,"The University of Texas Health Science Center at Houston, Houston, Texas, 77030, United States",,,Adelaide Hebert,,,,
Alopecia Areata,NCT05278858,Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata,https://clinicaltrials.gov/study/NCT05278858,YES,ALL,CHILD,PHASE4,Alopecia Areata,,,,,COMBINATION_PRODUCT: MedJet Device with intralesional triamcinolone,,,,,"University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States",,,Sonal Shah,,,,
Alopecia Areata,NCT00176982,"Plaquenil for Alopecia Areata, Alopecia Totalis",https://clinicaltrials.gov/study/NCT00176982,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Alopecia Areata,,,,,DRUG: Hydroxychloroquine,,,,,"University of Minnesota, Minneapolis, Minnesota, 55455, United States","State University of New York at Stony Brook, Stonybrook, New York, 11790, United States",,Maria Hordinsky,Richard Kalish,,,
Alopecia Areata,NCT05587257,Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT05587257,NO,ALL,"CHILD, ADULT",,Alopecia Areata,,,,,DEVICE: Fractional CO2 laser,DEVICE: Derma pen,DRUG: Niosome minoxidil,DRUG: Minoxidil Topical Spray,,,,,,,,,
Alopecia Areata,NCT06327581,Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT06327581,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Alopecia Areata,,,,,DRUG: Lactic Acid,DRUG: vit D,DRUG: Triamcinolone Acetonide,DRUG: Saline,,"Rana Ehab, Zagazig, 44519, Egypt",,,,,,,
Alopecia Areata,NCT06104839,Safety and Efficacy of Oral NXC-736 in Adult Participants With Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT06104839,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: NXC736,DRUG: Placebo,,,,,,,,,,,
Alopecia Areata,NCT05368103,Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT05368103,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,BIOLOGICAL: Daxdilimab,,,,,"Burke Pharmaceutical Research, Hot Springs, Arkansas, 71913, United States","First OC Dermatology Research, Inc., Fountain Valley, California, 92708, United States","ForCare Clinical Research, Tampa, Florida, 33613, United States",,,,,
Alopecia Areata,NCT04793945,Excimer Light and Topical Steroid in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT04793945,NO,ALL,"CHILD, ADULT",PHASE4,Alopecia Areata,,,,,COMBINATION_PRODUCT: topical steroid and 308nm-Excimer light therapy,,,,,,,,Fatma m zidan,,,,
Alopecia Areata,NCT04797650,Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2),https://clinicaltrials.gov/study/NCT04797650,YES,ALL,"ADULT, OLDER_ADULT",PHASE3,Alopecia Areata,,,,,DRUG: CTP-543 matching placebo,DRUG: CTP-543,,,,"Alliance Dermatology & Mohs Center, Phoenix, Arizona, 85032, United States","Johnson Dermatology, Fort Smith, Arkansas, 72916, United States","Dermatology Research Associates, Los Angeles, California, 90045, United States",,,,,
Alopecia Areata,NCT04228029,Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids,https://clinicaltrials.gov/study/NCT04228029,NO,ALL,ADULT,PHASE4,Alopecia Areata,,,,,DEVICE: Carboxytherapy,DRUG: Intralesional Steroid Injection,,,,"Kasr ElAiny Hospital, Cairo university, Cairo, El Manial, 11956, Egypt",,,,,,,
Alopecia Areata,NCT05502952,Combined Microneedling and Topical Pentoxifylline Vesrus Intalesional Pentoxifylline in Treatment of Alopecia Areata: Intra-indiviual Comparative Study,https://clinicaltrials.gov/study/NCT05502952,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,DRUG: Pentoxifylline,,,,,"Sohag University Hospital, Sohag, Egypt",,,,,,,
Alopecia Areata,NCT01950780,Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata,https://clinicaltrials.gov/study/NCT01950780,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Ruxolitinib,,,,,"Columbia University Medical Center, Department of Dermatology, New York, New York, 10032, United States",,,Julian Mackay-Wiggan,,,,
Alopecia Areata,NCT04147845,Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT04147845,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Alopecia Areata,,,,,OTHER: Fractional Carbon Dioxide Laser,OTHER: Microneedling using dermapen,OTHER: Triamcinolone Acetonide,OTHER: Platelet-rich plasma,,"Faculty of Medicine, Alexandria University, Alexandria, Egypt",,,Khaled El Mulla,Eman Elmorsy,,,
Alopecia Areata,NCT03535233,Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT03535233,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Alopecia Areata,,,,,DRUG: Triamcinolone Acetonide,DRUG: Minoxidil 5 % Topical Spray,DRUG: clobetasol propionate,,,,,,Nermine H El-Eishi,Heba M Mashaly,Solwan I El-Samanoudy,Rania M Abdel-Hay,
Alopecia Areata,NCT01520077,Vytorin in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT01520077,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Alopecia Areata,,,,,DRUG: vytorin,,,,,"University of Miami, Miami, Florida, 33136, United States",,,Lawrence Schachner,,,,
Alopecia Areata,NCT03651752,DPCP for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT03651752,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Alopecia Areata,,,,,DRUG: Diphenylcyclopropenone (DPCP) Ointment,,,,,"University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States","University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States",,Maria Hordinsky,,,,
Alopecia Areata,NCT01328678,A Study of Vitamin D in Subjects With Alopecia Areata,https://clinicaltrials.gov/study/NCT01328678,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,,,,,,"Avera Research Institute, Sioux Falls, South Dakota, 57105, United States",,,Wael Eid,,,,
Alopecia Areata,NCT04299503,Topical Crisaborole in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT04299503,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Crisaborole Topical Ointment,DRUG: Placebo Topical Ointment,,,,"Tufts Medical Center, Department of Dermatology, Boston, Massachusetts, 02111, United States",,,David Rosmarin,,,,
Alopecia Areata,NCT02684123,Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT02684123,YES,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,DRUG: Apremilast,DRUG: Placebo,,,,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States",,,,,,,
Alopecia Areata,NCT02299297,"Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis",https://clinicaltrials.gov/study/NCT02299297,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Tofacitinib,,,,,"Columbia University Medical Center, New York, New York, 10032, United States",,,Julian Mackay-Wiggan,,,,
Alopecia Areata,NCT05599607,Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT05599607,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,DIETARY_SUPPLEMENT: Probiotic mixture,DIETARY_SUPPLEMENT: Placebo,,,,"Centro DermatolÃ³gico EstÃ©tico, Alicante, 03014, Spain",,,,,,,
Alopecia Areata,NCT04338295,Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling,https://clinicaltrials.gov/study/NCT04338295,NO,MALE,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,DEVICE: Tattoo machine (SOL Nova Device),,,,,"Yale University, New Haven, Connecticut, 06519, United States",,,Brett King,,,,
Alopecia Areata,NCT03359356,Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD),https://clinicaltrials.gov/study/NCT03359356,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Dupilumab,DRUG: Placebo,,,,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States","The Rockefeller University Laboratory for Investigative Dermatology, New York, New York, 10065-6399, United States",,Emma Guttman,,,,
Alopecia Areata,NCT04518995,Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1),https://clinicaltrials.gov/study/NCT04518995,YES,ALL,"ADULT, OLDER_ADULT",PHASE3,Alopecia Areata,,,,,DRUG: CTP-543 matching placebo,DRUG: CTP-543,DRUG: CTP-543,,,"Total Skin and Beauty Dermatology Center, Birmingham, Alabama, 35205, United States","Kern Research, Inc., Bakersfield, California, 93301, United States","California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States",,,,,
Alopecia Areata,NCT01673789,Stem Cell Educator Therapy in Alopecia Areata,https://clinicaltrials.gov/study/NCT01673789,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Alopecia Areata,,,,,DEVICE: Stem Cell Educator,,,,,"The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050031, China",,,Yong Zhao,,,,
Alopecia Areata,NCT05556265,A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata,https://clinicaltrials.gov/study/NCT05556265,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Deucravacitinib,OTHER: Placebo,,,,"Local Institution - 0016, Santa Monica, California, 90404-2120, United States","Local Institution - 0036, New Haven, Connecticut, 06510, United States","Local Institution - 0018, Tampa, Florida, 33624-2038, United States",Bristol-Myers Squibb,,,,
Alopecia Areata,NCT05470413,Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT05470413,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Alopecia Areata,,,,,DRUG: SHR0302,DRUG: SHR0302,DRUG: Placebo,,,"The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China","Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing, China","China-Japan Friendship Hospital, Beijing, Beijing, China",,,,,
Alopecia Areata,NCT01898806,Intralesional Steroids in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT01898806,YES,ALL,"ADULT, OLDER_ADULT",PHASE4,Alopecia Areata,,,,,DRUG: Intralesional Triamcinolone 2.5 mg/ml,DRUG: Intralesional Triamcinolone 5 mg/ml,DRUG: Intralesional Triamcinolone 10 mg/ml,DRUG: Intralesional Saline,,"University of Minnesota, Minneapolis, Minnesota, 55455, United States","Columbia University Medical Center, Department of Dermatology, New York, New York, 10032, United States",,,,,,
Alopecia Areata,NCT01917058,A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT01917058,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Abatacept,DRUG: placebo,,,,"Columbia University Medical Center, Dept of Dermatology, New York, New York, 10032, United States",,,Julian Mackay-Wiggan,,,,
Alopecia Areata,NCT04740970,A Study of JNJ-64304500 in Participants With Alopecia Areata,https://clinicaltrials.gov/study/NCT04740970,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: JNJ-64304500,DRUG: Placebo,,,,"Forcare Clinical Research, Inc., Tampa, Florida, 33613, United States","Indiana Clinical Trial Center, Plainfield, Indiana, 46168, United States","Dermatology Specialists, Louisville, Kentucky, 40241, United States",Janssen Research & Development,,,,
Alopecia Areata,NCT05255237,Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT05255237,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Alopecia Areata,,,,,DRUG: Jaktinib,,,,,"11 Xizhimen South Street, Beijing, Beijing, China",,,Jianzhong Zhang,Qianjin Lu,,,
Alopecia Areata,NCT06340360,A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA),https://clinicaltrials.gov/study/NCT06340360,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Rezpegaldesleukin,DRUG: Placebo,,,,"Quest Dermatology Research, Northridge, California, 91324, United States","Atlanta Biomedical Clinical Research, Atlanta, Georgia, 30331, United States","Clinical Investigation Specialists, Inc., Gurnee, Illinois, 60031, United States",Study Director,,,,
Alopecia Areata,NCT02553330,A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA),https://clinicaltrials.gov/study/NCT02553330,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Placebo Cream,DRUG: Ruxolitinib Phosphate Cream,,,,"Birmingham, Alabama, United States","Hot Springs, Arkansas, United States","New Haven, Connecticut, United States",,,,,
Alopecia Areata,NCT02350023,Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata,https://clinicaltrials.gov/study/NCT02350023,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Alopecia Areata,,,,,DRUG: Topical latanoprost 0.005%,DRUG: Topical betamethasone 0.05%,,,,"Dept of Dermatology, PGIMER, Chandigarh, 160012, India",,,,,,,
Alopecia Areata,NCT04346316,A Phase II Study in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT04346316,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: SHR0302,,,,,"Quest Dermatology Research, Northridge, California, 91324, United States","Moore Clinical Research, Brandon, Florida, 33511, United States","Dawes Fretzin Clinical Research, Indianapolis, Indiana, 46250, United States",,,,,
Alopecia Areata,NCT06444451,A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT06444451,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Amlitelimab,DRUG: Placebo,,,,"Vital Prospects Clinical Research Institute, P.C. Site Number : 8400004, Tulsa, Oklahoma, 74136, United States","Health Concepts Site Number : 8400001, Rapid City, South Dakota, 57702, United States","Investigational Site Number : 0360003, East Melbourne, Victoria, 3002, Australia",,,,,
Alopecia Areata,NCT06060977,"A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants",https://clinicaltrials.gov/study/NCT06060977,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Alopecia Areata (AA),,,,,DRUG: IMG-007,,,,,"Northwest Arkansas Clinical Trials Center, PLLC/ Hull Dermatology P.A., Rogers, Arkansas, 72758, United States","Torrance Clinical Research Institute Inc., Lomita, California, 90717, United States","Alliance Clinical Research of Tampa, Tampa, Florida, 33615, United States",,,,,
Alopecia Areata,NCT05051761,Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT05051761,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Alopecia Areata,,,,,DRUG: Jaktinib,DRUG: placebo,,,,"Peking University People's Hospital, Beijing, Beijing, 100044, China","Hospital for Skin Diseases, Chinese Academy of medical Sciences, Nanjing, Jiangsu, 210042, China",,Jason Wu,,,,
Alopecia Areata,NCT05041803,European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT05041803,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Alopecia Areata,,,,,DRUG: CTP-543,,,,,"Service de Dermatologie CHRU de Brest - Hopital Morvan, Brest Cedex, Finistere, 29609, France","Service de Dermatologie Centre Hospitalier Universitaire de Nice - Hopital Archet 2, Nice, Provence-Alpes-Cote d'Azur, 06202, France","CHU de Bordeaux, Hopital Saint-Andre, Bordeaux, 33000, France",,,,,
Alopecia Areata,NCT05205070,A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT05205070,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,BIOLOGICAL: Rosnilimab,BIOLOGICAL: Placebo,,,,"10-105, Birmingham, Alabama, 35205, United States","Site10-103, Encinitas, California, 92024, United States","Site 10-113, Northridge, California, 91324, United States",Bruce Randazzo,,,,
Alopecia Areata,NCT04784533,A Study to Evaluate the Durability of Response Study of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT04784533,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: CTP-543,DRUG: Placebo,,,,"Total Skin and Beauty Dermatology Center, PC, Birmingham, Alabama, 35205, United States","Center for Dermatology and Plastic Surgery/CCT Research, Scottsdale, Arizona, 85260, United States","Kern Research, Inc., Bakersfield, California, 93301, United States",,,,,
Alopecia Areata,NCT04003376,Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata,https://clinicaltrials.gov/study/NCT04003376,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Alopecia Areata,,,,,DEVICE: fractional carbon dioxide laser alone,DRUG: Triamcinolone Acetonide 10mg/mL,BIOLOGICAL: platelet rich plasma,DRUG: vitamin D solution,,"Assiut University Hospital, Assiut, Egypt",,,Alaa Ghazally,,,,
Alopecia Areata,NCT02018042,An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata,https://clinicaltrials.gov/study/NCT02018042,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Abatacept,,,,,"Columbia University Medical Center - Department of Dermatology, New York, New York, 10032, United States",,,Julian Mackay-Wiggan,,,,
Alopecia Areata,NCT04034134,Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT04034134,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Jaktinib Hydrochloride Tablets,DRUG: Jaktinib Hydrochloride Tablets,DRUG: Jaktinib Hydrochloride Tablets,,,"Chongqing Chinese Traditional Medicine Hospital, Chongqing, Chongqing, 400011, China","The second xaingya hospital of central south university, Changsha, Hunan, 410011, China",,qianjin Lu,,,,
Alopecia Areata,NCT01453686,A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata,https://clinicaltrials.gov/study/NCT01453686,NO,ALL,CHILD,PHASE3,Alopecia Areata,,,,,DRUG: Hydrocortisone 1%,DRUG: Clobetasol Propionate 0.05%,,,,"The Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada",,,Colin Macarthur,,,,
Alopecia Areata,NCT05650333,A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age,https://clinicaltrials.gov/study/NCT05650333,NO,ALL,CHILD,PHASE1,Alopecia Areata,,,,,DRUG: Ritlecitinib 20 mg,,,,,"California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States","Pediatric Skin Research,LLC, Coral Gables, Florida, 33146, United States","Nicklaus Children's Hospital, Miami, Florida, 33155, United States",Pfizer .gov Call Center,,,,
Alopecia Areata,NCT02684097,A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT02684097,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Tralokinumab,DRUG: Placebo,,,,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States",,,Emma Guttman,,,,
Alopecia Areata,NCT06157905,Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT06157905,NO,ALL,ADULT,EARLY_PHASE1,Extensive Alopecia Areata,,,,,DRUG: Oral Tofacitinib citrate,,,,,"Services Institute of Medical Sciences, Lahore, Punjab, 54000, Pakistan",,,,,,,
Alopecia Areata,NCT03898479,Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT03898479,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Alopecia Areata,,,,,DRUG: CTP-543,,,,,"Total Skin and Beauty Dermatology Center, Birmingham, Alabama, 35203, United States","Alliance Dermatology & MOHS Center, Phoenix, Arizona, 85032, United States","Center for Dermatology and Plastic Surgery/CCT Research, Scottsdale, Arizona, 85260, United States",,,,,
Alopecia Areata,NCT02561585,LEO 124249 Ointment in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT02561585,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: LEO 124249,OTHER: Vehicle,,,,"Northwestern University, Evanston, Illinois, 60208, United States","The Icahn School of Medicine, Mount Sinai Hospital, New York, New York, 10029, United States",,Emma Guttman,,,,
Alopecia Areata,NCT03941548,Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT03941548,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: CTP-543,DRUG: CTP-543 Matching Placebo,,,,"Colorado Center for Dermatology and Skin Surgery, Centennial, Colorado, 80111, United States","ForCare Clinical Research, Tampa, Florida, 33613, United States","The Indiana Clinical Trials Center, PC, Plainfield, Indiana, 46168, United States",,,,,
Alopecia Areata,NCT00999869,The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata,https://clinicaltrials.gov/study/NCT00999869,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,DRUG: Botulinum toxin type A,DRUG: Triamcinolone acetonide,,,,"Department of Dermatology, Faculty of medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand","Siriraj hospital, Bangkok, 10700, Thailand",,Rattapon Thoungtong,Supenya Varothai,Rasthawathana Desomchoke,,
Alopecia Areata,NCT02557074,TREg Activation in the Treatment of the PELADE (Alopecia Areata),https://clinicaltrials.gov/study/NCT02557074,NO,ALL,ADULT,PHASE3,Alopecia Areata,,,,,DRUG: IL2,DRUG: placebo,,,,"AP-HM - La timone - Dermatologie, Marseille, Bouche Du RhÃ´ne, 13005, France","AP-HP St Louis - Dermatologie, Paris, Ile De France, 75000, France","CHU de Nimes - Dermatologie, NÃ®mes, Languedoc-Roussillon, 30000, France",Passeron Thierry,,,,
Alopecia Areata,NCT03899259,A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT03899259,YES,ALL,"ADULT, OLDER_ADULT",PHASE3,Alopecia Areata,,,,,DRUG: Baricitinib,DRUG: Placebo,,,,"Total Skin and Beauty Dermatology Center, PC, Birmingham, Alabama, 35205, United States","Investigate MD, Scottsdale, Arizona, 85255, United States","First OC Dermatology, Fountain Valley, California, 92708, United States",Call 1-877- (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9  -5  Eastern time (/ - 5 hours,,,,
Alopecia Areata,NCT03811912,Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT03811912,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: CTP-543,DRUG: CTP-543 Matching Placebo,,,,"Investigative Site, Irvine, California, 92697, United States","Investigative Site, San Francisco, California, 94118, United States","Investigative Site, New Haven, Connecticut, 06519, United States",Colleen E Hamilton,,,,
Alopecia Areata,NCT01246284,The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT01246284,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,DRUG: Triamcinolone acetonide,OTHER: Normal saline,,,,"The Skin Care Center, Vancouver General Hospital, 835 West 10th Ave, Vancouver, British Columbia, Canada",,,Jerry Shapiro,,,,
Alopecia Areata,NCT02974868,Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata,https://clinicaltrials.gov/study/NCT02974868,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: PF-06651600,DRUG: PF-06700841,DRUG: Placebo,,,"University of Alabama at Birmingham, Dermatology at the Whitaker Clinic, Birmingham, Alabama, 35233, United States","University of Alabama at Birmingham, The Kirklin Clinic, Birmingham, Alabama, 35233, United States","Southern California Dermatology, Inc., Santa Ana, California, 92701, United States",Pfizer .gov Call Center,,,,
Alopecia Areata,NCT02604888,Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females,https://clinicaltrials.gov/study/NCT02604888,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,OTHER: MEXIS/M6S Patent - lotion against alopecia,,,,,"George Mexis, Athens, 11253, Greece",,,Markos Papakonstantis,,,,
Alopecia Areata,NCT01559584,Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT01559584,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Alopecia Areata,,,,,RADIATION: ultraviolet A (UVA),DRUG: Triamcinolone Acetonide,,,,"Dermatology department - faculty of medicine- Cairo University, Cairo, Egypt",,,,,,,
Alopecia Areata,NCT00408798,Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin,https://clinicaltrials.gov/study/NCT00408798,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,"DRUG: Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units",,,,,"Department of Dermatology, The Skin Care Centre, Vancouver, British Columbia, V5Z 4E8, Canada",,,Jerry Shapiro,,,,
Alopecia Areata,NCT03325296,Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.,https://clinicaltrials.gov/study/NCT03325296,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: LEO 124249,OTHER: Ointment vehicle,,,,"Investigational site, Aarhus, 8000, Denmark","Investigational site, Gentofte, 2820, Denmark",,Study Director,,,,
Alopecia Areata,NCT00063076,Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata,https://clinicaltrials.gov/study/NCT00063076,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Alopecia Areata,,,,,DRUG: Targretin Gel 1%,,,,,"UT MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,Madeleine Duvic,,,,
Alopecia Areata,NCT03570749,A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT03570749,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Alopecia Areata,,,,,DRUG: Baricitinib,DRUG: Placebo,,,,"University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States","Coastal Clinical Research, Inc, Mobile, Alabama, 36608, United States","Johnson Dermatology, Fort Smith, Arkansas, 72916, United States",Call 1-877- (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9  - 5  Eastern time (/ - 5 hours,,,,
Alopecia Areata,NCT06239324,Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser,https://clinicaltrials.gov/study/NCT06239324,NO,ALL,ADULT,PHASE1|PHASE2,Alopecia Areata,,,,,DRUG: Latanoprost,,,,,"Qena Hospital, QinÄ, Egypt",,,Soheir AbdelHamid Ali,,,,
Alopecia Areata,NCT02636244,Safety and Efficacy Study of SHAPE Gel in Alopecia Areata,https://clinicaltrials.gov/study/NCT02636244,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: SHAPE Gel,,,,,,,,,,,,
Alopecia Areata,NCT03354637,A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT03354637,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: ATI-50002 high dose,DRUG: ATI-50002 low dose,DRUG: Placebo,,,"Aclaris Investigator Site, Encinitas, California, 92024, United States","Aclaris Investigator Site, Laguna Hills, California, 92653, United States","Aclaris Investigator Site, Redwood City, California, 94063, United States",,,,,
Alopecia Areata,NCT03137381,Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT03137381,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: CTP-543,DRUG: CTP-543 matching placebo,,,,"University of California, Irvine, Irvine, California, 92697, United States","Contour Dermatology & Cosmetic Surgery Center, Rancho Mirage, California, 92270, United States","Stanford University School of Medicine, Redwood City, California, 94064, United States",Colleen E. Hamilton,,,,
Alopecia Areata,NCT01797432,Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT01797432,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10),DEVICE: Restylane,,,,"University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States",,,,,,,
Alopecia Areata,NCT01017510,Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata,https://clinicaltrials.gov/study/NCT01017510,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,DEVICE: Subcutaneous injection luer syringe,DEVICE: DERMOJET (a syringe without a needle),,,,"Sheba Medical Center, Rmat Gan, Israel",,,-,,,,
Alopecia Areata,NCT00177021,Aldara for the Treatment of Extensive Alopecia Areata,https://clinicaltrials.gov/study/NCT00177021,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Alopecia Areata,,,,,DRUG: Aldara Cream 5%,,,,,"University of Minnesota, Minneapolis, Minnesota, 55455, United States",,,Maria Hordinsky,Marna Ericson,,,
Alopecia Areata,NCT00176969,Response of Topical Capsaicin in Alopecia Areata,https://clinicaltrials.gov/study/NCT00176969,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Alopecia Areata,,,,,DRUG: Capsaicin,,,,,"University of Minnesota, Minneapolis, Minnesota, 55455, United States",,,Maria Hordinsky,Marna Ericson,,,
Alopecia Areata,NCT00187577,Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT00187577,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,DRUG: Latanoprost (Xalatan),DRUG: Bimatoprost (Lumigan),DRUG: Topical application of latanoprost solution to eyelid,,,"University of California, San Francisco, San Francisco, California, 94117, United States",,,,,,,
Alopecia Areata,NCT05551793,Regeneron AA Multicenter (Dupilumab),https://clinicaltrials.gov/study/NCT05551793,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Dupilumab,DRUG: Placebo,,,,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States","UR Dermatology at College Town, Rochester, New York, 14620, United States",,Emma Guttman-Yassky,,,,
Alopecia Areata,NCT03473600,Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluation,https://clinicaltrials.gov/study/NCT03473600,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Alopecia Areata,,,,,PROCEDURE: Cryotherapy,DRUG: Triamcinolone acetonide injection,,,,"Faculty of medicine, Assiut, 71111, Egypt",,,,,,,
Alopecia Areata,NCT05954104,Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma,https://clinicaltrials.gov/study/NCT05954104,NO,ALL,"CHILD, ADULT",,Alopecia Areata,,,,,DRUG: Calcipotriol,,,,,"Faculty of Dentistary - Aswan University, Aswan, Egypt",,,Moustafa Adam,,,,
Alopecia Areata,NCT06471114,Evaluation of the Efficacy of Systemic Treatments for Alopecia (ESTAA),https://clinicaltrials.gov/study/NCT06471114,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,,,,,,,,,,"Chu Brest, Brest, 29609, France",,,,,,,
Alopecia Areata,NCT05251831,Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRP,https://clinicaltrials.gov/study/NCT05251831,NO,ALL,ADULT,EARLY_PHASE1,Alopecia Areata,,,,,DRUG: Intradermal injection,,,,,"Al-Azhar University in Cairo, Cairo, 11311, Egypt",,,Ahmed Mohamed abdelaal,,,,
Alopecia Areata,NCT01840046,Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata,https://clinicaltrials.gov/study/NCT01840046,NO,ALL,ADULT,PHASE1|PHASE2,Alopecia Areata,,,,,DRUG: Interleukin-2,,,,,"CHU de Nice - HÃ´pital Archet, Nice, Alpes-Maritimes, 06001, France",,,Thierry,,,,
Alopecia Areata,NCT05522556,Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600),https://clinicaltrials.gov/study/NCT05522556,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Alopecia Areata,,,,,DRUG: Ritlecitinib,,,,,,,,,,,,
Alopecia Areata,NCT00484679,Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT00484679,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,,,,,DRUG: Triamcinolone Acetonide 10 mg/mL (Kenalog-10),,,,,"University of Minnesota, Minneapolis, Minnesota, 55455, United States",,,Maria K Hordinsky,,,,
Alopecia Areata,NCT00176943,Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%,https://clinicaltrials.gov/study/NCT00176943,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Alopecia Areata,,,,,DRUG: Aldara Cream 5%,,,,,"University of Minnesota, Minneapolis, Minnesota, 55455, United States",,,Maria Hordinsky,Marna Ericson,,,
Alopecia Areata,NCT06279221,Litfulo Capsules Special Investigation,https://clinicaltrials.gov/study/NCT06279221,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Alopecia Areata,,,,,DRUG: LITFULO,,,,,"Pfizer, Tokyo, Japan",,,Pfizer .gov Call Center,,,,
Alopecia Areata,NCT06045624,A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy Subjects,https://clinicaltrials.gov/study/NCT06045624,NO,ALL,ADULT,PHASE1,Alopecia Areata,,,,,DRUG: OR-101 (Single ascending dose),DRUG: OR-101 (Food effect),DRUG: OR-101 (Multiple ascending dose),DRUG: Placebo,,"SCIENTIA Clinical Research Ltd, Randwick, New South Wales, 2031, Australia",,,,,,,
Alopecia Areata,NCT04445363,A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata,https://clinicaltrials.gov/study/NCT04445363,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Alopecia Areata(AA),,,,,DRUG: Jaktinib hydrochloride cream,DRUG: Placebo,,,,"The Second Xaingya Hospitalï¼Œcentral south university, Changsha, Hunan, 410011, China",,,qianjin lu,,,,
Alopecia Areata,NCT05196711,A Study to Evaluate the Safety of MAX-40070 in Healthy Subjects,https://clinicaltrials.gov/study/NCT05196711,NO,ALL,ADULT,PHASE1,Alopecia Areata,,,,,DRUG: MAX-40070,DRUG: Placebo,,,,,,,,,,,
Alopecia Areata,NCT02037191,The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade,https://clinicaltrials.gov/study/NCT02037191,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,ALOPECIA AREATA,,,,,DRUG: Methotrexate,DRUG: Placebo,,,,"Head Dermatology Department, Rouen, Haute Normandie, 76031, France","CHU de Rouen - HÃ´pitaux de Rouen, Rouen, Seine Maritime, 76031, France",,,,,,
Alopecia Areata,NCT03078686,Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata,https://clinicaltrials.gov/study/NCT03078686,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,Scarring Alopecia,,,,PROCEDURE: tSVF by lipoaspiration,PROCEDURE: PRP Concentration,PROCEDURE: Emulsification tSVF,PROCEDURE: cSVF isolation and concentration,PROCEDURE: cSVF in Normal Saline IV,"Kenneth Williams, DO, Irvine, California, 92618, United States","Regeneris Medical, North Attleboro, Massachusetts, 02760, United States","Regenevita LLC, Stevensville, Montana, 59870, United States",Robert W Alexander,Ken Williams,,,
Alopecia Areata,NCT06278402,"Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.",https://clinicaltrials.gov/study/NCT06278402,NO,ALL,"CHILD, ADULT",PHASE3,Alopecia Areata,Alopecia Totalis,Alopecia Universalis,,,DRUG: Tofacitinib,,,,,"Misbah Zari Qadir, Karachi, Sindh, Pakistan",,,,,,,
Alopecia Areata,NCT04238091,Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT04238091,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,Alopecia Totalis,Alopecia Universalis,,,DRUG: Fecal material transfer therapy,PROCEDURE: 4mm Punch Biopsy of Scalp,DIAGNOSTIC_TEST: Blood draw,PROCEDURE: Skin Microbiome sampling,PROCEDURE: Hair Microbiome Sampling,,,,Lindsey Bordone,,,,
Alopecia Areata,NCT00069589,Alopecia Areata Registry,https://clinicaltrials.gov/study/NCT00069589,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Alopecia Areata,Alopecia Totalis,Alopecia Universalis,Autoimmune Hair Loss,Alopecia Partialis,,,,,,"University of California, San Francisco, San Francisco, California, 94143, United States","University of Colorado - UCHSC - Health Science Center at Fitzsimons, Aurora, Colorado, 80010-7163, United States","University of Minnesota, Minneapolis, Minnesota, 55455, United States",Madeleine Duvic,,,,
Alopecia Areata,NCT05589610,Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT05589610,NO,ALL,ADULT,PHASE2,Alopecia Areata,Alopecia,Alopecia Totalis,Alopecia Universalis,,DRUG: EQ101,,,,,"Sinclair Dermatology, East Melbourne, Australia","Fremantle Dermatology, Fremantle, Australia","Premier Specialists, Kogarah, Australia",,,,,
Alopecia Areata,NCT04011748,Clinical Application of Stem Cell Educator Therapy in Alopecia Areata,https://clinicaltrials.gov/study/NCT04011748,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,Alopecia Totalis,Alopecia Universalis,,,COMBINATION_PRODUCT: Stem Cell Educator therapy,,,,,"Throne Biotechnologies, Paramus, New Jersey, 07652, United States",,,,,,,
Alopecia Areata,NCT02812342,Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants,https://clinicaltrials.gov/study/NCT02812342,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,Alopecia Totalis,Alopecia Universalis,,,DRUG: Tofacitinib ointment,,,,,"Yale-New Haven Hospital, New Haven, Connecticut, 06510, United States",,,Brett King,,,,
Alopecia Areata,NCT03759340,"ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)",https://clinicaltrials.gov/study/NCT03759340,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,Alopecia Universalis,Alopecia Totalis,,,DRUG: ATI 502 0.46% Topical Solution,,,,,"Aclaris Investigator Site, Rogers, Arkansas, 72758, United States","Aclaris Investigator Site, Denver, Colorado, 80210, United States","Aclaris Investigator Site, Boynton Beach, Florida, 33472, United States",,,,,
Alopecia Areata,NCT02312882,Tofacitinib for the Treatment of Alopecia Areata and Its Variants,https://clinicaltrials.gov/study/NCT02312882,YES,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,Alopecia Totalis,Alopecia Universalis,,,DRUG: Tofacitinib,,,,,"Stanford University, Stanford, California, 94305, United States",,,,,,,
Alopecia Areata,NCT03532958,Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT03532958,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,Alopecia Totalis,Alopecia Universalis,,,DRUG: BNZ-1,DRUG: Normal saline,,,,,,,,,,,
Alopecia Areata,NCT03551821,Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata,https://clinicaltrials.gov/study/NCT03551821,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata,Alopecia Totalis,Alopecia Universalis,,,DRUG: ATI-50002,,,,,"Aclaris Investigator Site, Boynton Beach, Florida, 33472, United States",,,,,,,
Alopecia Areata,NCT03155958,Ocular Finding in Alopecia Areata,https://clinicaltrials.gov/study/NCT03155958,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Hair Loss,,,,,,,,,,,,,,,,,
Alopecia Areata,NCT06283316,Systemic Treatments for Alopecia Areata Registry,https://clinicaltrials.gov/study/NCT06283316,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Alopecia Areata,Alopecia Totalis,Alopecia Universalis,Hair Loss,Hair Diseases,,,,,,"Erasmus University Medical Center, Rotterdam, Netherlands",,,,,,,
Alopecia Areata,NCT03240627,Efficacy and Safety of LH-8 in Paediatric Alopecia Areata,https://clinicaltrials.gov/study/NCT03240627,NO,ALL,"CHILD, ADULT",PHASE2|PHASE3,Alopecia Areata,Pediatric Disorder,,,,DRUG: LH-8,DRUG: Placebo,,,,"Multicenter Clinical Trials, Sofia, Bulgaria","Centre Sabourand - Hospital Saint-Louis, 1, Avenue Claude Vellefaux, Paris, 75010, France","Clinical Research Center for Hair and Skin Science, CharitÃ©-UniversitÃ¤tsmedizin Berlin, Berlin, Berlin,, 10117, Germany",,,,,
Alopecia Areata,NCT03873155,The Effectiveness of Mindfulness Based Cognitive Group Therapy for Social Anxiety Symptoms in People Living With Alopecia Areata,https://clinicaltrials.gov/study/NCT03873155,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Alopecia Areata,Social Anxiety,,,,BEHAVIORAL: Mindfulness Based Cognitive Therapy,,,,,"The University of Sheffield, Sheffield, South Yorkshire, S12LT, United Kingdom","Royal Hallamshire Hospital (Sheffield Teaching Hospital), Sheffield, South Yorkshire, United Kingdom",,,,,,
Alopecia Areata,NCT02197455,Tofacitnib for the Treatment of Alopecia Areata and Variants,https://clinicaltrials.gov/study/NCT02197455,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia Areata (AA),Alopecia Totalis (AT),Alopecia Universalis (AU),,,DRUG: Tofacitinib Administration,,,,,"Yale University, New Haven, Connecticut, United States",,,Brett King,,,,
Alopecia Areata,NCT01167946,Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata,https://clinicaltrials.gov/study/NCT01167946,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,Alopecia Totalis,Alopecia Universalis,Ophiasic Alopecia,,,DRUG: methylprednisolone sodium succinate,DRUG: methylprednisolone sodium succinate,DRUG: methylprednisolone sodium succinate,,,"King Khalid University Hospital, Riyadh, 11472, Saudi Arabia",,,Ghada A Binsaif,,,,
Alopecia Areata,NCT02548689,PAI-1 Expression in Non-scarring Hair Loss,https://clinicaltrials.gov/study/NCT02548689,NO,ALL,ADULT,,Androgenetic Alopecia,Telogen Effluvium,Alopecia Areata,,,,,,,,"Northwestern University Department of Dermatology, Chicago, Illinois, 60611, United States",,,Maria Colavincenzo,,,,
Alopecia Areata,NCT01023841,Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children,https://clinicaltrials.gov/study/NCT01023841,YES,ALL,CHILD,PHASE4,Eyelash Hypotrichosis,Alopecia Areata,,,,DRUG: bimatoprost ophthalmic solution 0.03%,DRUG: Vehicle Sterile Solution,,,,"Newport Beach, California, United States","SÃ£o Paulo, Brazil",,Medical Director,,,,
Alopecia Areata,NCT06357169,Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias,https://clinicaltrials.gov/study/NCT06357169,NO,ALL,ADULT,,Lichen Planopilaris of Scalp,Alopecia Areata,,,,DEVICE: Venus Glow,,,,,"University of Minnesota, Minneapolis, Minnesota, 55455, United States",,,Ronda Farah,Maria Hordinsky,,,
Alopecia Areata,NCT03594227,"ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis",https://clinicaltrials.gov/study/NCT03594227,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia,,,,,DRUG: ATI-501 400mg BID (Low dose),DRUG: ATI-501 600mg BID (Mid dose),DRUG: ATI-501 800mg BID (High dose),DRUG: Placebo,,"Aclaris Investigator Site, Hot Springs, Arkansas, 71913, United States","Aclaris Investigator Site, Rogers, Arkansas, 72758, United States","Aclaris Investigator Site, Denver, Colorado, 80210, United States",,,,,
Alopecia Areata,NCT06292533,Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study,https://clinicaltrials.gov/study/NCT06292533,NO,ALL,"ADULT, OLDER_ADULT",,Androgenic Alopecia,Alopecia,,,,DEVICE: Er:YAG laser,,,,,,,,Yang Mooi Lim,,,,
Alopecia Areata,NCT04341363,Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling,https://clinicaltrials.gov/study/NCT04341363,YES,MALE,"ADULT, OLDER_ADULT",,Androgenic Alopecia,,,,,DEVICE: Tattoo machine,,,,,"Yale University, New Haven, Connecticut, 06519, United States",,,Brett King,,,,
Alopecia Areata,NCT06319781,"A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo",https://clinicaltrials.gov/study/NCT06319781,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia Areata,Vitiligo,Atopic Dermatitis,Psoriasis,,OTHER: Observational,,,,,"Sanos Clinic, Gandrup, Gandrup, 9362, Denmark","Sanos Clinic, Herlev, Herlev, 2730, Denmark","Sanos Clinic, Vejle, Vejle, 7100, Denmark",Zarqa Ali,,,,
Alopecia Areata,NCT06409650,To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT06409650,NO,FEMALE,"ADULT, OLDER_ADULT",PHASE2,Alopecia,,,,,DRUG: KX-826 dosed at 2.5mg,DRUG: KX-826 dosed at 2.5mg,DRUG: KX-826 dosed at 5 mg,DRUG: KX-826 dosed at 5 mg,DRUG: Matching placebo to KX-826,"Beijing Friendship Hospital, Capital Medical University, Beijing, China","Beijing Tongren Hospital, Capital Medical University, Beijing, China","China-Japan Friendship Hospital, Beijing, China",,,,,
Alopecia Areata,NCT03052413,Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females,https://clinicaltrials.gov/study/NCT03052413,NO,FEMALE,ADULT,,Hair Loss,,,,,DIETARY_SUPPLEMENT: Nutrafol,DIETARY_SUPPLEMENT: placebo,,,,"New Jersey Plastic Surgery, Montclair, New Jersey, 07042, United States","Sadick Research Group, New York, New York, 10075, United States",,,,,,
Alopecia Areata,NCT04205214,A Randomised Control Trial of Integrative Cognitive Behavioural Therapy for Alopecia,https://clinicaltrials.gov/study/NCT04205214,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia,,,,,BEHAVIORAL: Integrative Cognitive Behavioural Therapy,,,,,"Royal Free Hospital, London, United Kingdom",,,Sharon Hart,,,,
Alopecia Areata,NCT04884347,Evaluation of the Efficacy of a Food Supplement in Reducing Hair Loss in Male Subjects,https://clinicaltrials.gov/study/NCT04884347,NO,MALE,ADULT,,Hair Loss,,,,,DIETARY_SUPPLEMENT: Alline proMEN,DIETARY_SUPPLEMENT: Placebo,,,,"Complife Italia S.r.l, Pavia, 27028, Italy",,,Vincenzo Nobile,,,,
Alopecia Areata,NCT03689452,The Effect of Platelet Rich Plasma on Non-scarring Alopecia,https://clinicaltrials.gov/study/NCT03689452,YES,FEMALE,"ADULT, OLDER_ADULT",,Androgenetic Alopecia,Alopecia,,,,DEVICE: Platelet Rich Plasma,DRUG: Normal saline,,,,"Icahn School of Medicine at Mount Sinai, New York, New York, 10028, United States",,,Hooman Khorasani,,,,
Alopecia Areata,NCT02302053,Efficacy of the New Viviscal Professional Strength Oral Supplement in Females With Thinning Hair,https://clinicaltrials.gov/study/NCT02302053,NO,FEMALE,"ADULT, OLDER_ADULT",,Hair Thinning,,,,,DIETARY_SUPPLEMENT: New Viviscal Professional Supplement,DIETARY_SUPPLEMENT: Placebo tablets,,,,,,,Glynis Ablon,Steven Dayan,,,
Alopecia Areata,NCT03206567,Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair,https://clinicaltrials.gov/study/NCT03206567,NO,FEMALE,"ADULT, OLDER_ADULT",,Hair Thinning,,,,,DIETARY_SUPPLEMENT: Nutrafol Supplement capsules,OTHER: Placebo capsules,,,,"Ablon Skin Institute & Research Center, Manhattan Beach, California, 90266, United States",,,Glynis Ablon,,,,
Alopecia Areata,NCT05970809,Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair Loss,https://clinicaltrials.gov/study/NCT05970809,NO,MALE,ADULT,,Male Pattern Baldness,Androgenetic Alopecia,Hair Loss/Baldness,Hair Loss,Pattern Baldness,DEVICE: SAGA-001 (A),DEVICE: SAGA-001 (B),,,,"Ankara Bilkent Åžehir Hastanesi Dermatoloji Klini, Ankara, Turkey","Ä°stanbul Ãœniversitesi CerrahpaÅŸa TÄ±p FakÃ¼ltesi, Dahili TÄ±p Bilimleri BÃ¶lÃ¼mÃ¼ Deri ve ZÃ¼hrevi HastalÄ±klar Ana Bilim DalÄ± Kocamustafa PaÅŸa, Istanbul, Turkey",,Server SerdaroÄŸlu,,,,
Alopecia Areata,NCT03976622,"Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata",https://clinicaltrials.gov/study/NCT03976622,NO,ALL,"ADULT, OLDER_ADULT",,Vitiligo,Psoriasis,Alopecia Areata,Atopic Dermatitis,,BIOLOGICAL: Blood samples,BIOLOGICAL: Skin biopsies,,,,"Service de Dermatologie - HÃ´pital Saint-AndrÃ©, Bordeaux, 33075, France",,,Julien,,,,
Alopecia Areata,NCT05210452,Treatment of Alopecia Using Follicular Stem Cells,https://clinicaltrials.gov/study/NCT05210452,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Alopecia,,,,,BIOLOGICAL: Follicular stem cells,OTHER: Standard treatment according to the clinical protocols,,,,,,,Zinaida Kvacheva,,,,
Alopecia Areata,NCT06355856,Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss,https://clinicaltrials.gov/study/NCT06355856,NO,MALE,ADULT,PHASE4,Alopecia,,,,,DRUG: DNN.22.17.036,DRUG: 10573048700,,,,,,,,,,,
Alopecia Areata,NCT05339958,Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair,https://clinicaltrials.gov/study/NCT05339958,NO,MALE,ADULT,,Hair Thinning,,,,,DIETARY_SUPPLEMENT: NutrafolÂ® Men Hair Growth Nutraceutical,OTHER: Placebo Supplement,,,,"Ablon Skin Institute and Research Center, Manhattan Beach, California, 90266, United States","Therapeutic Clinical Research, San Diego, California, 92123, United States",,,,,,
Alopecia Areata,NCT04558242,Low Level Light Device as a Primary Therapy for Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT04558242,NO,ALL,"ADULT, OLDER_ADULT",,Androgenetic Alopecia,Hair Loss,Thinning Hair,Balding,,DEVICE: Genix,DEVICE: Sham,,,,"NST Consultants, Inc., Mendham, New Jersey, 07945, United States",,,Adam Bodian,,,,
Alopecia Areata,NCT04048031,Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Peri-menopausal and Menopausal Women With Thinning Hair,https://clinicaltrials.gov/study/NCT04048031,NO,FEMALE,"ADULT, OLDER_ADULT",,Hair Thinning,,,,,DIETARY_SUPPLEMENT: Nutrafol Supplement Capsules,OTHER: Placebo Capsules,,,,"Ablon Skin Institute & Research Center, Manhattan Beach, California, 90266, United States",,,Glynis Ablon,,,,
Alopecia Areata,NCT05332743,Nutraceutical Supplement With Vegan Botanicals in Females With Self-Perceived Thinning Hair,https://clinicaltrials.gov/study/NCT05332743,NO,FEMALE,ADULT,,Hair Thinning,,,,,DIETARY_SUPPLEMENT: Nutrafol Vegan Women's Hair Supplement,,,,,"Ablon Skin Institute and Research Center, Manhattan Beach, California, 90266, United States","Integrative Skin Science and Research, Sacramento, California, 95815, United States",,,,,,
Alopecia Areata,NCT04459650,A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer,https://clinicaltrials.gov/study/NCT04459650,NO,ALL,ADULT,EARLY_PHASE1,Alopecia,,,,,PROCEDURE: Platelet Rich Plasma system,,,,,"Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, 10065, United States",,,Anthony M Rossi,,,,
Alopecia Areata,NCT05213936,Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color,https://clinicaltrials.gov/study/NCT05213936,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia,,,,,DEVICE: Scalp cooling with hairstyle,DEVICE: Scalp cooling with conditioner and water emulsion,,,,"Montefiore Medical Center, Bronx, New York, 10461, United States",,,Beth McLellan,,,,
Alopecia Areata,NCT04897555,LLLT for Alopecia of the Eyebrow in Women,https://clinicaltrials.gov/study/NCT04897555,NO,FEMALE,"ADULT, OLDER_ADULT",,Alopecia,,,,,DEVICE: LLLT,,,,,"NST Consultants, Inc., Mendham, New Jersey, 07945, United States","Bodian Dermatology, Great Neck, New York, 11021, United States",,Adam Bodian,,,,
Alopecia Areata,NCT06362941,Evaluation of an Oral Hair Supplement to Improve Hair Strength and Support Growth in Women and Men,https://clinicaltrials.gov/study/NCT06362941,NO,ALL,"ADULT, OLDER_ADULT",,Hair Thinning,,,,,DIETARY_SUPPLEMENT: Nutrafol Women's Hair Growth Supplemnt,DIETARY_SUPPLEMENT: Nutrafol Women's Balance Hair Growth Supplement,DIETARY_SUPPLEMENT: Nutrafol Women's Vegan Hair Growth Supplement,DIETARY_SUPPLEMENT: Nutrafol Women's Postpartum Hair Growth Supplement,DIETARY_SUPPLEMENT: Nutrafol Men's Hair Growth Supplement,"Dermatology Consulting Services, High Point, North Carolina, 27262, United States",,,,,,,
Alopecia Areata,NCT06376409,Prospective Study of Nutraceutical Supplements to Support Hair Growth in Females,https://clinicaltrials.gov/study/NCT06376409,NO,FEMALE,"ADULT, OLDER_ADULT",,Hair Thinning,,,,,DIETARY_SUPPLEMENT: Nutrafol Women's Hair Growth Supplement,DIETARY_SUPPLEMENT: Nutrafol Women's Balance Hair Growth Supplement,DIETARY_SUPPLEMENT: Nutrafol Women's Vegan Hair Growth Supplement,DIETARY_SUPPLEMENT: Nutrafol Women's Postpartum Hair Growth Supplement,,"Integrative Skin Science and Research, Sacramento, California, 95815, United States",,,,,,,
Alopecia Areata,NCT02297360,Viviscal Extra-Strength Formulation To Promote Hair Growth And Decrease Shedding In Women With Thinning Hair,https://clinicaltrials.gov/study/NCT02297360,NO,FEMALE,"ADULT, OLDER_ADULT",,Hair Thinning,,,,,DIETARY_SUPPLEMENT: Viviscal Extra-Strength Supplement,OTHER: Placebo tablet,,,,,,,Glynis Ablon,,,,
Alopecia Areata,NCT04721548,Treatment of Androgenetic Alopecia in Men for 24 Weeks,https://clinicaltrials.gov/study/NCT04721548,NO,MALE,"ADULT, OLDER_ADULT",PHASE3,Alopecia,,,,,DRUG: Minoxidil Topical Foam,DRUG: Placebo,,,,"Eurofarma Laboratorios S.A, SÃ£o Paulo, 06696-000, Brazil",,,,,,,
Alopecia Areata,NCT03488108,Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women,https://clinicaltrials.gov/study/NCT03488108,YES,FEMALE,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Alopecia,,,,,OTHER: Platelet Rich Plasma,DRUG: Minoxidil Foam,,,,"Mayo Clinic Florida, Jacksonville, Florida, 32224, United States",,,Alison Bruce,,,,
Alopecia Areata,NCT02288858,To Evaluate the Effects of Viviscal Oral Supplements When Used by Females With Self-perceived Thinning Hair,https://clinicaltrials.gov/study/NCT02288858,NO,ALL,ADULT,,Hair Thinning,,,,,DIETARY_SUPPLEMENT: Viviscal Oral Supplement Tablets,,,,,"Stephens Associates Inc., Richardson, Texas, 75081, United States",,,Ronald L Rizer,,,,
Alopecia Areata,NCT03284021,Fraxel Laser for Alopecia,https://clinicaltrials.gov/study/NCT03284021,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia,,,,,DEVICE: Fractional erbium-glass 1550 nm laser,,,,,"Northwestern University Department of Dermatology, Chicago, Illinois, 60611, United States",,,Murad Alam,,,,
Alopecia Areata,NCT02087319,Effect of PRP on the Therapy for Hair Growth,https://clinicaltrials.gov/study/NCT02087319,NO,ALL,"ADULT, OLDER_ADULT",,Hair Loss/Baldness,,,,,"OTHER: hair loss, baldness (patient's own platelet-rich plasma)",,,,,"China Medical University Hospital, Taichung, Taiwan",,,Jeng Long-Bin,,,,
Alopecia Areata,NCT05391178,Improving Disease Severity,https://clinicaltrials.gov/study/NCT05391178,NO,ALL,"ADULT, OLDER_ADULT",,Psoriasis,Alopecia Areata,Polymorphous Light Eruption,,,OTHER: Lumiton yarn sleeve,OTHER: Lumiton yarn hat,OTHER: Lumiton yarn shirt,,,"Wake Forest University Health Sciences, Dermatology, Winston-Salem, North Carolina, 27157, United States",,,Joseph Jorizzo,,,,
Alopecia Areata,NCT05984862,Role of Bandage After FUE Hair Transplantation,https://clinicaltrials.gov/study/NCT05984862,NO,ALL,"ADULT, OLDER_ADULT",,Hair Loss/Baldness,,,,,DEVICE: Bandage,,,,,,,,Muhammad Sarfraz Khan,,,,
Alopecia Areata,NCT02676310,"Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)",https://clinicaltrials.gov/study/NCT02676310,NO,MALE,ADULT,PHASE1,Alopecia,"Alopecia, Androgenetic",Baldness,,,DRUG: Bimatoprost,,,,,"DermResearch, LLC, Austin, Texas, 78759, United States","J&S Studies Inc., College Station, Texas, 77845, United States","E&R Research Foundation, Lynchburg, Virginia, 24501, United States",Medical Director,,,,
Alopecia Areata,NCT02014584,Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT02014584,YES,MALE,ADULT,PHASE3,Alopecia,,,,,DRUG: Dutasteride,DRUG: Placebo,,,,"GSK Investigational Site, Santiago, RegiÃ³n Metro De Santiago, 7580206, Chile","GSK Investigational Site, Pokfulam, Hong Kong","GSK Investigational Site, Shatin, Hong Kong",Clinical Trials,,,,
Alopecia Areata,NCT02919735,"Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)",https://clinicaltrials.gov/study/NCT02919735,NO,FEMALE,"ADULT, OLDER_ADULT",PHASE2,Alopecia,,,,,DRUG: CG 428 cutaneous solution,DRUG: Placebo cutaneous solution,,,,"CHUV Lausanne, Lausanne, 1011, Switzerland",,,Khalil,,,,
Alopecia Areata,NCT01145625,Clinical Trial in Females With Female Pattern Hair Loss,https://clinicaltrials.gov/study/NCT01145625,YES,FEMALE,"ADULT, OLDER_ADULT",PHASE3,Alopecia,,,,,DRUG: 5% Minoxidil,DRUG: 2% Minoxidil,,,,"Burke Pharmaceutical Research, Hot Springs, Arkansas, 71913, United States","University of Minnesota, Minneapolis, Minnesota, 55455, United States","Academic Dermatology Associates, Albuquerque, New Mexico, 87106, United States",Clare Kendall,,,,
Alopecia Areata,NCT01831791,A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT01831791,YES,MALE,ADULT,PHASE3,Alopecia,,,,,DRUG: Dutasteride 0.5 mg,,,,,"GSK Investigational Site, Fukuoka, 812-0025, Japan","GSK Investigational Site, Osaka, 530-0057, Japan","GSK Investigational Site, Osaka, 532-0003, Japan",Clinical Trials,,,,
Alopecia Areata,NCT00801086,Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain,https://clinicaltrials.gov/study/NCT00801086,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Alopecia,,,,,DRUG: 7% (w/v) Tempol alcohol-based gel (MTS-01),DRUG: alcohol-based gel,,,,"University of Arizona, Tucson, Arizona, 85724, United States","University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States",,James Metz,,,,
Alopecia Areata,NCT02781311,A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males,https://clinicaltrials.gov/study/NCT02781311,YES,MALE,ADULT,PHASE2,Alopecia,,,,,DRUG: Setipiprant,DRUG: Placebo,DRUG: Finasteride,,,"Burke Pharmaceutical Research, Hot Springs, Arkansas, 71913, United States","Petrus Center for Aesthetic Surgery & Hair Transplantation, Little Rock, Arkansas, 72205, United States","Therapeutics Clinical Research, San Diego, California, 92123, United States",Joan-En Lin,,,,
Alopecia Areata,NCT01111981,Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia,https://clinicaltrials.gov/study/NCT01111981,NO,FEMALE,"ADULT, OLDER_ADULT",PHASE4,Alopecia,,,,,DRUG: Clobetasol Propionate 0.05% Emollient Foam,,,,,"Callender Center for Clinical Research, Mitchellville, Maryland, 20721, United States",,,Valerie Callender,Cherie Young,,,
Alopecia Areata,NCT06146166,"The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome",https://clinicaltrials.gov/study/NCT06146166,NO,FEMALE,"ADULT, OLDER_ADULT",,Hair Thinning,,,,,DIETARY_SUPPLEMENT: Oral herbal supplement,DIETARY_SUPPLEMENT: Oral placebo supplement,,,,"Integrative Skin and Research, Sacramento, California, 95815, United States",,,,,,,
Alopecia Areata,NCT05296863,Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT05296863,NO,MALE,ADULT,PHASE3,"Alopecia, Androgenetic",Hair Loss/Baldness,,,,COMBINATION_PRODUCT: Non-concentrated adipose-derived stem cell conditioned media and 5% Minoxidil,COMBINATION_PRODUCT: Concentrated adipose-derived stem cell conditioned media and 5% Minoxidil,COMBINATION_PRODUCT: Placebo and 5% Minoxidil,,,"Universitas Indonesia, Jakarta Pusat, Jakarta, 10430, Indonesia",,,,,,,
Alopecia Areata,NCT00197379,The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT00197379,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia,,,,,DRUG: roxithromycin,,,,,"Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan",,,Masahiro Takigawa,,,,
Alopecia Areata,NCT05129800,Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study,https://clinicaltrials.gov/study/NCT05129800,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Androgenetic Alopecia,Hair Loss,Alopecia,,,OTHER: Platelet-rich plasma,OTHER: Mesotherapy,,,,,,,Athanasios J Stefanis,,,,
Alopecia Areata,NCT05460611,1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia,https://clinicaltrials.gov/study/NCT05460611,NO,ALL,"ADULT, OLDER_ADULT",,Scarring Alopecia,Androgenetic Alopecia,,,,DEVICE: Sciton HALO 1470nm Non-ablative laser,,,,,"Montefiore Einstein Advanced Care, Elmsford, New York, 10523, United States",,,Kseniya Kobets,,,,
Alopecia Areata,NCT00418249,Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women,https://clinicaltrials.gov/study/NCT00418249,NO,FEMALE,"ADULT, OLDER_ADULT",PHASE2,Alopecia,,,,,DRUG: AS101,,,,,"Tel Aviv, Israel",,,Danny Ben-Amitai,,,,
Alopecia Areata,NCT03427905,Autologous Adipose-Derived Adult Stromal Vascular Cell Transplantation for Alopecia,https://clinicaltrials.gov/study/NCT03427905,NO,ALL,"ADULT, OLDER_ADULT",,Hair Loss/Baldness,Alopecia,,,,PROCEDURE: Lipoaspiration,PROCEDURE: Transplantation,,,,"Lebanese University, faculty of Sciences, section II and III, Beirut, 99, Lebanon",,,Nehman Makdissy,Rami Anderi,,,
Alopecia Areata,NCT01651689,Hair Counts From Vertical and Horizontal Sections of Scalp Biopsy SPecimens in Thai Population With Alopecia,https://clinicaltrials.gov/study/NCT01651689,NO,ALL,"ADULT, OLDER_ADULT",,Alopecia,,,,,,,,,,"Siriraj hospital, Bangkok, 10700, Thailand",,,Rattapon Thuangtong,,,,
Alopecia Areata,NCT03331003,"""iRestore"" Light Therapy Apparatus",https://clinicaltrials.gov/study/NCT03331003,NO,ALL,ADULT,,Alopecia,,,,,DEVICE: low level light therapy,DEVICE: non-LLLT wavelength group,,,,,,,,,,,
Alopecia Areata,NCT01904721,A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA),https://clinicaltrials.gov/study/NCT01904721,YES,MALE,ADULT,PHASE2,Alopecia,"Alopecia, Androgenetic",Baldness,,,DRUG: Bimatoprost Solution 1,DRUG: Bimatoprost Solution 2,DRUG: Bimatoprost Vehicle,,,"Fridley, Minnesota, United States",,,Medical Director,,,,
Alopecia Areata,NCT01004809,AVODARTÂ® Alopecia Post-marketing Surveillance (PMS),https://clinicaltrials.gov/study/NCT01004809,NO,MALE,ADULT,,Alopecia,,,,,DRUG: Dutasteride,,,,,"GSK Investigational Site, Daejeon, 301-721, Korea, Republic of",,,Clinical Trials,,,,
Alopecia Areata,NCT01325337,Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia,https://clinicaltrials.gov/study/NCT01325337,YES,MALE,ADULT,PHASE2,Alopecia,"Alopecia, Androgenetic",Baldness,,,DRUG: bimatoprost Formulation A,DRUG: bimatoprost Formulation B,DRUG: bimatoprost Formulation C,DRUG: bimatoprost vehicle solution,DRUG: minoxidil 5% solution,"Portland, Oregon, United States","Berlin, Germany",,Medical Director,,,,
Alopecia Areata,NCT00441116,A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT00441116,YES,MALE,ADULT,PHASE3,Alopecia,,,,,DRUG: Dutasteride 0.5mg oral tablets,,,,,,,,Clinical Trials,,,,
Alopecia Areata,NCT01189279,Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia,https://clinicaltrials.gov/study/NCT01189279,YES,ALL,ADULT,PHASE1,Alopecia,"Alopecia, Androgenetic",Baldness,,,DRUG: bimatoprost Formulation A,DRUG: bimatoprost Formulation B,DRUG: bimatoprost Formulation C,,,"Tempe, Arizona, United States",,,,,,,
Melanoma,NCT05928962,An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas,https://clinicaltrials.gov/study/NCT05928962,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanomas,,,,,DRUG: Recombinant Human Adenovirus Type 5 Injection,,,,,"Fujian Cancer Hospital, Department of Internal Medicine, Ward 19, Fuzhou, Fujian, China",,,,,,,
Melanoma,NCT01502696,Adjuvant PEG Intron in Ulcerated Melanoma,https://clinicaltrials.gov/study/NCT01502696,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Ulcerated Melanomas,,,,,BIOLOGICAL: PEG IFN alfa-2b,,,,,"Medical University of Graz, Graz, Austria","Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet, Brussels, Belgium","Universitair Ziekenhuis Gent, Ghent, Belgium",Alexander Eggermont,,,,
Melanoma,NCT03783325,Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma,https://clinicaltrials.gov/study/NCT03783325,NO,ALL,"ADULT, OLDER_ADULT",,Nevi and Melanomas,,,,,BEHAVIORAL: UV Counseling,OTHER: UV Photo,OTHER: Biological Sample,,,"University of Colorado, Aurora, Colorado, 80045, United States",,,Neil Box,,,,
Melanoma,NCT04020809,Neoadjuvant Atezolizumab in Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT04020809,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Cutaneous Melanoma,,,,,DRUG: Atezolizumab,,,,,"Houston Methodist Hospital, Houston, Texas, 77030, United States",,,Nestor Esnaola,,,,
Melanoma,NCT03541148,Evaluation of Oncoxin-ViusidÂ® in Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT03541148,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,"Cutaneous Melanoma, Stage II",Malignant Cutaneous Melanoma,"Cutaneous Melanoma, Stage III",,,DIETARY_SUPPLEMENT: Oncoxin-Viusid,,,,,"Manuel Fajardo Clinical Surgical University Hospital, La Habana, 10600, Cuba",,,Olaine R. Gray Lovio,,,,
Melanoma,NCT04702854,Evaluation of Ultrasound Biomicroscopy in the Local Staging of Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT04702854,NO,ALL,"ADULT, OLDER_ADULT",,Cutaneous Melanoma,,,,,DIAGNOSTIC_TEST: Ultrasound Biomicroscopy,,,,,"CHU de Nice, Nice, France",,,Nicolas,,,,
Melanoma,NCT05172232,Diagnostic Precision of the AI Tool Dermalyzer to Identify Malignant Melanomas in Subjects Seeking Primary Care for Melanoma-suspected Cutaneous Lesions,https://clinicaltrials.gov/study/NCT05172232,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,DIAGNOSTIC_TEST: Dermalyzer,,,,,"Region Ã–stergÃ¶tland Primary Care, LinkÃ¶ping, Docent, 58185, Sweden","Region Stockholm Primary Care, Stockholm, Sweden","Region Kalmar and Kronoberg, VÃ¤xjÃ¶, Sweden",Magnus Falk,,,,
Melanoma,NCT05572463,A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT05572463,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Unresectable Cutaneous Melanoma,Metastatic Cutaneous Melanoma,,,,COMBINATION_PRODUCT: Sintilimab + IBI110,,,,,"University of California San Francisco Medical Center, San Francisco, California, 94143, United States","Henry Ford Hospital, Detroit, Michigan, 48202, United States","Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States",,,,,
Melanoma,NCT04253080,Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors,https://clinicaltrials.gov/study/NCT04253080,NO,ALL,"ADULT, OLDER_ADULT",,Cutaneous Melanoma,,,,,BIOLOGICAL: Blood sample,BIOLOGICAL: Cutaneous melanoma biopsy,,,,"Dermatology department, Paris, Ile De France, 75014, France",,,Armelle Blondel,,,,
Melanoma,NCT02355587,Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes,https://clinicaltrials.gov/study/NCT02355587,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Cutaneous Melanoma,,,,,,,,,,"Sutter Health, Santa Rosa, California, 95403, United States","Elizabeth Liotta Dermatology, Frederick, Maryland, 21702, United States","University of Nevada, Las Vegas, Nevada, 89102, United States",Robert Cook,,,,
Melanoma,NCT03313206,Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma,https://clinicaltrials.gov/study/NCT03313206,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Head and Neck Mucosal Melanomas,,,,,DRUG: Pembrolizumab,PROCEDURE: Surgery,RADIATION: IMRT,DRUG: Lenvatinib,,"Gustave Roussy, Villejuif, Val De Marne, 94805, France",,,Antoine,,,,
Melanoma,NCT05253872,The MELAcare Study: A New Method for Surveillance of Melanoma Patients,https://clinicaltrials.gov/study/NCT05253872,NO,ALL,"ADULT, OLDER_ADULT",,Cutaneous Melanoma,,,,,OTHER: The MelaCare intervention,,,,,"Herlev and Gentofte Hospital, Copenhagen, 2730, Denmark",,,Lisbet R HÃ¶lmich,,,,
Melanoma,NCT02288897,PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT02288897,YES,ALL,"ADULT, OLDER_ADULT",PHASE3,Cutaneous Melanoma,,,,,DRUG: PV-10 (10% rose bengal disodium),"DRUG: Dacarbazine, temozolomide or talimogene laherparepvec",,,,"Sharp Memorial Hospital - Clinical Oncology Research, San Diego, California, 92123, United States","Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, 33140, United States","Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612, United States",Eric Wachter,Sanjiv Agarwala,,,
Melanoma,NCT03396952,Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma,https://clinicaltrials.gov/study/NCT03396952,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Stage III Cutaneous Melanoma,Stage IIIA Cutaneous Melanoma,Stage IIIB Cutaneous Melanoma,Stage IIIC Cutaneous Melanoma,Stage IV Cutaneous Melanoma,DRUG: Aspirin,BIOLOGICAL: Ipilimumab,OTHER: Laboratory Biomarker Analysis,BIOLOGICAL: Pembrolizumab,,"University of Califonia, San Francisco, San Francisco, California, 94143, United States",,,Adil Daud,,,,
Melanoma,NCT04884997,A Study of Toripalimab or Combining With Temozolomideï¼ˆivï¼‰ in the Treatment of Advanced/Metastatic Malignant Melanoma,https://clinicaltrials.gov/study/NCT04884997,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: toripalimab,DRUG: Temozolomide Injection,,,,"Department of Medical Onocology, First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, 310003, China",,,Yulong Zheng,,,,
Melanoma,NCT02355574,5-year Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay Results,https://clinicaltrials.gov/study/NCT02355574,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Cutaneous Melanoma,,,,,,,,,,"Northside Hospital, Atlanta, Georgia, 30342, United States","University of Louisville, Louisville, Kentucky, 40202, United States","Saint Louis University, Saint Louis, Missouri, 63103, United States",Robert Cook,,,,
Melanoma,NCT04778449,"Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma",https://clinicaltrials.gov/study/NCT04778449,NO,ALL,"ADULT, OLDER_ADULT",,Cutaneous Melanoma,,,,,OTHER: Medical Chart Review,OTHER: Questionnaire Administration,,,,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,Jennifer L McQuade,,,,
Melanoma,NCT04274816,Intradermal Injection of Anti-CTLA-4 in Patients With Stage I/II Melanoma,https://clinicaltrials.gov/study/NCT04274816,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Cutaneous Melanoma,,,,,DRUG: Tremelimumab,,,,,,,,Tanja D de Gruijl,Alfons  van den Eertwegh,,,
Melanoma,NCT04253574,Comparison of PET/CT and Ultrasound in Staging of Malignant Melanoma,https://clinicaltrials.gov/study/NCT04253574,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,DIAGNOSTIC_TEST: Imaging with 18F-FDG PET/CT and/or Ultrasound,,,,,,,,Joachim Hohmann,,,,
Melanoma,NCT03842943,Neoadjuvant Combination Immunotherapy for Stage III Melanoma,https://clinicaltrials.gov/study/NCT03842943,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Cutaneous Melanoma,,,,,DRUG: Pembrolizumab,DRUG: Talimogene Laherparepvec,,,,"University of Louisville, Louisville, Kentucky, 40202, United States",,,Michael Egger,,,,
Melanoma,NCT00424515,Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma,https://clinicaltrials.gov/study/NCT00424515,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Mucosal Melanoma,Acral/Lentiginous Melanoma,Chronically Sun Damaged Melanomas,,,DRUG: Imatinib,,,,,"University of Colorado at Denver Health Sciences Center, Denver, Colorado, 80045, United States","H. Lee Moffitt Cancer Center, Tampa, Florida, 33612, United States","University of Chicago, Chicago, Illinois, 60637, United States",F. Stephen Hodi,,,,
Melanoma,NCT03655756,pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT03655756,YES,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,"Cutaneous Melanoma, Stage III","Cutaneous Melanoma, Stage IV",,,,BIOLOGICAL: IFx-Hu2.0,,,,,"H. Lee Moffitt Cancer Center, Tampa, Florida, 33612, United States",,,Joseph Markowitz,,,,
Melanoma,NCT04924413,L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT04924413,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Tislelizumab,,,,,"Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, 450008, China",,,Quanli Gao,,,,
Melanoma,NCT01729663,"Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients",https://clinicaltrials.gov/study/NCT01729663,NO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,Cutaneous Melanoma,,,,,"BIOLOGICAL: CSF470 vaccine, BCG, Molgramostim",DRUG: interferon alpha 2b,,,,"Instituto MÃ©dico Alexander Fleming, Buenos Aires, Capital Federal, 1426, Argentina",,,JosÃ© Mordoh,,,,
Melanoma,NCT00991250,SentoCloneÂ® Compared to Reference Treatment in Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT00991250,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: SentoCloneÂ®,DRUG: TemodalÂ® or Dacarbazine MedacÂ®,,,,"Lunds Universitetssjukhus, Lund, SkÃ¥ne, 22185, Sweden","SÃ¶dersjukhuset, Stockholm, Stockholms LÃ¤n, 11883, Sweden","Karolinska Sjukhuset, Stockholm, Stockholms LÃ¤n, 17176, Sweden",Christian Ingvar,,,,
Melanoma,NCT04123470,A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma,https://clinicaltrials.gov/study/NCT04123470,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,GENETIC: delolimogene mupadenorepvec,BIOLOGICAL: atezolizumab,,,,"Cedars-Sinai Medical Center, The Angeles Clinic and Research Institute, Los Angeles, California, 90025, United States","Baylor St Luke's Medical Center, Houston, Texas, 77030, United States","Uppsala University Hospital, Uppsala, 75185, Sweden",Angelica Loskog,,,,
Melanoma,NCT04648163,Suction Drain in Axillary Lymph Node Dissection for Malignant Melanoma,https://clinicaltrials.gov/study/NCT04648163,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,,,,,,"Medical University of Graz, Graz, Styria, 8036, Austria",,,David B Lumenta,,,,
Melanoma,NCT03649529,Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy,https://clinicaltrials.gov/study/NCT03649529,NO,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,Malignant Melanoma,,,,,BIOLOGICAL: GPA-TriMAR-T,,,,,"Hainan Cancer Hospital, Haikou, Hainan, 570100, China","The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, 570100, China",,Haifeng Lin,,,,
Melanoma,NCT00087477,A Pilot Study of Pivanex in Patients With Malignant Melanoma,https://clinicaltrials.gov/study/NCT00087477,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,DRUG: Pivanex,,,,,"Mt. Sinai Comprehensive Cancer Center, Miami Beach, Florida, 33140, United States",,,,,,,
Melanoma,NCT01247623,Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT01247623,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: GV1001,,,,,"Oslo University Hospital, Oslo, Postbox 4953, 0424, Norway",,,,,,,
Melanoma,NCT04593485,Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital Tract,https://clinicaltrials.gov/study/NCT04593485,NO,FEMALE,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Camrelizumab for injection,,,,,"Fudan University Shanghai Cancer Center, Shanghai, Shanghai, 200032, China","Fudan University Shanghai Cancer Center, Shanghai, China",,Xiaohua Wu,,,,
Melanoma,NCT02068196,A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.,https://clinicaltrials.gov/study/NCT02068196,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Malignant Melanoma,,,,,PROCEDURE: Blood sampling for Pre-existing immunity,DRUG: Ipilimumab,,,,"Haukeland University Hospital, Bergen, Norway","Nordland Hospital BodÃ¸, BodÃ¸, Norway","SÃ¸rlandet Hospital, Kristiansand, Kristiansand, Norway",Tormod K Guren,,,,
Melanoma,NCT00323206,Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma,https://clinicaltrials.gov/study/NCT00323206,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,BIOLOGICAL: IL-12p DNA,PROCEDURE: Intratumoral Electroporation,,,,"H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States",,,Adil Daud,,,,
Melanoma,NCT05200143,"Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma",https://clinicaltrials.gov/study/NCT05200143,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Refractory Cutaneous Melanoma,,,,,DRUG: Ipilimumab,DRUG: Nivolumab,DRUG: Cabozantinib,,,"Providence Portland Medical Center, Portland, Oregon, 97213, United States",,,Matthew Taylor,,,,
Melanoma,NCT00513604,Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma,https://clinicaltrials.gov/study/NCT00513604,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Melanoma,Malignant Melanoma,"Melanoma, Experimental",Experimental Melanomas,,BIOLOGICAL: aldesleukin,BIOLOGICAL: therapeutic autologous lymphocytes,DRUG: Cyclophosphamide,DRUG: Fludarabine phosphate,RADIATION: Total body irradiation,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,Deborah E Citrin,,,,
Melanoma,NCT00498836,"Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma",https://clinicaltrials.gov/study/NCT00498836,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: CP-4055,DRUG: Sorafenib (Nexavar),,,,"University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, 15232, United States","Cancer Therapy and Research Center, Institute for Drug Development, San Antonio, Texas, 78229, United States","The Norwegian Radium Hospital, Oslo, NO-0310, Norway",Svein Dueland,,,,
Melanoma,NCT01557114,Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT01557114,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: Ipilimumab,RADIATION: Radiotherapy,,,,"Gustave Roussy Cancer Campus, Villejuif, Val de Marne, 94805, France","Institut Gustave Roussy, Villejuif, 94805, France",,,,,,
Melanoma,NCT03116412,A Randomized Trial to Assess the Role of Imaging During Follow up After Radical Surgery of High Risk Melanoma,https://clinicaltrials.gov/study/NCT03116412,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,PROCEDURE: CT or PET scans,,,,,"SÃ¶dra Ã„lvsborgs sjukhus, Boras, Sweden","MÃ¤larsjukhuset Eskilstuna, Eskilstuna, Sweden","Falu lasarett, Falun, Sweden",Gustav Ullenhag,,,,
Melanoma,NCT02275416,Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma,https://clinicaltrials.gov/study/NCT02275416,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,DRUG: Ipilimumab,BIOLOGICAL: UV1 vaccine,BIOLOGICAL: GM-CSF,,,"Oslo University Hospital, Radiumhospitalet, Oslo, 0379, Norway",,,Tormod Guren,,,,
Melanoma,NCT01227551,A Study of Intratumoral CAVATAKâ„¢ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM ),https://clinicaltrials.gov/study/NCT01227551,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: Coxsackievirus A21 (CVA21),,,,,"Moores UCSD Cancer Center, La Jolla, California, 92093, United States","St Mary's Medical Center, San Francisco, California, 94117, United States","Mount Sinai Medical Center, Miami Beach, Florida, 33140, United States",Robert Andtbacka,,,,
Melanoma,NCT04285749,Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas,https://clinicaltrials.gov/study/NCT04285749,NO,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,Malignant Melanoma,,,,,DRUG: Fluvastatin,OTHER: RNA-sequencing,OTHER: Gene expression profiling,,,,,,Wesley Yu,,,,
Melanoma,NCT00535314,Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT00535314,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: RTA 402 Dose1,DRUG: RTA 402 Dose2,,,,,,,,,,,
Melanoma,NCT00963261,Quality of Life and Psychological Well-being in Patients With Malignant Melanoma,https://clinicaltrials.gov/study/NCT00963261,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,BEHAVIORAL: psycho-oncological intervention,,,,,"University Medical Center Freiburg, Department of Dermatology, Freiburg, 79104, Germany","University Medical Center Collogne, Department of Dermatology, KÃ¶ln, 50937, Germany",,Katrin Reuter,Dorothee Nashan,,,
Melanoma,NCT00864253,A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma,https://clinicaltrials.gov/study/NCT00864253,YES,ALL,"ADULT, OLDER_ADULT",PHASE3,Malignant Melanoma,,,,,DRUG: ABI-007,DRUG: Dacarbazine,,,,"University of Alabama at Birmingham, Birmingham, Alabama, 35243, United States","AZ Cancer Ctr, Scottsdale, Arizona, 85258, United States","Arizona Cancer Center, Tucson, Arizona, 85724, United States",Evan Hersh,Ileana Elias,,,
Melanoma,NCT00179608,Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy,https://clinicaltrials.gov/study/NCT00179608,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: CC-5013,,,,,"MD Anderson Cancer Center, Houston, Texas, 77030-4009, United States",,,,,,,
Melanoma,NCT03860883,Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT03860883,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,"Cutaneous Melanoma, Stage II",,,,,PROCEDURE: Wide Local Excision = 1cm Margin,PROCEDURE: Wide Local Excision = 2cm Margin,,,,"University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, 36604, United States","Banner MD Anderson Cancer Center, Gilbert, Arizona, 85234, United States","Mayo Clinic Phoenix, Phoenix, Arizona, 85054, United States",Michael Henderson,Marc Moncrieff,,,
Melanoma,NCT01211262,Study to Assess the Tolerability of a Bispecific Targeted Biologic IMCgp100 in Malignant Melanoma,https://clinicaltrials.gov/study/NCT01211262,YES,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: IMCgp100,,,,,"The Angeles Clinic, Los Angeles, California, 90025, United States","Yale Cancer Center, New Haven, Connecticut, 06520-8028, United States","Memorial Slone Kettering Cancer Center, New York, New York, 10065, United States",Namir Hassan,,,,
Melanoma,NCT00300612,Vaccine Treatment for Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT00300612,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: HyperAcute-Melanoma Vaccine,,,,,"H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States",,,Ronald C. DeConti,Charles J. Link,,,
Melanoma,NCT04789421,"Advanced Non-invasive Diagnostics for Early Cutaneous Tumor Diagnosis, Clinical-therapeutic and Economic Management",https://clinicaltrials.gov/study/NCT04789421,NO,ALL,"ADULT, OLDER_ADULT",,Cutaneous Melanoma,,,,,"DEVICE: Clinical, dermoscopy and Reflective confocal microscopy evaluations","DEVICE: Clinical, dermoscopy evaluations",,,,,,,Giovanni Pellacani,,,,
Melanoma,NCT01253096,Intratumoral Application of L19IL2 in Patients With Malignant Melanoma,https://clinicaltrials.gov/study/NCT01253096,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Intratumoral injections of L19IL2,,,,,"UniversitÃ¤tsklinik Graz, Graz, Austria","Medizinischen Hochschule Hannover, Hannover, Germany","University Hospital, Tuebingen, Germany",Claus Garbe,,,,
Melanoma,NCT01588847,Anesthesia and Cancer Recurrence im Malignant Melanoma,https://clinicaltrials.gov/study/NCT01588847,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,PROCEDURE: Spinal anesthesia with Bupivacaine hyperbar 0.5 %,"PROCEDURE: General anesthesia with Sufentanil, Propofol and Rocuronium and Sevoflurane",,,,"Fachklinik Hornheide, Department of Anesthesiology, Intensive Care and Pain Therapy, MÃ¼nster, D-48157, Germany",,,Hugo K Van Aken,,,,
Melanoma,NCT00142454,NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting),https://clinicaltrials.gov/study/NCT00142454,YES,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: Imiquimod,BIOLOGICAL: NY-ESO-1 protein,,,,"NYU Cancer Institute, New York, New York, 10016, United States",,,Nina Bhardwaj,Sylvia Adams,,,
Melanoma,NCT03278665,4SC-202 in Combination With Pembrolizumab in Patients Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy,https://clinicaltrials.gov/study/NCT03278665,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,DRUG: 4SC-202 in combination with Pembrolizumab,,,,,"UniversitÃ¤tsklinikum Essen, Essen, Germany","Medizinische Hochschule Hannover, Hannover, Germany","UniversitÃ¤tsklinikum Heidelberg, Heidelberg, Germany",Dirk Schadendorf,,,,
Melanoma,NCT02272855,A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma,https://clinicaltrials.gov/study/NCT02272855,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: HF10 plus Ipilimumab,,,,,"Clinical Site, San Francisco, California, 94115, United States","Clinical Site, Atlanta, Georgia, 30322, United States","Clinical Site, Portland, Oregon, 97239, United States",Robert Andtbacka,,,,
Melanoma,NCT02535078,Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT02535078,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,DRUG: Tebentafusp (IMCgp100),DRUG: durvalumab,DRUG: tremelimumab,,,"The Angeles Clinic and Research Institute, Los Angeles, California, 90025, United States","Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States","Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States",,,,,
Melanoma,NCT06294379,Shared Decision Making in Melanoma Patients Receiving Adjuvant Therapy,https://clinicaltrials.gov/study/NCT06294379,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,,,,,,"Odense University Hospital, Odense C, 5000, Denmark",,,,,,,
Melanoma,NCT02968680,Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT02968680,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Cutaneous Melanoma,Melanoma,,,,PROCEDURE: Sentinel Lymph Node Biopsy,DEVICE: Ultrasonography,DRUG: Sonazoid,,,"USC / Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States",,,Kevin King,,,,
Melanoma,NCT04547946,Observational Study for Melanoma Adjuvant Treatment With TafinlarÂ® + MekinistÂ® (Dabrafenib + Trametinib),https://clinicaltrials.gov/study/NCT04547946,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,DRUG: dabrafenib + trametinib,,,,,"Novartis Investigative Site, Coimbra, Center, 3000-075, Portugal","Novartis Investigative Site, Oporto, North, 4200-319, Portugal",,Novartis Pharmaceuticals,,,,
Melanoma,NCT01942603,Minimal SN Tumor Burden,https://clinicaltrials.gov/study/NCT01942603,NO,ALL,"ADULT, OLDER_ADULT",,Cutaneous Melanoma,,,,,,,,,,"U.Z. Leuven - Campus Gasthuisberg, Leuven, Belgium","CHRU de Lille, Lille, France","CHU de Nice - Hopital De L'Archet, Nice, France",,,,,
Melanoma,NCT01278940,Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT01278940,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: Dendritic Cells (DC) malignant melanoma,PROCEDURE: IL-2,,,,,,,Steinar Aamdal,,,,
Melanoma,NCT03843593,A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery,https://clinicaltrials.gov/study/NCT03843593,NO,ALL,"ADULT, OLDER_ADULT",,Cutaneous Melanoma,,,,,BEHAVIORAL: Demographics Questionnaire,BEHAVIORAL: Adjuvant Treatment Beliefs Scale10,BEHAVIORAL: Functional Assessment of Cancer Therapy - Melanoma (FACT-M)11,BEHAVIORAL: Functional Assessment of Chronic Illness Therapy - Treatment Satisfaction - General (FACIT-TS-G)13,BEHAVIORAL: Decisional Regret14,"Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, 07920, United States","Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, 10604, United States","Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States",Paul Chapman,,,,
Melanoma,NCT00145158,Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT00145158,YES,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: 8 HLA-A2-restricted peptides and Montanide ISA51,BIOLOGICAL: 8 HLA-A2-restricted peptides and CpG 7909,,,,"Clinique Universitaires St-Luc, Brussels, B-1200, Belgium","Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium",,Nicolas VanBaren,Thierry,,,
Melanoma,NCT00235482,Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma (PXS-X02),https://clinicaltrials.gov/study/NCT00235482,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: Coxsackievirus A21,,,,,"Melanoma Unit, Mater Misericordiae Hospital, Newcastle, New South Wales, 2298, Australia",,,,,,,
Melanoma,NCT03628417,Confirmatory Trial in the Evaluation of Ca Electroporation for the Treatment of Cutaneous Metastases,https://clinicaltrials.gov/study/NCT03628417,YES,ALL,"ADULT, OLDER_ADULT",,Cutaneous Melanoma,,,,,PROCEDURE: Calcium Electroporation,PROCEDURE: Bleomycin based electrochemotherapy,,,,,,,,,,,
Melanoma,NCT00358319,Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma,https://clinicaltrials.gov/study/NCT00358319,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,DRUG: Karenitecin,DRUG: Valproic Acid,,,,"H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States",,,Adil Daud,,,,
Melanoma,NCT02650492,Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma,https://clinicaltrials.gov/study/NCT02650492,NO,ALL,"ADULT, OLDER_ADULT",,Melanoma,Malignant Melanoma,,,,DEVICE: Immunostimulating Interstitial Laser Thermotherapy,,,,,"Karolinska University Hospital Solna, Stockholm, 17176, Sweden",,,Johan Hansson,,,,
Melanoma,NCT00087776,Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma,https://clinicaltrials.gov/study/NCT00087776,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,DRUG: Chemotherapy,,,,,"Luitpold Pharmaceuticals, Inc., Norristown, Pennsylvania, 19403, United States",,,,,,,
Melanoma,NCT00729950,Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma,https://clinicaltrials.gov/study/NCT00729950,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,BIOLOGICAL: MDX-010,,,,,"Arizona Cancer Center, Tucson, Arizona, 85724-5024, United States","USC/Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States","Piedmont Oncology Specialists, Charlotte, North Carolina, 28207, United States",Bristol-Myers Squibb,,,,
Melanoma,NCT01137006,"An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant Melanoma",https://clinicaltrials.gov/study/NCT01137006,YES,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,BIOLOGICAL: IMC-20D7S (Cohort 1A),BIOLOGICAL: IMC-20D7S (Cohort 2A),BIOLOGICAL: IMC-20D7S (Cohort 3A),BIOLOGICAL: IMC-20D7S (Cohort 4A),BIOLOGICAL: IMC-20D7S (Cohort 1B),"ImClone Investigational Site, Boston, Massachusetts, 02114, United States","ImClone Investigational Site, New York, New York, 10021, United States",,E-mail: ClinicalTrials@ ImClone.com,,,,
Melanoma,NCT04217382,Pre Transplantation Melanoma,https://clinicaltrials.gov/study/NCT04217382,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,OTHER: patient with melanoma pre transplantation,,,,,"service de dermatologie - hopital Edouard Herriot, Lyon, Rhone, 69003, France",,,Emilie,,,,
Melanoma,NCT00327600,Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT00327600,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,DRUG: imexon,DRUG: DTIC,,,,"Investigational Site 009, Los Angeles, California, 90033, United States","Investigational Site 002, Santa Monica, California, 90404, United States","University of CO Anschutz Cancer Pavilion, Aurora, Colorado, 80010, United States",Evan Hersh,,,,
Melanoma,NCT01636960,A Study of Pegylated Interferon Alfa-2b (MK-4031) as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (MK-4031-370),https://clinicaltrials.gov/study/NCT01636960,YES,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,BIOLOGICAL: PegIFN alfa-2b,,,,,,,,Medical Director,,,,
Melanoma,NCT03538314,UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma,https://clinicaltrials.gov/study/NCT03538314,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: UV1,DRUG: GM-CSF,,,,"John Wayne Cancer Center, Santa Monica, California, 90404, United States","University of Iowa Carver College of Medicine, Iowa City, Iowa, 52242, United States","St. Luke's University Health Network, Easton, Pennsylvania, 18045, United States",,,,,
Melanoma,NCT01138410,Study of a DNA Immunotherapy to Treat Melanoma,https://clinicaltrials.gov/study/NCT01138410,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: SCIB1,,,,,"Department of Medical Oncology, The Royal Surrey County Hospital, Guildford, Surrey, GU2 7XX, United Kingdom","St James' Institute of Oncology, Leeds, LS9 7TF, United Kingdom","Christie Hospital, Manchester, M20 4BX, United Kingdom",Poulam M Patel,Paul Lorigan,Maria Marples,,
Melanoma,NCT01124734,High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma,https://clinicaltrials.gov/study/NCT01124734,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Interleukin-2,DRUG: Temozolomide,,,,"Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033, United States",,,,,,,
Melanoma,NCT01455259,Phase I/IIa AdCD40L Immunogene Therapy for Malignant Melanoma and Other Solid Tumors,https://clinicaltrials.gov/study/NCT01455259,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: AdCD40L,,,,,"Uppsala University Hospital, Uppsala, 75185, Sweden",,,Thomas H TÃ¶tterman,Gustav Ullenhag,Angelica  Loskog,,
Melanoma,NCT00963664,Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma,https://clinicaltrials.gov/study/NCT00963664,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Melanoma,Malignant Melanoma,,,,DRUG: lovastatin,DRUG: interferon alfa-2b,,,,"NeoPlas Innovation, Nashville, Tennessee, 37027, United States",,,Stephen B. Cantrell,,,,
Melanoma,NCT01696045,"Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma",https://clinicaltrials.gov/study/NCT01696045,YES,ALL,CHILD,PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: Ipilimumab,,,,,"Phoenix Children'S Hospital, Phoenix, Arizona, 85016, United States","Childrens Hospital Of La, Los Angeles, California, 90027, United States","Children'S Hospital Of Orange County, Orange, California, 92868, United States",Bristol-Myers Squibb,,,,
Melanoma,NCT01264081,Lapatinib in Stage IV Melanoma With ERBB4 Mutations,https://clinicaltrials.gov/study/NCT01264081,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Lapatinib,,,,,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,Udo Rudloff,,,,
Melanoma,NCT00145041,Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction,https://clinicaltrials.gov/study/NCT00145041,YES,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: Vincristine Sulfate Liposomes Injection,,,,,"University of Texas M.D. Anderson Cancer Center, Houston, Texas, 77030, United States",,,Agop Bedikian,,,,
Melanoma,NCT03034395,Study of 1cm Versus 2cm Margins for the Surgical Treatment of cT2N0M0 Melanoma,https://clinicaltrials.gov/study/NCT03034395,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,PROCEDURE: Wide Local Excision,,,,,"University of Kansas Medical Center, Kansas City, Kansas, 66160, United States",,,Joshua Mammen,,,,
Melanoma,NCT02537600,Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis,https://clinicaltrials.gov/study/NCT02537600,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Cobimetinib + Vemurafenib combination treatment,,,,,"CHU de Bordeaux, Bordeaux, 33000, France","CHU Ambroise ParÃ©, Boulogne, 92104, France","CHU Brest - HÃ´pital Morvan, Brest, France",Thierry Lesimple,,,,
Melanoma,NCT01024231,Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma,https://clinicaltrials.gov/study/NCT01024231,YES,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: BMS-936558 (MDX1106-04),DRUG: Ipilimumab,,,,"Yale University School Of Medicine, New Haven, Connecticut, 06520, United States","Medstar Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia, 20007, United States","Memorial Sloan Kettering Nassau, New York, New York, 11065, United States",Bristol-Myers Squibb,,,,
Melanoma,NCT02223884,A Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy,https://clinicaltrials.gov/study/NCT02223884,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: docetaxel 35mg/m2,DRUG: Carboplatin AUC3,,,,"Severance Hospital, Seoul, 120-752, Korea, Republic of",,,,,,,
Melanoma,NCT00733798,A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma,https://clinicaltrials.gov/study/NCT00733798,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Melanoma,Malignant Melanoma,Metastatic Melanoma,,,DRUG: 131I-TM601,,,,,"Lacks Cancer Center, Grand Rapids, Michigan, 49503, United States","New York University School of Medicine, New York, New York, 10016, United States","Mary Crowley Cancer Center, Dallas, Texas, 75246, United States",Thomas Gribbin,Neil Senzer,Anna Pavlick,,
Melanoma,NCT02673970,Biomarkers for the Activity of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma,https://clinicaltrials.gov/study/NCT02673970,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,,,,,,"UZ Brussel, Jette, Brabant, 1090, Belgium","UZ Brussel, Jette, Brussels, 1090, Belgium",,Bart NEyns,,,,
Melanoma,NCT05089370,Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma,https://clinicaltrials.gov/study/NCT05089370,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,COMBINATION_PRODUCT: Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab,,,,,"University of Colorado Hospital, Aurora, Colorado, 80045, United States",,,Martin McCarter,,,,
Melanoma,NCT01543464,Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients,https://clinicaltrials.gov/study/NCT01543464,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Chemotherapy: Temozolomide,,,,,"Trine Zeeberg Iversen, BrÃ¸nshÃ¸j, Copenhagen, 2700, Denmark",,,Trine Zeeberg Iversen,Inge Marie Svane,,,
Melanoma,NCT05675709,Enhancing Skin Cancer Early Detection and Treatment in Primary Care,https://clinicaltrials.gov/study/NCT05675709,NO,ALL,"ADULT, OLDER_ADULT",,Cutaneous Melanoma,,,,,BEHAVIORAL: Training and Education,,,,,"OHSU Knight Cancer Institute, Portland, Oregon, 97239, United States",,,Susan A Flocke,,,,
Melanoma,NCT00539591,Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma,https://clinicaltrials.gov/study/NCT00539591,YES,ALL,"CHILD, ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Peginterferon alfa-2b,DRUG: Temozolomide,DRUG: Recombinant interferon alfa-2b,,,"Rady Children's Hospital, San Diego, California, 92123, United States","St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States","The Children's Cancer Hospital at UT M.D. Anderson Cancer Center, Houston, Texas, 77030, United States",Alberto Pappo,,,,
Melanoma,NCT02889861,IMCgp100-401 Rollover Study,https://clinicaltrials.gov/study/NCT02889861,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: IMCgp100,,,,,"Memorial Slone Kettering Cancer Center, New York, New York, 10065, United States","Dept of Oncology & Haematology, Churchill Hospital, Oxford, Oxfordshire, OX3 7LJ, United Kingdom","Dept of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, G12 OYN, United Kingdom",,,,,
Melanoma,NCT01898039,Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients,https://clinicaltrials.gov/study/NCT01898039,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: A2/4-1BBL melanoma vaccine,PROCEDURE: DNP sensititzation,DRUG: Cyclophosphamide,,,"Sharett Institute of Oncology, Hadassah Medical Organization, Jerusalem, 91120, Israel",,,,,,,
Melanoma,NCT03448666,ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases,https://clinicaltrials.gov/study/NCT03448666,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,COMBINATION_PRODUCT: Pembrolizumab,,,,,"IEO Istituto Europeo di Oncologia, Milan, 20141, Italy",,,Pier Fr Ferrucci,,,,
Melanoma,NCT02071940,PLX3397 KIT in Acral aNd mucOsal Melanoma,https://clinicaltrials.gov/study/NCT02071940,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: PLX3397,,,,,"The Christie NHS Foundation Trust, Manchester, Greater Manchester, M20 4BX, United Kingdom","The Beatson West of Scotland Cancer Centre, Glasgow, Scotland, G12 OXH, United Kingdom","Abertawe Bro Morgannwg University Health Board, Singleton Hospital, Swansea, Wales, SA2 8QA, United Kingdom",,,,,
Melanoma,NCT03563729,Melanoma Metastasized to the Brain and Steroids,https://clinicaltrials.gov/study/NCT03563729,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Pembrolizumab Injection [Keytruda],DRUG: Ipilimumab Injection [Yervoy],DRUG: Nivolumab Injection [Opdivo],DRUG: Encorafenib,DRUG: Binimetinib,"Herlev Universityhospital, Herlev, Hovedstaden, 2730, Denmark","Aarhus Universityhospital, Aarhus, Midt, 8000, Denmark","Odense Universityhospital, Odense, Syd, 5000, Denmark",Troels H Borch,,,,
Melanoma,NCT00911443,"Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma",https://clinicaltrials.gov/study/NCT00911443,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: Dacarbazine + Interferon alpha + Thymosin-alpha-1 1.6 mg,BIOLOGICAL: Dacarbazine + Interferon alpha + Thymosin-alpha-1 3.2 mg,BIOLOGICAL: Dacarbazine + Interferon alpha + Thymosin-alpha-1 6.4 mg,BIOLOGICAL: Dacarbazine + Thymosin-alpha-1 3.2 mg,DRUG: Dacarbazine + Interferon alpha,"CHU de Grenoble Hopital Albert Michallon Service de Dermatologie, La Tronche, 38043, France","CHU de Limoges Hopital Dupuytren Service de Dermatologie, Limoges, 87042, France","Hopital Saint-Eloi Service de Dermatologie, Montpellier, 34295, France",Virginia Ferraresi,Roberto Camerini,,,
Melanoma,NCT04904185,ImmPACT Expanded Multiple Antigen Specific Endogenously Derived T Cells (MASE-T) to Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT04904185,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: Cyclophosphamide,DRUG: Fludarabine Phosphate,BIOLOGICAL: Multiple Antigen Specific Endogenously derived T cells,DRUG: Pembrolizumab,,"National Center for Cancer Immune Therapy (CCIT-DK), Herlev, 2730, Denmark",,,Inge M Svane,Tine J Monberg,,,
Melanoma,NCT04382664,UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma,https://clinicaltrials.gov/study/NCT04382664,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: UV1,BIOLOGICAL: Sargramostim,BIOLOGICAL: Ipilimumab,BIOLOGICAL: Nivolumab,,"Mayo Clinic Hospital, Phoenix, Arizona, 85016-4880, United States","Highlands Oncology Group, Fayetteville, Arkansas, 72703, United States","University of California Irvine Health, Orange, California, 92868, United States",Karl Lewis,,,,
Melanoma,NCT03383237,Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma,https://clinicaltrials.gov/study/NCT03383237,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Apatinib,,,,,"Henan Cancer Hospital, Zhengzhou, Henan, 450008, China",,,Zibing Wang,,,,
Melanoma,NCT02303951,Neoadjuvant Vemurafenib + Cobimetinib + Atezolizumab in Melanoma: NEO-VC,https://clinicaltrials.gov/study/NCT02303951,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Vemurafenib,DRUG: Cobimetinib,DRUG: Atezolizumab,,,"Department of Dermatology & Skin Cancer University Hospital La Timone, Aix-Marseille University, Marseille, 13385, France","Department of Dermatology, University Hospital of Nantes, Nantes, 44093, France","Hopital Saint-Louis Hopitaux Universitaires Saint-Louis Laboisiere Fernand-Widal, Paris, 75010, France",Claus Garbe,,,,
Melanoma,NCT03903458,Tinostamustine and Nivolumab in Advanced Melanoma,https://clinicaltrials.gov/study/NCT03903458,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: Tinostamustine,,,,,"Kantonsspital GraubÃ¼nden, Chur, 7000, Switzerland","Cantonal Hospital St.Gallen, St.Gallen, 9007, Switzerland",,Markus Joerger,,,,
Melanoma,NCT00111696,Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT00111696,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,BIOLOGICAL: MEDI-522,,,,,"University Of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, 15213, United States",,,Stergios Moschos,,,,
Melanoma,NCT01705392,Bevacizumab vs Dacarbazine in Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01705392,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Metastatic Malignant Melanoma,Unresectable Malignant Melanoma,,,,DRUG: Bevacizumab,DRUG: Propranolol,DRUG: Enalapril,DRUG: Dacarbazine,,"Haukeland University Hospital, Bergen, 5021, Norway",,,Oddbjorn Straume,Olav Mella,,,
Melanoma,NCT05756556,T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma,https://clinicaltrials.gov/study/NCT05756556,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Melanoma,Malignant Melanoma,,,,COMBINATION_PRODUCT: T3011 + Cobimetinib,,,,,"Gabrail Cancer and Research Center, Canton, Ohio, 44718, United States",,,,,,,
Melanoma,NCT04223648,Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma,https://clinicaltrials.gov/study/NCT04223648,NO,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,Malignant Melanoma,,,,,"DRUG: tremelimumab/durvalumab, ipilimumab/nivolumab and nivolumab monotherapy",,,,,,,,Michael Hurwitz,,,,
Melanoma,NCT04126876,A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma,https://clinicaltrials.gov/study/NCT04126876,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Tilsotolimod,DRUG: Saline (0.9% sodium chloride),,,,"VU Medical Centere, Amsterdam, 1081 HV, Netherlands",,,Tanja de Gruijl,Alfons  van den Eertwegh,,,
Melanoma,NCT00104884,FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma,https://clinicaltrials.gov/study/NCT00104884,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,Melanoma,,,,DRUG: Depsipeptide,,,,,,,,David H. Lawson,,,,
Melanoma,NCT02434354,A Tissue Collection Study of Pembrolizumab (MK-3475) in Subjects With Resectable Advanced Melanoma,https://clinicaltrials.gov/study/NCT02434354,YES,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: pembrolizumab,,,,,"Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States",,,Tara Mitchell,,,,
Melanoma,NCT02902042,Encorafenib + Binimetinib + Pembrolizumab in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma,https://clinicaltrials.gov/study/NCT02902042,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,DRUG: Encorafenib,DRUG: Binimetinib,DRUG: Pembrolizumab,DRUG: Pembrolizumab alone,,"UniversitÃ¤tsklinikum Freiburg, Freiburg, Baden-WÃ¼rttemberg, 79106, Germany","Klinikum Augsburg SÃ¼d, Augsburg, Bavaria, 86179, Germany","Klinikum rechts der Isar, MÃ¼nchen, Bavaria, 81675, Germany",,,,,
Melanoma,NCT00350597,GM-CSF as Adjuvant Therapy of Melanoma,https://clinicaltrials.gov/study/NCT00350597,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF),,,,,"Northern California Melanoma Center, San Francisco, California, 94109, United States",,,Lynn E. Spitler,,,,
Melanoma,NCT04889118,Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advanced Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)-China Extension Study,https://clinicaltrials.gov/study/NCT04889118,YES,ALL,"ADULT, OLDER_ADULT",PHASE3,Malignant Melanoma,,,,,BIOLOGICAL: Pembrolizumab,DRUG: Lenvatinib,DRUG: Placebo for lenvatinib,,,"Beijing Cancer Hospital (0601), Beijing, Beijing, 100036, China","Fujian Provincial Cancer Hospital ( Site 0612), Fuzhou, Fujian, 350014, China","Sun Yat-Sen University Cancer Center (0602), Guangzhou, Guangdong, 510000, China",Medical Director,,,,
Melanoma,NCT02828202,"Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary",https://clinicaltrials.gov/study/NCT02828202,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,OTHER: Biological,OTHER: Tissular,OTHER: Quality of life,,,"CHU d'Amiens, Amiens, France","CH Annecy Genevois, Annecy, France","CHU de BesanÃ§on, BesanÃ§on, France",Celeste Lebbe,Brigitte Dreno,,,
Melanoma,NCT02612168,Melanoma Image Analysis Algorithm (MIAA) Validation Study,https://clinicaltrials.gov/study/NCT02612168,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,DEVICE: Melanoma Image Analysis Algorithm (MIAA),,,,,"Royal Devon and Exeter, Exeter, Devon, EX2 5DW, United Kingdom","Whipps Corss Hospital, Leytonstone, London, E11 1NR, United Kingdom","Royal Stoke University Hospital, Stoke, Staffordshire, ST4 6QG, United Kingdom",Ioulios Palamaras,,,,
Melanoma,NCT00034554,Study of gp75 Vaccine in Patients With Stage III and IV Melanoma,https://clinicaltrials.gov/study/NCT00034554,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,BIOLOGICAL: gp75 DNA vaccine,,,,,"ImClone Investigational Site, New York, New York, 10021, United States",,,E-mail: ClinicalTrials@ ImClone.com,,,,
Melanoma,NCT06221397,Clinical Validation Study of an AI-based CAD System for Early Non-Invasive Detection of Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT06221397,NO,ALL,"ADULT, OLDER_ADULT",,Melanoma,"Melanoma, Skin",,,,,,,,,"University Hospital of Cruces, Barakaldo, Biscay, 48903, Spain",,,JesÃºs Gardeazabal,Rosa MarÃ­a Ize,,,
Melanoma,NCT01002560,The Identification of Novel Prognostic Markers in Melanoma,https://clinicaltrials.gov/study/NCT01002560,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,,,,,,"Royal Marsden NHS Foundation Trust, Sutton, Surrey, SM2 5PT, United Kingdom",,,Professor Martin Gore,,,,
Melanoma,NCT03178851,Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma,https://clinicaltrials.gov/study/NCT03178851,YES,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,BIOLOGICAL: Atezolizumab,DRUG: Cobimetinib,BIOLOGICAL: Atezolizumab,BIOLOGICAL: Atezolizumab,,"HonorHealth Research Institute - Bisgrove, Scottsdale, Arizona, 85258, United States","University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora, Colorado, 80045, United States","Karmanos Cancer Institute, Detroit, Michigan, 48201, United States",Clinical Trials,,,,
Melanoma,NCT06388252,Electrochemotherapy Induces Changes in the Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Patients With Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT06388252,NO,ALL,"ADULT, OLDER_ADULT",,Cutaneous Malignant Melanoma,,,,,PROCEDURE: Electrochemotherapy with Intratumoral Cysplatin,PROCEDURE: Electrochemotherapy with Intravenous Bleomycin,,,,"Institute of Oncology Ljubljana, Ljubljana, 1000, Slovenia",,,Barbara PeriÄ‡,,,,
Melanoma,NCT03197636,Co-stimulatory Markers and Vitamin D Status in Anti-PD1 Treated Melanoma Patients,https://clinicaltrials.gov/study/NCT03197636,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,DRUG: Pembrolizumab,,,,,"AUH, Aarhus, 8000, Denmark",,,,,,,
Melanoma,NCT00299689,Phase II Trial of Ontak With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT00299689,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Denileukin diftitox,,,,,"James Graham Brown Cancer Center, Univ. of Louisville, Louisville, Kentucky, 40202, United States",,,Jason Chesney,,,,
Melanoma,NCT01077050,SciBase International Melanoma Pivotal Study,https://clinicaltrials.gov/study/NCT01077050,YES,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,DEVICE: SciBase III Electrical Impedance Spectrometer,,,,,"University of Arizona, Tucson, Arizona, 85719, United States","Sahlgrenska University Hospital, Gothenburg, 41345, Sweden",,Ulrik H Birgersson,,,,
Melanoma,NCT01288963,"IL-2 ""SELECT"" Tissue Collection Protocol in Patients With Advanced Melanoma",https://clinicaltrials.gov/study/NCT01288963,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,DRUG: IL-2,,,,,"Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States",,,David McDermott,,,,
Melanoma,NCT01480323,A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2,https://clinicaltrials.gov/study/NCT01480323,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Interleukin-2,DRUG: Ipilimumab,,,,"University Hospital TÃ¼bingen, TÃ¼bingen, 72076, Germany",,,Benjamin Weide,,,,
Melanoma,NCT02410863,Biopsy- and Biology-driven Optimization of Targeted Therapy in Subjects With Advanced Melanoma,https://clinicaltrials.gov/study/NCT02410863,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Dabrafenib,DRUG: Trametinib,,,,"National Centre for Tumour Diseases (NCT), Heidelberg, BW, 69120, Germany","University Hospital TÃ¼bingen, TÃ¼bingen, BW, 72076, Germany","Elbe Kliniken Stade - Buxtehude GmbH, Clinic for Dermatology, Buxtehude, Lower Saxony, 21614, Germany",Dirk Schadendorf,,,,
Melanoma,NCT00651703,Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients,https://clinicaltrials.gov/study/NCT00651703,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: CYT004-MelQbG10 + Montanide,BIOLOGICAL: CYT004-MelQbG10 + Montanide + Imiquimod,BIOLOGICAL: CYT004-MelQbG10 + Imiquimod,BIOLOGICAL: CYT004-MelQbG10 intra nodal injection,,"Ludwig Institute for Cancer Research; CHUV, Lausanne, VD, CH-1005, Switzerland","Dermatologische Klinik, UniversitÃ¤tsSpital ZÃ¼rich, Zurich, CH-8091, Switzerland",,,,,,
Melanoma,NCT05050006,ITIL-168 in Advanced Melanoma,https://clinicaltrials.gov/study/NCT05050006,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Advanced Cutaneous Melanoma,,,,,BIOLOGICAL: ITIL-168,,,,,"University of California San Diego, Moores Cancer Center, La Jolla, California, 92093, United States","The Angeles Clinic and Research Institute, Los Angeles, California, 90025, United States","USC - Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States",Instil Study Director,,,,
Melanoma,NCT01689519,A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01689519,YES,ALL,"ADULT, OLDER_ADULT",PHASE3,Malignant Melanoma,,,,,DRUG: Placebo,DRUG: Vemurafenib,DRUG: Cobimetinib,,,"University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States","The Angeles Clinic and Research Institute - W LA Office, Los Angeles, California, 90025, United States","University of California Davis Health System, Sacramento, California, 95817, United States",Clinical Trials,,,,
Melanoma,NCT02902029,Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma,https://clinicaltrials.gov/study/NCT02902029,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Vemurafenib,DRUG: Cobimetinib,DRUG: Atezolizumab,,,"HÃ´pital Ambroise-ParÃ©, Boulogne-Billancourt, 92104, France","Hospital Claude Huriez, Lille, 59000, France","HÃ´pital de la Timone, Marseille, 13885, France",Dirk Schadendorf,,,,
Melanoma,NCT03820986,Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003),https://clinicaltrials.gov/study/NCT03820986,YES,ALL,"ADULT, OLDER_ADULT",PHASE3,Malignant Melanoma,,,,,BIOLOGICAL: Pembrolizumab,DRUG: Lenvatinib,DRUG: Placebo for lenvatinib,,,"The Angeles Clinic and Research Institute ( Site 0707), Los Angeles, California, 90025, United States","UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0704), San Francisco, California, 30322, United States","California Pacific Medical Center Research Institute ( Site 0705), San Francisco, California, 94115, United States",Medical Director,,,,
Melanoma,NCT00060710,CP-461 in the Treatment of Patients With Advanced Melanoma,https://clinicaltrials.gov/study/NCT00060710,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: CP-461,,,,,"Columbia Presbyterian Medical Center, New York, New York, 10032, United States",,,,,,,
Melanoma,NCT03551626,Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes,https://clinicaltrials.gov/study/NCT03551626,YES,ALL,"ADULT, OLDER_ADULT",PHASE3,Malignant Melanoma,,,,,DRUG: Dabrafenib,DRUG: Trametinib,,,,"Novartis Investigative Site, Rosario, Sante Fe, S200KZE, Argentina","Novartis Investigative Site, Buenos Aires, C1125ABE, Argentina","Novartis Investigative Site, Cordoba, X5004BAL, Argentina",Novartis Pharmaceuticals,,,,
Melanoma,NCT03084640,Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced Melanoma,https://clinicaltrials.gov/study/NCT03084640,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: CMP-001,DRUG: Pembrolizumab,DRUG: CMP-001,,,"University of California, Los Angeles, Los Angeles, California, 90095, United States","University of Colorado, Aurora, Colorado, 80045, United States","University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States",,,,,
Melanoma,NCT00306566,Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients,https://clinicaltrials.gov/study/NCT00306566,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: CYT004-MelQbG10,,,,,"Centre Pluridisciplinaire d'Oncologie & LICR, CHUV, Lausanne, Vaude, 1011, Switzerland",,,Danielle Lienard,,,,
Melanoma,NCT00135408,A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide,https://clinicaltrials.gov/study/NCT00135408,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Ipilimumab+ Placebo,DRUG: Ipilimumab+ Budesonide,,,,"Los Angeles, California, United States","San Francisco, California, United States","Charlotte, North Carolina, United States",,,,,
Melanoma,NCT02938728,Definition of an Immune Signature Predictive of Anti-PD1 (Programmed Death-1) Antibody in the Treatment of Advanced Melanoma,https://clinicaltrials.gov/study/NCT02938728,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,OTHER: Biopsies,,,,,,,,,,,,
Melanoma,NCT02050321,A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma,https://clinicaltrials.gov/study/NCT02050321,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Acitretin,DRUG: Vemurafenib,,,,"University of Arizona Cancer Center, Tucson, Arizona, 85724, United States",,,Lee Cranmer,,,,
Melanoma,NCT00715793,Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT00715793,YES,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,DRUG: Decitabine,DRUG: Temozolomide,PROCEDURE: biopsy,,,"UPMC Cancer Centers, Pittsburgh, Pennsylvania, 15232, United States",,,Hussein Tawbi,,,,
Melanoma,NCT00204594,Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28,https://clinicaltrials.gov/study/NCT00204594,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,DRUG: rM28,DRUG: autologous PBMCs,,,,"University of Tuebingen, Department of dermatology, Tuebingen, 72076, Germany",,,,,,,
Melanoma,NCT00086489,"CP-675,206 In Patients With Advanced Melanoma",https://clinicaltrials.gov/study/NCT00086489,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,"DRUG: CP-675,206","DRUG: CP-675,206",,,,"Research Site, Los Angeles, California, 90095, United States","Research Site, Tampa, Florida, 33612, United States","Research Site, Chicago, Illinois, 60637-1460, United States",,,,,
Melanoma,NCT02935790,Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab,https://clinicaltrials.gov/study/NCT02935790,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: ACY-241,DRUG: nivolumab,DRUG: ipilimumab,,,"NYU Langone Medical Center, New York, New York, 10016, United States",,,Jeffrey S Weber,Elizabeth Buchbinder,,,
Melanoma,NCT01748448,Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome,https://clinicaltrials.gov/study/NCT01748448,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Cutaneous Malignant Melanoma,,,,,DRUG: Vitamin D,DRUG: arachides oleum raffinatum,,,,"Universitair Ziekenhuis Antwerpen, Dermatology, Edegem, 2650, Belgium","UZLeuven Gasthuisberg, Leuven, 3000, Belgium","Chef de Service du Service Universitaire de Dermatologie, LiÃ¨ge, 4000, Belgium",Marjan Garmyn,,,,
Melanoma,NCT01307397,A Study of Vemurafenib in Participants With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01307397,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,Malignant Melanoma,,,,,DRUG: Vemurafenib,,,,,"University ""Mother Theresa"" Hospital Center; Oncology Department, Tirana, 1000, Albania","Hospital Britanico; Oncologia, Buenos Aires, C1280AEB, Argentina","FundaciÃ³n CIDEA, Buenos Aires, C1425DTG, Argentina",Clinical Trials,,,,
Melanoma,NCT02523313,Immunotherapy With Nivolumab or Nivolumab Plus Ipilimumab vs. Double Placebo for Stage IV Melanoma w. NED,https://clinicaltrials.gov/study/NCT02523313,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Nivolumab + Placebo,DRUG: Nivolumab + Ipilimumab,DRUG: Double Placebo Control,,,"CharitÃ© Berlin, Berlin, 10117, Germany","Elbe Klinikum Buxtehude, Buxtehude, 21614, Germany","UniversitÃ¤tsklinikum Dresden, Dresden, 01307, Germany",Dirk Schadendorf,,,,
Melanoma,NCT00483301,"A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma",https://clinicaltrials.gov/study/NCT00483301,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Sorafenib (BAY 43-9006),DRUG: ABI-007(Abraxane),,,,"Dr. Steven O'Day, Los Angeles, California, 90025, United States","Mt. Sinai Medical Center, Miami Beach, Florida, 33140, United States",,,,,,
Melanoma,NCT01656642,A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01656642,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: Atezolizumab,DRUG: Cobimetinib,DRUG: Vemurafenib,,,"UCLA, Los Angeles, California, 90024, United States","The Angeles Clinic and Research Institute - W LA Office, Los Angeles, California, 90025, United States","University of Colorado Health Science Center; Biomedical Research Bldg. Room 511, Aurora, Colorado, 80045, United States",Clinical Trials,,,,
Melanoma,NCT01704287,Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (MK-3475-002/P08719/KEYNOTE-002),https://clinicaltrials.gov/study/NCT01704287,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: Pembrolizumab,DRUG: Carboplatin,DRUG: Paclitaxel,DRUG: Dacarbazine,DRUG: Temozolomide,,,,Medical Director,,,,
Melanoma,NCT01248936,A Study of RO5185426 in Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01248936,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: RO5185426,,,,,"Tucson, Arizona, 85724-5078, United States","Los Angeles, California, 90095, United States","San Francisco, California, 94115, United States",Clinical Trials,,,,
Melanoma,NCT02186249,Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma,https://clinicaltrials.gov/study/NCT02186249,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,DRUG: Nivolumab,DRUG: Ipilimumab,,,,"Banner MD Anderson Cancer Center, Gilbert, Arizona, 85234, United States","Mayo Clinic Arizona, Phoenix, Arizona, 85054, United States","6501 Truxtun Avenue, Bakersfield, California, 93309, United States",Bristol-Myers Squibb,,,,
Melanoma,NCT00370136,Sentinel Node With Ultrasound Contrast in Melanoma,https://clinicaltrials.gov/study/NCT00370136,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,DRUG: ultrasound contrast,,,,,"Copenhagen univercity hospital, Department of Radiology, section of ultrasound, Copenhagen, 2100, Denmark",,,Michael B Nielsen,,,,
Melanoma,NCT01522664,A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma,https://clinicaltrials.gov/study/NCT01522664,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: DEDN6526A,,,,,"Los Angeles, California, 90025, United States","Sarasota, Florida, 34232, United States","Detroit, Michigan, 48201, United States",Clinical Trials,,,,
Melanoma,NCT01511913,"A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma",https://clinicaltrials.gov/study/NCT01511913,NO,ALL,"ADULT, OLDER_ADULT",,Advanced Cutaneous Melanoma,,,,,,,,,,"Local Institution, Gilbert, Arizona, 85234, United States","Local Institution, Hot Springs, Arkansas, 71913, United States","Local Institution, Encinitas, California, 92024, United States",Bristol-Myers Squibb,,,,
Melanoma,NCT01990248,An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS),https://clinicaltrials.gov/study/NCT01990248,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,,,,,,"LKH Feldkirch; Onkologie, Feldkirch, 6800, Austria","Ordensklinikum Linz Elisabethinen ; Dermatologie, Linz, 4020, Austria","Krankenhaus Hietzing Wien, Wien, 1130, Austria",Clinical Trials,,,,
Melanoma,NCT01898585,An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01898585,NO,ALL,"ADULT, OLDER_ADULT",PHASE4,Malignant Melanoma,,,,,DRUG: Zelboraf,,,,,"National Hospital; Oncotherapy Dept, Bloemfontein, 9301, South Africa","Groote Schuur Hospital ( Uni of Capetown ); Oncology Dept, Cape Town, 7506, South Africa","Cape Town Oncology Trials, Cape Town, 7570, South Africa",Clinical Trials,,,,
Melanoma,NCT01910181,A Study of Vemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01910181,YES,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: Vemurafenib,,,,,"Beijing Cancer Hospital, Beijing, 100142, China","Sun Yet-sen University Cancer Center, Guangzhou, 510060, China",,Clinical Trials,,,,
Melanoma,NCT01744860,Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples,https://clinicaltrials.gov/study/NCT01744860,YES,ALL,"CHILD, ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,,,,,,"Boulogne Billancourt, 92104, France","Colmar, 68024, France","Lille, 59037, France",Clinical Trials,,,,
Melanoma,NCT00145145,Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT00145145,YES,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: MAGE-3.A1 peptide and CpG 7909,,,,,"Cliniques Universitaires Saint-Luc (UCL), Brussels, B-1200, Belgium","Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium",,Nicolas van Baren,Thierry Boon,,,
Melanoma,NCT01164007,A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01164007,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Bevacizumab,DRUG: Dacarbazine,,,,"Istituto Europeo Di Oncologia, Milano, Lombardia, 20141, Italy",,,Clinical Trials,,,,
Melanoma,NCT00949702,A Study of Vemurafenib in Previously Treated Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT00949702,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: vemurafenib,,,,,"UCLA - School of Medicine; Division of Hematology/Oncology, Los Angeles, California, 90095-6984, United States","University of Colorado, Denver, Colorado, 80262, United States","Moffitt Cancer Center, Tampa, Florida, 33612, United States",Clinical Trials,,,,
Melanoma,NCT00052156,Vaccine Therapy for Patients With Stage IV Melanoma,https://clinicaltrials.gov/study/NCT00052156,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Malignant Melanoma,,,,,BIOLOGICAL: CancerVax vaccine (CANVAXIN),,,,,"Arizona Cancer Center, Tucson, Arizona, 85724, United States","Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, 72205, United States","University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States",,,,,
Melanoma,NCT00052130,Vaccine Therapy for Patients With Stage III Melanoma,https://clinicaltrials.gov/study/NCT00052130,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Malignant Melanoma,,,,,BIOLOGICAL: CancerVax vaccine (CANVAXIN),,,,,"Arizona Cancer Center, Tucson, Arizona, 85724, United States","Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, 72205, United States","University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States",,,,,
Melanoma,NCT00039000,Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma,https://clinicaltrials.gov/study/NCT00039000,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Malignant Melanoma,,,,,DRUG: HSPPC-96 or Oncophage,,,,,"Birmingham, Alabama, United States","Scottsdale, Arizona, United States","Berkeley, California, United States",,,,,
Melanoma,NCT01069627,A Study of Avastin (Bevacizumab) in Combination With Fotemustine in Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01069627,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: bevacizumab [Avastin],DRUG: fotemustine,,,,"Firenze, 50100, Italy","Genova, 16132, Italy","Milano, 20133, Italy",Clinical Trials,,,,
Melanoma,NCT01164891,A Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01164891,YES,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: RO5185426,,,,,"ZÃ¼rich, 8091, Switzerland",,,Clinical Trials,,,,
Melanoma,NCT01253564,A Study of RO5185426 in Previously Treated Melanoma Patients With Brain Metastases,https://clinicaltrials.gov/study/NCT01253564,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: RO5185426,,,,,"CHUV; Departement d'Oncologie, Lausanne, 1011, Switzerland","UniversitÃ¤tsspital ZÃ¼rich; Dermatologische Klinik, ZÃ¼rich, 8091, Switzerland",,Clinical Trials,,,,
Melanoma,NCT01107418,A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01107418,YES,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: RO5185426,DRUG: RO5185426,DRUG: RO5185426,DRUG: RO5185426,DRUG: RO5185426,"La Jolla, California, 92093, United States","San Francisco, California, 94115, United States","Stanford, California, 94305, United States",Clinical Trials,,,,
Melanoma,NCT01519323,BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations,https://clinicaltrials.gov/study/NCT01519323,YES,ALL,CHILD,PHASE1,Malignant Melanoma,,,,,DRUG: vemurafenib,,,,,"Los Angeles, California, 90027, United States","Aurora, Colorado, 80045, United States","St. Petersburgh, Florida, 33701, United States",Clinical Trials,,,,
Melanoma,NCT01378975,A Study of Vemurafenib in Metastatic Melanoma Participants With Brain Metastases,https://clinicaltrials.gov/study/NCT01378975,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Vemurafenib,,,,,"Los Angeles, California, 90025, United States","Aurora, Colorado, 80045, United States","Tampa, Florida, 33612-9497, United States",Clinical Trials,,,,
Melanoma,NCT05620290,MRI-Guided Focused Ultrasound Radiosensitization for Patients With Malignant Melanoma and Non Melanoma Skin Cancer,https://clinicaltrials.gov/study/NCT05620290,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Melanoma,,,,,DRUG: Definity,DEVICE: Sonalleve Focused Ultrasound Device,,,,"Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada",,,Dr. Gregory Czarnota,,,,
Melanoma,NCT03493230,Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients With Metastatic Malignant Melanoma Treated With Targeted Therapies or Immunotherapy ( MALT ),https://clinicaltrials.gov/study/NCT03493230,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma Stage IV,Malignant Melanoma Stage III,,,,BIOLOGICAL: quantification of BRAF and NRAS mutation,,,,,,,,Elodie -,,,,
Melanoma,NCT01586195,"Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E",https://clinicaltrials.gov/study/NCT01586195,YES,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Vemurafenib,,,,,"Arizona Cancer Center, Tucson, Arizona, 85724, United States","UCSD Moores Cancer Center, La Jolla, California, 92093, United States","UCLA School of Medicine; Hematology/Oncology, Los Angeles, California, 90095, United States",Clinical Trials,,,,
Melanoma,NCT05628883,"Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma",https://clinicaltrials.gov/study/NCT05628883,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Metastatic Melanoma,Unresectable Melanoma,Acral Melanoma,Mucosal Melanoma,Cutaneous Melanoma,BIOLOGICAL: TBio-4101,DRUG: Cyclophosphamide,DRUG: Fludarabine,DRUG: Interleukin-2,,"Moffitt Cancer Center, Tampa, Florida, 33612, United States",,,Amod Sarnaik,,,,
Melanoma,NCT00826995,Comparison of Video-Based Versus Written Patient Education on Melanoma,https://clinicaltrials.gov/study/NCT00826995,NO,ALL,"ADULT, OLDER_ADULT",,Melanoma,Malignant Melanoma,,,,OTHER: Patient Educational Materials,,,,,"University of California Davis Department of Dermatology, Sacramento, California, 95816, United States",,,April W Armstrong,,,,
Melanoma,NCT00616564,Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma,https://clinicaltrials.gov/study/NCT00616564,NO,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: GM-CSF,,,,,"Jose Lutzky, MD, Miami Beach, Florida, 33140, United States","David Lawson, MD, Atlanta, Georgia, 30322, United States",,Jose Lutzky,,,,
Melanoma,NCT01001299,A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01001299,YES,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: Drug cocktail,DRUG: RO5185426,,,,"UCLA - School of Medicine, Los Angeles, California, 90095, United States","Massachusetts General Hospital;Hematology/ Oncology, Boston, Massachusetts, 02114, United States","Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States",Clinical Trials,,,,
Melanoma,NCT01006980,A Study of Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3),https://clinicaltrials.gov/study/NCT01006980,YES,ALL,"ADULT, OLDER_ADULT",PHASE3,Malignant Melanoma,,,,,DRUG: Vemurafenib,DRUG: Dacarbazine,,,,"Birmingham, Alabama, 35243, United States","Tucson, Arizona, 85724, United States","Los Angeles, California, 90095-1752, United States",Clinical Trials,,,,
Melanoma,NCT01271803,A Study of Vemurafenib and GDC-0973 (Cobimetinib) in Participants With BRAFV600E Mutation-Positive Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01271803,YES,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: Cobimetinib,DRUG: vemurafenib,,,,"UCLA Department of Medicine, Los Angeles, California, 90024, United States","University of California at San Francisco, San Francisco, California, 94115, United States","The Angeles Clinic and Research Institute, Santa Monica Office, Santa Monica, California, 90025, United States",Clinical Trials,,,,
Melanoma,NCT02938299,Neoadjuvant L19IL2/L19TNF- Pivotal Study,https://clinicaltrials.gov/study/NCT02938299,NO,ALL,"ADULT, OLDER_ADULT",PHASE3,Malignant Melanoma,,,,,DRUG: L19IL2 + L19TNF,PROCEDURE: Surgery,,,,"HÃ´pital de la Timone, Marseille, 13 005, France","HÃ´pital Universitaire de Nantes, Nantes, 44 093, France","Institut Gustave Roussy, Villejuif, 94 805, France",Katharina C. KÃ¤hler,Mario Santinami,Piotr Rutkowski,,
Melanoma,NCT05900102,EVALUATING THE CURRENT STANDARD OF CARE FOR PATIENTS DIAGNOSED WITH MALIGNANT MELANOMA OF THE HEAD AND NECK - ACCESS TO STAGING AND SURGICAL TREATMENT,https://clinicaltrials.gov/study/NCT05900102,NO,ALL,"ADULT, OLDER_ADULT",,Melanoma (Skin),Melanoma,,,,,,,,,,,,,,,,
Melanoma,NCT04293289,Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma,https://clinicaltrials.gov/study/NCT04293289,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,Angiosarcoma,,,,"OTHER: CICS-1 (investigational device),SPM-011(investigational drug)",,,,,"National Cancer Center Hospital, Chuo Ku, Tokyo, 104-0045, Japan",,,,,,,
Melanoma,NCT00204607,Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients,https://clinicaltrials.gov/study/NCT00204607,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: mRNA,DRUG: GM-CSF s.c.,,,,"Department of Dermatology, University of TÃ¼bingen, TÃ¼bingen, 72076, Germany",,,Claus Garbe,,,,
Melanoma,NCT02143999,An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma,https://clinicaltrials.gov/study/NCT02143999,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,,,,,,"Policlinico Ospedaliero Ss Annunziata; U.O. Di Clinica Oncologica, Chieti, Abruzzo, 66100, Italy","IRCCS IST. Tumori Fondaz. Pascale; S.C. Oncologia Medica,Melanoma,Immunoterapia E Terapie Innovative, Napoli, Campania, 80131, Italy","Azienda Ospedaliero-Universitaria S.Orsola-Malpighi; UnitÃ Operativa Oncologia Medica, Bologna, Emilia-Romagna, 40138, Italy",Clinical Trials,,,,
Melanoma,NCT02296996,Dabrafenib and Trametinib for BRAF-inhibitor Pretreated Patients,https://clinicaltrials.gov/study/NCT02296996,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Malignant Melanoma,,,,,DRUG: Dabrafenib + Trametinib,,,,,"UZ Brussel, Brussels, 1090, Belgium",,,Neyns Bart,,,,
Melanoma,NCT00204516,Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens,https://clinicaltrials.gov/study/NCT00204516,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: mRNA coding for melanoma associated antigens,DRUG: GM-CSF,,,,"Department of Dermatology, University of Tuebingen, Tuebingen, 72076, Germany",,,Claus Garbe,,,,
Melanoma,NCT01264380,A Study of the Effect of Food on the Pharmacokinetics of Single Dose RO5185426 And the Safety And Efficacy of Continuous Administration in Patients With BRAF V600E Mutation-Positive Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01264380,YES,ALL,"ADULT, OLDER_ADULT",PHASE1,Malignant Melanoma,,,,,DRUG: RO5185426,DRUG: RO5185426,DRUG: RO5185426,,,"La Jolla, California, 92037, United States","Los Angeles, California, 90095-1752, United States","San Francisco, California, 94115-1705, United States",Clinical Trials,,,,
Melanoma,NCT00966173,International Melanoma Algorithm Training Study - IMATS,https://clinicaltrials.gov/study/NCT00966173,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,DEVICE: SciBase III Electrical Impedance Spectrometer,,,,,"Sahlgrenska University Hospital, Dpt. of Dermatology, Gothenburg, 41345, Sweden",,,,,,,
Melanoma,NCT04375527,Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma,https://clinicaltrials.gov/study/NCT04375527,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Clinical Stage III Cutaneous Melanoma AJCC v8,Clinical Stage IV Cutaneous Melanoma AJCC v8,Locally Advanced Cutaneous Melanoma,Metastatic Cutaneous Melanoma,Pathologic Stage III Cutaneous Melanoma AJCC v8,DRUG: Binimetinib,BIOLOGICAL: Nivolumab,OTHER: Questionnaire Administration,,,"University of California at Los Angeles, Los Angeles, California, 90095, United States",,,Roger Lo,,,,
Melanoma,NCT06424626,A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma,https://clinicaltrials.gov/study/NCT06424626,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Melanoma,Mucosal Melanoma,Metastatic Melanoma,,,DRUG: AK104+Axitinib,DRUG: AK112+Axitinib,,,,"Beijing Cancer Hospital, Beijing, 100142, China",,,Jun Guo,,,,
Melanoma,NCT01444560,"miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi",https://clinicaltrials.gov/study/NCT01444560,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Cutaneous Melanoma,Nevi,,,,,,,,,"Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, NRW, 44791, Germany",,,Falk G Bechara,,,,
Melanoma,NCT05645484,The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant Melanoma,https://clinicaltrials.gov/study/NCT05645484,NO,ALL,"ADULT, OLDER_ADULT",,Melanoma,,,,,DRUG: 18F-PFPN,DRUG: 18F-FDG,,,,"China, Hubei Province, Wuhan, Hubei, 430022, China",,,Xiaoli Lan,,,,
Melanoma,NCT04460053,Neurofilament Light Protein in Peripheral Blood Used as a Biomarker for Neurotoxicity After Isolated Limb Perfusion.,https://clinicaltrials.gov/study/NCT04460053,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,PROCEDURE: Neurofilament light protein measurement in Isolated limb perfused patients,,,,,"Sahlgrenska University Hospital, Gothenburg, 413 45, Sweden",,,Roger Olofsson Bagge,,,,
Melanoma,NCT00462423,"Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study",https://clinicaltrials.gov/study/NCT00462423,YES,ALL,"ADULT, OLDER_ADULT",PHASE2,Metastatic Malignant Melanoma,,,,,DRUG: Avastin,DRUG: Abraxane,,,,"Northern California Melanoma Center, San Francisco, California, 94117, United States","The Angeles Clinic and Research Institute, Santa Monica, California, 90404, United States",,Lynn E. Spitler,,,,
Melanoma,NCT01559818,A Long Term Follow up Study for Patients Who Previously Took Part in the Phase I Study IMM-101-001,https://clinicaltrials.gov/study/NCT01559818,YES,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Malignant Melanoma,,,,,BIOLOGICAL: IMM-101,,,,,"St Georges University of London, London, United Kingdom",,,Alberto Fusi,,,,
Melanoma,NCT04364230,Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma),https://clinicaltrials.gov/study/NCT04364230,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Melanoma,Ocular Melanoma,Uveal Melanoma,,,DRUG: 6MHP,DRUG: NeoAg-mBRAF,DRUG: PolyICLC,DRUG: CDX-1140,,"Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, 44195, United States","University of Virginia, Charlottesville, Virginia, 22908, United States",,Craig L. Slingluff,,,,
Melanoma,NCT03325101,Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery,https://clinicaltrials.gov/study/NCT03325101,NO,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,Stage III Cutaneous Melanoma AJCC v7,Stage IIIA Cutaneous Melanoma AJCC v7,Stage IIIB Cutaneous Melanoma AJCC v7,Stage IIIC Cutaneous Melanoma AJCC v7,Stage IV Cutaneous Melanoma AJCC v6 and v7,PROCEDURE: Cryosurgery,BIOLOGICAL: Pembrolizumab,PROCEDURE: Pheresis,BIOLOGICAL: Therapeutic Autologous Dendritic Cells,,"Mayo Clinic, Rochester, Minnesota, 55905, United States",,,Matthew S. Block,,,,
Melanoma,NCT02574533,Pilot Study of Vigilâ„¢ + Pembrolizumab for Advanced Melanoma,https://clinicaltrials.gov/study/NCT02574533,NO,ALL,"ADULT, OLDER_ADULT",PHASE1,Melanoma Recurrent,Malignant Melanoma,Melanoma,,,BIOLOGICAL: Vigil,DRUG: Pembrolizumab,,,,"Texas Oncology P.A., Texas Cancer Center, Abilene, Texas, 79606, United States","Mary Crowley Medical Research Centers, Dallas, Texas, 75230, United States","Cancer Care Northwest, Spokane, Washington, 99202, United States",Luisa Manning,,,,
Melanoma,NCT03409419,PET Imaging of the Immune System Using Analog Probes,https://clinicaltrials.gov/study/NCT03409419,NO,ALL,"ADULT, OLDER_ADULT",,Malignant Melanoma,,,,,DRUG: [18F] CFA,,,,,"University of California, Los Angeles, Los Angeles, California, 90095, United States",,,Antoni Ribas,,,,
Melanoma,NCT04548817,Neurocutaneous Melanocytosis Registry,https://clinicaltrials.gov/study/NCT04548817,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Cutaneous Melanocytic Neoplasm,Large Cutaneous Melanocytic Nevi,Neurocutaneous Melanocytosis,,,,,,,,"Boston Children's Hospital (Data Analysis Only), Boston, Massachusetts, 02115, United States","Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, 10065, United States",,Yasmin Khakoo,,,,
Melanoma,NCT01482260,Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma,https://clinicaltrials.gov/study/NCT01482260,NO,ALL,"CHILD, ADULT, OLDER_ADULT",,Cutaneous Malignant Melanoma,,,,,PROCEDURE: Biopsy,,,,,"Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, NRW, 44791, Germany",,,Falk G Bechara,Peter Altmeyer,,,
Melanoma,NCT03677739,Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families,https://clinicaltrials.gov/study/NCT03677739,NO,ALL,"ADULT, OLDER_ADULT",,Clinical Stage 0 Cutaneous Melanoma AJCC v8,Clinical Stage I Cutaneous Melanoma AJCC v8,Clinical Stage IA Cutaneous Melanoma AJCC v8,Clinical Stage IB Cutaneous Melanoma AJCC v8,Clinical Stage II Cutaneous Melanoma AJCC v8,OTHER: Informational Intervention,OTHER: Informational Intervention,OTHER: Survey Administration,,,"Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08903, United States","MD Anderson Cancer Center, Houston, Texas, 77030, United States",,Sharon Manne,,,,
Melanoma,NCT02501551,"Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy",https://clinicaltrials.gov/study/NCT02501551,NO,ALL,"ADULT, OLDER_ADULT",PHASE2,Melanoma,,,,,DRUG: regorafenib,,,,,"Severance Hospital, Yonsei University Health System, Seoul, 120-752, Korea, Republic of",,,,,,,
